%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/


%% Created for bhaibeka at 2010-11-10 10:32:43 -0500 


%% Saved with string encoding Unicode (UTF-8) 



@article{montojo2010genemania,
	Abstract = {SUMMARY: The GeneMANIA Cytoscape plugin brings fast gene function prediction capabilities to the desktop. GeneMANIA identifies the most related genes to a query gene set using a guilt-by-association approach. The plugin uses over 800 networks from six organisms and each related gene is traceable to the source network used to make the prediction. Users may add their own interaction networks and expression profile data to complement or override the default data. Availability and Implementation: The GeneMANIA Cytoscape plugin is implemented in Java and is freely available at http://www.genemania.org/plugin/. CONTACT: gary.bader@utoronto.ca; quaid.morris@utoronto.ca.},
	Author = {Montojo, J and Zuberi, K and Rodriguez, H and Kazi, F and Wright, G and Donaldson, S L and Morris, Q and Bader, G D},
	Date-Added = {2010-11-10 10:32:30 -0500},
	Date-Modified = {2010-11-10 10:32:43 -0500},
	Doi = {10.1093/bioinformatics/btq562},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Month = {Nov},
	Number = {22},
	Pages = {2927-8},
	Pmc = {PMC2971582},
	Pmid = {20926419},
	Pst = {ppublish},
	Title = {GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop},
	Volume = {26},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/btq562}}

@article{mostafavi2008genemania,
	Abstract = {BACKGROUND: Most successful computational approaches for protein function prediction integrate multiple genomics and proteomics data sources to make inferences about the function of unknown proteins. The most accurate of these algorithms have long running times, making them unsuitable for real-time protein function prediction in large genomes. As a result, the predictions of these algorithms are stored in static databases that can easily become outdated. We propose a new algorithm, GeneMANIA, that is as accurate as the leading methods, while capable of predicting protein function in real-time. RESULTS: We use a fast heuristic algorithm, derived from ridge regression, to integrate multiple functional association networks and predict gene function from a single process-specific network using label propagation. Our algorithm is efficient enough to be deployed on a modern webserver and is as accurate as, or more so than, the leading methods on the MouseFunc I benchmark and a new yeast function prediction benchmark; it is robust to redundant and irrelevant data and requires, on average, less than ten seconds of computation time on tasks from these benchmarks. CONCLUSION: GeneMANIA is fast enough to predict gene function on-the-fly while achieving state-of-the-art accuracy. A prototype version of a GeneMANIA-based webserver is available at http://morrislab.med.utoronto.ca/prototype.},
	Author = {Mostafavi, Sara and Ray, Debajyoti and Warde-Farley, David and Grouios, Chris and Morris, Quaid},
	Date-Added = {2010-11-10 10:30:14 -0500},
	Date-Modified = {2010-11-10 10:30:29 -0500},
	Doi = {10.1186/gb-2008-9-s1-s4},
	Journal = {Genome Biol},
	Journal-Full = {Genome biology},
	Mesh = {Algorithms; Animals; Computer Communication Networks; Genomics; Mice; Proteins; Proteomics; Saccharomyces cerevisiae; Time Factors},
	Pages = {S4},
	Pmc = {PMC2447538},
	Pmid = {18613948},
	Pst = {ppublish},
	Title = {GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function},
	Volume = {9 Suppl 1},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/gb-2008-9-s1-s4}}

@article{korkola2007identification,
	Abstract = {BACKGROUND: Breast cancer is a heterogeneous disease, presenting with a wide range of histologic, clinical, and genetic features. Microarray technology has shown promise in predicting outcome in these patients. METHODS: We profiled 162 breast tumors using expression microarrays to stratify tumors based on gene expression. A subset of 55 tumors with extensive follow-up was used to identify gene sets that predicted outcome. The predictive gene set was further tested in previously published data sets. RESULTS: We used different statistical methods to identify three gene sets associated with disease free survival. A fourth gene set, consisting of 21 genes in common to all three sets, also had the ability to predict patient outcome. To validate the predictive utility of this derived gene set, it was tested in two published data sets from other groups. This gene set resulted in significant separation of patients on the basis of survival in these data sets, correctly predicting outcome in 62-65\% of patients. By comparing outcome prediction within subgroups based on ER status, grade, and nodal status, we found that our gene set was most effective in predicting outcome in ER positive and node negative tumors. CONCLUSION: This robust gene selection with extensive validation has identified a predictive gene set that may have clinical utility for outcome prediction in breast cancer patients.},
	Author = {Korkola, James E and Blaveri, Ekaterina and DeVries, Sandy and Moore, 2nd, Dan H and Hwang, E Shelley and Chen, Yunn-Yi and Estep, Anne L H and Chew, Karen L and Jensen, Ronald H and Waldman, Frederic M},
	Date-Added = {2010-10-18 07:46:40 -0400},
	Date-Modified = {2010-10-18 07:46:55 -0400},
	Doi = {10.1186/1471-2407-7-61},
	Journal = {BMC Cancer},
	Journal-Full = {BMC cancer},
	Mesh = {Breast Neoplasms; Female; Gene Expression Profiling; Humans; Oligonucleotide Array Sequence Analysis; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Survival Analysis; Treatment Outcome},
	Pages = {61},
	Pmc = {PMC1855059},
	Pmid = {17428335},
	Pst = {epublish},
	Title = {Identification of a robust gene signature that predicts breast cancer outcome in independent data sets},
	Volume = {7},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2407-7-61}}

@article{korkola2003differentiation,
	Abstract = {Invasive lobular and ductal breast tumors have distinct histologies and clinical presentation. Other than altered expression of E-cadherin, little is known about the underlying biology that distinguishes the tumor subtypes. We used cDNA microarrays to identify genes differentially expressed between lobular and ductal tumors. Unsupervised clustering of tumors failed to distinguish between the two subtypes. Prediction analysis for microarrays (PAM) was able to predict tumor type with an accuracy of 93.7\%. Genes that were significantly differentially expressed between the two groups were identified by MaxT permutation analysis using t tests (20 cDNA clones and 10 unique genes), significance analysis for microarrays (33 cDNA clones and 15 genes, at an estimated false discovery rate of 2\%), and PAM (31 cDNAs and 15 genes). There were 8 genes identified by all three of these related methods (E-cadherin, survivin, cathepsin B, TPI1, SPRY1, SCYA14, TFAP2B, and thrombospondin 4), and an additional 3 that were identified by significance analysis for microarrays and PAM (osteopontin, HLA-G, and CHC1). To validate the differential expression of these genes, 7 of them were tested by real-time quantitative PCR, which verified that they were differentially expressed in lobular versus ductal tumors. In conclusion, specific changes in gene expression distinguish lobular from ductal breast carcinomas. These genes may be important in understanding the basis of phenotypic differences among breast cancers.},
	Author = {Korkola, James E and DeVries, Sandy and Fridlyand, Jane and Hwang, E Shelley and Estep, Anne L H and Chen, Yunn-Yi and Chew, Karen L and Dairkee, Shanaz H and Jensen, Ronald M and Waldman, Frederic M},
	Date-Added = {2010-10-15 08:25:47 -0400},
	Date-Modified = {2010-10-15 08:25:58 -0400},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Gene Expression Profiling; Humans; Multigene Family; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction},
	Month = {Nov},
	Number = {21},
	Pages = {7167-75},
	Pmid = {14612510},
	Pst = {ppublish},
	Title = {Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis},
	Volume = {63},
	Year = {2003}}

@url{bittner2005expo,
	Author = {Michael Bittner},
	Date-Added = {2010-10-14 13:27:44 -0400},
	Date-Modified = {2010-10-14 13:29:16 -0400},
	Title = {Expression Project for Oncology (expO)},
	Urldate = {2005},
	Urll = {https://expo.intgen.org/geo/},
	Bdsk-Url-1 = {https://expo.intgen.org/geo/}}

@article{miller2007changes,
	Abstract = {OBJECTIVE: The aim of the study was to identify changes in tumour expression profiling associated with short-term therapy of breast cancer patients with letrozole. EXPERIMENTAL DESIGN: Microarray analysis was performed on RNA extracted from paired tumour core biopsies taken before and after 14 days of treatment with letrozole (2.5 mg/daily) in 58 patients. Changes in expression profile were identified by three different approaches on the basis of frequency of changes, magnitude of changes and significance analysis of microarray. RESULTS: No single gene was consistently changed by therapy in all cases. Fifty-two genes, however, were downregulated and 36 upregulated in at least 45 of the 58 cases. In terms of quantitative change, 46 genes showed at least a median 1.5-fold change in expression. Significance analysis of microarray identified 62 genes that were significantly changed by therapy (P<0.0001, 56 downregulated and six upregulated). All three approaches showed that greater numbers of genes were downregulated rather than upregulated. Merging data produced a total of 143 genes, which were subject to gene ontology and cluster analysis. The ontology of the 91 downregulated genes showed that they were functionally associated with cell cycle progression, particularly mitosis. In contrast, upregulated genes were associated with organ development, connective tissue extracellular matrix regulation and inflammatory response. Cluster analysis segregated the patients into four groups differing in patterns of gene expression. CONCLUSION: Genes have been identified which either change markedly or consistently in breast cancer after 14 days treatment with letrozole. These are new important data in understanding letrozole's molecular mechanism of action in breast cancers.},
	Author = {Miller, William R and Larionov, Alexey A and Renshaw, Lorna and Anderson, Thomas J and White, Sharon and Murray, Juliette and Murray, Emma and Hampton, Garret and Walker, John R and Ho, Steven and Krause, Andreas and Evans, Dean B and Dixon, John Michael},
	Date-Added = {2010-10-14 08:56:11 -0400},
	Date-Modified = {2010-10-14 08:56:22 -0400},
	Doi = {10.1097/FPC.0b013e32820b853a},
	Journal = {Pharmacogenet Genomics},
	Journal-Full = {Pharmacogenetics and genomics},
	Mesh = {Aromatase Inhibitors; Breast Neoplasms; Cluster Analysis; Databases, Nucleic Acid; Female; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Nitriles; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Transcription, Genetic; Triazoles},
	Month = {Oct},
	Number = {10},
	Pages = {813-26},
	Pmid = {17885619},
	Pst = {ppublish},
	Title = {Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole},
	Volume = {17},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1097/FPC.0b013e32820b853a}}

@article{popovici2010effect,
	Abstract = {INTRODUCTION: As part of the MicroArray Quality Control (MAQC)-II project, this analysis examines how the choice of univariate feature-selection methods and classification algorithms may influence the performance of genomic predictors under varying degrees of prediction difficulty represented by three clinically relevant endpoints. METHODS: We used gene-expression data from 230 breast cancers (grouped into training and independent validation sets), and we examined 40 predictors (five univariate feature-selection methods combined with eight different classifiers) for each of the three endpoints. Their classification performance was estimated on the training set by using two different resampling methods and compared with the accuracy observed in the independent validation set. RESULTS: A ranking of the three classification problems was obtained, and the performance of 120 models was estimated and assessed on an independent validation set. The bootstrapping estimates were closer to the validation performance than were the cross-validation estimates. The required sample size for each endpoint was estimated, and both gene-level and pathway-level analyses were performed on the obtained models. CONCLUSIONS: We showed that genomic predictor accuracy is determined largely by an interplay between sample size and classification difficulty. Variations on univariate feature-selection methods and choice of classification algorithm have only a modest impact on predictor performance, and several statistically equally good predictors can be developed for any given classification problem.},
	Author = {Popovici, Vlad and Chen, Weijie and Gallas, Brandon G and Hatzis, Christos and Shi, Weiwei and Samuelson, Frank W and Nikolsky, Yuri and Tsyganova, Marina and Ishkin, Alex and Nikolskaya, Tatiana and Hess, Kenneth R and Valero, Vicente and Booser, Daniel and Delorenzi, Mauro and Hortobagyi, Gabriel N and Shi, Leming and Symmans, W Fraser and Pusztai, Lajos},
	Date-Added = {2010-10-13 19:59:34 -0400},
	Date-Modified = {2010-10-13 20:01:31 -0400},
	Doi = {10.1186/bcr2468},
	Journal = {Breast Cancer Res},
	Journal-Full = {Breast cancer research : BCR},
	Mesh = {Algorithms; Area Under Curve; Breast Neoplasms; Female; Gene Expression Profiling; Humans; Receptors, Estrogen; Sample Size},
	Number = {1},
	Pages = {R5},
	Pmc = {PMC2880423},
	Pmid = {20064235},
	Pst = {ppublish},
	Title = {Effect of training-sample size and classification difficulty on the accuracy of genomic predictors},
	Volume = {12},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/bcr2468}}

@article{reyal2008comprehensive,
	Abstract = {INTRODUCTION: Several gene expression signatures have been proposed and demonstrated to be predictive of outcome in breast cancer. In the present article we address the following issues: Do these signatures perform similarly? Are there (common) molecular processes reported by these signatures? Can better prognostic predictors be constructed based on these identified molecular processes? METHODS: We performed a comprehensive analysis of the performance of nine gene expression signatures on seven different breast cancer datasets. To better characterize the functional processes associated with these signatures, we enlarged each signature by including all probes with a significant correlation to at least one of the genes in the original signature. The enrichment of functional groups was assessed using four ontology databases. RESULTS: The classification performance of the nine gene expression signatures is very similar in terms of assigning a sample to either a poor outcome group or a good outcome group. Nevertheless the concordance in classification at the sample level is low, with only 50\% of the breast cancer samples classified in the same outcome group by all classifiers. The predictive accuracy decreases with the number of poor outcome assignments given to a sample. The best classification performance was obtained for the group of patients with only good outcome assignments. Enrichment analysis of the enlarged signatures revealed 11 functional modules with prognostic ability. The combination of the RNA-splicing and immune modules resulted in a classifier with high prognostic performance on an independent validation set. CONCLUSIONS: The study revealed that the nine signatures perform similarly but exhibit a large degree of discordance in prognostic group assignment. Functional analyses indicate that proliferation is a common cellular process, but that other functional categories are also enriched and show independent prognostic ability. We provide new evidence of the potentially promising prognostic impact of immunity and RNA-splicing processes in breast cancer.},
	Author = {Reyal, Fabien and van Vliet, Martin H and Armstrong, Nicola J and Horlings, Hugo M and de Visser, Karin E and Kok, Marlen and Teschendorff, Andrew E and Mook, Stella and van 't Veer, Laura and Caldas, Carlos and Salmon, Remy J and van de Vijver, Marc J and Wessels, Lodewyk F A},
	Date-Added = {2010-08-24 11:18:29 -0400},
	Date-Modified = {2010-08-24 11:18:38 -0400},
	Doi = {10.1186/bcr2192},
	Journal = {Breast Cancer Res},
	Journal-Full = {Breast cancer research : BCR},
	Mesh = {Breast Neoplasms; Cell Proliferation; Computational Biology; Databases, Genetic; Female; Gene Expression Profiling; Humans; Immune System Processes; Prognosis; RNA Splicing; Survival Rate},
	Number = {6},
	Pages = {R93},
	Pmc = {PMC2656909},
	Pmid = {19014521},
	Pst = {ppublish},
	Title = {A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer},
	Volume = {10},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/bcr2192}}

@article{heidorn2007biological,
	Abstract = {Data management and integration are complicated and ongoing problems that will require commitment of resources and expertise from the various biological science communities. Primary components of successful cross-scale integration are smooth information management and migration from one context to another. We call for a broadening of the definition of bioinformatics and bioinformatics training to span biological disciplines and biological scales. Training programs are needed that educate a new kind of informatics professional, Biological Information Specialists, to work in collaboration with various discipline-specific research personnel. Biological Information Specialists are an extension of the informationist movement that began within library and information science (LIS) over 30 years ago as a professional position to fill a gap in clinical medicine. These professionals will help advance science by improving access to scientific information and by freeing scientists who are not interested in data management to concentrate on their science.},
	Author = {Heidorn, P Bryan and Palmer, Carole L and Wright, Dan},
	Date-Added = {2010-08-24 11:00:48 -0400},
	Date-Modified = {2010-08-24 11:01:04 -0400},
	Doi = {10.1186/1747-5333-2-1},
	Journal = {J Biomed Discov Collab},
	Journal-Full = {Journal of biomedical discovery and collaboration},
	Pages = {1},
	Pmc = {PMC1802079},
	Pmid = {17295920},
	Pst = {epublish},
	Title = {Biological information specialists for biological informatics},
	Volume = {2},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1747-5333-2-1}}

@article{kanehisa2000kegg,
	Abstract = {KEGG (Kyoto Encyclopedia of Genes and Genomes) is a knowledge base for systematic analysis of gene functions, linking genomic information with higher order functional information. The genomic information is stored in the GENES database, which is a collection of gene catalogs for all the completely sequenced genomes and some partial genomes with up-to-date annotation of gene functions. The higher order functional information is stored in the PATHWAY database, which contains graphical representations of cellular processes, such as metabolism, membrane transport, signal transduction and cell cycle. The PATHWAY database is supplemented by a set of ortholog group tables for the information about conserved subpathways (pathway motifs), which are often encoded by positionally coupled genes on the chromosome and which are especially useful in predicting gene functions. A third database in KEGG is LIGAND for the information about chemical compounds, enzyme molecules and enzymatic reactions. KEGG provides Java graphics tools for browsing genome maps, comparing two genome maps and manipulating expression maps, as well as computational tools for sequence comparison, graph comparison and path computation. The KEGG databases are daily updated and made freely available (http://www. genome.ad.jp/kegg/).},
	Author = {Kanehisa, M and Goto, S},
	Date-Added = {2010-08-24 10:56:37 -0400},
	Date-Modified = {2010-08-24 10:56:49 -0400},
	Journal = {Nucleic Acids Res},
	Journal-Full = {Nucleic acids research},
	Mesh = {Animals; Databases, Factual; Gene Expression; Genome; Humans; Information Storage and Retrieval; Japan; Proteins},
	Month = {Jan},
	Number = {1},
	Pages = {27-30},
	Pmc = {PMC102409},
	Pmid = {10592173},
	Pst = {ppublish},
	Title = {KEGG: kyoto encyclopedia of genes and genomes},
	Volume = {28},
	Year = {2000}}

@article{ma2010detection,
	Abstract = {BACKGROUND: Prognosis is of critical interest in breast cancer research. Biomedical studies suggest that genomic measurements may have independent predictive power for prognosis. Gene profiling studies have been conducted to search for predictive genomic measurements. Genes have the inherent pathway structure, where pathways are composed of multiple genes with coordinated functions. The goal of this study is to identify gene pathways with predictive power for breast cancer prognosis. Since our goal is fundamentally different from that of existing studies, a new pathway analysis method is proposed. RESULTS: The new method advances beyond existing alternatives along the following aspects. First, it can assess the predictive power of gene pathways, whereas existing methods tend to focus on model fitting accuracy only. Second, it can account for the joint effects of multiple genes in a pathway, whereas existing methods tend to focus on the marginal effects of genes. Third, it can accommodate multiple heterogeneous datasets, whereas existing methods analyze a single dataset only. We analyze four breast cancer prognosis studies and identify 97 pathways with significant predictive power for prognosis. Important pathways missed by alternative methods are identified. CONCLUSIONS: The proposed method provides a useful alternative to existing pathway analysis methods. Identified pathways can provide further insights into breast cancer prognosis.},
	Author = {Ma, Shuangge and Kosorok, Michael R},
	Date-Added = {2010-08-24 10:11:12 -0400},
	Date-Modified = {2010-08-24 10:11:25 -0400},
	Doi = {10.1186/1471-2105-11-1},
	Journal = {BMC Bioinformatics},
	Journal-Full = {BMC bioinformatics},
	Mesh = {Breast Neoplasms; Computational Biology; Female; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Prognosis; Signal Transduction; Tumor Markers, Biological},
	Pages = {1},
	Pmc = {PMC2837025},
	Pmid = {20043860},
	Pst = {epublish},
	Title = {Detection of gene pathways with predictive power for breast cancer prognosis},
	Volume = {11},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2105-11-1}}

@book{pearl2000causality,
	Author = {Judea Pearl},
	Date-Added = {2010-07-21 15:26:02 -0400},
	Date-Modified = {2010-07-21 15:27:35 -0400},
	Publisher = {Cambridge University Pres},
	Title = {Causality: Models, Reasoning, and Inference},
	Url = {http://www.amazon.com/Causality-Reasoning-Inference-Judea-Pearl/dp/0521773628},
	Year = {2000},
	Bdsk-Url-1 = {http://www.amazon.com/Causality-Reasoning-Inference-Judea-Pearl/dp/0521773628}}

@article{hsu2010immune,
	Abstract = {ABSTRACT The host immune response can impact cancer growth, prognosis, and response to therapy. In colorectal cancer, the presence of cells involved with T-cell-mediated adaptive immunity predicts survival better than the current staging method. We used the expression of genes recently associated with host immune responses (T(H1)-mediated adaptive immunity, inflammation, and immune suppression) to perform hierarchical clustering of multiple large cohorts of cancer specimens to determine if immune-related gene expression resulted in clinical significant groupings of tumors. Microarray data from prostate cancer (n = 79), breast cancer (n = 132), lung cancer (n = 84), glioblastoma multiforme (n = 120), and lymphoma (n = 127) were analyzed. Among adenocarcinomas, the T(H1)-mediated adaptive immunity genes were consistently associated with better prognosis, while genes associated with inflammation and immune suppression were variably associated with outcome. Specifically, increased expression of the T(H1)-mediated adaptive immunity genes was associated with good prognosis in breast cancer patients under 45 years of age (p = .04, hazard ratio [HR] = 0.42) and in prostate cancer patients (p = .03, HR = 0.36) but not in lung cancer patients (p = 0.45, HR = 1.37). In lymphoma, patients with increased expression of inflammation and immune suppression genes had better prognosis than those expressing the T(H1)-mediated adaptive immunity genes (p = .01, HR = 0.43) and in glioblastoma multiforme, the expression of inflammation genes conferred improved prognosis than those expressing immune suppression genes (p = 0.05, HR = 0.62). In aggregate, the gene expression signatures implicating specific components of the immune response hold prognostic import across solid tumors.},
	Author = {Hsu, David S and Kim, Mickey K and Balakumaran, Bala S and Acharya, Chaitanya R and Anders, Carey K and Clay, Tim and Lyerly, H Kim and Drake, Charles G and Morse, Michael A and Febbo, Phillip G},
	Date-Added = {2010-07-21 10:18:21 -0400},
	Date-Modified = {2010-07-21 10:18:41 -0400},
	Doi = {10.3109/07357900903095755},
	Journal = {Cancer Invest},
	Journal-Full = {Cancer investigation},
	Month = {Aug},
	Number = {7},
	Pages = {765-773},
	Pmid = {20569070},
	Pst = {ppublish},
	Title = {Immune Signatures Predict Prognosis in Localized Cancer},
	Volume = {28},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.3109/07357900903095755}}

@article{wang2010bmi1,
	Abstract = {Knockout and knockdown studies have shown that the polycomb gene Bmi-1 is important for mouse postnatal and prenatal neural stem cells (NSCs) self-renewal and proliferation. Different downstream targets of Bmi-1 gene have been identified in mouse, including Ink4a/Arf locus in adult NSCs and p21 gene in embryonic NSCs. However, little is known regarding the role of Bmi-1 in human NSCs. Here, using lentiviral-delivered shRNA knockdown and over-expression techniques, we examined whether Bmi-1 is required for the self-renewal and proliferation of human fetal NSCs (hfNSCs) in vitro. Our results showed that shRNA-mediated Bmi-1 reduction profoundly impaired hfNSCs self-renewal and proliferation, whereas Bmi-1 over-expression promoted hfNSCs self-renewal capacity. Interestingly, different from mouse embryonic NSCs, Bmi-1 repressed Ink4a/Arf locus instead of p21 gene in human fetal NSCs. Moreover, Bmi-1 knockdown induced obvious senescence phenotype in hfNSCs. Further studies on the Bmi-1 pathways would help to understand the molecular mechanisms underlying hfNSCs self-renewal and human brain development.},
	Author = {Wang, Yang and Guan, Yunqian and Wang, Fang and Huang, Aihua and Wang, Shuyan and Zhang, Y Alex},
	Date-Added = {2010-07-21 10:14:57 -0400},
	Date-Modified = {2010-07-21 10:15:11 -0400},
	Doi = {10.1016/j.neulet.2010.04.006},
	Journal = {Neurosci Lett},
	Journal-Full = {Neuroscience letters},
	Month = {May},
	Number = {2},
	Pages = {74-8},
	Pmid = {20385206},
	Pst = {ppublish},
	Title = {Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro},
	Volume = {476},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neulet.2010.04.006}}

@article{lowell2006notch,
	Abstract = {A central challenge in embryonic stem (ES) cell biology is to understand how to impose direction on primary lineage commitment. In basal culture conditions, the majority of ES cells convert asynchronously into neural cells. However, many cells resist differentiation and others adopt nonneural fates. Mosaic activation of the neural reporter Sox-green fluorescent protein suggests regulation by cell-cell interactions. We detected expression of Notch receptors and ligands in mouse ES cells and investigated the role of this pathway. Genetic manipulation to activate Notch constitutively does not alter the stem cell phenotype. However, upon withdrawal of self-renewal stimuli, differentiation is directed rapidly and exclusively into the neural lineage. Conversely, pharmacological or genetic interference with Notch signalling suppresses the neural fate choice. Notch promotion of neural commitment requires parallel signalling through the fibroblast growth factor receptor. Stromal cells expressing Notch ligand stimulate neural specification of human ES cells, indicating that this is a conserved pathway in pluripotent stem cells. These findings define an unexpected and decisive role for Notch in ES cell fate determination. Limiting activation of endogenous Notch results in heterogeneous lineage commitment. Manipulation of Notch signalling is therefore likely to be a key factor in taking command of ES cell lineage choice.},
	Author = {Lowell, Sally and Benchoua, Alexandra and Heavey, Barry and Smith, Austin G},
	Date-Added = {2010-07-21 10:13:14 -0400},
	Date-Modified = {2010-07-21 10:13:26 -0400},
	Doi = {10.1371/journal.pbio.0040121},
	Journal = {PLoS Biol},
	Journal-Full = {PLoS biology},
	Mesh = {Animals; Cell Differentiation; Cell Lineage; Cells, Cultured; Embryonic Stem Cells; Gene Expression Regulation; Humans; Mice; Neurons; Phenotype; Pluripotent Stem Cells; Receptors, Notch; Signal Transduction},
	Month = {May},
	Number = {5},
	Pages = {e121},
	Pmc = {PMC1431581},
	Pmid = {16594731},
	Pst = {ppublish},
	Title = {Notch promotes neural lineage entry by pluripotent embryonic stem cells},
	Volume = {4},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pbio.0040121}}

@article{liu2005mammary,
	Abstract = {The mammary gland epithelial components are thought to arise from stem cells that undergo both self-renewal and differentiation. Self-renewal has been shown to be regulated by the Hedgehog, Notch, and Wnt pathways and the transcription factor B lymphoma Mo-MLV insertion region 1 (Bmi-1). We review data about the existence of stem cells in the mammary gland and the pathways regulating the self-renewal of these cells. We present evidence that deregulation of the self-renewal in stem cells/progenitors might be a key event in mammary carcinogenesis. If 'tumor stem cells' are inherently resistant to current therapies, targeting stem cell self-renewal pathways might provide a novel approach for breast cancer treatment.},
	Author = {Liu, Suling and Dontu, Gabriela and Wicha, Max S},
	Date-Added = {2010-07-21 10:10:04 -0400},
	Date-Modified = {2010-07-21 10:10:17 -0400},
	Doi = {10.1186/bcr1021},
	Journal = {Breast Cancer Res},
	Journal-Full = {Breast cancer research : BCR},
	Mesh = {Breast Neoplasms; Cell Transformation, Neoplastic; Female; Humans; Mammary Glands, Human; Receptors, Notch; Signal Transduction; Stem Cells; Trans-Activators; Transcription Factors; Wnt Proteins},
	Number = {3},
	Pages = {86-95},
	Pmc = {PMC1143566},
	Pmid = {15987436},
	Pst = {ppublish},
	Title = {Mammary stem cells, self-renewal pathways, and carcinogenesis},
	Volume = {7},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/bcr1021}}

@article{jiang2008hedgehog,
	Abstract = {The Hedgehog (Hh) family of secreted proteins governs a wide variety of processes during embryonic development and adult tissue homeostasis. Here we review the current understanding of the molecular and cellular basis of Hh morphogen gradient formation and signal transduction, and the multifaceted roles of Hh signaling in development and tumorigenesis. We discuss how the Hh pathway has diverged during evolution and how it integrates with other signaling pathways to control cell growth and patterning.},
	Author = {Jiang, Jin and Hui, Chi-Chung},
	Date-Added = {2010-07-21 10:09:04 -0400},
	Date-Modified = {2010-07-21 10:09:19 -0400},
	Doi = {10.1016/j.devcel.2008.11.010},
	Journal = {Dev Cell},
	Journal-Full = {Developmental cell},
	Mesh = {Animals; Cell Differentiation; Cell Proliferation; Drosophila; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Models, Biological; Neoplasms; Neurons; Signal Transduction; Stem Cells},
	Month = {Dec},
	Number = {6},
	Pages = {801-12},
	Pmid = {19081070},
	Pst = {ppublish},
	Title = {Hedgehog signaling in development and cancer},
	Volume = {15},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.devcel.2008.11.010}}

@article{zhou2005wnt,
	Abstract = {The epithelial-mesenchymal transition have begun to attracted many attentions as a potential mechanism for metastasis. The phenotypic changes of increased motility and invasiveness of cancer cells are reminiscent of epithelial-mesenchymal transition (EMT) that associates with the downregulation of E-cadherin. Snail, zinc finger transcription factor, triggers this process by repressing E-cadherin expression. Recently Snail was found to be dually regulated GSK-3beta through protein stability and cellular localization. The involvement of GSK-3beta and beta-Trcp in the regulation of Snail is particular interesting, because these two molecules are also known to involve in the regulation of Wnt and hedgehog pathways that are known to control cell fate and morphogenesis during development and tumorigenesis. Here, we briefly compare these pathways and propose the possibility of cross-talk among these pathways in the regulation of cell adhesion, cell fate, and migration during metastasis.},
	Author = {Zhou, Binhua P and Hung, Mien-Chie},
	Date-Added = {2010-07-21 10:05:44 -0400},
	Date-Modified = {2010-07-21 10:06:00 -0400},
	Journal = {Cell Cycle},
	Journal-Full = {Cell cycle (Georgetown, Tex.)},
	Mesh = {Glycogen Synthase Kinase 3; Hedgehog Proteins; Humans; Neoplasm Metastasis; Signal Transduction; Trans-Activators; Transcription Factors; Wnt Proteins; beta-Transducin Repeat-Containing Proteins},
	Month = {Jun},
	Number = {6},
	Pages = {772-6},
	Pmid = {15917668},
	Pst = {ppublish},
	Title = {Wnt, hedgehog and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis},
	Volume = {4},
	Year = {2005}}

@article{dievart1999involvement,
	Abstract = {The MMTV/neu transgenic (Tg) mice spontaneously develop mammary tumors stochastically after a long latent period, suggesting that the c-neu/erbB2 oncogene is not sufficient for tumor formation. To identify putative collaborator(s) of the c-neu/erbB2, we used the provirus insertional mutagenesis approach with mammary tumors arising in MMTV/neu Tg mice infected with the mouse mammary tumor virus (MMTV). The Notch1 gene was identified as a novel target for MMTV provirus insertional activation. In Notch1-rearranged tumors, the Notch1 gene was interrupted by the MMTV provirus insertion upstream of the exons coding for the TM domain. These insertions led to overexpression of novel 5' truncated approximately 7 kb RNA coding for 280 kDa mutant protein harboring only the Notch1 ectodomain, N(EC)mut. These may be involved in tumor formation. Another consequence of these insertions was the expression of truncated 3' Notch1 transcripts (3.5 - 4.5 kb) and proteins (86 - 110 kDa) deleted of most of the extracellular sequences (Notch1intra). We found that 3' truncated Notch1intra can transform HC11 mouse mammary epithelial cells in vitro. Deletion analysis revealed that the ankyrin-repeats and the domain 1 (aa 1751 - 1821) are required, while a signal peptide, the two conserved cysteines (C1652 and C1685) and the OPA and PEST sequences are dispensable for transformation. These results indicate that the N-terminally truncated Notch1intra protein behaves as an oncogene in this system.},
	Author = {Di{\'e}vart, A and Beaulieu, N and Jolicoeur, P},
	Date-Added = {2010-07-21 10:04:55 -0400},
	Date-Modified = {2010-07-21 10:05:07 -0400},
	Doi = {10.1038/sj.onc.1202991},
	Journal = {Oncogene},
	Journal-Full = {Oncogene},
	Mesh = {Animals; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Cells, Cultured; Cytoplasm; Epithelium; Exons; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Membrane Proteins; Mice; Mice, Inbred C3H; Mice, Nude; Mice, Transgenic; Mutagenesis, Insertional; Proviruses; Receptor, Notch1; Receptor, erbB-2; Receptors, Cell Surface; Repetitive Sequences, Amino Acid; Transcription Factors},
	Month = {Oct},
	Number = {44},
	Pages = {5973-81},
	Pmid = {10557086},
	Pst = {ppublish},
	Title = {Involvement of Notch1 in the development of mouse mammary tumors},
	Volume = {18},
	Year = {1999},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.onc.1202991}}

@article{dontu2004role,
	Abstract = {INTRODUCTION: Notch signaling has been implicated in the regulation of cell-fate decisions such as self-renewal of adult stem cells and differentiation of progenitor cells along a particular lineage. Moreover, depending on the cellular and developmental context, the Notch pathway acts as a regulator of cell survival and cell proliferation. Abnormal expression of Notch receptors has been found in different types of epithelial metaplastic lesions and neoplastic lesions, suggesting that Notch may act as a proto-oncogene. The vertebrate Notch1 and Notch4 homologs are involved in normal development of the mammary gland, and mutated forms of these genes are associated with development of mouse mammary tumors. METHODS: In order to determine the role of Notch signaling in mammary cell-fate determination, we have utilized a newly described in vitro system in which mammary stem/progenitor cells can be cultured in suspension as nonadherent 'mammospheres'. Notch signaling was activated using exogenous ligands, or was inhibited using previously characterized Notch signaling antagonists. RESULTS: Utilizing this system, we demonstrate that Notch signaling can act on mammary stem cells to promote self-renewal and on early progenitor cells to promote their proliferation, as demonstrated by a 10-fold increase in secondary mammosphere formation upon addition of a Notch-activating DSL peptide. In addition to acting on stem cells, Notch signaling is also able to act on multipotent progenitor cells, facilitating myoepithelial lineage-specific commitment and proliferation. Stimulation of this pathway also promotes branching morphogenesis in three-dimensional Matrigel cultures. These effects are completely inhibited by a Notch4 blocking antibody or a gamma secretase inhibitor that blocks Notch processing. In contrast to the effects of Notch signaling on mammary stem/progenitor cells, modulation of this pathway has no discernable effect on fully committed, differentiated, mammary epithelial cells. CONCLUSION: These studies suggest that Notch signaling plays a critical role in normal human mammary development by acting on both stem cells and progenitor cells, affecting self-renewal and lineage-specific differentiation. Based on these findings we propose that abnormal Notch signaling may contribute to mammary carcinogenesis by deregulating the self-renewal of normal mammary stem cells.},
	Author = {Dontu, Gabriela and Jackson, Kyle W and McNicholas, Erin and Kawamura, Mari J and Abdallah, Wissam M and Wicha, Max S},
	Date-Added = {2010-07-21 10:04:10 -0400},
	Date-Modified = {2010-07-21 10:04:22 -0400},
	Doi = {10.1186/bcr920},
	Journal = {Breast Cancer Res},
	Journal-Full = {Breast cancer research : BCR},
	Mesh = {Cell Differentiation; Cells, Cultured; Epithelial Cells; Female; Humans; Mammary Glands, Human; Proto-Oncogene Proteins; Receptor, Notch1; Receptors, Cell Surface; Receptors, Notch; Signal Transduction; Stem Cells; Transcription Factors},
	Number = {6},
	Pages = {R605-15},
	Pmc = {PMC1064073},
	Pmid = {15535842},
	Pst = {ppublish},
	Title = {Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells},
	Volume = {6},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/bcr920}}

@article{haupt1993bmi,
	Abstract = {The bmi-1 gene was discovered as a frequent target of Moloney virus insertion in virally accelerated B-lymphoid tumors of E mu-myc transgenic mice and hence is thought to collaborate with the myc gene in lymphomagenesis, but its oncogenic potential has not previously been tested directly. To determine whether bmi-1 overexpression can contribute to hematopoietic neoplasia in vivo, strains of transgenic mice were generated in which bmi-1 expression was directed to the lymphoid compartment by a coupled immunoglobulin heavy chain enhancer (E mu). Although the E mu-bmi-1 transgene was expressed in both B and T cells, lymphoid development was not perturbed. Nevertheless, 14\% of the mice in the strain with highest expression have developed lymphoma. Unexpectedly, most tumors were of the T-cell lineage, although one case of B lymphoma was observed. Furthermore, cross breeding E mu-bmi-1 and E mu-myc mice established that the bmi-1 transgene markedly accelerated the onset of pre-B and B lymphomas. These results demonstrate directly that bmi-1 can contribute to lymphomagenesis in the T and B cell lineages and collaborate with the myc gene in tumor development.},
	Author = {Haupt, Y and Bath, M L and Harris, A W and Adams, J M},
	Date-Added = {2010-07-21 10:02:57 -0400},
	Date-Modified = {2010-07-21 10:03:08 -0400},
	Journal = {Oncogene},
	Journal-Full = {Oncogene},
	Mesh = {Animals; Genes, myc; Lymphoma, B-Cell; Lymphoma, T-Cell; Mice; Mice, Transgenic; Nuclear Proteins; Proto-Oncogene Proteins; Repressor Proteins; Zinc Fingers},
	Month = {Nov},
	Number = {11},
	Pages = {3161-4},
	Pmid = {8414519},
	Pst = {ppublish},
	Title = {bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis},
	Volume = {8},
	Year = {1993}}

@article{pietersen2008bmi1,
	Abstract = {PolycombGroup (PcG) proteins are epigenetic silencers involved in maintaining cellular identity, and their deregulation can result in cancer [1]. Mice without the PcG gene Bmi1 are runted and suffer from progressive loss of hematopoietic and neural stem cells [2-4]. Here, we assess the effects of Bmi1 on stem cells and differentiation of an epithelial tissue in vivo. We chose the mammary gland because it allows limiting dilution transplantations [5, 6] and because Bmi1 is overexpressed in breast cancer [7, 8]. Our analyses show that Bmi1 is expressed in all cells of the mouse mammary gland and is especially high in luminal cells. Loss of Bmi1 results in a severe mammary-epithelium growth defect, which can be rescued by codeletion of the Ink4a/Arf locus or pregnancy. Even though mammary stem cells are present in the absence of Bmi1, their activity is reduced, and this is only partially due to Ink4a/Arf expression. Interestingly, loss of Bmi1 causes premature lobuloalveolar differentiation, whereas overexpression of Bmi1 inhibits lobuloalveolar differentiation induced by pregnancy hormones. Because Bmi1 affects not only mammary stem cells but also more committed cells, our data warrant a more detailed analysis of the different roles of Bmi1 in breast-cancer etiology.},
	Author = {Pietersen, Alexandra M and Evers, Bastiaan and Prasad, Asheeta A and Tanger, Ellen and Cornelissen-Steijger, Paulien and Jonkers, Jos and van Lohuizen, Maarten},
	Date-Added = {2010-07-21 09:52:41 -0400},
	Date-Modified = {2010-07-21 09:52:55 -0400},
	Doi = {10.1016/j.cub.2008.06.070},
	Journal = {Curr Biol},
	Journal-Full = {Current biology : CB},
	Mesh = {Animals; Cell Differentiation; Cell Proliferation; Epithelial Cells; Female; Mammary Glands, Animal; Mice; Mice, Knockout; Nuclear Proteins; Pregnancy; Proto-Oncogene Proteins; Repressor Proteins; Stem Cells},
	Month = {Jul},
	Number = {14},
	Pages = {1094-9},
	Pmid = {18635350},
	Pst = {ppublish},
	Title = {Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium},
	Volume = {18},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.cub.2008.06.070}}

@article{locker1992ki67,
	Abstract = {Immunoreactivity of the monoclonal antibody Ki67, which recognizes an antigen expressed in cells active in the cell cycle, has been investigated by immunocytochemistry in a series of 67 primary breast cancers. The percentage of tumour cell nuclei stained by Ki67 (labelling index) was related to tumour histological grade, mitotic frequency, oestrogen receptor status and tumour type. No correlation was found with patient age, tumour size or lymph node stage. A high Ki67 labelling index was significantly associated with diminished patient survival and disease-free interval, which demonstrates an important role for this monoclonal antibody as a prognostic marker in breast cancer.},
	Author = {Locker, A P and Birrell, K and Bell, J A and Nicholson, R I and Elston, C W and Blamey, R W and Ellis, I O},
	Date-Added = {2010-07-21 09:47:09 -0400},
	Date-Modified = {2010-07-21 09:47:27 -0400},
	Journal = {Eur J Surg Oncol},
	Journal-Full = {European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
	Mesh = {Antibodies, Monoclonal; Breast Neoplasms; Cell Division; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Life Tables; Neoplasm Staging; Nuclear Proteins; Prognosis; Survival Analysis},
	Month = {Jun},
	Number = {3},
	Pages = {224-9},
	Pmid = {1607032},
	Pst = {ppublish},
	Title = {Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival},
	Volume = {18},
	Year = {1992}}

@article{barnard1987proliferative,
	Abstract = {Sixty cases of primary breast carcinoma have been studied using a monoclonal antibody, Ki67, which recognizes an antigen expressed by cells in G1, S, G2, and M phases of the cell cycle but not Go. A Ki67 score (positive cells/total tumour cells) was determined, and possible relationships between this index of cellular proliferation and a number of clinical and pathological parameters were investigated. There was a strong positive correlation between the Ki67 score and mitotic index (p less than 0.001), a weak negative correlation with age (p less than 0.02), and weak positive correlations with histological tumour grade (p less than 0.03), tumour necrosis (p less than 0.01), and cellular reaction (p less than 0.01). No relationship was noted between the Ki67 score and tumour size, nodal status, tumour oestrogen receptor levels, or menopausal status. The Ki67 score may prove to be an objective indicator of biological behaviour and thus be of clinical significance, particularly since it is not strongly related to other clinical and pathological parameters used in predicting outcome in breast carcinoma.},
	Author = {Barnard, N J and Hall, P A and Lemoine, N R and Kadar, N},
	Date-Added = {2010-07-21 09:46:19 -0400},
	Date-Modified = {2010-07-21 09:46:32 -0400},
	Doi = {10.1002/path.1711520407},
	Journal = {J Pathol},
	Journal-Full = {The Journal of pathology},
	Mesh = {Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Breast Neoplasms; Cell Count; Cell Division; Female; Humans; Middle Aged; Mitotic Index; Receptors, Estrogen},
	Month = {Aug},
	Number = {4},
	Pages = {287-95},
	Pmid = {3668731},
	Pst = {ppublish},
	Title = {Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables},
	Volume = {152},
	Year = {1987},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/path.1711520407}}

@article{culhane2010genesigdb,
	Abstract = {The primary objective of most gene expression studies is the identification of one or more gene signatures; lists of genes whose transcriptional levels are uniquely associated with a specific biological phenotype. Whilst thousands of experimentally derived gene signatures are published, their potential value to the community is limited by their computational inaccessibility. Gene signatures are embedded in published article figures, tables or in supplementary materials, and are frequently presented using non-standard gene or probeset nomenclature. We present GeneSigDB (http://compbio.dfci.harvard.edu/genesigdb) a manually curated database of gene expression signatures. GeneSigDB release 1.0 focuses on cancer and stem cells gene signatures and was constructed from more than 850 publications from which we manually transcribed 575 gene signatures. Most gene signatures (n = 560) were successfully mapped to the genome to extract standardized lists of EnsEMBL gene identifiers. GeneSigDB provides the original gene signature, the standardized gene list and a fully traceable gene mapping history for each gene from the original transcribed data table through to the standardized list of genes. The GeneSigDB web portal is easy to search, allows users to compare their own gene list to those in the database, and download gene signatures in most common gene identifier formats.},
	Author = {Culhane, Aed{\'\i}n C and Schwarzl, Thomas and Sultana, Razvan and Picard, Kermshlise C and Picard, Shaita C and Lu, Tim H and Franklin, Katherine R and French, Simon J and Papenhausen, Gerald and Correll, Mick and Quackenbush, John},
	Date-Added = {2010-07-19 08:29:18 -0400},
	Date-Modified = {2010-07-19 08:29:35 -0400},
	Doi = {10.1093/nar/gkp1015},
	Journal = {Nucleic Acids Res},
	Journal-Full = {Nucleic acids research},
	Mesh = {Algorithms; Computational Biology; Databases, Genetic; Databases, Nucleic Acid; Databases, Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Information Storage and Retrieval; Internet; Neoplasms; Oligonucleotide Array Sequence Analysis; Software; Stem Cells},
	Month = {Jan},
	Number = {Database issue},
	Pages = {D716-25},
	Pmc = {PMC2808880},
	Pmid = {19934259},
	Pst = {ppublish},
	Title = {GeneSigDB--a curated database of gene expression signatures},
	Volume = {38},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/nar/gkp1015}}

@article{moinfar2008basallike,
	Abstract = {This review deals with studies that have used cDNA microarrays and immunohistochemistry to identify a subtype of breast carcinoma known as basal-like carcinoma. The key breast carcinoma studies are critically discussed to highlight methodological problems in cohort selection, definitions, interpretation of results and statistical analysis. The review concludes that basal-like carcinomas do not reflect a single, biologically uniform group of breast cancers, but show significant variations in their phenotypes, grades, immunoprofiles and clinical behavior, just as a wide range of subtypes and behaviors is observed among epithelial/luminal-derived breast carcinomas. Well-designed studies with comparison of low-grade nonbasal versus low-grade basal and high-grade nonbasal versus high-grade basal carcinomas are necessary before one can be convinced that this subtype represents a distinct clinicopathological entity.},
	Author = {Moinfar, Farid},
	Date-Added = {2010-07-18 18:04:11 -0400},
	Date-Modified = {2010-07-18 18:04:26 -0400},
	Doi = {10.1159/000123850},
	Journal = {Pathobiology},
	Journal-Full = {Pathobiology : journal of immunopathology, molecular and cellular biology},
	Mesh = {Breast Neoplasms; Carcinoma, Basal Cell; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Phenotype},
	Number = {2},
	Pages = {119-31},
	Pmid = {18544967},
	Pst = {ppublish},
	Title = {Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes},
	Volume = {75},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1159/000123850}}

@techreport{murphy2001active,
	Author = {Kevin P. Murphy},
	Date-Added = {2010-07-14 11:28:51 -0400},
	Date-Modified = {2010-07-14 11:30:30 -0400},
	Institution = {University of California},
	Title = {Active Learning of Causal Bayes Net Structure},
	Year = {2001}}

@conference{larjo2008active,
	Author = {Antti Larjo and Harri Lahdesmaki and Marc Facciotti and Nitin Baliga and Olli Yli-Harja and Ilya Shmulevich},
	Booktitle = {Fifth International Workshop on Computational Systems Biology},
	Date-Added = {2010-07-14 11:22:56 -0400},
	Date-Modified = {2010-07-29 17:25:53 -0400},
	Title = {Active Learning of Bayesian Network Structure in a Realistic Setting},
	Year = {2008}}

@article{pournara2004reconstruction,
	Abstract = {MOTIVATION: The analysis of high-throughput experimental data, for example from microarray experiments, is currently seen as a promising way of finding regulatory relationships between genes. Bayesian networks have been suggested for learning gene regulatory networks from observational data. Not all causal relationships can be inferred from correlation data alone. Often several equivalent but different directed graphs explain the data equally well. Intervention experiments where genes are manipulated can help to narrow down the range of possible networks. RESULTS: We describe an active learning algorithm that suggests an optimized sequence of intervention experiments. Simulation experiments show that our selection scheme is better than an unguided choice of interventions in learning the correct network and compares favorably in running time and results with methods based on value of information calculations.},
	Author = {Pournara, Iosifina and Wernisch, Lorenz},
	Date-Added = {2010-07-13 11:25:23 -0400},
	Date-Modified = {2010-07-13 11:25:37 -0400},
	Doi = {10.1093/bioinformatics/bth337},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Algorithms; Animals; Artificial Intelligence; Bayes Theorem; Computer Simulation; Gene Expression Profiling; Gene Expression Regulation; Humans; Models, Biological; Models, Statistical; Neoplasm Proteins; Neoplasms; Signal Transduction},
	Month = {Nov},
	Number = {17},
	Pages = {2934-42},
	Pmid = {15180938},
	Pst = {ppublish},
	Title = {Reconstruction of gene networks using Bayesian learning and manipulation experiments},
	Volume = {20},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/bth337}}

@inproceedings{markowetz2005probabilistic,
	Author = {Florian Markowetz and Steffen Grossmann and Rainer Spang},
	Booktitle = {Artificial Intelligence and Statistics},
	Date-Added = {2010-07-13 10:56:06 -0400},
	Date-Modified = {2010-07-13 11:26:25 -0400},
	Publisher = {Society for Artificial Intelligence and Statistics},
	Title = {Probabilistic Soft Interventions in Conditional Gaussian Networks},
	Year = {2005}}

@article{werhli2007reconstructing,
	Abstract = {There have been various attempts to reconstruct gene regulatory networks from microarray expression data in the past. However, owing to the limited amount of independent experimental conditions and noise inherent in the measurements, the results have been rather modest so far. For this reason it seems advisable to include biological prior knowledge, related, for instance, to transcription factor binding locations in promoter regions or partially known signalling pathways from the literature. In the present paper, we consider a Bayesian approach to systematically integrate expression data with multiple sources of prior knowledge. Each source is encoded via a separate energy function, from which a prior distribution over network structures in the form of a Gibbs distribution is constructed. The hyperparameters associated with the different sources of prior knowledge, which measure the influence of the respective prior relative to the data, are sampled from the posterior distribution with MCMC. We have evaluated the proposed scheme on the yeast cell cycle and the Raf signalling pathway. Our findings quantify to what extent the inclusion of independent prior knowledge improves the network reconstruction accuracy, and the values of the hyperparameters inferred with the proposed scheme were found to be close to optimal with respect to minimizing the reconstruction error.},
	Author = {Werhli, Adriano V and Husmeier, Dirk},
	Date-Added = {2010-07-13 10:16:38 -0400},
	Date-Modified = {2010-07-13 10:16:53 -0400},
	Doi = {10.2202/1544-6115.1282},
	Journal = {Stat Appl Genet Mol Biol},
	Journal-Full = {Statistical applications in genetics and molecular biology},
	Mesh = {Bayes Theorem; Gene Expression; Genes, Regulator; Immunoprecipitation; Markov Chains; Monte Carlo Method; Probability},
	Pages = {Article15},
	Pmid = {17542777},
	Pst = {ppublish},
	Title = {Reconstructing gene regulatory networks with bayesian networks by combining expression data with multiple sources of prior knowledge},
	Volume = {6},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.2202/1544-6115.1282}}

@article{imoto2003combining,
	Abstract = {We propose a statistical method for estimating a gene network based on Bayesian networks from microarray gene expression data together with biological knowledge including protein-protein interactions, protein-DNA interactions, binding site information, existing literature and so on. Unfortunately, microarray data do not contain enough information for constructing gene networks accurately in many cases. Our method adds biological knowledge to the estimation method of gene networks under a Bayesian statistical framework, and also controls the trade-off between microarray information and biological knowledge automatically. We conduct Monte Carlo simulations to show the effectiveness of the proposed method. We analyze Saccharomyces cerevisiae gene expression data as an application.},
	Author = {Imoto, Seiya and Higuchi, Tomoyuki and Goto, Takao and Tashiro, Kousuke and Kuhara, Satoru and Miyano, Satoru},
	Date-Added = {2010-07-13 09:50:38 -0400},
	Date-Modified = {2010-07-13 09:50:50 -0400},
	Journal = {Proc IEEE Comput Soc Bioinform Conf},
	Journal-Full = {Proceedings / IEEE Computer Society Bioinformatics Conference. IEEE Computer Society Bioinformatics Conference},
	Mesh = {Bayes Theorem; Computer Simulation; Databases, Factual; Gene Expression; Gene Expression Regulation, Fungal; Models, Biological; Models, Statistical; Oligonucleotide Array Sequence Analysis; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Systems Biology; Systems Integration},
	Pages = {104-13},
	Pmid = {16452784},
	Pst = {ppublish},
	Title = {Combining microarrays and biological knowledge for estimating gene networks via Bayesian networks},
	Volume = {2},
	Year = {2003}}

@article{imoto2004combining,
	Abstract = {We propose a statistical method for estimating a gene network based on Bayesian networks from microarray gene expression data together with biological knowledge including protein-protein interactions, protein-DNA interactions, binding site information, existing literature and so on. Microarray data do not contain enough information for constructing gene networks accurately in many cases. Our method adds biological knowledge to the estimation method of gene networks under a Bayesian statistical framework, and also controls the trade-off between microarray information and biological knowledge automatically. We conduct Monte Carlo simulations to show the effectiveness of the proposed method. We analyze Saccharomyces cerevisiae gene expression data as an application.},
	Author = {Imoto, Seiya and Higuchi, Tomoyuki and Goto, Takao and Tashiro, Kousuke and Kuhara, Satoru and Miyano, Satoru},
	Date-Added = {2010-07-13 09:46:19 -0400},
	Date-Modified = {2010-07-13 09:46:37 -0400},
	Journal = {J Bioinform Comput Biol},
	Journal-Full = {Journal of bioinformatics and computational biology},
	Mesh = {Algorithms; Bayes Theorem; Computer Simulation; Databases, Factual; Gene Expression Regulation, Fungal; Information Storage and Retrieval; Models, Biological; Models, Statistical; Oligonucleotide Array Sequence Analysis; Saccharomyces cerevisiae Proteins; Signal Transduction},
	Month = {Mar},
	Number = {1},
	Pages = {77-98},
	Pmid = {15272434},
	Pst = {ppublish},
	Title = {Combining microarrays and biological knowledge for estimating gene networks via bayesian networks},
	Volume = {2},
	Year = {2004}}

@article{shah2009python,
	Author = {Abhik Shah and Peter Woolf},
	Date-Added = {2010-07-13 09:33:35 -0400},
	Date-Modified = {2010-07-13 09:36:11 -0400},
	Journal = {Journal of Machine Learning Research},
	Rating = {0},
	Title = {Python Environment for Bayesian Learning: Inferring the Structure of Bayesian Networks from Knowledge and Data},
	Url = {http://jmlr.csail.mit.edu/papers/v10/shah09a.html},
	Volume = {10},
	Year = {2009},
	Bdsk-Url-1 = {http://jmlr.csail.mit.edu/papers/v10/shah09a.html}}

@article{ioannidis2009Repeatability,
	Abstract = {Given the complexity of microarray-based gene expression studies, guidelines encourage transparent design and public data availability. Several journals require public data deposition and several public databases exist. However, not all data are publicly available, and even when available, it is unknown whether the published results are reproducible by independent scientists. Here we evaluated the replication of data analyses in 18 articles on microarray-based gene expression profiling published in Nature Genetics in 2005-2006. One table or figure from each article was independently evaluated by two teams of analysts. We reproduced two analyses in principle and six partially or with some discrepancies; ten could not be reproduced. The main reason for failure to reproduce was data unavailability, and discrepancies were mostly due to incomplete data annotation or specification of data processing and analysis. Repeatability of published microarray studies is apparently limited. More strict publication rules enforcing public data availability and explicit description of data processing and analysis should be considered.},
	Author = {Ioannidis, John P A and Allison, David B and Ball, Catherine A and Coulibaly, Issa and Cui, Xiangqin and Culhane, Aed{\'\i}n C and Falchi, Mario and Furlanello, Cesare and Game, Laurence and Jurman, Giuseppe and Mangion, Jon and Mehta, Tapan and Nitzberg, Michael and Page, Grier P and Petretto, Enrico and van Noort, Vera},
	Date-Added = {2010-07-11 17:02:04 -0400},
	Date-Modified = {2010-07-11 17:02:14 -0400},
	Doi = {10.1038/ng.295},
	Journal = {Nat Genet},
	Journal-Full = {Nature genetics},
	Mesh = {Animals; Data Interpretation, Statistical; Databases, Genetic; Gene Expression Profiling; Genome-Wide Association Study; Humans; Oligonucleotide Array Sequence Analysis; Peer Review, Research; Publications; Reproducibility of Results},
	Month = {Feb},
	Number = {2},
	Pages = {149-55},
	Pmid = {19174838},
	Pst = {ppublish},
	Title = {Repeatability of published microarray gene expression analyses},
	Volume = {41},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ng.295}}

@article{bauer2010erprher2,
	Abstract = {BACKGROUND:The 2007 St Gallen international expert consensus statement describes three risk categories and provides recommendations for treatment of early breast cancer. The set of recommendations on how to best treat primary breast cancer is recognized and used by clinicians worldwide. We now examine the variability of five-year survival of the 2007 St Gallen Risk Classifications utilizing the ER/PR/HER2 subtypes.METHODS:Using the population-based California Cancer Registry, 114,786 incident cases of Stages 1-3 invasive breast cancer diagnosed between 2000 and 2006 were identified. Cases were assigned to Low, Intermediate, or High Risk categories. Five-year relative survival was computed for the three St Gallen risk categories and for the ER/PR/HER2 subtypes for further differentiation.RESULTS AND DISCUSSION:There were 9,124 (13%) cases classified as Low Risk, 44,234 (65%) cases as Intermediate Risk, and 14,340 (21%) as High Risk. Within the Intermediate Risk group, 33,735 (76%) were node-negative (Intermediate Risk 2) and 10,499 (24%) were node-positive (Intermediate Risk 3). For the High Risk group, 6,149 (43%) had 1 to 3 positive axillary lymph nodes (High Risk 4) and 8,191 (57%) had four or more positive lymph nodes (High Risk 5). 
Using five-year relative survival as the principal criterion, we found the following: a) There was very little difference between the Low Risk and Intermediate Risk categories; b) Use of the ER/PR/HER2 subtypes within the Intermediate and High Risk categories separated each into a group with better five-year survival (ER-positive) and a group with worse survival (ER-negative), irrespective of HER2-status; c) The heterogeneity of the High Risk category was most evident when one examined the ER/PR/HER2 subtypes with four or more positive axillary lymph nodes; (d) HER2-positivity did not always translate to worse survival, as noted when one compared the triple positive subtype (ER+/PR+/HER2+) to the triple negative subtype (ER-/PR-/HER2-); and (e) ER-negativity appeared to be a stronger predictor of poor survival than HER2-positivity. CONCLUSION:The use of ER/PR/HER2 subtype highlights the marked heterogeneity of the Intermediate and High Risk categories of the 2007 St Gallen statements. The use of ER/PR/HER2 subtypes and correlation with molecular classification of breast cancer is recommended.
},
	Author = {Bauer, Katrina and Parise, Carol and Caggiano, Vincent},
	Date-Added = {2010-05-21 14:12:16 -0400},
	Date-Modified = {2010-05-21 14:12:16 -0400},
	Doi = {10.1186/1471-2407-10-228},
	Issn = {1471-2407},
	Journal = {BMC Cancer},
	Number = {1},
	Pages = {228},
	Title = {Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer},
	Url = {http://www.biomedcentral.com/1471-2407/10/228},
	Volume = {10},
	Year = {2010},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2407/10/228},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2407-10-228}}

@misc{shi2010maqc2,
	Author = {Leming Shi},
	Date-Added = {2010-05-17 16:12:49 -0400},
	Date-Modified = {2010-06-21 10:19:49 -0400},
	Title = {MAQC-II Project: human breast cancer (BR) data set},
	Year = {2010}}

@article{ertel2010bimodal,
	Abstract = {With insights gained through molecular profiling, cancer is recognized as a heterogeneous disease with distinct subtypes and outcomes that can be predicted by a limited number of biomarkers. Statistical methods such as supervised classification and machine learning identify distinguishing features associated with disease subtype but are not necessarily clear or interpretable on a biological level. Genes with bimodal transcript expression, however, may serve as excellent candidates for disease biomarkers with each mode of expression readily interpretable as a biological state. The recent article by Wang et al, entitled "The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data," provides a bimodality index for identifying and scoring transcript expression profiles as biomarker candidates with the benefit of having a direct relation to power and sample size. This represents an important step in candidate biomarker discovery that may help streamline the pipeline through validation and clinical application.},
	Author = {Ertel, Adam},
	Date-Added = {2010-05-08 12:00:09 +0200},
	Date-Modified = {2010-05-08 12:00:24 +0200},
	Journal = {Cancer Inform},
	Journal-Full = {Cancer informatics},
	Pages = {11-4},
	Pmc = {PMC2834379},
	Pmid = {20234772},
	Pst = {epublish},
	Title = {Bimodal gene expression and biomarker discovery},
	Volume = {9},
	Year = {2010}}

@article{wang2009bimodality,
	Abstract = {MOTIVATION: Identifying genes with bimodal expression patterns from large-scale expression profiling data is an important analytical task. Model-based clustering is popular for this purpose. That technique commonly uses the Bayesian information criterion (BIC) for model selection. In practice, however, BIC appears to be overly sensitive and may lead to the identification of bimodally expressed genes that are unreliable or not clinically useful. We propose using a novel criterion, the bimodality index, not only to identify but also to rank meaningful and reliable bimodal patterns. The bimodality index can be computed using either a mixture model-based algorithm or Markov chain Monte Carlo techniques. RESULTS: We carried out simulation studies and applied the method to real data from a cancer gene expression profiling study. Our findings suggest that BIC behaves like a lax cutoff based on the bimodality index, and that the bimodality index provides an objective measure to identify and rank meaningful and reliable bimodal patterns from large-scale gene expression datasets. R code to compute the bimodality index is included in the ClassDiscovery package of the Object-Oriented Microarray and Proteomic Analysis (OOMPA) suite available at the web site http;//bioinformatics.mdanderson.org/Software/OOMPA.},
	Author = {Wang, Jing and Wen, Sijin and Symmans, W Fraser and Pusztai, Lajos and Coombes, Kevin R},
	Date-Added = {2010-05-08 11:58:48 +0200},
	Date-Modified = {2010-05-08 11:59:00 +0200},
	Journal = {Cancer Inform},
	Journal-Full = {Cancer informatics},
	Pages = {199-216},
	Pmc = {PMC2730180},
	Pmid = {19718451},
	Pst = {epublish},
	Title = {The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data},
	Volume = {7},
	Year = {2009}}

@article{richardson2006x,
	Abstract = {Sporadic basal-like cancers (BLC) are a distinct class of human breast cancers that are phenotypically similar to BRCA1-associated cancers. Like BRCA1-deficient tumors, most BLC lack markers of a normal inactive X chromosome (Xi). Duplication of the active X chromosome and loss of Xi characterized almost half of BLC cases tested. Others contained biparental but nonheterochromatinized X chromosomes or gains of X chromosomal DNA. These abnormalities did not lead to a global increase in X chromosome transcription but were associated with overexpression of a small subset of X chromosomal genes. Other, equally aneuploid, but non-BLC rarely displayed these X chromosome abnormalities. These results suggest that X chromosome abnormalities contribute to the pathogenesis of BLC, both inherited and sporadic.},
	Author = {Richardson, Andrea L and Wang, Zhigang C and De Nicolo, Arcangela and Lu, Xin and Brown, Myles and Miron, Alexander and Liao, Xiaodong and Iglehart, J Dirk and Livingston, David M and Ganesan, Shridar},
	Date-Added = {2010-04-08 14:35:33 -0400},
	Date-Modified = {2010-04-08 14:35:43 -0400},
	Doi = {10.1016/j.ccr.2006.01.013},
	Journal = {Cancer Cell},
	Journal-Full = {Cancer cell},
	Mesh = {Alleles; BRCA1 Protein; Biological Markers; Biological Transport; Breast Neoplasms; Cell Nucleus; Chromosome Aberrations; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 17; Chromosomes, Human, X; Cohort Studies; CpG Islands; DNA Methylation; Female; Gene Expression; Gene Silencing; Genes, X-Linked; Humans; Neoplasms, Basal Cell; RNA, Messenger; RNA, Untranslated; Uniparental Disomy},
	Month = {Feb},
	Number = {2},
	Pages = {121-32},
	Pmid = {16473279},
	Pst = {ppublish},
	Title = {X chromosomal abnormalities in basal-like human breast cancer},
	Volume = {9},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ccr.2006.01.013}}

@article{silver2010efficacy,
	Abstract = {PURPOSE Cisplatin is a chemotherapeutic agent not used routinely for breast cancer treatment. As a DNA cross-linking agent, cisplatin may be effective treatment for hereditary BRCA1-mutated breast cancers. Because sporadic triple-negative breast cancer (TNBC) and BRCA1-associated breast cancer share features suggesting common pathogenesis, we conducted a neoadjuvant trial of cisplatin in TNBC and explored specific biomarkers to identify predictors of response. PATIENTS AND METHODS Twenty-eight women with stage II or III breast cancers lacking estrogen and progesterone receptors and HER2/Neu (TNBC) were enrolled and treated with four cycles of cisplatin at 75 mg/m(2) every 21 days. After definitive surgery, patients received standard adjuvant chemotherapy and radiation therapy per their treating physicians. Clinical and pathologic treatment response were assessed, and pretreatment tumor samples were evaluated for selected biomarkers. Results Six (22\%) of 28 patients achieved pathologic complete responses, including both patients with BRCA1 germline mutations;18 (64\%) patients had a clinical complete or partial response. Fourteen (50\%) patients showed good pathologic responses (Miller-Payne score of 3, 4, or 5), 10 had minor responses (Miller-Payne score of 1 or 2), and four (14\%) progressed. All TNBCs clustered with reference basal-like tumors by hierarchical clustering. Factors associated with good cisplatin response include young age (P = .001), low BRCA1 mRNA expression (P = .03), BRCA1 promoter methylation (P = .04), p53 nonsense or frameshift mutations (P = .01), and a gene expression signature of E2F3 activation (P = .03). CONCLUSION Single-agent cisplatin induced response in a subset of patients with TNBC. Decreased BRCA1 expression may identify subsets of TNBCs that are cisplatin sensitive. Other biomarkers show promise in predicting cisplatin response.},
	Author = {Silver, Daniel P and Richardson, Andrea L and Eklund, Aron C and Wang, Zhigang C and Szallasi, Zoltan and Li, Qiyuan and Juul, Nicolai and Leong, Chee-Onn and Calogrias, Diana and Buraimoh, Ayodele and Fatima, Aquila and Gelman, Rebecca S and Ryan, Paula D and Tung, Nadine M and De Nicolo, Arcangela and Ganesan, Shridar and Miron, Alexander and Colin, Christian and Sgroi, Dennis C and Ellisen, Leif W and Winer, Eric P and Garber, Judy E},
	Date-Added = {2010-03-15 16:18:25 -0400},
	Date-Modified = {2010-03-15 16:18:35 -0400},
	Doi = {10.1200/JCO.2009.22.4725},
	Journal = {J Clin Oncol},
	Journal-Full = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
	Month = {Mar},
	Number = {7},
	Pages = {1145-53},
	Pmid = {20100965},
	Pst = {ppublish},
	Title = {Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer},
	Volume = {28},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1200/JCO.2009.22.4725}}

@article{waddell2009subtypes,
	Abstract = {Extensive expression profiling studies have shown that sporadic breast cancer is composed of five clinically relevant molecular subtypes. However, although BRCA1-related tumours are known to be predominantly basal-like, there are few published data on other classes of familial breast tumours. We analysed a cohort of 75 BRCA1, BRCA2 and non-BRCA1/2 breast tumours by gene expression profiling and found that 74\% BRCA1 tumours were basal-like, 73\% of BRCA2 tumours were luminal A or B, and 52\% non-BRCA1/2 tumours were luminal A. Thirty-four tumours were also analysed by single nucleotide polymorphism-comparative genomic hybridization (SNP-CGH) arrays. Copy number data could predict whether a tumour was basal-like or luminal with high accuracy, but could not predict its mutation class. Basal-like BRCA1 and basal-like non-BRCA1 tumours were very similar, and contained the highest number of chromosome aberrations. We identified regions of frequent gain containing potential driver genes in the basal (8q and 12p) and luminal A tumours (1q and 17q). Regions of homozygous loss associated with decreased expression of potential tumour suppressor genes were also detected, including in basal tumours (5q and 9p), and basal and luminal tumours (10q). This study highlights the heterogeneity of familial tumours and the clinical consequences for treatment and prognosis.},
	Author = {Waddell, Nic and Arnold, Jeremy and Cocciardi, Sibylle and da Silva, Leonard and Marsh, Anna and Riley, Joan and Johnstone, Cameron N and Orloff, Mohammed and Assie, Guillaume and Eng, Charis and Reid, Lynne and Keith, Patricia and Yan, Max and Fox, Stephen and Devilee, Peter and Godwin, Andrew K and Hogervorst, Frans B L and Couch, Fergus and {kConFab Investigators} and Grimmond, Sean and Flanagan, James M and Khanna, Kumkum and Simpson, Peter T and Lakhani, Sunil R and Chenevix-Trench, Georgia},
	Date-Added = {2010-03-15 16:17:25 -0400},
	Date-Modified = {2010-03-15 16:17:41 -0400},
	Doi = {10.1007/s10549-009-0653-1},
	Journal = {Breast Cancer Res Treat},
	Journal-Full = {Breast cancer research and treatment},
	Month = {Dec},
	Pmid = {19960244},
	Pst = {aheadofprint},
	Title = {Subtypes of familial breast tumours revealed by expression and copy number profiling},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-009-0653-1}}

@article{farmer2005identification,
	Abstract = {Previous microarray studies on breast cancer identified multiple tumour classes, of which the most prominent, named luminal and basal, differ in expression of the oestrogen receptor alpha gene (ER). We report here the identification of a group of breast tumours with increased androgen signalling and a 'molecular apocrine' gene expression profile. Tumour samples from 49 patients with large operable or locally advanced breast cancers were tested on Affymetrix U133A gene expression microarrays. Principal components analysis and hierarchical clustering split the tumours into three groups: basal, luminal and a group we call molecular apocrine. All of the molecular apocrine tumours have strong apocrine features on histological examination (P=0.0002). The molecular apocrine group is androgen receptor (AR) positive and contains all of the ER-negative tumours outside the basal group. Kolmogorov-Smirnov testing indicates that oestrogen signalling is most active in the luminal group, and androgen signalling is most active in the molecular apocrine group. ERBB2 amplification is commoner in the molecular apocrine than the other groups. Genes that best split the three groups were identified by Wilcoxon test. Correlation of the average expression profile of these genes in our data with the expression profile of individual tumours in four published breast cancer studies suggest that molecular apocrine tumours represent 8-14\% of tumours in these studies. Our data show that it is possible with microarray data to divide mammary tumour cells into three groups based on steroid receptor activity: luminal (ER+ AR+), basal (ER- AR-) and molecular apocrine (ER- AR+).},
	Author = {Farmer, Pierre and Bonnefoi, Herve and Becette, Veronique and Tubiana-Hulin, Michele and Fumoleau, Pierre and Larsimont, Denis and Macgrogan, Gaetan and Bergh, Jonas and Cameron, David and Goldstein, Darlene and Duss, Stephan and Nicoulaz, Anne-Laure and Brisken, Cathrin and Fiche, Maryse and Delorenzi, Mauro and Iggo, Richard},
	Date-Added = {2010-03-15 16:16:26 -0400},
	Date-Modified = {2010-03-15 16:19:42 -0400},
	Doi = {10.1038/sj.onc.1208561},
	Journal = {Oncogene},
	Journal-Full = {Oncogene},
	Mesh = {Apocrine Glands; Biopsy; Breast Neoplasms; Female; Humans; Oligonucleotide Array Sequence Analysis; Phenotype; Receptor, erbB-2; Receptors, Androgen; Receptors, Estrogen; Signal Transduction},
	Month = {Jul},
	Number = {29},
	Pages = {4660-71},
	Pmid = {15897907},
	Pst = {ppublish},
	Title = {Identification of molecular apocrine breast tumours by microarray analysis},
	Volume = {24},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.onc.1208561}}

@article{natrajan2009integrative,
	Abstract = {Breast cancer is a heterogeneous disease caused by the accumulation of genetic changes in neoplastic cells. We hypothesised that molecular subtypes of breast cancer may be driven by specific constellations of genes whose expression is regulated by gene copy number aberrations. To address this question, we analysed a series of 48 microdissected grade III ductal carcinomas using high resolution microarray comparative genomic hybridisation and mRNA expression arrays. There were 5,931 genes whose expression significantly correlates with copy number identified; out of these, 1,897 genes were significantly differentially expressed between basal-like, HER2 and luminal tumours. Ingenuity Pathway Analysis (IPA) revealed that 'G1/S cell cycle regulation' and 'BRCA1 in DNA damage control' pathways were significantly enriched for genes whose expression correlates with copy number and are differentially expressed between the molecular subtypes of breast cancer. IPA of genes whose expression significantly correlates with copy number in each molecular subtype individually revealed that canonical pathways involved in oestrogen receptor (ER) signalling and DNA repair are enriched for these genes. We also identified 32, 157 and 265 genes significantly overexpressed when amplified in basal-like, HER2 and luminal cancers, respectively. These lists include known and novel potential therapeutic targets (e.g. HER2 and PPM1D in HER2 cancers). Our results provide strong circumstantial evidence that different patterns of genetic aberrations in distinct molecular subtypes of breast cancer contribute to their specific transcriptomic profiles and that biological phenomena characteristic of each subtype (e.g. proliferation, HER2 and ER signalling) may be driven by specific patterns of copy number aberrations.},
	Author = {Natrajan, Rachael and Weigelt, Britta and Mackay, Alan and Geyer, Felipe C and Grigoriadis, Anita and Tan, David S P and Jones, Chris and Lord, Christopher J and Vatcheva, Radost and Rodriguez-Pinilla, Socorro M and Palacios, Jose and Ashworth, Alan and Reis-Filho, Jorge S},
	Date-Added = {2010-03-15 16:14:58 -0400},
	Date-Modified = {2010-03-15 16:15:11 -0400},
	Doi = {10.1007/s10549-009-0501-3},
	Journal = {Breast Cancer Res Treat},
	Journal-Full = {Breast cancer research and treatment},
	Month = {Aug},
	Pmid = {19688261},
	Pst = {aheadofprint},
	Title = {An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-009-0501-3}}

@article{tothill2008novel,
	Abstract = { The study aim to identify novel molecular subtypes of ovarian cancer by gene expression profiling with linkage to clinical and pathologic features.
 Microarray gene expression profiling was done on 285 serous and endometrioid tumors of the ovary, peritoneum, and fallopian tube. -means clustering was applied to identify robust molecular subtypes. Statistical analysis identified differentially expressed genes, pathways, and gene ontologies. Laser capture microdissection, pathology review, and immunohistochemistry validated the array-based findings. Patient survival within -means groups was evaluated using Cox proportional hazards models. Class prediction validated -means groups in an independent dataset. A semisupervised survival analysis of the array data was used to compare against unsupervised clustering results.
 Optimal clustering of array data identified six molecular subtypes. Two subtypes represented predominantly serous low malignant potential and low-grade endometrioid subtypes, respectively. The remaining four subtypes represented higher grade and advanced stage cancers of serous and endometrioid morphology. A novel subtype of high-grade serous cancers reflected a mesenchymal cell type, characterized by overexpression of  and  and low expression of differentiation markers, including CA125 and MUC1. A poor prognosis subtype was defined by a reactive stroma gene expression signature, correlating with extensive desmoplasia in such samples. A similar poor prognosis signature could be found using a semisupervised analysis. Each subtype displayed distinct levels and patterns of immune cell infiltration. Class prediction identified similar subtypes in an independent ovarian dataset with similar prognostic trends.
 Gene expression profiling identified molecular subtypes of ovarian cancer of biological and clinical importance.
},
	Author = {Tothill, Richard W. and Tinker, Anna V. and George, Joshy and Brown, Robert and Fox, Stephen B. and Lade, Stephen and Johnson, Daryl S. and Trivett, Melanie K. and Etemadmoghadam, Dariush and Locandro, Bianca and Traficante, Nadia and Fereday, Sian and Hung, Jillian A. and Chiew, Yoke-Eng and Haviv, Izhak and Gertig, Dorota and deFazio, Anna and Bowtell, David D.L.},
	Date-Added = {2010-02-28 20:46:52 -0500},
	Date-Modified = {2010-02-28 20:46:52 -0500},
	Doi = {10.1158/1078-0432.CCR-08-0196},
	Eprint = {http://clincancerres.aacrjournals.org/content/14/16/5198.full.pdf+html},
	Journal = {Clinical Cancer Research},
	Number = {16},
	Pages = {5198-5208},
	Title = {{Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome}},
	Url = {http://clincancerres.aacrjournals.org/content/14/16/5198.abstract},
	Volume = {14},
	Year = {2008},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/content/14/16/5198.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-08-0196}}

@misc{bentink2010gene,
	Author = {Bentink, Stefan},
	Date-Added = {2010-02-28 20:39:00 -0500},
	Date-Modified = {2010-03-01 10:24:49 -0500},
	Journal = {Manuscript in preparation},
	Title = {Personal communicaton},
	Year = {2010}}

@techreport{ng2005bivariate,
	Author = {Vivian W. Ng and Leo Breiman},
	Date-Added = {2010-02-03 17:12:45 -0500},
	Date-Modified = {2010-02-03 17:12:45 -0500},
	Title = {Bivariate variable selection for classification problem},
	Year = {2005}}

@article{meyer2008informationtheoritic,
	Abstract = {The paper presents an original filter approach for effective feature selection in microarray data characterized by a large number of input variables and a few samples. The approach is based on the use of a new information-theoretic selection, the double input symmetrical relevance (DISR), which relies on a measure of variable complementarity. This measure evaluates the additional information that a set of variables provides about the output with respect to the sum of each single variable contribution. We show that a variable selection approach based on DISR can be formulated as a quadratic optimization problem: the dispersion sum problem (DSP). To solve this problem, we use a strategy based on backward elimination and sequential replacement (BESR). The combination of BESR and the DISR criterion is compared in theoretical and experimental terms to recently proposed information-theoretic criteria. Experimental results on a synthetic dataset as well as on a set of eleven microarray classification tasks show that the proposed technique is competitive with existing filter selection methods.},
	Author = {Meyer, P. E. and Schretter, C. and Bontempi, G.},
	Booktitle = {Selected Topics in Signal Processing, IEEE Journal of},
	Citeulike-Article-Id = {3450696},
	Citeulike-Linkout-0 = {http://dx.doi.org/10.1109/JSTSP.2008.923858},
	Citeulike-Linkout-1 = {http://ieeexplore.ieee.org/xpls/abs\_all.jsp?arnumber=4550559},
	Date-Added = {2010-02-03 11:06:40 -0500},
	Date-Modified = {2010-02-03 11:07:01 -0500},
	Doi = {10.1109/JSTSP.2008.923858},
	Journal = {Selected Topics in Signal Processing, IEEE Journal of},
	Keywords = {feature-selection, markov-blanket, survey},
	Number = {3},
	Pages = {261--274},
	Posted-At = {2008-10-25 21:57:55},
	Priority = {5},
	Title = {Information-Theoretic Feature Selection in Microarray Data Using Variable Complementarity},
	Url = {http://dx.doi.org/10.1109/JSTSP.2008.923858},
	Volume = {2},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1109/JSTSP.2008.923858}}

@article{mesirov2010accessible,
	Author = {Mesirov, Jill P.},
	Date-Added = {2010-01-28 16:44:42 -0500},
	Date-Modified = {2010-01-28 16:44:57 -0500},
	Doi = {10.1126/science.1179653},
	Eprint = {http://www.sciencemag.org/cgi/reprint/327/5964/415.pdf},
	Journal = {Science},
	Number = {5964},
	Pages = {415-416},
	Title = {{Accessible Reproducible Research}},
	Url = {http://www.sciencemag.org},
	Volume = {327},
	Year = {2010},
	Bdsk-Url-1 = {http://www.sciencemag.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1126/science.1179653}}

@article{andre2006molecular,
	Annote = {10.1038/ncponc0636},
	Author = {Andre, Fabrice and Pusztai, Lajos},
	Date = {2006/11//print},
	Date-Added = {2010-01-26 11:45:10 -0500},
	Date-Modified = {2010-01-26 11:45:23 -0500},
	Isbn = {1743-4254},
	Journal = {Nat Clin Prac Oncol},
	M3 = {10.1038/ncponc0636},
	Month = {11},
	Number = {11},
	Pages = {621--632},
	Publisher = {Nature Publishing Group},
	Title = {Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/ncponc0636},
	Volume = {3},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ncponc0636}}

@article{schmidtkittler2003latent,
	Abstract = {According to the present view, metastasis marks the end in a sequence of  genomic changes underlying the progression of an epithelial cell to a lethal  cancer. Here, we aimed to find out at what stage of tumor development  transformed cells leave the primary tumor and whether a defined genotype  corresponds to metastatic disease. To this end, we isolated single  disseminated cancer cells from bone marrow of breast cancer patients and  performed single-cell comparative genomic hybridization. We analyzed  disseminated tumor cells from patients after curative resection of the primary  tumor (stage M0), as presumptive progenitors of manifest metastasis, and from  patients with manifest metastasis (stage M1). Their genomic data were compared  with those from microdissected areas of matched primary tumors. Disseminated  cells from M0-stage patients displayed significantly fewer chromosomal  aberrations than primary tumors or cells from M1-stage patients (  < 0.008 and  < 0.0001, respectively), and their aberrations  appeared to be randomly generated. In contrast, primary tumors and M1 cells  harbored different and characteristic chromosomal imbalances. Moreover,  applying machine-learning methods for the classification of the genotypes, we  could correctly identify the presence or absence of metastatic disease in a  patient on the basis of a single-cell genome. We suggest that in breast  cancer, tumor cells may disseminate in a far less progressed genomic state  than previously thought, and that they acquire genomic aberrations typical of  metastatic cells thereafter. Thus, our data challenge the widely held view  that the precursors of metastasis are derived from the most advanced clone  within the primary tumor.
},
	Author = {Schmidt-Kittler, Oleg and Ragg, Thomas and Daskalakis, Angela and Granzow, Martin and Ahr, Andre and Blankenstein, Thomas J. F. and Kaufmann, Manfred and Diebold, Joachim and Arnholdt, Hans and M{\"u}ller, Peter and Bischoff, Joachim and Harich, Detlev and Schlimok, G{\"u}nter and Riethm{\"u}ller, Gert and Eils, Roland and Klein, Christoph A.},
	Date-Added = {2009-12-24 11:02:18 -0500},
	Date-Modified = {2009-12-24 11:02:18 -0500},
	Doi = {10.1073/pnas.1331931100},
	Eprint = {http://www.pnas.org/content/100/13/7737.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {13},
	Pages = {7737-7742},
	Title = {{From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression}},
	Url = {http://www.pnas.org/content/100/13/7737.abstract},
	Volume = {100},
	Year = {2003},
	Bdsk-Url-1 = {http://www.pnas.org/content/100/13/7737.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.1331931100}}

@article{cardoso2007mindact,
	Abstract = {One of the main challenges in oncology today has become to distinguish accurately between those patients who need adjuvant treatment and those who do not. This, together with the identification of the best type of therapy for the individual patient and the development of drugs targeting specific characteristics of tumour cells, are the goals of treatment tailoring or personalized medicine. The MINDACT trial (Microarray In Node negative Disease may Avoid ChemoTherapy) was recently launched with the aim of prospectively validating the superior performance of a new prognostic RNA-based tool--the Amsterdam 70-gene profiler MammaPrint, in order to implement its use in clinical practice later on. This manuscript shortly reviews the rational, design and logistics of MINDACT.},
	Author = {Cardoso, Fatima and Piccart-Gebhart, Martine and Van't Veer, Laura and Rutgers, Emiel and {TRANSBIG Consortium}},
	Date-Added = {2009-12-23 17:57:31 -0500},
	Date-Modified = {2009-12-23 17:57:46 -0500},
	Doi = {10.1016/j.molonc.2007.10.004},
	Journal = {Mol Oncol},
	Journal-Full = {Molecular oncology},
	Mesh = {Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Gene Expression Profiling; Genomics; Humans; Multicenter Studies as Topic; Mutation; Oligonucleotide Array Sequence Analysis; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design},
	Month = {Dec},
	Number = {3},
	Pages = {246-51},
	Pmid = {19383299},
	Title = {The MINDACT trial: the first prospective clinical validation of a genomic tool},
	Volume = {1},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.molonc.2007.10.004}}

@article{pusztai2008mda3,
	Author = {L. Pusztai},
	Date-Added = {2009-11-24 11:08:10 +0100},
	Date-Modified = {2009-11-24 11:08:36 +0100},
	Title = {unpublished},
	Year = {2008}}

@article{harris2007predictors,
	Abstract = { To assess pathologic complete response (pCR), clinical response, feasibility, safety, and potential predictors of response to preoperative trastuzumab plus vinorelbine in patients with operable, human epidermal growth factor receptor 2 (HER2){\"A}{\`\i}positive breast cancer.
 Forty-eight patients received preoperative trastuzumab and vinorelbine weekly for 12 weeks. Single and multigene biomarker studies were done in an attempt to identify predictors of response.
 Eight of 40 (20%) patients achieved pCR (95% confidence interval, 9-36%). Of 9 additional patients recruited for protocol-defined toxicity analysis, 8 were evaluable; 42 of 48 (88%) patients had clinical response (16 patients, clinical complete response; 26 patients, clinical partial response). T tumors more frequently exhibited clinical complete response ( = 0.05) and showed a trend to exhibit pCR ( = 0.07). Five (13%) patients experienced grade 1 cardiac dysfunction during preoperative treatment. Neither HER2 nor estrogen receptor status changed significantly after exposure to trastuzumab and vinorelbine. RNA profiling identified three top-level clusters by unsupervised analysis. Tumors with extremes of response [pCR ( = 3) versus nonresponse ( = 3)] fell into separate groups by hierarchical clustering. No predictive genes were identified in pCR tumors. Nonresponding tumors were more likely to be T stage ( = 0.02) and express basal markers ( < 0.00001), growth factors, and growth factor receptors. Insulin-like growth factor-I receptor membrane expression was associated with a lower response rate (50% versus 97%;  = 0.001).
 Preoperative trastuzumab plus vinorelbine is active and well tolerated in patients with HER2-positive, operable, stage II/III breast cancer. HER2-overexpressing tumors with a basal-like phenotype, or with expression of insulin-like growth factor-I receptor and other proteins involved in growth factor pathways, are more likely to be resistant to this regimen.
},
	Author = {Harris, Lyndsay N. and You, Fanglei and Schnitt, Stuart J. and Witkiewicz, Agnes and Lu, Xin and Sgroi, Dennis and Ryan, Paula D. and Come, Steven E. and Burstein, Harold J. and Lesnikoski, Beth-Ann and Kamma, Madhavi and Friedman, Paula N. and Gelman, Rebecca and Iglehart, J. Dirk and Winer, Eric P.},
	Date-Added = {2009-11-24 10:49:40 +0100},
	Date-Modified = {2009-11-24 10:49:40 +0100},
	Doi = {10.1158/1078-0432.CCR-06-1304},
	Eprint = {http://clincancerres.aacrjournals.org/content/13/4/1198.full.pdf+html},
	Journal = {Clinical Cancer Research},
	Number = {4},
	Pages = {1198-1207},
	Title = {{Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer}},
	Url = {http://clincancerres.aacrjournals.org/content/13/4/1198.abstract},
	Volume = {13},
	Year = {2007},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/content/13/4/1198.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-06-1304}}

@article{andre2007igr2,
	Author = {F. andre},
	Date-Added = {2009-11-24 10:12:08 +0100},
	Date-Modified = {2009-11-24 11:08:01 +0100},
	Title = {unpublished},
	Year = {2007}}

@article{parker2009supervised,
	Abstract = {PurposeTo improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression-based "intrinsic" subtypes luminal A, luminal B, HER2-enriched, and basal-like.  MethodsA 50-gene subtype predictor was developed using microarray and quantitative reverse transcriptase polymerase chain reaction data from 189 prototype samples. Test sets from 761 patients (no systemic therapy) were evaluated for prognosis, and 133 patients were evaluated for prediction of pathologic complete response (pCR) to a taxane and anthracycline regimen.  ResultsThe intrinsic subtypes as discrete entities showed prognostic significance (P = 2.26E-12) and remained significant in multivariable analyses that incorporated standard parameters (estrogen receptor status, histologic grade, tumor size, and node status). A prognostic model for node-negative breast cancer was built using intrinsic subtype and clinical information. The C-index estimate for the combined model (subtype and tumor size) was a significant improvement on either the clinicopathologic model or subtype model alone. The intrinsic subtype model predicted neoadjuvant chemotherapy efficacy with a negative predictive value for pCR of 97%.  ConclusionDiagnosis by intrinsic subtype adds significant prognostic and predictive information to standard parameters for patients with breast cancer. The prognostic properties of the continuous risk score will be of value for the management of node-negative breast cancers. The subtypes and risk score can also be used to assess the likelihood of efficacy from neoadjuvant chemotherapy.
},
	Author = {Parker, Joel S. and Mullins, Michael and Cheang, Maggie C.U. and Leung, Samuel and Voduc, David and Vickery, Tammi and Davies, Sherri and Fauron, Christiane and He, Xiaping and Hu, Zhiyuan and Quackenbush, John F. and Stijleman, Inge J. and Palazzo, Juan and Marron, J.S. and Nobel, Andrew B. and Mardis, Elaine and Nielsen, Torsten O. and Ellis, Matthew J. and Perou, Charles M. and Bernard, Philip S.},
	Date-Added = {2009-10-22 17:08:35 +0200},
	Date-Modified = {2009-10-22 17:08:35 +0200},
	Doi = {10.1200/JCO.2008.18.1370},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/27/8/1160.pdf},
	Journal = {J Clin Oncol},
	Number = {8},
	Pages = {1160-1167},
	Title = {{Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/27/8/1160},
	Volume = {27},
	Year = {2009},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/27/8/1160},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2008.18.1370}}

@article{bos2009genes,
	Annote = {10.1038/nature08021},
	Author = {Bos, Paula D. and Zhang, Xiang H. -F. and Nadal, Cristina and Shu, Weiping and Gomis, Roger R. and Nguyen, Don X. and Minn, Andy J. and van de Vijver, Marc J. and Gerald, William L. and Foekens, John A. and Massague, Joan},
	Date = {2009/06/18/print},
	Date-Added = {2009-10-15 13:45:08 +0200},
	Date-Modified = {2009-10-15 13:45:08 +0200},
	Day = {18},
	Isbn = {0028-0836},
	Journal = {Nature},
	L3 = {http://www.nature.com/nature/journal/v459/n7249/suppinfo/nature08021_S1.html},
	M3 = {10.1038/nature08021},
	Month = {06},
	Number = {7249},
	Pages = {1005--1009},
	Publisher = {Macmillan Publishers Limited. All rights reserved},
	Title = {Genes that mediate breast cancer metastasis to the brain},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nature08021},
	Volume = {459},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature08021}}

@article{gong2007determination,
	Abstract = {BACKGROUND: Gene expression microarrays are being used to develop new prognostic and predictive tests for breast cancer, and might be used at the same time to confirm oestrogen-receptor status and ERBB2 status. Our goal was to establish a new method to assign oestrogen receptor and ERBB2-receptor status to breast carcinoma based on mRNA expression measured using Affymetrix U133A gene-expression profiling. METHODS: We used gene expression data of 495 breast cancer samples to assess the correlation between oestrogen receptor (ESR1) and ERBB2 mRNA and clinical status of these genes (as established by immunohistochemical [IHC] or fluorescence in-situ hybridisation [FISH], or both). Data from 195 fine-needle aspiration (FNA) samples were used to define mRNA cutoff values that assign receptor status. We assessed the accuracy of these cutoffs in two independent datasets: 123 FNA samples and 177 tissue samples (ie, resected or core-needle biopsied tissues). Profiling was done at two institutions by use of the same platform (Affymetrix U133A GeneChip). All data were uniformly normalised with dCHIP software. FINDINGS: ESR1 and ERBB2 mRNA levels correlated closely with routine measurements for receptor status in all three datasets. Spearman's correlation coefficients ranged from 0.62 to 0.77. An ESR1 mRNA cutoff value of 500 identified oestrogen-receptor-positive status with an overall accuracy of 90\% (training set), 88\% (first validation set), and 96\% (second validation set). An ERBB2 mRNA threshold of 1150 identified ERBB2-positive status with the overall accuracy of 93\% (training set), 89\% (first validation set), and 90\% (second validation set). Reproducibility of mRNA measurements in 34 replicate experiments was high (correlation coefficient 0.975 for ESR1, 0.984 for ERBB2). INTERPRETATION: Amounts of ESR1 and ERBB2 mRNA as measured by the Affymetrix GeneChip reliably and reproducibly establish oestrogen-receptor status and ERBB2 status, respectively.},
	Author = {Gong, Yun and Yan, Kai and Lin, Feng and Anderson, Keith and Sotiriou, Christos and Andre, Fabrice and Holmes, Frankie A and Valero, Vicente and Booser, Daniel and Pippen, Jr, John E and Vukelja, Svetislava and Gomez, Henry and Mejia, Jaime and Barajas, Luis J and Hess, Kenneth R and Sneige, Nour and Hortobagyi, Gabriel N and Pusztai, Lajos and Symmans, W Fraser},
	Date-Added = {2009-10-13 14:23:10 +0200},
	Date-Modified = {2009-10-13 14:23:22 +0200},
	Doi = {10.1016/S1470-2045(07)70042-6},
	Journal = {Lancet Oncol},
	Journal-Full = {The lancet oncology},
	Mesh = {Breast Neoplasms; Gene Expression Profiling; Genes, erbB-2; Humans; RNA, Messenger; Receptors, Estrogen},
	Month = {Mar},
	Number = {3},
	Pages = {203-11},
	Pmid = {17329190},
	Title = {Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S1470-2045(07)70042-6}}

@article{lu2008predicting,
	Abstract = {Data from gene expression arrays hold an enormous amount of biological information. We sought to determine if global gene expression in primary breast cancers contained information about biologic, histologic, and anatomic features of the disease in individual patients. Microarray data from the tumors of 129 patients were analyzed for the ability to predict biomarkers [estrogen receptor (ER) and HER2], histologic features [grade and lymphatic-vascular invasion (LVI)], and stage parameters (tumor size and lymph node metastasis). Multiple statistical predictors were used and the prediction accuracy was determined by cross-validation error rate; multidimensional scaling (MDS) allowed visualization of the predicted states under study. Models built from gene expression data accurately predict ER and HER2 status, and divide tumor grade into high-grade and low-grade clusters; intermediate-grade tumors are not a unique group. In contrast, gene expression data is inaccurate at predicting tumor size, lymph node status or LVI. The best model for prediction of nodal status included tumor size, LVI status and pathologically defined tumor subtype (based on combinations of ER, HER2, and grade); the addition of microarray-based prediction to this model failed to improve the prediction accuracy. Global gene expression supports a binary division of ER, HER2, and grade, clearly separating tumors into two categories; intermediate values for these bio-indicators do not define intermediate tumor subsets. Results are consistent with a model of regional metastasis that depends on inherent biologic differences in metastatic propensity between breast cancer subtypes, upon which time and chance then operate.},
	Author = {Lu, Xuesong and Lu, Xin and Wang, Zhigang C and Iglehart, J Dirk and Zhang, Xuegong and Richardson, Andrea L},
	Date-Added = {2009-10-13 10:32:50 +0200},
	Date-Modified = {2009-10-13 10:33:19 +0200},
	Doi = {10.1007/s10549-007-9596-6},
	Journal = {Breast Cancer Res Treat},
	Journal-Full = {Breast cancer research and treatment},
	Mesh = {Breast Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Screening; Humans; Logistic Models; Lymphatic Metastasis; Models, Genetic; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Predictive Value of Tests; Receptor, erbB-2; Receptors, Estrogen; Reproducibility of Results},
	Month = {Mar},
	Number = {2},
	Pages = {191-201},
	Pmid = {18297396},
	Title = {Predicting features of breast cancer with gene expression patterns},
	Volume = {108},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-007-9596-6}}

@article{huang2003gene,
	Abstract = {BACKGROUND: Correlation of risk factors with genomic data promises to provide specific treatment for individual patients, and needs interpretation of complex, multivariate patterns in gene expression data, as well as assessment of their ability to improve clinical predictions. We aimed to predict nodal metastatic states and relapse for breast cancer patients. METHODS: We analysed DNA microarray data from samples of primary breast tumours, using non-linear statistical analyses to assess multiple patterns of interactions of groups of genes that have predictive value for the individual patient, with respect to lymph node metastasis and cancer recurrence. FINDINGS: We identified aggregate patterns of gene expression (metagenes) that associate with lymph node status and recurrence, and that are capable of predicting outcomes in individual patients with about 90\% accuracy. The metagenes defined distinct groups of genes, suggesting different biological processes underlying these two characteristics of breast cancer. Initial external validation came from similarly accurate predictions of nodal status of a small sample in a distinct population. INTERPRETATION: Multiple aggregate measures of profiles of gene expression define valuable predictive associations with lymph node metastasis and disease recurrence for individual patients. Gene expression data have the potential to aid accurate, individualised, prognosis. Importantly, these data are assessed in terms of precise numerical predictions, with ranges of probabilities of outcome. Precise and statistically valid assessments of risks specific for patients, will ultimately be of most value to clinicians faced with treatment decisions.},
	Author = {Huang, Erich and Cheng, Skye H and Dressman, Holly and Pittman, Jennifer and Tsou, Mei Hua and Horng, Cheng Fang and Bild, Andrea and Iversen, Edwin S and Liao, Ming and Chen, Chii Ming and West, Mike and Nevins, Joseph R and Huang, Andrew T},
	Date-Added = {2009-10-06 10:42:14 +0200},
	Date-Modified = {2009-10-06 10:42:27 +0200},
	Doi = {10.1016/S0140-6736(03)13308-9},
	Journal = {Lancet},
	Journal-Full = {Lancet},
	Mesh = {Adult; Breast Neoplasms; Female; Gene Expression Profiling; Humans; Lymphatic Metastasis; Middle Aged; Oligonucleotide Array Sequence Analysis; Predictive Value of Tests; Prognosis; Risk Factors},
	Month = {May},
	Number = {9369},
	Pages = {1590-6},
	Pmid = {12747878},
	Title = {Gene expression predictors of breast cancer outcomes},
	Volume = {361},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0140-6736(03)13308-9}}

@article{li2009retrn,
	Author = {Yong Li and Yanming Zhu and Xi Bai and Hua Cai and Wei Ji and Dianjing Guo},
	Date-Added = {2009-09-24 10:17:15 +0200},
	Date-Modified = {2009-09-24 10:17:15 +0200},
	Doi = {DOI: 10.1016/j.ygeno.2009.08.009},
	Issn = {0888-7543},
	Journal = {Genomics},
	Keywords = {Scale-free},
	Pages = {-},
	Title = {ReTRN: A retriever of real transcriptional regulatory network and expression data for evaluating structure learning algorithm},
	Url = {http://www.sciencedirect.com/science/article/B6WG1-4X315FV-1/2/9c6aa94f06bc32d8afd3588e48052d15},
	Volume = {In Press, Corrected Proof},
	Year = {2009},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/B6WG1-4X315FV-1/2/9c6aa94f06bc32d8afd3588e48052d15},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/j.ygeno.2009.08.009}}

@article{vandenbulcke2006syntren,
	Abstract = {BACKGROUND:The development of algorithms to infer the structure of gene regulatory networks based on expression data is an important subject in bioinformatics research. Validation of these algorithms requires benchmark data sets for which the underlying network is known. Since experimental data sets of the appropriate size and design are usually not available, there is a clear need to generate well-characterized synthetic data sets that allow thorough testing of learning algorithms in a fast and reproducible manner.RESULTS:In this paper we describe a network generator that creates synthetic transcriptional regulatory networks and produces simulated gene expression data that approximates experimental data. Network topologies are generated by selecting subnetworks from previously described regulatory networks. Interaction kinetics are modeled by equations based on Michaelis-Menten and Hill kinetics. Our results show that the statistical properties of these topologies more closely approximate those of genuine biological networks than do those of different types of random graph models. Several user-definable parameters adjust the complexity of the resulting data set with respect to the structure learning algorithms.CONCLUSION:This network generation technique offers a valid alternative to existing methods. The topological characteristics of the generated networks more closely resemble the characteristics of real transcriptional networks. Simulation of the network scales well to large networks. The generator models different types of biological interactions and produces biologically plausible synthetic gene expression data.},
	Author = {Van den Bulcke, Tim and Van Leemput, Koenraad and Naudts, Bart and van Remortel, Piet and Ma, Hongwu and Verschoren, Alain and De Moor, Bart and Marchal, Kathleen},
	Date-Added = {2009-09-24 10:12:44 +0200},
	Date-Modified = {2009-09-24 10:12:44 +0200},
	Doi = {10.1186/1471-2105-7-43},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {43},
	Pubmedid = {16438721},
	Title = {SynTReN: a generator of synthetic gene expression data for design and analysis of structure learning algorithms},
	Url = {http://www.biomedcentral.com/1471-2105/7/43},
	Volume = {7},
	Year = {2006},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/7/43},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-7-43}}

@article{schemper2009estimation,
	Author = {Michael Schemper and Samo Wakounig and Georg Heinze},
	Date-Added = {2009-09-21 10:59:11 +0200},
	Date-Modified = {2009-09-21 11:01:08 +0200},
	Journal = {Statistics in Medicine},
	Number = {19},
	Pages = {2473-2489},
	Title = {The estimation of average hazard ratios by weighted Cox regression},
	Volume = {28},
	Year = {2009},
	Bdsk-Url-1 = {http://www3.interscience.wiley.com/journal/122405822/abstract?CRETRY=1&SRETRY=0}}

@book{nascimento2005fuzzy,
	Author = {S. Nascimento},
	Date-Added = {2009-09-11 14:45:06 +0200},
	Date-Modified = {2009-09-11 14:46:50 +0200},
	Isbn = {1586034898},
	Month = {January},
	Publisher = {IOS Press},
	Series = {Frontiers in Artificial Intelligence and Applications},
	Title = {Fuzzy Clustering via Proportional Membership Model},
	Year = {2005},
	Bdsk-Url-1 = {http://www.amazon.com/gp/product/1586034898}}

@article{normand1999tutorial,
	Author = {Sharon-Lise T. Normand},
	Date-Added = {2009-09-07 17:08:37 +0200},
	Date-Modified = {2009-09-07 17:13:58 +0200},
	Journal = {Statistics in Medicine},
	Number = {3},
	Pages = {321-359},
	Title = {Meta-analysis: formulating, evaluating, combining, and reporting},
	Volume = {18},
	Year = {1999},
	Bdsk-Url-1 = {http://www3.interscience.wiley.com/journal/30003680/abstract}}

@article{teschendorff2006pack,
	Abstract = {Motivation: Elucidating the molecular taxonomy of cancers and finding biological and clinical markers from microarray experiments is problematic due to the large number of variables being measured. Feature selection methods that can identify relevant classifiers or that can remove likely false positives prior to supervised analysis are therefore desirable.  Results: We present a novel feature selection procedure based on a mixture model and a non-gaussianity measure of a gene's expression profile. The method can be used to find genes that define either small outlier subgroups or major subdivisions, depending on the sign of kurtosis. The method can also be used as a filtering step, prior to supervised analysis, in order to reduce the false discovery rate. We validate our methodology using six independent datasets by rediscovering major classifiers in ER negative and ER positive breast cancer and in prostate cancer. Furthermore, our method finds two novel subtypes within the basal subgroup of ER negative breast tumours, associated with apoptotic and immune response functions respectively, and with statistically different clinical outcome.  Availability: An R-function pack that implements the methods used here has been added to vabayelMix, available from (www.cran.r-project.org).  Contact: aet21@cam.ac.uk  Supplementary information: Supplementary information is available at Bioinformatics online.
},
	Author = {Teschendorff, Andrew E. and Naderi, Ali and Barbosa-Morais, Nuno L. and Caldas, Carlos},
	Date-Added = {2009-08-25 16:16:46 +0200},
	Date-Modified = {2009-08-25 16:16:46 +0200},
	Doi = {10.1093/bioinformatics/btl174},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/22/18/2269.pdf},
	Journal = {Bioinformatics},
	Number = {18},
	Pages = {2269-2275},
	Title = {{PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/18/2269},
	Volume = {22},
	Year = {2006},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/18/2269},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btl174}}

@inproceedings{tsamardinos2003towards,
	Author = {Ioannis Tsamardinos and Constantin F. Aliferis},
	Booktitle = {in Proceedings of the Ninth International Workshop on Artificial Intelligence and Statistics},
	Date-Added = {2009-08-06 07:48:59 +0200},
	Date-Modified = {2009-08-06 07:48:59 +0200},
	Publisher = {Morgan Kaufmann Publishers},
	Title = {Towards Principled Feature Selection: Relevancy, Filters and Wrappers},
	Year = {2003}}

@article{cohen2008getting,
	Author = {Cohen, K. Bretonnel AND Hunter, Lawrence},
	Date-Added = {2009-08-05 15:23:39 +0200},
	Date-Modified = {2009-08-05 15:23:39 +0200},
	Doi = {10.1371/journal.pcbi.0040020},
	Journal = {PLoS Comput Biol},
	Month = {01},
	Number = {1},
	Pages = {e20},
	Publisher = {Public Library of Science},
	Title = {Getting Started in Text Mining},
	Url = {http://dx.plos.org/10.1371%2Fjournal.pcbi.0040020},
	Volume = {4},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.plos.org/10.1371/journal.pcbi.0040020},
	Bdsk-Url-2 = {http://dx.doi.org/10.1371/journal.pcbi.0040020}}

@inproceedings{friedman2000using,
	Address = {New York, NY, USA},
	Author = {Friedman, Nir and Linial, Michal and Nachman, Iftach and Pe'er, Dana},
	Booktitle = {RECOMB '00: Proceedings of the fourth annual international conference on Computational molecular biology},
	Date-Added = {2009-08-04 10:26:51 +0200},
	Date-Modified = {2009-08-04 10:26:51 +0200},
	Doi = {http://doi.acm.org/10.1145/332306.332355},
	Isbn = {1-58113-186-0},
	Location = {Tokyo, Japan},
	Pages = {127--135},
	Publisher = {ACM},
	Title = {Using Bayesian networks to analyze expression data},
	Year = {2000},
	Bdsk-Url-1 = {http://doi.acm.org/10.1145/332306.332355}}

@article{spellman1998comprehensive,
	Abstract = {We sought to create a comprehensive catalog of yeast genes whose transcript levels vary periodically within the cell cycle. To this end, we used DNA microarrays and samples from yeast cultures synchronized by three independent methods: [alpha] factor arrest, elutriation, and arrest of a cdc15 temperature-sensitive mutant. Using periodicity and correlation algorithms, we identified 800 genes that meet an objective minimum criterion for cell cycle regulation. In separate experiments, designed to examine the effects of inducing either the G1 cyclin Cln3p or the B-type cyclin Clb2p, we found that the mRNA levels of more than half of these 800 genes respond to one or both of these cyclins. Furthermore, we analyzed our set of cell cycle-regulated genes for known and new promoter elements and show that several known elements (or variations thereof) contain information predictive of cell cycle regulation. A full description and complete data sets are available at http://cellcycle-www.stanford.edu
},
	Author = {Spellman, Paul T. and Sherlock, Gavin and Zhang, Michael Q. and Iyer, Vishwanath R. and Anders, Kirk and Eisen, Michael B. and Brown, Patrick O. and Botstein, David and Futcher, Bruce},
	Date-Added = {2009-08-04 10:10:27 +0200},
	Date-Modified = {2009-08-04 10:10:27 +0200},
	Eprint = {http://www.molbiolcell.org/cgi/reprint/9/12/3273.pdf},
	Journal = {Mol. Biol. Cell},
	Number = {12},
	Pages = {3273-3297},
	Title = {{Comprehensive Identification of Cell Cycle-regulated Genes of the Yeast Saccharomyces cerevisiae by Microarray Hybridization}},
	Url = {http://www.molbiolcell.org/cgi/content/abstract/9/12/3273},
	Volume = {9},
	Year = {1998},
	Bdsk-Url-1 = {http://www.molbiolcell.org/cgi/content/abstract/9/12/3273}}

@book{shipley2000cause,
	Author = {Bill Shipley},
	Date-Added = {2009-08-04 07:42:50 +0200},
	Date-Modified = {2009-08-04 08:18:51 +0200},
	Isbn = {9780521791533},
	Publisher = {Cambridge University Press},
	Title = {Cause and Correlation in Biology: A User's Guide to Path Analysis, Structural Equations and Causal Inference},
	Year = {2000},
	Bdsk-Url-1 = {http://www.cup.cam.ac.uk/uk/catalogue/email.asp?isbn=9780521791533}}

@article{friedman2004inferring,
	Abstract = {High-throughput genome-wide molecular assays, which probe cellular networks from different perspectives, have become central to molecular biology. Probabilistic graphical models are useful for extracting meaningful biological insights from the resulting data sets. These models provide a concise representation of complex cellular networks by composing simpler submodels. Procedures based on well-understood principles for inferring such models from data facilitate a model-based methodology for analysis and discovery. This methodology and its capabilities are illustrated by several recent applications to gene expression data.
},
	Author = {Friedman, Nir},
	Date-Added = {2009-08-03 16:06:37 +0200},
	Date-Modified = {2009-08-03 16:06:37 +0200},
	Doi = {10.1126/science.1094068},
	Eprint = {http://www.sciencemag.org/cgi/reprint/303/5659/799.pdf},
	Journal = {Science},
	Number = {5659},
	Pages = {799-805},
	Title = {{Inferring Cellular Networks Using Probabilistic Graphical Models}},
	Url = {http://www.sciencemag.org/cgi/content/abstract/303/5659/799},
	Volume = {303},
	Year = {2004},
	Bdsk-Url-1 = {http://www.sciencemag.org/cgi/content/abstract/303/5659/799},
	Bdsk-Url-2 = {http://dx.doi.org/10.1126/science.1094068}}

@article{schadt2005integrative,
	Abstract = {A key goal of biomedical research is to elucidate the complex network of gene interactions underlying complex traits such as common human diseases. Here we detail a multistep procedure for identifying potential key drivers of complex traits that integrates DNA-variation and gene-expression data with other complex trait data in segregating mouse populations. Ordering gene expression traits relative to one another and relative to other complex traits is achieved by systematically testing whether variations in DNA that lead to variations in relative transcript abundances statistically support an independent, causative or reactive function relative to the complex traits under consideration. We show that this approach can predict transcriptional responses to single gene-perturbation experiments using gene-expression data in the context of a segregating mouse population. We also demonstrate the utility of this approach by identifying and experimentally validating the involvement of three new genes in susceptibility to obesity.},
	Author = {Schadt, Eric E and Lamb, John and Yang, Xia and Zhu, Jun and Edwards, Steve and Guhathakurta, Debraj and Sieberts, Solveig K and Monks, Stephanie and Reitman, Marc and Zhang, Chunsheng and Lum, Pek Yee and Leonardson, Amy and Thieringer, Rolf and Metzger, Joseph M and Yang, Liming and Castle, John and Zhu, Haoyuan and Kash, Shera F and Drake, Thomas A and Sachs, Alan and Lusis, Aldons J},
	Date-Added = {2009-08-03 15:24:49 +0200},
	Date-Modified = {2009-08-03 15:25:06 +0200},
	Doi = {10.1038/ng1589},
	Journal = {Nat Genet},
	Journal-Full = {Nature genetics},
	Mesh = {11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; DNA-Binding Proteins; Female; Gene Expression; Gene Expression Profiling; Genetic Predisposition to Disease; Genome; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Genetic; Obesity; Quantitative Trait Loci; Receptors, Complement; Repressor Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta2},
	Month = {Jul},
	Number = {7},
	Pages = {710-7},
	Pmid = {15965475},
	Title = {An integrative genomics approach to infer causal associations between gene expression and disease},
	Volume = {37},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ng1589}}

@article{tang2009integrating,
	Abstract = {ABSTRACT: Following the publication of the complete human genomic sequence, the post-genomic era is driven by the need to extract useful information from genomic data. Genomics, transcriptomics, proteomics, metabolomics, epidemiological data and microbial data provide different angles to our understanding of gene-environment interactions and the determinants of disease and health. Our goal and our challenge are to integrate these very different types of data and perspectives of disease into a global model suitable for dissecting the mechanisms of disease and for predicting novel therapeutic strategies. This review aims to highlight the need for and problems with complex data integration, and proposes a framework for data integration. While there are many obstacles to overcome, biological models based upon multiple datasets will probably become the basis that drives future biomedical research.},
	Author = {Tang, Jing and Tan, Chong Yew and Oresic, Matej and Vidal-Puig, Antonio},
	Date-Added = {2009-08-03 15:17:39 +0200},
	Date-Modified = {2009-08-03 15:17:54 +0200},
	Doi = {10.1186/gm35},
	Journal = {Genome Med},
	Journal-Full = {Genome medicine},
	Month = {Mar},
	Number = {3},
	Pages = {35},
	Pmid = {19341506},
	Title = {Integrating post-genomic approaches as a strategy to advance our understanding of health and disease},
	Volume = {1},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/gm35}}

@inbook{bishop2006graphical,
	Author = {Christopher M. Bishop},
	Chapter = {8},
	Date-Added = {2009-08-03 15:06:45 +0200},
	Date-Modified = {2009-08-03 15:11:10 +0200},
	Isbn = {0-387-31073-8},
	Pages = {359-422},
	Publisher = {Springer},
	Series = {Information Science and Statistics},
	Title = {Graphical Models},
	Volume = {Pattern Recognition and Machine Learning},
	Year = {2006},
	Bdsk-Url-1 = {http://www.springer.com/computer/computer+imaging/book/978-0-387-31073-2}}

@article{olsen2009impact,
	Abstract = {The reverse engineering of transcription regulatory networks from expression data is gaining large interest in the bioinformatics community. An important family of inference techniques is represented by algorithms based on information theoretic measures which rely on the computation of pairwise mutual information. This paper aims to study the impact of the entropy estimator on the quality of the inferred networks. This is done by means of a comprehensive study which takes into consideration three state-of-the-art mutual information algorithms: ARACNE, CLR, and MRNET. Two different setups are considered in this work. The first one considers a set of 12 synthetically generated datasets to compare 8 different entropy estimators and three network inference algorithms. The two methods emerging as the most accurate ones from the first set of experiments are the MRNET method combined with the newly applied Spearman correlation and the CLR method combined with the Pearson correlation. The validation of these two techniques is then carried out on a set of 10 public domain microarray datasets measuring the transcriptional regulatory activity in the yeast organism.},
	Author = {Olsen, Catharina and Meyer, Patrick E and Bontempi, Gianluca},
	Date-Added = {2009-08-03 14:49:32 +0200},
	Date-Modified = {2009-08-03 14:49:58 +0200},
	Doi = {10.1155/2009/308959},
	Journal = {EURASIP J Bioinform Syst Biol},
	Journal-Full = {EURASIP journal on bioinformatics \& systems biology},
	Pages = {308959},
	Pmid = {19148299},
	Title = {On the impact of entropy estimation on transcriptional regulatory network inference based on mutual information},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1155/2009/308959}}

@article{meyer2007information,
	Abstract = {The paper presents MRNET, an original method for inferring genetic networks from microarray data. The method is based on maximum relevance/minimum redundancy (MRMR), an effective information-theoretic technique for feature selection in supervised learning. The MRMR principle consists in selecting among the least redundant variables the ones that have the highest mutual information with the target. MRNET extends this feature selection principle to networks in order to infer gene-dependence relationships from microarray data. The paper assesses MRNET by benchmarking it against RELNET, CLR, and ARACNE, three state-of-the-art information-theoretic methods for large (up to several thousands of genes) network inference. Experimental results on thirty synthetically generated microarray datasets show that MRNET is competitive with these methods.},
	Author = {Meyer, Patrick E and Kontos, Kevin and Lafitte, Frederic and Bontempi, Gianluca},
	Date-Added = {2009-08-03 14:49:12 +0200},
	Date-Modified = {2009-08-03 14:49:24 +0200},
	Doi = {10.1155/2007/79879},
	Journal = {EURASIP J Bioinform Syst Biol},
	Journal-Full = {EURASIP journal on bioinformatics \& systems biology},
	Pages = {79879},
	Pmid = {18354736},
	Title = {Information-theoretic inference of large transcriptional regulatory networks},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1155/2007/79879}}

@inbook{kontos2008nested,
	Author = {K. Kontos and G. Bontempi},
	Date-Added = {2009-08-03 14:43:04 +0200},
	Date-Modified = {2009-08-03 14:47:13 +0200},
	Doi = {10.1007/978-3-540-70600-7_21},
	Isbn = {978-3-540-70598-},
	Publisher = {Springer Berlin Heidelberg},
	Series = {Communications in Computer and Information Science},
	Title = {Nested q-Partial Graphs for Genetic Network Inference from "Small n, Large p" Microarray Data},
	Volume = {Bioinformatics Research and Development},
	Year = {2008},
	Bdsk-Url-1 = {http://www.springerlink.com/content/t0xu80q2425036n5/}}

@article{ambroise2009inferring,
	Author = {C. Ambroise and J. Chiquet and C. Matias},
	Date-Added = {2009-08-03 14:29:47 +0200},
	Date-Modified = {2009-08-03 14:33:21 +0200},
	Doi = {10.1214/08-EJS314},
	Issn = {1935-7524},
	Journal = {Electronic Journal of Statistics},
	Pages = {205-238},
	Title = {Inferring sparse Gaussian graphical models with latent structure},
	Volume = {3},
	Year = {2009},
	Bdsk-Url-1 = {http://www.i-journals.org/ejs/viewarticle.php?id=314&layout=abstract}}

@conference{schafer2005learning,
	Author = {Juliane Schafer and Korbinian Strimmer},
	Booktitle = {SCIENCE OF COMPLEX NETWORKS: From Biology to the Internet and WWW},
	Date-Added = {2009-08-03 14:17:16 +0200},
	Date-Modified = {2009-08-03 14:18:44 +0200},
	Doi = {10.1063/1.1985393},
	Editor = {Jose F. F. Mendes and S. N. Dorogovtsev and A. Povolotsky and F. V. Abreu and J. G. Oliveira},
	Journal = {SCIENCE OF COMPLEX NETWORKS: From Biology to the Internet and WWW: CNET 2004},
	Keywords = {Gaussian processes; graph theory; large-scale systems; inference mechanisms; biology; Bayes methods},
	Location = {Aveiro (Portugal)},
	Number = {1},
	Pages = {263-276},
	Publisher = {American Institute of Physics},
	Title = {Learning Large-Scale Graphical Gaussian Models from Genomic Data},
	Url = {http://link.aip.org/link/?APC/776/263/1},
	Volume = {776},
	Year = {2005},
	Bdsk-Url-1 = {http://link.aip.org/link/?APC/776/263/1},
	Bdsk-Url-2 = {http://dx.doi.org/10.1063/1.1985393}}

@article{onitilo2009breast,
	Abstract = {Objective: To compare the clinicopathologic features and survival in the four breast cancer subtypes defined by immunohistochemistry (IHC) expression of estrogen receptor (ER) or progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2): ER/PR+, Her2+; ER/PR+, Her2-; ER/PR-, Her2+; and ER/PR-, Her2-.  Methods: A 7-year retrospective study of 1134 invasive breast cancer subjects. Clinical and pathologic features and survival of the four subtypes were compared.  Results: Using ER/PR+ and Her2- as a reference, ER/PR-, Her2- had the worst overall survival (hazard ratio, 1.8; 95% confidence interval [CI], 1.06-3.2) and the worst disease-free survival (hazard ratio, 1.5; 95% CI, 0.8-3.0). In ER/PR+, Her2-, chemotherapy conferred significant overall and disease-free survival advantages. Subtype comparison revealed statistically significant differences in outcomes.  Conclusion: The triple negative subtype has the worst overall and disease free survival. Efforts should be directed at standardization of current testing methods and development of more reliable and reproducible testing.
},
	Author = {Onitilo, Adedayo A. and Engel, Jessica M. and Greenlee, Robert T. and Mukesh, Bickol N.},
	Date-Added = {2009-07-28 14:19:08 +0200},
	Date-Modified = {2009-07-28 14:19:47 +0200},
	Doi = {10.3121/cmr.2009.825},
	Eprint = {http://www.clinmedres.org/cgi/reprint/7/1-2/4.pdf},
	Journal = {Clinical Medicine \& Research},
	Number = {1-2},
	Pages = {4-13},
	Title = {{Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival}},
	Url = {http://www.clinmedres.org/cgi/content/abstract/7/1-2/4},
	Volume = {7},
	Year = {2009},
	Bdsk-Url-1 = {http://www.clinmedres.org/cgi/content/abstract/7/1-2/4},
	Bdsk-Url-2 = {http://dx.doi.org/10.3121/cmr.2009.825}}

@article{mosley2009intrinsic,
	Abstract = {BACKGROUND:While global breast cancer gene expression data sets have considerable commonality in terms of their data content, the populations that they represent and the data collection methods utilized can be quite disparate. We sought to assess the extent and consequence of these systematic differences with respect to identifying clinically significant prognostic groups.METHODS:We ascertained how effectively unsupervised clustering employing randomly generated sets of genes could segregate tumors into prognostic groups using four well-characterized breast cancer data sets.RESULTS:Using a common set of 5,000 randomly generated lists (70 genes/list), the percentages of clusters with significant differences in metastasis latencies (HR p-value < 0.01) was 62%, 15%, 21% and 0% in the NKI2 (Netherlands Cancer Institute), Wang, TRANSBIG and KJX64/KJ125 data sets, respectively. Among ER positive tumors, the percentages were 38%, 11%, 4% and 0%, respectively. Few random lists were predictive among ER negative tumors in any data set. Clustering was associated with ER status and, after globally adjusting for the effects of ER-alpha gene expression, the percentages were 25%, 33%, 1% and 0%, respectively. The impact of adjusting for ER status depended on the extent of confounding between ER-alpha gene expression and markers of proliferation.CONCLUSION:It is highly probable to identify a statistically significant association between a given gene list and prognosis in the NKI2 dataset due to its large sample size and the interrelationship between ER-alpha expression and markers of proliferation. In most respects, the TRANSBIG data set generated similar outcomes as the NKI2 data set, although its smaller sample size led to fewer statistically significant results.},
	Author = {Mosley, Jonathan and Keri, Ruth},
	Date-Added = {2009-07-26 12:41:02 +0200},
	Date-Modified = {2009-07-26 12:41:16 +0200},
	Doi = {10.1186/1471-2407-9-214},
	Issn = {1471-2407},
	Journal = {BMC Cancer},
	Number = {1},
	Pages = {214},
	Pubmedid = {19563679},
	Title = {Intrinsic bias in breast cancer gene expression data sets},
	Url = {http://www.biomedcentral.com/1471-2407/9/214},
	Volume = {9},
	Year = {2009},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2407/9/214},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2407-9-214}}

@article{climent2007deletion,
	Abstract = {Despite the recent consensus on the eligibility of adjuvant systemic therapy in patients with lymph node-negative breast cancer (NNBC) based on clinicopathologic criteria, specific biological markers are needed to predict sensitivity to the different available therapeutic options. We examined the feasibility of developing a genomic predictor of chemotherapy response and recurrence risk in 185 patients with NNBC using assembled arrays containing 2,460 bacterial artificial chromosome clones for scanning the genome for DNA copy number changes. After surgery, 90 patients received anthracycline-based chemotherapy, whereas 95 did not. Tamoxifen was administered to patients with hormone receptor-positive tumors. The association of genomic and clinicopathologic data and outcome was computed using Cox proportional hazard models and multiple testing adjustment procedures. Analysis of NNBC genomes revealed a common genomic signature. Specific DNA copy number aberrations were associated with hormonal receptor status, but not with other clinicopathologic variables. In patients treated with chemotherapy, none of the genomic changes were significantly correlated with recurrence. In patients not receiving chemotherapy, deletion of eight bacterial artificial chromosome clones clustered to chromosome 11q was independently associated with relapse (disease-free survival at 10 years {+/-} SE, 40% {+/-} 14% versus 86% {+/-} 6%; P < 0.0001). The 54 patients with deletion of 11q (29%) did not present more aggressive clinicopathologic features than those without 11q loss. The adverse influence of 11q deletion on clinical outcome was confirmed in an independent validation series of 88 patients with NNBC. Our data suggests that patients with NNBC with the 11q deletion might benefit from anthracycline-based chemotherapy despite other clinical, pathologic, or genetic features. However, these initial findings should be evaluated in randomized clinical trials. [Cancer Res 2007;67(2):818-26]
},
	Author = {Climent, Joan and Dimitrow, Peter and Fridlyand, Jane and Palacios, Jose and Siebert, Reiner and Albertson, Donna G. and Gray, Joe W. and Pinkel, Daniel and Lluch, Ana and Martinez-Climent, Jose A.},
	Date-Added = {2009-07-10 10:48:54 +0200},
	Date-Modified = {2009-07-10 10:48:54 +0200},
	Doi = {10.1158/0008-5472.CAN-06-3307},
	Eprint = {http://cancerres.aacrjournals.org/cgi/reprint/67/2/818.pdf},
	Journal = {Cancer Res},
	Number = {2},
	Pages = {818-826},
	Title = {{Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer}},
	Url = {http://cancerres.aacrjournals.org/cgi/content/abstract/67/2/818},
	Volume = {67},
	Year = {2007},
	Bdsk-Url-1 = {http://cancerres.aacrjournals.org/cgi/content/abstract/67/2/818},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/0008-5472.CAN-06-3307}}

@article{chari2008sigma2,
	Abstract = {BACKGROUND:High throughput microarray technologies have afforded the investigation of genomes, epigenomes, and transcriptomes at unprecedented resolution. However, software packages to handle, analyze, and visualize data from these multiple 'omics disciplines have not been adequately developed.RESULTS:Here, we present SIGMA2, a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes. Multi-dimensional datasets can be simultaneously visualized and analyzed with respect to each dimension, allowing combinatorial integration of the different assays belonging to the different 'omics.CONCLUSION:The identification of genes altered at multiple levels such as copy number, loss of heterozygosity (LOH), DNA methylation and the detection of consequential changes in gene expression can be concertedly performed, establishing SIGMA2 as a novel tool to facilitate the high throughput systems biology analysis of cancer.},
	Author = {Chari, Raj and Coe, Bradley and Wedseltoft, Craig and Benetti, Marie and Wilson, Ian and Vucic, Emily and MacAulay, Calum and Ng, Raymond and Lam, Wan},
	Date-Added = {2009-07-10 10:20:52 +0200},
	Date-Modified = {2009-07-10 10:20:52 +0200},
	Doi = {10.1186/1471-2105-9-422},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {422},
	Pubmedid = {18840289},
	Title = {SIGMA2: A system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes},
	Url = {http://www.biomedcentral.com/1471-2105/9/422},
	Volume = {9},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/9/422},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-9-422}}

@article{robinson2009differential,
	Abstract = {BACKGROUND:The latest generation of Affymetrix microarrays are designed to interrogate expression over the entire length of every locus, thus giving the opportunity to study alternative splicing genome-wide. The Exon 1.0 ST (sense target) platform, with versions for Human, Mouse and Rat, is designed primarily to probe every known or predicted exon. The smaller Gene 1.0 ST array is designed as an expression microarray but still interrogates expression with probes along the full length of each well-characterized transcript. We explore the possibility of using the Gene 1.0 ST platform to identify differential splicing events.RESULTS:We propose a strategy to score differential splicing by using the auxiliary information from fitting the statistical model, RMA (robust multichip analysis). RMA partitions the probe-level data into probe effects and expression levels, operating robustly so that if a small number of probes behave differently than the rest, they are downweighted in the fitting step. We argue that adjacent poorly fitting probes for a given sample can be evidence of differential splicing and have designed a statistic to search for this behaviour. Using a public tissue panel dataset, we show many examples of tissue-specific alternative splicing. Furthermore, we show that evidence for putative alternative splicing has a strong correspondence between the Gene 1.0 ST and Exon 1.0 ST platforms.CONCLUSION:We propose a new approach, FIRMAGene, to search for differentially spliced genes using the Gene 1.0 ST platform. Such an analysis complements the search for differential expression. We validate the method by illustrating several known examples and we note some of the challenges in interpreting the probe-level data.Software implementing our methods is freely available as an R package.},
	Author = {Robinson, Mark and Speed, Terence},
	Date-Added = {2009-07-10 10:04:07 +0200},
	Date-Modified = {2009-07-10 10:04:07 +0200},
	Doi = {10.1186/1471-2105-10-156},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {156},
	Pubmedid = {19463149},
	Title = {Differential splicing using whole-transcript microarrays},
	Url = {http://www.biomedcentral.com/1471-2105/10/156},
	Volume = {10},
	Year = {2009},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/10/156},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-10-156}}

@article{menezes2009integrated,
	Abstract = {BACKGROUND:Genes that play an important role in tumorigenesis are expected to show association between DNA copy number and RNA expression. Optimal power to find such associations can only be achieved if analysing copy number and gene expression jointly. Furthermore, some copy number changes extend over larger chromosomal regions affecting the expression levels of multiple resident genes.  RESULTS:We propose to analyse copy number and expression array data using gene sets, rather than individual genes. The proposed model is robust and sensitive. We re-analysed two publicly available datasets as illustration. These two independent breast cancer datasets yielded similar patterns of association between gene dosage and gene expression levels, in spite of different platforms having been used. Our comparisons show a clear advantage to using sets of genes' expressions to detect associations with long-spanning, low-amplitude copy number aberrations. In addition, our model allows for using additional explanatory variables and does not require mapping between copy number and expression probes.CONCLUSIONS:We developed a general and flexible tool for integration of multiple microarray data sets, and showed how the identification of genes whose expression is affected by copy number aberrations provides a powerful approach to prioritize putative targets for functional validation.
},
	Author = {Menezes, Renee and Boetzer, Marten and Sieswerda, Melle and Ommen, Gert-Jan and Boer, Judith},
	Date-Added = {2009-07-10 10:00:01 +0200},
	Date-Modified = {2009-07-10 10:00:01 +0200},
	Doi = {10.1186/1471-2105-10-203},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {203},
	Pubmedid = {19563656},
	Title = {Integrated analysis of DNA copy number and gene expression microarray data using gene sets},
	Url = {http://www.biomedcentral.com/1471-2105/10/203},
	Volume = {10},
	Year = {2009},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/10/203},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-10-203}}

@article{alibes2007idconverter,
	Abstract = {BACKGROUND:Researchers involved in the annotation of large numbers of gene, clone or protein identifiers are usually required to perform a one-by-one conversion for each identifier. When the field of research is one such as microarray experiments, this number may be around 30,000.RESULTS:To help researchers map accession numbers and identifiers among clones, genes, proteins and chromosomal positions, we have designed and developed IDconverter and IDClight. They are two user-friendly, freely available web server applications that also provide additional functional information by mapping the identifiers on to pathways, Gene Ontology terms, and literature references. Both tools are high-throughput oriented and include identifiers for the most common genomic databases. These tools have been compared to other similar tools, showing that they are among the fastest and the most up-to-date.CONCLUSION:These tools provide a fast and intuitive way of enriching the information coming out of high-throughput experiments like microarrays. They can be valuable both to wet-lab researchers and to bioinformaticians.},
	Author = {Alibes, Andreu and Yankilevich, Patricio and Canada, Andres and Diaz-Uriarte, Ramon},
	Date-Added = {2009-07-10 09:35:02 +0200},
	Date-Modified = {2009-07-10 09:35:02 +0200},
	Doi = {10.1186/1471-2105-8-9},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {9},
	Pubmedid = {17214880},
	Title = {IDconverter and IDClight: Conversion and annotation of gene and protein IDs},
	Url = {http://www.biomedcentral.com/1471-2105/8/9},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/8/9},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-8-9}}

@article{dai2005evolving,
	Abstract = {Genome-wide expression profiling is a powerful tool for implicating novel gene ensembles in cellular mechanisms of health and disease. The most popular platform for genome-wide expression profiling is the Affymetrix GeneChip. However, its selection of probes relied on earlier genome and transcriptome annotation which is significantly different from current knowledge. The resultant informatics problems have a profound impact on analysis and interpretation the data. Here, we address these critical issues and offer a solution. We identified several classes of problems at the individual probe level in the existing annotation, under the assumption that current genome and transcriptome databases are more accurate than those used for GeneChip design. We then reorganized probes on more than a dozen popular GeneChips into gene-, transcript- and exon-specific probe sets in light of up-to-date genome, cDNA/EST clustering and single nucleotide polymorphism information. Comparing analysis results between the original and the redefined probe sets reveals [~]30-50% discrepancy in the genes previously identified as differentially expressed, regardless of analysis method. Our results demonstrate that the original Affymetrix probe set definitions are inaccurate, and many conclusions derived from past GeneChip analyses may be significantly flawed. It will be beneficial to re-analyze existing GeneChip data with updated probe set definitions.
},
	Author = {Dai, Manhong and Wang, Pinglang and Boyd, Andrew D. and Kostov, Georgi and Athey, Brian and Jones, Edward G. and Bunney, William E. and Myers, Richard M. and Speed, Terry P. and Akil, Huda and Watson, Stanley J. and Meng, Fan},
	Date-Added = {2009-07-07 13:45:19 +0200},
	Date-Modified = {2009-07-07 13:45:19 +0200},
	Doi = {10.1093/nar/gni179},
	Eprint = {http://nar.oxfordjournals.org/cgi/reprint/33/20/e175.pdf},
	Journal = {Nucl. Acids Res.},
	Number = {20},
	Pages = {e175-},
	Title = {{Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data}},
	Url = {http://nar.oxfordjournals.org/cgi/content/abstract/33/20/e175},
	Volume = {33},
	Year = {2005},
	Bdsk-Url-1 = {http://nar.oxfordjournals.org/cgi/content/abstract/33/20/e175},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/nar/gni179}}

@article{thomassen2006prediction,
	Abstract = {Promising results for prediction of outcome in breast cancer have been obtained by genome wide gene expression profiling. Some studies have suggested that an extensive overtreatment of breast cancer patients might be reduced by risk assessment with gene expression profiling. A patient group hardly examined in these studies is the low-risk patients for whom outcome is very difficult to predict with currently used methods. These patients do not receive adjuvant treatment according to the guidelines of the Danish Breast Cancer Cooperative Group (DBCG). In this study, 26 tumors from low-risk patients were examined with gene expression profiling. An intermediate risk group of 34 low-malignant T2 tumors that fulfilled all other low-risk criteria than tumor size was included to increase statistical power. A 32-gene classifier, HUMAC32, was identified and it predicted metastases with 80\% sensitivity and 77\% specificity. The classifier was also validated in an independent group of high-risk tumors resulting in comparable performance of HUMAC32 and a 70-gene classifier developed for this group. Furthermore, the 70-gene signature was tested in our low- and intermediate-risk samples. The results demonstrated high cross-platform consistency of the classifiers. Higher performance of HUMAC32 was demonstrated among the low-malignant cancers compared with the 70-gene classifier. This suggests that although the metastatic potential to some extend is determined by the same genes in groups of tumors with different characteristics and risk, expression-based classification specifically developed in low-risk patients have higher predictive power in this group.},
	Author = {Thomassen, Mads and Tan, Qihua and Eiriksdottir, Freyja and Bak, Martin and Cold, S{\o}ren and Kruse, Torben A},
	Date-Added = {2009-06-30 12:03:27 +0200},
	Date-Modified = {2009-06-30 12:05:01 +0200},
	Doi = {10.1002/ijc.22449},
	Journal = {Int J Cancer},
	Journal-Full = {International journal of cancer. Journal international du cancer},
	Mesh = {Breast Neoplasms; Female; Gene Expression Profiling; Humans; Middle Aged; Neoplasm Metastasis; Prognosis; RNA, Messenger; Tumor Markers, Biological},
	Month = {Mar},
	Number = {5},
	Pages = {1070-5},
	Pmid = {17131339},
	Title = {Prediction of metastasis from low-malignant breast cancer by gene expression profiling},
	Volume = {120},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/ijc.22449}}

@article{thomassen2008gene,
	Abstract = {BACKGROUND:Metastasis is believed to progress in several steps including different pathways but the determination and understanding of these mechanisms is still fragmentary. Microarray analysis of gene expression patterns in breast tumors has been used to predict outcome in recent studies. Besides classification of outcome, these global expression patterns may reflect biological mechanisms involved in metastasis of breast cancer. Our purpose has been to investigate pathways and transcription factors involved in metastasis by use of gene expression data sets.METHODS:We have analyzed 8 publicly available gene expression data sets. A global approach, "gene set enrichment analysis" as well as an approach focusing on a subset of significantly differently regulated genes, GenMAPP, has been applied to rank pathway gene sets according to differential regulation in metastasizing tumors compared to non-metastasizing tumors. Meta-analysis has been used to determine overrepresentation of pathways and transcription factors targets, concordant deregulated in metastasizing breast tumors, in several data sets.RESULTS:The major findings are up-regulation of cell cycle pathways and a metabolic shift towards glucose metabolism reflected in several pathways in metastasizing tumors. Growth factor pathways seem to play dual roles; EGF and PDGF pathways are decreased, while VEGF and sex-hormone pathways are increased in tumors that metastasize. Furthermore, migration, proteasome, immune system, angiogenesis, DNA repair and several signal transduction pathways are associated to metastasis. Finally several transcription factors e.g. E2F, NFY, and YY1 are identified as being involved in metastasis.CONCLUSION:By pathway meta-analysis many biological mechanisms beyond major characteristics such as proliferation are identified. Transcription factor analysis identifies a number of key factors that support central pathways. Several previously proposed treatment targets are identified and several new pathways that may constitute new targets are identified.},
	Author = {Thomassen, Mads and Tan, Qihua and Kruse, Torben},
	Date-Added = {2009-06-30 11:55:13 +0200},
	Date-Modified = {2009-06-30 11:55:13 +0200},
	Doi = {10.1186/1471-2407-8-394},
	Issn = {1471-2407},
	Journal = {BMC Cancer},
	Number = {1},
	Pages = {394},
	Pubmedid = {19116006},
	Title = {Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer},
	Url = {http://www.biomedcentral.com/1471-2407/8/394},
	Volume = {8},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2407/8/394},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2407-8-394}}

@article{andre2009molecular,
	Abstract = {Purpose: We used high-resolution oligonucleotide comparative genomic hybridization (CGH) arrays and matching gene expression array data to identify dysregulated genes and to classify breast cancers according to gene copy number anomalies.  Experimental Design: DNA was extracted from 106 pretreatment fine needle aspirations of stage II-III breast cancers that received preoperative chemotherapy. CGH was done using Agilent Human 4 x 44K arrays. Gene expression data generated with Affymetrix U133A gene chips was also available on 103 patients. All P values were adjusted for multiple comparisons.  Results: The average number of copy number abnormalities in individual tumors was 76 (range 1-318). Eleven and 37 distinct minimal common regions were gained or lost in >20% of samples, respectively. Several potential therapeutic targets were identified, including FGFR1 that showed high-level amplification in 10% of cases. Close correlation between DNA copy number and mRNA expression levels was detected. Nonnegative matrix factorization (NMF) clustering of DNA copy number aberrations revealed three distinct molecular classes in this data set. NMF class I was characterized by a high rate of triple-negative cancers (64%) and gains of 6p21. VEGFA, E2F3, and NOTCH4 were also gained in 29% to 34% of triple-negative tumors. A gain of ERBB2 gene was observed in 52% of NMF class II and class III was characterized by a high rate of estrogen receptor-positive tumors (73%) and a low rate of pathologic complete response to preoperative chemotherapy (3%).  Conclusion: The present study identified dysregulated genes that could classify breast cancer and may represent novel therapeutic targets for molecular subsets of cancers.
},
	Author = {Andre, Fabrice and Job, Bastien and Dessen, Philippe and Tordai, Attila and Michiels, Stefan and Liedtke, Cornelia and Richon, Catherine and Yan, Kai and Wang, Bailang and Vassal, Gilles and Delaloge, Suzette and Hortobagyi, Gabriel N. and Symmans, W. Fraser and Lazar, Vladimir and Pusztai, Lajos},
	Date-Added = {2009-06-29 15:06:19 +0200},
	Date-Modified = {2009-06-29 15:06:31 +0200},
	Doi = {10.1158/1078-0432.CCR-08-1791},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/15/2/441.pdf},
	Journal = {Clin Cancer Res},
	Number = {2},
	Pages = {441-451},
	Title = {{Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/15/2/441},
	Volume = {15},
	Year = {2009},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/15/2/441},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-08-1791}}

@article{carrivick2006identification,
	Abstract = {We apply a new Bayesian data analysis technique (latent process decomposition) to four recent microarray datasets for breast cancer. Compared to hierarchical cluster analysis, for example, this technique has advantages such as objective assessment of the optimal number of sample or gene clusters in the data, penalization of overcomplex models fitting to noise in the data and a common latent space of explanatory variables for samples and genes. Our analysis provides a clearer insight into these datasets, enabling assignment of patients to one of four principal processes, each with a distinct clinical outcome. One process is indolent and associated with under-expression across a number of genes associated with tumour growth. One process is associated with over expression of  and . The most aggressive process is associated with abnormal expression of transcription factor genes, including members of the  family of transcription factor genes.
},
	Author = {Carrivick, L and Rogers, S and Clark, J and Campbell, C and Girolami, M and Cooper, C},
	Date-Added = {2009-06-29 10:02:19 +0200},
	Date-Modified = {2009-06-29 10:02:19 +0200},
	Doi = {10.1098/rsif.2005.0093},
	Eprint = {http://rsif.royalsocietypublishing.org/content/3/8/367.full.pdf+html},
	Journal = {Journal of The Royal Society Interface},
	Number = {8},
	Pages = {367-381},
	Title = {{Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques}},
	Url = {http://rsif.royalsocietypublishing.org/content/3/8/367.abstract},
	Volume = {3},
	Year = {2006},
	Bdsk-Url-1 = {http://rsif.royalsocietypublishing.org/content/3/8/367.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1098/rsif.2005.0093}}

@article{lancashire2009validated,
	Abstract = {Gene expression microarrays allow for the high throughput analysis of huge numbers of gene transcripts and this technology has been widely applied to the molecular and biological classification of cancer patients and in predicting clinical outcome. A potential handicap of such data intensive molecular technologies is the translation to clinical application in routine practice. In using an artificial neural network bioinformatic approach, we have reduced a 70 gene signature to just 9 genes capable of accurately predicting distant metastases in the original dataset. Upon validation in a follow-up cohort, this signature was an independent predictor of metastases free and overall survival in the presence of the 70 gene signature and other factors. Interestingly, the ANN signature and CA9 expression also split the groups defined by the 70 gene signature into prognostically distinct groups. Subsequently, the presence of protein for the principal prognosticator gene was categorically assessed in breast cancer tissue of an experimental and independent validation patient cohort, using immunohistochemistry. Importantly our principal prognosticator, CA9, showed that it is capable of selecting an aggressive subgroup of patients who are known to have poor prognosis.},
	Author = {Lancashire, L J and Powe, D G and Reis-Filho, J S and Rakha, E and Lemetre, C and Weigelt, B and Abdel-Fatah, T M and Green, A R and Mukta, R and Blamey, R and Paish, E C and Rees, R C and Ellis, I O and Ball, G R},
	Date-Added = {2009-06-27 08:09:49 +0200},
	Date-Modified = {2009-06-27 08:10:12 +0200},
	Doi = {10.1007/s10549-009-0378-1},
	Journal = {Breast Cancer Res Treat},
	Journal-Full = {Breast cancer research and treatment},
	Month = {Apr},
	Pmid = {19347577},
	Title = {A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-009-0378-1}}

@article{gerds2008performance,
	Abstract = {For medical decision making and patient information, predictions of future status variables play an important role. Risk prediction models can be derived with many different statistical approaches. To compare them, measures of predictive performance are derived from ROC methodology and from probability forecasting theory. These tools can be applied to assess single markers, multivariable regression models and complex model selection algorithms. This article provides a systematic review of the modern way of assessing risk prediction models. Particular attention is put on proper benchmarks and resampling techniques that are important for the interpretation of measured performance. All methods are illustrated with data from a clinical study in head and neck cancer patients.},
	Address = {Department of Biostatistics, Oster Farimagsgade 5 opg. B, Postboks 2099, 1014 Kobenhavn. tag@biostat.ku.dk},
	Author = {Gerds, Thomas A and Cai, Tianxi and Schumacher, Martin},
	Copyright = {(c) 2008 WILEY-VCH Verlag GmbH \& Co. KGaA, Weinheim},
	Crdt = {2008/07/30 09:00},
	Da = {20080804},
	Date = {2008 Aug},
	Date-Added = {2009-06-26 17:32:11 +0200},
	Date-Modified = {2009-06-26 17:32:25 +0200},
	Dcom = {20081103},
	Doi = {10.1002/bimj.200810443},
	Edat = {2008/07/30 09:00},
	Issn = {1521-4036 (Electronic)},
	Jid = {7708048},
	Journal = {Biom J},
	Jt = {Biometrical journal. Biometrische Zeitschrift},
	Language = {eng},
	Mh = {Algorithms; Benchmarking; Bias (Epidemiology); *Decision Making, Computer-Assisted; Head and Neck Neoplasms/diagnosis; Humans; *Models, Statistical; Prognosis; ROC Curve; Risk Assessment/methods},
	Mhda = {2008/11/04 09:00},
	Month = {Aug},
	Number = {4},
	Own = {NLM},
	Pages = {457--479},
	Pl = {Germany},
	Pmid = {18663757},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Rf = {83},
	Sb = {IM},
	Source = {Biom J. 2008 Aug;50(4):457-79.},
	Status = {MEDLINE},
	Title = {The performance of risk prediction models.},
	Volume = {50},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/bimj.200810443}}

@article{gonen2005concordance,
	Abstract = {The concordance probability is used to evaluate the discriminatory power and the predictive accuracy of nonlinear statistical models. We derive an analytical expression for the concordance probability in the Cox proportional hazards model. The proposed estimator is a function of the regression parameters and the covariate distribution only and does not use the observed event and censoring times. For this reason it is asymptotically unbiased, unlike Harrell's c-index based on informative pairs. The asymptotic distribution of the concordance probability estimate is derived using U-statistic theory and the methodology is applied to a predictive model in lung cancer.
},
	Author = {Gonen, Mithat and Heller, Glenn},
	Date-Added = {2009-06-26 16:37:09 +0200},
	Date-Modified = {2009-06-26 16:37:09 +0200},
	Doi = {10.1093/biomet/92.4.965},
	Eprint = {http://biomet.oxfordjournals.org/cgi/reprint/92/4/965.pdf},
	Journal = {Biometrika},
	Number = {4},
	Pages = {965-970},
	Title = {{Concordance probability and discriminatory power in proportional hazards regression}},
	Url = {http://biomet.oxfordjournals.org/cgi/content/abstract/92/4/965},
	Volume = {92},
	Year = {2005},
	Bdsk-Url-1 = {http://biomet.oxfordjournals.org/cgi/content/abstract/92/4/965},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/biomet/92.4.965}}

@article{rody2007poor,
	Abstract = {Purpose: A common characteristic of mammary carcinomas is an inverse relationship between the estrogen receptor (ER) status and the proliferative activity of the tumor. Yet, a subset of ER-positive breast cancers is characterized by a high proliferation, suggesting malfunctions in ER responsiveness that influence the biological and therapeutic behavior of tumor cells. The expression of several ER-dependent genes seems to be dysregulated among those "uncoupled" tumors. One of those genes is plexin B1, a cell-surface receptor for the semaphorin Sema4D (CD 100). However, the biological role of plexin B1 in breast cancer is largely unknown.  Experimental Design: Expression data of plexin B1 were obtained from Affymetrix microarray analysis of n = 119 breast cancer specimens. Validation was done by quantitative real-time PCR and protein expression was evaluated by immunohistochemistry. Expression data were compared with clinical characteristics as well as follow-up data of the disease.  Results: Low plexin B1 expression levels characterize a more aggressive tumor phenotype. The expression of plexin B1 is strongly correlated with the ER status. However, even among ER-positive tumors, loss of plexin B1 is associated with an impaired prognosis of breast cancer patients in both univariate (all patients, P = 0.0062; ER positive, P = 0.0107) and multivariate analyses (all patients, P = 0.032; ER positive, P = 0.022). Immunohistochemistry reveals that the tumor cells themselves and not the endothelial cells are the major source of plexin B1 expression in the tumor.  Conclusion: Plexin B1 acts not only as a new important prognostic but should also represent a predictive marker indicating an endocrine resistance. These data give a new insight in markers that could be involved in endocrine dysregulation of breast cancer.
},
	Author = {Rody, Achim and Holtrich, Uwe and Gaetje, Regine and Gehrmann, Mathias and Engels, Knut and von Minckwitz, Gunter and Loibl, Sibylle and Diallo-Danebrock, Raihanatou and Ruckhaberle, Eugen and Metzler, Dirk and Ahr, Andre and Solbach, Christine and Karn, Thomas and Kaufmann, Manfred},
	Date-Added = {2009-06-17 10:32:20 +0200},
	Date-Modified = {2009-06-17 10:32:20 +0200},
	Doi = {10.1158/1078-0432.CCR-06-2433},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/13/4/1115.pdf},
	Journal = {Clin Cancer Res},
	Number = {4},
	Pages = {1115-1122},
	Title = {{Poor Outcome in Estrogen Receptor-Positive Breast Cancers Predicted by Loss of Plexin B1}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/4/1115},
	Volume = {13},
	Year = {2007},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/4/1115},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-06-2433}}

@article{ruckhaberle2007microarray,
	Abstract = {Beside their structural role for the cell membrane the family of sphingolipids act as effector molecules in signal transduction with links to various aspects of cancer initiation, progression and treatment response. The "sphingolipid rheostat" balances between apoptosis inducing ceramid and growth promoting sphingosine-1-phosphate. We analyzed gene expression of 43 proteins from this pathway in different subtypes of breast cancer using microarray data of 1,269 tumor samples (test set n=171; validation sets n=1098) and observed significant differences for several genes. Sphingosine kinase 1 (SPHK1), ceramide galactosyltransferase (UGT8), and Ganglioside GD3-Synthase (ST8SIA1) displayed higher expression among ER negative tumors. In contrast, glucosylceramidsynthase (GCS), dihydroceramidsynthases (LASS4, LASS 6) and acid ceramidase (ASAH1) were higher expressed in ER positive samples. Survival analysis revealed a worse outcome of patients with high SPHK1 expression. To avoid a confounding effect of the ER status we also restricted the analysis to 750 patients with ER positive tumors. Again a worse outcome was observed for tumors displaying high SPHK1 expression. While 75.8+/-1.9% of the patients with tumors low in SPHK1 expression were free of metastasis at 5 years, this was the case for only 64.9+/-3.6% of patients with tumors displaying high SPHK1 expression (P=0.008). Immunohistochemistry identified the carcinoma cells as the major source of SPHK1 expression in the tumor. The correlation of SPHK1 with a poor prognosis as well as its high expression among ER negative tumors are in line with the antiapoptotic and proliferative properties of its product sphingosine-1-phosphate. Targeting of the sphingolipid rheostat may thus open new treatment options.},
	Address = {Department of Gynecology, J. W. Goethe-University, 60590, Frankfurt, Germany.},
	Author = {Ruckhaberle, Eugen and Rody, Achim and Engels, Knut and Gaetje, Regine and von Minckwitz, Gunter and Schiffmann, Susanne and Grosch, Sabine and Geisslinger, Gerd and Holtrich, Uwe and Karn, Thomas and Kaufmann, Manfred},
	Crdt = {2007/12/07 09:00},
	Da = {20080930},
	Date = {2008 Nov},
	Date-Added = {2009-06-17 10:25:28 +0200},
	Date-Modified = {2009-06-17 10:25:39 +0200},
	Dcom = {20081210},
	Dep = {20071204},
	Doi = {10.1007/s10549-007-9836-9},
	Edat = {2007/12/07 09:00},
	Issn = {0167-6806 (Print)},
	Jid = {8111104},
	Journal = {Breast Cancer Res Treat},
	Jt = {Breast cancer research and treatment},
	Language = {eng},
	Mh = {Breast Neoplasms/*enzymology/pathology; Carcinoma, Ductal, Breast/enzymology/pathology; Carcinoma, Lobular/enzymology/pathology; Female; *Gene Expression Profiling; Humans; Immunoenzyme Techniques; Lysophospholipids/*metabolism; Middle Aged; *Oligonucleotide Array Sequence Analysis; Phosphotransferases (Alcohol Group Acceptor)/genetics/*metabolism; Prognosis; Receptor, erbB-2/metabolism; Receptors, Estrogen/metabolism; Sphingosine/*analogs \& derivatives/metabolism; Survival Rate; Tumor Markers, Biological/genetics/metabolism},
	Mhda = {2008/12/17 09:00},
	Month = {Nov},
	Number = {1},
	Own = {NLM},
	Pages = {41--52},
	Phst = {2007/11/20 {$[$}received{$]$}; 2007/11/20 {$[$}accepted{$]$}; 2007/12/04 {$[$}aheadofprint{$]$}},
	Pl = {Netherlands},
	Pmid = {18058224},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Lysophospholipids); 0 (Receptors, Estrogen); 0 (Tumor Markers, Biological); 123-78-4 (Sphingosine); 26993-30-6 (sphingosine 1-phosphate); EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)); EC 2.7.1.- (sphingosine kinase); EC 2.7.1.112 (Receptor, erbB-2)},
	Sb = {IM},
	Source = {Breast Cancer Res Treat. 2008 Nov;112(1):41-52. Epub 2007 Dec 4.},
	Status = {MEDLINE},
	Title = {Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.},
	Volume = {112},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-007-9836-9}}

@article{yu2008precisely,
	Abstract = {Successful tumor development and progression involves the complex interplay of both pro- and anti-oncogenic signaling pathways. Genetic components balancing these opposing activities are likely to require tight regulation, because even subtle alterations in their expression may disrupt this balance with major consequences for various cancer-associated phenotypes. Here, we describe a cassette of cancer-specific genes exhibiting precise transcriptional control in solid tumors. Mining a database of tumor gene expression profiles from six different tissues, we identified 48 genes exhibiting highly restricted levels of gene expression variation in tumors (n = 270) compared to nonmalignant tissues (n = 71). Comprising genes linked to multiple cancer-related pathways, the restricted expression of this "Poised Gene Cassette" (PGC) was robustly validated across 11 independent cohorts of approximately 1,300 samples from multiple cancer types. In three separate experimental models, subtle alterations in PGC expression were consistently associated with significant differences in metastatic and invasive potential. We functionally confirmed this association in siRNA knockdown experiments of five PGC genes (p53CSV, MAP3K11, MTCH2, CPSF6, and SKIP), which either directly enhanced the invasive capacities or inhibited the proliferation of AGS cancer cells. In primary tumors, similar subtle alterations in PGC expression were also repeatedly associated with clinical outcome in multiple cohorts. Taken collectively, these findings support the existence of a common set of precisely controlled genes in solid tumors. Since inducing small activity changes in these genes may prove sufficient to potently influence various tumor phenotypes such as metastasis, targeting such precisely regulated genes may represent a promising avenue for novel anti-cancer therapies.},
	Address = {National Cancer Centre, Singapore, Singapore.},
	Author = {Yu, Kun and Ganesan, Kumaresan and Tan, Lay Keng and Laban, Mirtha and Wu, Jeanie and Zhao, Xiao Dong and Li, Hongmin and Leung, Carol Ho Wing and Zhu, Yansong and Wei, Chia Lin and Hooi, Shing Chuan and Miller, Lance and Tan, Patrick},
	Crdt = {2008/07/19 09:00},
	Da = {20080718},
	Date = {2008},
	Date-Added = {2009-06-17 09:29:37 +0200},
	Date-Modified = {2009-06-17 09:29:59 +0200},
	Dcom = {20080915},
	Dep = {20080718},
	Doi = {10.1371/journal.pgen.1000129},
	Edat = {2008/07/19 09:00},
	Issn = {1553-7404 (Electronic)},
	Jid = {101239074},
	Journal = {PLoS Genet},
	Jt = {PLoS genetics},
	Language = {eng},
	Lr = {20081120},
	Mh = {Animals; Cohort Studies; Colonic Neoplasms/genetics/pathology; Computational Biology/methods; Databases, Factual; Gene Expression Profiling; *Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Metastasis/*genetics/*physiopathology; Neoplasms/genetics/*metabolism; Oligonucleotide Array Sequence Analysis; RNA, Small Interfering; Reproducibility of Results; Sensitivity and Specificity; *Survival; Transcription, Genetic; Xenograft Model Antitumor Assays},
	Mhda = {2008/09/16 09:00},
	Number = {7},
	Oid = {NLM: PMC2444049},
	Own = {NLM},
	Pages = {e1000129},
	Phst = {2008/01/15 {$[$}received{$]$}; 2008/06/17 {$[$}accepted{$]$}},
	Pl = {United States},
	Pmc = {PMC2444049},
	Pmid = {18636107},
	Pst = {epublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (RNA, Small Interfering)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers.},
	Volume = {4},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pgen.1000129}}

@article{karn2009data,
	Abstract = {Pooling of microarray datasets seems to be a reasonable approach to increase sample size when a heterogeneous disease like breast cancer is concerned. Different methods for the adaption of datasets have been used in the literature. We have analyzed influences of these strategies using a pool of 3,030 Affymetrix U133A microarrays from breast cancer samples. We present data on the resulting concordance with biochemical assays of well known parameters and highlight critical pitfalls. We further propose a method for the inference of cutoff values directly from the data without prior knowledge of the true result. The cutoffs derived by this method displayed high specificity and sensitivity. Markers with a bimodal distribution like ER, PgR, and HER2 discriminate different biological subtypes of disease with distinct clinical courses. In contrast, markers displaying a continuous distribution like proliferation markers as Ki67 rather describe the composition of the mixture of cells in the tumor.},
	Address = {Department of Obstetrics and Gynecology, J. W. Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany, t.karn@em.uni-frankfurt.de.},
	Author = {Karn, T and Metzler, D and Ruckhaberle, E and Hanker, L and Gatje, R and Solbach, C and Ahr, A and Schmidt, M and Holtrich, U and Kaufmann, M and Rody, A},
	Crdt = {2009/05/21 09:00},
	Da = {20090520},
	Date = {2009 May 20},
	Date-Added = {2009-06-17 08:37:55 +0200},
	Date-Modified = {2009-06-17 08:38:11 +0200},
	Dep = {20090520},
	Doi = {10.1007/s10549-009-0416-z},
	Edat = {2009/05/21 09:00},
	Issn = {1573-7217 (Electronic)},
	Jid = {8111104},
	Journal = {Breast Cancer Res Treat},
	Jt = {Breast cancer research and treatment},
	Language = {ENG},
	Mhda = {2009/05/21 09:00},
	Month = {May},
	Own = {NLM},
	Phst = {2009/02/04 {$[$}received{$]$}; 2009/04/29 {$[$}accepted{$]$}; 2009/05/20 {$[$}aheadofprint{$]$}},
	Pmid = {19455418},
	Pst = {aheadofprint},
	Pt = {JOURNAL ARTICLE},
	Status = {Publisher},
	Title = {Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-009-0416-z}}

@article{sjoblom2006consensus,
	Abstract = {The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of approximately 90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.},
	Address = {Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.},
	Author = {Sjoblom, Tobias and Jones, Sian and Wood, Laura D and Parsons, D Williams and Lin, Jimmy and Barber, Thomas D and Mandelker, Diana and Leary, Rebecca J and Ptak, Janine and Silliman, Natalie and Szabo, Steve and Buckhaults, Phillip and Farrell, Christopher and Meeh, Paul and Markowitz, Sanford D and Willis, Joseph and Dawson, Dawn and Willson, James K V and Gazdar, Adi F and Hartigan, James and Wu, Leo and Liu, Changsheng and Parmigiani, Giovanni and Park, Ben Ho and Bachman, Kurtis E and Papadopoulos, Nickolas and Vogelstein, Bert and Kinzler, Kenneth W and Velculescu, Victor E},
	Cin = {Science. 2007 Feb 9;315(5813):762-4; author reply 764-5. PMID: 17297725; Science. 2007 Feb 9;315(5813):762; author reply 764-5. PMID: 17289959; Science. 2007 Feb 9;315(5813):762; author reply 764-5. PMID: 17297724; Science. 2007 Sep 14;317(5844):1500. PMID: 17872428; Science. 2007 Sep 14;317(5844):1500. PMID: 17872429; Science. 2007 Sep 14;317(5844):1500; author reply 1500. PMID: 17872427},
	Crdt = {2006/09/09 09:00},
	Da = {20061013},
	Date = {2006 Oct 13},
	Date-Added = {2009-06-11 14:18:51 +0200},
	Date-Modified = {2009-06-11 14:19:03 +0200},
	Dcom = {20061025},
	Dep = {20060907},
	Doi = {10.1126/science.1133427},
	Edat = {2006/09/09 09:00},
	Gr = {CA 121113/CA/NCI NIH HHS/United States; CA 43460/CA/NCI NIH HHS/United States; CA 57345/CA/NCI NIH HHS/United States; CA 62924/CA/NCI NIH HHS/United States; CA109274/CA/NCI NIH HHS/United States; GM 07309/GM/NIGMS NIH HHS/United States; HHSN261200433002C/PHS HHS/United States; P30-CA43703/CA/NCI NIH HHS/United States; RR 017698/RR/NCRR NIH HHS/United States},
	Issn = {1095-9203 (Electronic)},
	Jid = {0404511},
	Journal = {Science},
	Jt = {Science (New York, N.Y.)},
	Language = {eng},
	Lr = {20071114},
	Mh = {Amino Acid Substitution; Breast Neoplasms/*genetics; Cell Line, Tumor; Colorectal Neoplasms/*genetics; Computational Biology; *Consensus Sequence; Databases, Nucleic Acid; Female; *Genes, Neoplasm; Genome, Human; Humans; Male; *Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA},
	Mhda = {2006/10/26 09:00},
	Month = {Oct},
	Number = {5797},
	Own = {NLM},
	Pages = {268--274},
	Phst = {2006/09/07 {$[$}aheadofprint{$]$}},
	Pii = {1133427},
	Pl = {United States},
	Pmid = {16959974},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {The consensus coding sequences of human breast and colorectal cancers.},
	Volume = {314},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1133427}}

@article{greenman2007patterns,
	Abstract = {Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.},
	Address = {Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.},
	Author = {Greenman, Christopher and Stephens, Philip and Smith, Raffaella and Dalgliesh, Gillian L and Hunter, Christopher and Bignell, Graham and Davies, Helen and Teague, Jon and Butler, Adam and Stevens, Claire and Edkins, Sarah and O'Meara, Sarah and Vastrik, Imre and Schmidt, Esther E and Avis, Tim and Barthorpe, Syd and Bhamra, Gurpreet and Buck, Gemma and Choudhury, Bhudipa and Clements, Jody and Cole, Jennifer and Dicks, Ed and Forbes, Simon and Gray, Kris and Halliday, Kelly and Harrison, Rachel and Hills, Katy and Hinton, Jon and Jenkinson, Andy and Jones, David and Menzies, Andy and Mironenko, Tatiana and Perry, Janet and Raine, Keiran and Richardson, Dave and Shepherd, Rebecca and Small, Alexandra and Tofts, Calli and Varian, Jennifer and Webb, Tony and West, Sofie and Widaa, Sara and Yates, Andy and Cahill, Daniel P and Louis, David N and Goldstraw, Peter and Nicholson, Andrew G and Brasseur, Francis and Looijenga, Leendert and Weber, Barbara L and Chiew, Yoke-Eng and DeFazio, Anna and Greaves, Mel F and Green, Anthony R and Campbell, Peter and Birney, Ewan and Easton, Douglas F and Chenevix-Trench, Georgia and Tan, Min-Han and Khoo, Sok Kean and Teh, Bin Tean and Yuen, Siu Tsan and Leung, Suet Yi and Wooster, Richard and Futreal, P Andrew and Stratton, Michael R},
	Cin = {Nature. 2007 Mar 8;446(7132):145-6. PMID: 17344839},
	Crdt = {2007/03/09 09:00},
	Da = {20070308},
	Date = {2007 Mar 8},
	Date-Added = {2009-06-11 14:17:00 +0200},
	Date-Modified = {2009-06-11 14:17:13 +0200},
	Dcom = {20070327},
	Doi = {10.1038/nature05610},
	Edat = {2007/03/09 09:00},
	Gr = {Wellcome Trust/United Kingdom},
	Issn = {1476-4687 (Electronic)},
	Jid = {0410462},
	Journal = {Nature},
	Jt = {Nature},
	Language = {eng},
	Lr = {20070813},
	Mh = {Amino Acid Sequence; DNA Mutational Analysis; Genes, Neoplasm/*genetics; Genome, Human/*genetics; *Genomics; Humans; Molecular Sequence Data; Mutation/*genetics; Neoplasm Proteins/chemistry/genetics; Neoplasms/*genetics; Protein Kinases/chemistry/genetics},
	Mhda = {2007/03/28 09:00},
	Month = {Mar},
	Number = {7132},
	Own = {NLM},
	Pages = {153--158},
	Phst = {2006/09/07 {$[$}received{$]$}; 2007/01/18 {$[$}accepted{$]$}},
	Pii = {nature05610},
	Pl = {England},
	Pmid = {17344846},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't},
	Rn = {0 (Neoplasm Proteins); EC 2.7.1.37 (Protein Kinases)},
	Sb = {IM},
	Source = {Nature. 2007 Mar 8;446(7132):153-8.},
	Status = {MEDLINE},
	Title = {Patterns of somatic mutation in human cancer genomes.},
	Volume = {446},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature05610}}

@article{mosley2008cell,
	Abstract = {BACKGROUND:Numerous gene lists or "classifiers" have been derived from global gene expression data that assign breast cancers to good and poor prognosis groups. A remarkable feature of these molecular signatures is that they have few genes in common, prompting speculation that they may use distinct genes to measure the same pathophysiological process(es), such as proliferation. However, this supposition has not been rigorously tested. If gene-based classifiers function by measuring a minimal number of cellular processes, we hypothesized that the informative genes for these processes could be identified and the data sets could be adjusted for the predictive contributions of those genes. Such adjustment would then attenuate the predictive function of any signature measuring that same process.RESULTS:We tested this hypothesis directly using a novel iterative-subtractive approach. We evaluated five gene expression data sets that sample a broad range of breast cancer subtypes. In all data sets, the dominant cluster capable of predicting metastasis was heavily populated by genes that fluctuate in concert with the cell cycle. When six well-characterized classifiers were examined, all contained a higher than expected proportion of genes that correlate with this cluster. Furthermore, when the data sets were globally adjusted for the cell cycle cluster, each classifier lost its ability to assign tumors to appropriate high and low risk groups. In contrast, adjusting for other predictive gene clusters did not impact their performance.CONCLUSION:These data indicate that the discriminative ability of breast cancer classifiers is dependent upon genes that correlate with cell cycle progression.},
	Author = {Mosley, Jonathan and Keri, Ruth},
	Date-Added = {2009-06-10 10:36:46 +0200},
	Date-Modified = {2009-06-10 10:36:46 +0200},
	Doi = {10.1186/1755-8794-1-11},
	Issn = {1755-8794},
	Journal = {BMC Medical Genomics},
	Number = {1},
	Pages = {11},
	Pubmedid = {18439262},
	Title = {Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists},
	Url = {http://www.biomedcentral.com/1755-8794/1/11},
	Volume = {1},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1755-8794/1/11},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1755-8794-1-11}}

@article{boehm2007integrative,
	Author = {Boehm, Jesse S. and Zhao, Jean J. and Yao, Jun and Kim, So Young and Firestein, Ron and Dunn, Ian F. and Sjostrom, Sarah K. and Garraway, Levi A. and Weremowicz, Stanislawa and Richardson, Andrea L. and Greulich, Heidi and Stewart, Carly J. and Mulvey, Laura A. and Shen, Rhine R. and Ambrogio, Lauren and Hirozane-Kishikawa, Tomoko and Hill, David E. and Vidal, Marc and Meyerson, Matthew and Grenier, Jennifer K. and Hinkle, Greg and Root, David E. and Roberts, Thomas M. and Lander, Eric S. and Polyak, Kornelia and Hahn, William C.},
	Date-Added = {2009-06-10 09:56:51 +0200},
	Date-Modified = {2009-06-10 09:57:05 +0200},
	Id = {S0092-8674(07)00532-6 DOI - 10.1016/j.cell.2007.03.052},
	Isbn = {0092-8674},
	Month = {06},
	Number = {6},
	Pages = {1065--1079},
	Title = {Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene},
	Ty = {ABST},
	Url = {http://linkinghub.elsevier.com/retrieve/pii/S0092867407005326},
	Volume = {129},
	Year = {2007/06/15},
	Bdsk-Url-1 = {http://linkinghub.elsevier.com/retrieve/pii/S0092867407005326}}

@article{saeed2003tm4,
	Address = {Institute for Genomic Research, Rockville, MD, USA.},
	Author = {Saeed, A I and Sharov, V and White, J and Li, J and Liang, W and Bhagabati, N and Braisted, J and Klapa, M and Currier, T and Thiagarajan, M and Sturn, A and Snuffin, M and Rezantsev, A and Popov, D and Ryltsov, A and Kostukovich, E and Borisovsky, I and Liu, Z and Vinsavich, A and Trush, V and Quackenbush, J},
	Crdt = {2003/03/05 04:00},
	Da = {20030304},
	Date = {2003 Feb},
	Date-Added = {2009-06-09 09:28:11 +0200},
	Date-Modified = {2009-06-09 09:28:33 +0200},
	Dcom = {20030815},
	Edat = {2003/03/05 04:00},
	Issn = {0736-6205 (Print)},
	Jid = {8306785},
	Journal = {Biotechniques},
	Jt = {BioTechniques},
	Language = {eng},
	Lr = {20061115},
	Mh = {*Database Management Systems; Hypermedia; Information Storage and Retrieval/*methods; Oligonucleotide Array Sequence Analysis/*methods; Sequence Alignment; Sequence Analysis, DNA/*methods; *Software; Software Design; User-Computer Interface},
	Mhda = {2003/08/16 05:00},
	Month = {Feb},
	Number = {2},
	Own = {NLM},
	Pages = {374--378},
	Pl = {United States},
	Pmid = {12613259},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {TM4: a free, open-source system for microarray data management and analysis.},
	Volume = {34},
	Year = {2003}}

@article{zhang200876gene,
	Abstract = {Purpose To assess the benefit from adjuvant systemic tamoxifen therapy in breast cancer risk groups identified by the previously established prognostic 76-gene signature. Methods In 300 lymph node-negative (LNN), estrogen receptor-positive (ER+) breast cancer patients (136 treated with adjuvant tamoxifen, 164 having received no systemic adjuvant therapy), distant metastasis-free survival (DMFS) as a function of the 76-gene signature was determined in a multicenter fashion. Results In 136 tamoxifen-treated patients, the 76-gene signature identified a group of patients with a poor prognosis [hazard ratio (HR), 4.62; P = 0.0248]. These patients showed a 12.3% absolute benefit of tamoxifen in 10-year DMFS (HR, 0.52; P = 0.0318) compared with untreated high-risk patients. This represented a 71% increase in relative benefit compared with the 7.2% absolute benefit observed for all 300 patients without using the gene signature. In the low-risk group there was no significant 10-year DMFS benefit of tamoxifen. Conclusions The 76-gene signature defines high-risk patients who benefit from adjuvant tamoxifen therapy. Although we did not study the value of chemotherapy in this study, low-risk patients identified by the 76-gene signature have a prognosis good enough that chemotherapy would be difficult to justify. The prognosis of these patients is sufficiently good, in fact, that a disease-free benefit for tamoxifen therapy is difficult to prove, though benefits in terms of loco-regional relapse and a reduction in risk for contralateral breast cancer might justify hormonal therapy in these patients.},
	Address = {Veridex LLC, Johnson \& Johnson Company, San Diego, CA, USA.},
	Author = {Zhang, Y and Sieuwerts, AM and McGreevy, M and Casey, G and Cufer, T and Paradiso, A and Harbeck, N and Span, PN and Hicks, DG and Crowe, J and Tubbs, RR and Budd, GT and Lyons, J and Sweep, FC and Schmitt, M and Schittulli, F and Golouh, R and Talantov, D and Wang, Y and Foekens, JA},
	Crdt = {2008/09/30 09:00},
	Da = {20080929},
	Date = {2008 Sep 23},
	Date-Added = {2009-05-22 13:15:00 +0200},
	Date-Modified = {2009-05-22 13:15:15 +0200},
	Dep = {20080923},
	Doi = {10.1007/s10549-008-0183-2},
	Edat = {2008/09/30 09:00},
	Issn = {1573-7217 (Electronic)},
	Jid = {8111104},
	Journal = {Breast Cancer Res Treat},
	Jt = {Breast cancer research and treatment},
	Language = {ENG},
	Mhda = {2008/09/30 09:00},
	Month = {Sep},
	Own = {NLM},
	Phst = {2008/08/28 {$[$}received{$]$}; 2008/09/02 {$[$}accepted{$]$}; 2008/09/23 {$[$}aheadofprint{$]$}},
	Pmid = {18821012},
	Pst = {aheadofprint},
	Pt = {JOURNAL ARTICLE},
	Status = {Publisher},
	Title = {The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-008-0183-2}}

@article{quackenbush2007extracting,
	Abstract = {The promise of the genome project was that a complete sequence would provide us with information that would transform biology and medicine. But the `parts list' that has emerged from the genome project is far from the `wiring diagram' and `circuit logic' we need to understand the link between genotype, environment and phenotype. While genomic technologies such as DNA microarrays, proteomics and metabolomics have given us new tools and new sources of data to address these problems, a number of crucial elements remain to be addressed before we can begin to close the loop and develop a predictive quantitative biology that is the stated goal of so much of current biological research, including systems biology. Our approach to this problem has largely been one of integration, bringing together a vast wealth of information to better interpret the experimental data we are generating in genomic assays and creating publicly available databases and software tools to facilitate the work of others. Recently, we have used a similar approach to trying to understand the biological networks that underlie the phenotypic responses we observe and starting us on the road to developing a predictive biology.
},
	Author = {Quackenbush, John},
	Date-Added = {2009-05-11 17:45:01 +0200},
	Date-Modified = {2009-05-11 17:45:01 +0200},
	Doi = {10.1242/jeb.004432},
	Eprint = {http://jeb.biologists.org/cgi/reprint/210/9/1507.pdf},
	Journal = {J Exp Biol},
	Number = {9},
	Pages = {1507-1517},
	Title = {{Extracting biology from high-dimensional biological data}},
	Url = {http://jeb.biologists.org/cgi/content/abstract/210/9/1507},
	Volume = {210},
	Year = {2007},
	Bdsk-Url-1 = {http://jeb.biologists.org/cgi/content/abstract/210/9/1507},
	Bdsk-Url-2 = {http://dx.doi.org/10.1242/jeb.004432}}

@article{brooksbank2006data,
	Abstract = {Access to data is something that every molecular biologist takes for granted nowadays, but data alone is of little use unless it is made available in a useable form through the development and global uptake of data standards. The challenge of standards development has been taken up by grass-roots movements working within several different branches of the biomedical research community. Many of these initiatives are proving extremely successful; for example, the Gene Ontology, which provides a controlled vocabulary for describing the properties of gene products, the Microarray Gene Expression Data Society's standards for describing microarray experiments, and the emerging standards developed by the Proteomics Standards Initiative are gaining broad acceptance. Standards development now faces its greatest ever challenge--the integration of diverse data types to fulfill the goals of systems biology. Now is the time for the communities that are developing these standards, the funding bodies that have invested so heavily in high-throughput data generation, and the publishers of biomedical research papers to cooperate fully to make the goals of integrated data analysis a reality.},
	Address = {EMBL-European Bioinformatics Institute, Hinxton, Cambridge, United Kingdom. cath@ebi.ac.uk},
	Author = {Brooksbank, Cath and Quackenbush, John},
	Crdt = {2006/08/12 09:00},
	Da = {20060811},
	Date = {2006 Summer},
	Date-Added = {2009-05-11 17:43:34 +0200},
	Date-Modified = {2009-05-11 17:43:49 +0200},
	Dcom = {20071107},
	Doi = {10.1089/omi.2006.10.94},
	Edat = {2006/08/12 09:00},
	Issn = {1536-2310 (Print)},
	Jid = {101131135},
	Journal = {OMICS},
	Jt = {Omics : a journal of integrative biology},
	Language = {eng},
	Mh = {Animals; Computational Biology/economics/*standards/trends; Data Collection/economics/*standards; Databases, Factual/economics/*standards/trends; Information Storage and Retrieval/economics/*standards/trends},
	Mhda = {2007/11/08 09:00},
	Month = {Summer},
	Number = {2},
	Own = {NLM},
	Pages = {94--99},
	Pl = {United States},
	Pmid = {16901212},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Rf = {24},
	Sb = {IM},
	Source = {OMICS. 2006 Summer;10(2):94-9.},
	Status = {MEDLINE},
	Title = {Data standards: a call to action.},
	Volume = {10},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1089/omi.2006.10.94}}

@article{djebbari2008seeded,
	Abstract = {BACKGROUND:DNA microarrays and other genomics-inspired technologies provide large datasets that often include hidden patterns of correlation between genes reflecting the complex processes that underlie cellular metabolism and physiology. The challenge in analyzing large-scale expression data has been to extract biologically meaningful inferences regarding these processes - often represented as networks - in an environment where the datasets are often imperfect and biological noise can obscure the actual signal. Although many techniques have been developed in an attempt to address these issues, to date their ability to extract meaningful and predictive network relationships has been limited. Here we describe a method that draws on prior information about gene-gene interactions to infer biologically relevant pathways from microarray data. Our approach consists of using preliminary networks derived from the literature and/or protein-protein interaction data as seeds for a Bayesian network analysis of microarray results.RESULTS:Through a bootstrap analysis of gene expression data derived from a number of leukemia studies, we demonstrate that seeded Bayesian Networks have the ability to identify high-confidence gene-gene interactions which can then be validated by comparison to other sources of pathway data.CONCLUSION:The use of network seeds greatly improves the ability of Bayesian Network analysis to learn gene interaction networks from gene expression data. We demonstrate that the use of seeds derived from the biomedical literature or high-throughput protein-protein interaction data, or the combination, provides improvement over a standard Bayesian Network analysis, allowing networks involving dynamic processes to be deduced from the static snapshots of biological systems that represent the most common source of microarray data. Software implementing these methods has been included in the widely used TM4 microarray analysis package.},
	Author = {Djebbari, Amira and Quackenbush, John},
	Date-Added = {2009-05-11 17:32:19 +0200},
	Date-Modified = {2009-05-11 17:32:19 +0200},
	Doi = {10.1186/1752-0509-2-57},
	Issn = {1752-0509},
	Journal = {BMC Systems Biology},
	Number = {1},
	Pages = {57},
	Pubmedid = {18601736},
	Title = {Seeded Bayesian Networks: Constructing genetic networks from microarray data},
	Url = {http://www.biomedcentral.com/1752-0509/2/57},
	Volume = {2},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1752-0509/2/57},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1752-0509-2-57}}

@article{aryee2008optimized,
	Author = {Aryee, Martin J. A. and Quackenbush, John},
	Date-Added = {2009-05-11 17:31:19 +0200},
	Date-Modified = {2009-05-11 17:31:19 +0200},
	Doi = {10.1021/pr700858e},
	Eprint = {http://pubs.acs.org/doi/pdf/10.1021/pr700858e},
	Journal = {Journal of Proteome Research},
	Number = {9},
	Pages = {4089-4094},
	Title = {An Optimized Predictive Strategy for Interactome Mapping&#x2020;},
	Url = {http://pubs.acs.org/doi/abs/10.1021/pr700858e},
	Volume = {7},
	Year = {2008},
	Bdsk-Url-1 = {http://pubs.acs.org/doi/abs/10.1021/pr700858e},
	Bdsk-Url-2 = {http://dx.doi.org/10.1021/pr700858e}}

@article{kahvejian2009what,
	Annote = {10.1038/nbt1494},
	Author = {Kahvejian, Avak and Quackenbush, John and Thompson, John F},
	Date-Added = {2009-05-11 17:25:40 +0200},
	Date-Modified = {2009-05-11 17:25:40 +0200},
	Isbn = {1087-0156},
	Journal = {Nat Biotech},
	M3 = {10.1038/nbt1494},
	Month = {10},
	Number = {10},
	Pages = {1125--1133},
	Publisher = {Nature Publishing Group},
	Title = {What would you do if you could sequence everything?},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nbt1494},
	Volume = {26},
	Year = {2008/10//print},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt1494}}

@article{mar2009datadriven,
	Abstract = {BACKGROUND:High-throughput real-time quantitative reverse transcriptase polymerase chain reaction (qPCR) is a widely used technique in experiments where expression patterns of genes are to be profiled. Current stage technology allows the acquisition of profiles for a moderate number of genes (50 to a few thousand), and this number continues to grow. The use of appropriate normalization algorithms for qPCR-based data is therefore a highly important aspect of the data preprocessing pipeline.RESULTS:We present and evaluate two data-driven normalization methods that directly correct for technical variation and represent robust alternatives to standard housekeeping gene-based approaches. We evaluated the performance of these methods against a single gene housekeeping gene method and our results suggest that quantile normalization performs best. These methods are implemented in freely-available software as an R package qpcrNorm distributed through the Bioconductor project.CONCLUSION:The utility of the approaches that we describe can be demonstrated most clearly in situations where standard housekeeping genes are regulated by some experimental condition. For large qPCR-based data sets, our approaches represent robust, data-driven strategies for normalization.},
	Author = {Mar, Jessica and Kimura, Yasumasa and Schroder, Kate and Irvine, Katharine and Hayashizaki, Yoshihide and Suzuki, Harukazu and Hume, David and Quackenbush, John},
	Date-Added = {2009-05-11 17:22:27 +0200},
	Date-Modified = {2009-05-11 17:22:37 +0200},
	Doi = {10.1186/1471-2105-10-110},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {110},
	Pubmedid = {19374774},
	Title = {Data-driven normalization strategies for high-throughput quantitative RT-PCR},
	Url = {http://www.biomedcentral.com/1471-2105/10/110},
	Volume = {10},
	Year = {2009},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/10/110},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-10-110}}

@article{eleuteri2003novel,
	Abstract = {A feedforward neural network architecture aimed at survival probability estimation is presented which generalizes the standard, usually linear, models described in literature. The network builds an approximation to the survival probability of a system at a given time, conditional on the system features. The resulting model is described in a hierarchical Bayesian framework. Experiments with synthetic and real world data compare the performance of this model with the commonly used standard ones.},
	Address = {DMA, Universita di Napoli Federico II, Naples, Italy. eleuteri{\char64}na.infn.it},
	Author = {Eleuteri, Antonio and Tagliaferri, Roberto and Milano, Leopoldo and De Placido, Sabino and De Laurentiis, Michele},
	Crdt = {2003/07/10 05:00},
	Da = {20030709},
	Date = {2003 Jun-Jul},
	Date-Added = {2009-04-23 09:41:25 +0200},
	Date-Modified = {2009-04-23 09:41:40 +0200},
	Dcom = {20030916},
	Doi = {10.1016/S0893-6080(03)00098-4},
	Edat = {2003/07/10 05:00},
	Issn = {0893-6080 (Print)},
	Jid = {8805018},
	Journal = {Neural Netw},
	Jt = {Neural networks : the official journal of the International Neural Network Society},
	Language = {eng},
	Lr = {20061115},
	Mh = {Bayes Theorem; *Models, Biological; *Neural Networks (Computer); *Survival Analysis},
	Mhda = {2003/09/17 05:00},
	Month = {Jun-Jul},
	Number = {5-6},
	Own = {NLM},
	Pages = {855--864},
	Pii = {S0893-6080(03)00098-4},
	Pl = {United States},
	Pmid = {12850044},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Sb = {IM},
	Source = {Neural Netw. 2003 Jun-Jul;16(5-6):855-64.},
	Status = {MEDLINE},
	Title = {A novel neural network-based survival analysis model.},
	Volume = {16},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0893-6080(03)00098-4}}

@article{lundin1999artificial,
	Abstract = {In this study, we evaluated the accuracy of a neural network in predicting 5-, 10- and 15-year breast-cancer-specific survival. A series of 951 breast cancer patients was divided into a training set of 651 and a validation set of 300 patients. Eight variables were entered as input to the network: tumor size, axillary nodal status, histological type, mitotic count, nuclear pleomorphism, tubule formation, tumor necrosis and age. The area under the ROC curve (AUC) was used as a measure of accuracy of the prediction models in generating survival estimates for the patients in the independent validation set. The AUC values of the neural network models for 5-, 10- and 15-year breast-cancer-specific survival were 0.909, 0.886 and 0.883, respectively.The corresponding AUC values for logistic regression were 0.897, 0.862 and 0.858. Axillary lymph node status (N0 vs. N+) predicted 5-year survival with a specificity of 71% and a sensitivity of 77%. The sensitivity of the neural network model was 91% at this specificity level. The rate of false predictions at 5 years was 82/300 for nodal status and 40/300 for the neural network. When nodal status was excluded from the neural network model, the rate of false predictions increased only to 49/300 (AUC 0. 877). An artificial neural network is very accurate in the 5-, 10- and 15-year breast-cancer-specific survival prediction. The consistently high accuracy over time and the good predictive performance of a network trained without information on nodal status demonstrate that neural networks can be important tools for cancer survival prediction. Copyright Copyright 1999 S. Karger AG, Basel},
	Address = {Department of Oncology, University of Helsinki, Finland.},
	Author = {Lundin, M and Lundin, J and Burke, H B and Toikkanen, S and Pylkkanen, L and Joensuu, H},
	Crdt = {1999/11/27 00:00},
	Da = {20000119},
	Date = {1999 Nov},
	Date-Added = {2009-04-23 09:35:50 +0200},
	Date-Modified = {2009-04-23 09:36:06 +0200},
	Dcom = {20000119},
	Edat = {1999/11/27},
	Issn = {0030-2414 (Print)},
	Jid = {0135054},
	Journal = {Oncology},
	Jt = {Oncology},
	Language = {eng},
	Lr = {20061115},
	Mh = {Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms/*diagnosis/genetics/*mortality/pathology; Disease-Free Survival; Female; Humans; Logistic Models; Middle Aged; *Neural Networks (Computer); Predictive Value of Tests; Prognosis; Survival Analysis; Survival Rate},
	Mhda = {1999/11/27 00:01},
	Month = {Nov},
	Number = {4},
	Own = {NLM},
	Pages = {281--286},
	Pii = {ocl57281},
	Pl = {SWITZERLAND},
	Pmid = {10575312},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Sb = {IM},
	Source = {Oncology. 1999 Nov;57(4):281-6.},
	Status = {MEDLINE},
	Title = {Artificial neural networks applied to survival prediction in breast cancer.},
	Volume = {57},
	Year = {1999}}

@article{hess2006pharmacogenomic,
	Abstract = {PURPOSE: We developed a multigene predictor of pathologic complete response (pCR) to preoperative weekly paclitaxel and fluorouracil-doxorubicin-cyclophosphamide (T/FAC) chemotherapy and assessed its predictive accuracy on independent cases. PATIENTS AND METHODS: One hundred thirty-three patients with stage I-III breast cancer were included. Pretreatment gene expression profiling was performed with oligonecleotide microarrays on fine-needle aspiration specimens. We developed predictors of pCR from 82 cases and assessed accuracy on 51 independent cases. RESULTS: Overall pCR rate was 26% in both cohorts. In the training set, 56 probes were identified as differentially expressed between pCR versus residual disease, at a false discovery rate of 1%. We examined the performance of 780 distinct classifiers (set of genes + prediction algorithm) in full cross-validation. Many predictors performed equally well. A nominally best 30-probe set Diagonal Linear Discriminant Analysis classifier was selected for independent validation. It showed significantly higher sensitivity (92% v 61%) than a clinical predictor including age, grade, and estrogen receptor status. The negative predictive value (96% v 86%) and area under the curve (0.877 v 0.811) were nominally better but not statistically significant. The combination of genomic and clinical information yielded a predictor not significantly different from the genomic predictor alone. In 31 samples, RNA was hybridized in replicate with resulting predictions that were 97% concordant. CONCLUSION: A 30-probe set pharmacogenomic predictor predicted pCR to T/FAC chemotherapy with high sensitivity and negative predictive value. This test correctly identified all but one of the patients who achieved pCR (12 of 13 patients) and all but one of those who were predicted to have residual disease had residual cancer (27 of 28 patients).},
	Address = {Department of Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA.},
	Author = {Hess, Kenneth R and Anderson, Keith and Symmans, W Fraser and Valero, Vicente and Ibrahim, Nuhad and Mejia, Jaime A and Booser, Daniel and Theriault, Richard L and Buzdar, Aman U and Dempsey, Peter J and Rouzier, Roman and Sneige, Nour and Ross, Jeffrey S and Vidaurre, Tatiana and Gomez, Henry L and Hortobagyi, Gabriel N and Pusztai, Lajos},
	Crdt = {2006/08/10 09:00},
	Da = {20060911},
	Date = {2006 Sep 10},
	Date-Added = {2009-03-30 11:33:00 +0200},
	Date-Modified = {2009-03-30 11:33:11 +0200},
	Dcom = {20060926},
	Dep = {20060808},
	Doi = {10.1200/JCO.2006.05.6861},
	Edat = {2006/08/10 09:00},
	Gr = {R01-CA106290/CA/NCI NIH HHS/United States},
	Issn = {1527-7755 (Electronic)},
	Jid = {8309333},
	Journal = {J Clin Oncol},
	Jt = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
	Language = {eng},
	Lr = {20071114},
	Mh = {Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/*therapeutic use; Breast Neoplasms/*drug therapy/*genetics/pathology; Cyclophosphamide/administration \& dosage; Doxorubicin/administration \& dosage; Female; Fluorouracil/administration \& dosage; Gene Expression Profiling; *Gene Expression Regulation, Neoplastic; Humans; Microarray Analysis; Middle Aged; Neoplasm Staging; Oligonucleotides; Paclitaxel/administration \& dosage; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Sensitivity and Specificity},
	Mhda = {2006/09/27 09:00},
	Month = {Sep},
	Number = {26},
	Own = {NLM},
	Pages = {4236--4244},
	Phst = {2006/08/08 {$[$}aheadofprint{$]$}},
	Pii = {JCO.2006.05.6861},
	Pl = {United States},
	Pmid = {16896004},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't},
	Rn = {0 (Oligonucleotides); 23214-92-8 (Doxorubicin); 33069-62-4 (Paclitaxel); 50-18-0 (Cyclophosphamide); 51-21-8 (Fluorouracil)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.},
	Volume = {24},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1200/JCO.2006.05.6861}}

@article{shieh2009detecting,
	Author = {Shieh, Albert D. and Hung, Yeung Sam},
	Date-Added = {2009-03-25 09:12:15 +0100},
	Date-Modified = {2009-03-25 09:13:48 +0100},
	Journal = {Statistical Applications in Genetics and Molecular Biology},
	Number = {1},
	Pages = {13},
	Title = {Detecting Outlier Samples in Microarray Data},
	Volume = {8},
	Year = {2009},
	Bdsk-Url-1 = {http://www.bepress.com/sagmb/vol8/iss1/art13}}

@techreport{leon2005robust,
	Author = {Leon, Larry and Cai, Tianxi and Wei, L. J.},
	Date-Added = {2009-03-24 16:52:06 +0100},
	Date-Modified = {2009-03-24 16:54:34 +0100},
	Institution = {Harvard University},
	Month = {January},
	Number = {Working Paper 20},
	Title = {Robust Inferences For Covariate Effects On Survival Time With Censored Linear Regression Models},
	Year = {2005},
	Bdsk-Url-1 = {http://www.bepress.com/harvardbiostat/paper20/}}

@article{lin1989robust,
	Author = {Lin, D. Y. and Weil, J.},
	Date-Added = {2009-03-24 16:49:18 +0100},
	Date-Modified = {2009-03-24 16:51:21 +0100},
	Journal = {Journal of American Statistical Asscoiation},
	Number = {408},
	Pages = {1074--1078},
	Title = {The robust inference for the Cox proportional hazards model},
	Volume = {84},
	Year = {1989}}

@article{turney1995technical,
	Address = {Hingham, MA, USA},
	Author = {Turney,, Peter},
	Date-Added = {2009-03-23 19:16:22 +0100},
	Date-Modified = {2009-03-23 19:16:22 +0100},
	Doi = {http://dx.doi.org/10.1007/BF00993473},
	Issn = {0885-6125},
	Journal = {Mach. Learn.},
	Number = {1-2},
	Pages = {23--33},
	Publisher = {Kluwer Academic Publishers},
	Title = {Technical Note: Bias and the Quantification of Stability},
	Volume = {20},
	Year = {1995},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/BF00993473}}

@phdthesis{krizek2008feature,
	Author = {Krizek, Pavel},
	Date-Added = {2009-03-23 18:58:44 +0100},
	Date-Modified = {2009-03-23 19:01:06 +0100},
	Month = {June},
	School = {Czech Technical University in Prague},
	Title = {Feature selection: stability, algorithms, and evaluation},
	Year = {2008},
	Bdsk-Url-1 = {ftp://cmp.felk.cvut.cz/pub/cmp/articles/krizek/Krizek-%20TR-%202008-%2016.pdf}}

@book{rousseeuw2003robust,
	Address = {New York, NY, USA},
	Author = {Rousseeuw, Peter J. and Leroy, A. M.},
	Date-Added = {2009-03-23 18:20:17 +0100},
	Date-Modified = {2009-03-23 18:20:17 +0100},
	Publisher = {John Wiley \& Sons, Inc.},
	Title = {Robust regression and outlier detection},
	Year = {2003}}

@article{rousseuw1984least,
	Author = {Rousseuw, Peter J.},
	Date-Added = {2009-03-23 18:12:56 +0100},
	Date-Modified = {2009-03-23 18:14:40 +0100},
	Journal = {Journal of American Statistical Asscoiation},
	Pages = {871--880},
	Title = {Least Median Squares regression},
	Volume = {79},
	Year = {1984}}

@book{andersen2007modern,
	Author = {Andersen, Robert},
	Date-Added = {2009-03-23 18:07:53 +0100},
	Date-Modified = {2009-03-23 18:10:34 +0100},
	Isbn = {978-1412940726},
	Publisher = {Sage Publications, Inc},
	Series = {Quantitative Applications in the Social Sciences},
	Title = {Modern Methods for Robust Regression},
	Year = {2007},
	Bdsk-Url-1 = {http://www.amazon.com/Methods-Regression-Quantitative-Applications-Sciences/dp/1412940729}}

@book{hampel2005robust,
	Abstract = {Introducing concepts, theory, and applications, <i>Robust Statistics</i> is accessible to a broad audience, avoiding allusions to high-powered mathematics while emphasizing ideas, heuristics, and background. The text covers the approach based on the influence function (the effect of an outlier on an estimater, for example) and related notions such as the breakdown point. It also treats the change-of-variance function, fundamental concepts and results in the framework of estimation of a single parameter, and applications to estimation of covariance matrices and regression parameters. <i>Robust Statistics</i> is a leading-edge resource suitable for use both as a textbook or a reference on robust statistics for all practitioners and students.},
	Address = {New York},
	Author = {Hampel, Frank R. and Ronchetti, Elvezio M. and Rousseeuw, Peter J. and Stahel, Werner A.},
	Citeulike-Article-Id = {1023511},
	Date-Added = {2009-03-23 18:05:46 +0100},
	Date-Modified = {2009-03-23 18:05:46 +0100},
	Edition = {revised},
	Howpublished = {Paperback},
	Isbn = {0471735779},
	Keywords = {asymptotics, robust\_inference, robustness},
	Month = {April},
	Posted-At = {2007-01-03 20:23:28},
	Priority = {2},
	Publisher = {Wiley-Interscience},
	Title = {Robust Statistics: The Approach Based on Influence Functions (Wiley Series in Probability and Statistics)},
	Url = {http://www.amazon.ca/exec/obidos/redirect?tag=citeulike09-20\&amp;path=ASIN/0471735779},
	Year = {2005},
	Bdsk-Url-1 = {http://www.amazon.ca/exec/obidos/redirect?tag=citeulike09-20%5C&amp;path=ASIN/0471735779}}

@techreport{dunne2002solutions,
	Author = {Kevin Dunne and Padraig Cunningham and Francisco Azuaje},
	Date-Added = {2009-03-23 10:10:56 +0100},
	Date-Modified = {2009-03-23 10:10:56 +0100},
	Institution = {Journal of Machine Learning Research},
	Title = {``Solutions to Instability Problems with Sequential Wrapper-based Approaches to Feature Selection'', submitted to The},
	Year = {2002}}

@inproceedings{kuncheva2007stability,
	Address = {Anaheim, CA, USA},
	Author = {Kuncheva, Ludmila I.},
	Booktitle = {AIAP'07: Proceedings of the 25th conference on Proceedings of the 25th IASTED International Multi-Conference},
	Date-Added = {2009-03-23 10:09:58 +0100},
	Date-Modified = {2009-03-23 10:09:58 +0100},
	Location = {Innsbruck, Austria},
	Pages = {390--395},
	Publisher = {ACTA Press},
	Title = {A stability index for feature selection},
	Year = {2007}}

@inproceedings{kalousis2005stability,
	Address = {Washington, DC, USA},
	Author = {Kalousis,, Alexandros and Prados,, Julien and Hilario,, Melanie},
	Booktitle = {ICDM '05: Proceedings of the Fifth IEEE International Conference on Data Mining},
	Date-Added = {2009-03-23 10:01:08 +0100},
	Date-Modified = {2009-03-23 10:01:08 +0100},
	Doi = {http://dx.doi.org/10.1109/ICDM.2005.135},
	Isbn = {0-7695-2278-5},
	Pages = {218--225},
	Publisher = {IEEE Computer Society},
	Title = {Stability of Feature Selection Algorithms},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1109/ICDM.2005.135}}

@article{kalousis2007stability,
	Author = {Kalousis and Alexandros and Prados and Julien and Hilario and Melanie},
	Date-Added = {2009-03-23 09:35:43 +0100},
	Date-Modified = {2009-03-23 09:36:30 +0100},
	Doi = {http://dx.doi.org/10.1007/s10115-006-0040-8},
	Issn = {0219-1377},
	Journal = {Knowledge and Information Systems},
	Month = {May},
	Number = {1},
	Pages = {95--116},
	Priority = {2},
	Publisher = {Springer},
	Title = {Stability of feature selection algorithms: a study on high-dimensional spaces},
	Url = {http://dx.doi.org/10.1007/s10115-006-0040-8},
	Volume = {12},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10115-006-0040-8}}

@article{sotiriou2009geneexpression,
	Author = {Sotiriou, Christos and Pusztai, Lajos},
	Date-Added = {2009-02-19 08:13:28 +0100},
	Date-Modified = {2009-02-19 08:13:28 +0100},
	Doi = {10.1056/NEJMra0801289},
	Eprint = {http://content.nejm.org/cgi/reprint/360/8/790.pdf},
	Journal = {N Engl J Med},
	Number = {8},
	Pages = {790-800},
	Title = {{Gene-Expression Signatures in Breast Cancer}},
	Url = {http://content.nejm.org},
	Volume = {360},
	Year = {2009},
	Bdsk-Url-1 = {http://content.nejm.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1056/NEJMra0801289}}

@article{rodgers1988thirteen,
	Abstract = {In 1885, Sir Francis Galton first defined the term "regression" and completed the theory of bivariate correlation. A decade later, Karl Pearson developed the index that we still use to measure correlation, Pearson's r. Our article is written in recognition of the 100th anniversary of Galton's first discussion of regression and correlation. We begin with a brief history. Then we present 13 different formulas, each of which represents a different computational and conceptual definition of r. Each formula suggests a different way of thinking about this index, from algebraic, geometric, and trigonometric settings. We show that Pearson's r (or simple functions of r) may variously be thought of as a special type of mean, a special type of variance, the ratio of two means, the ratio of two variances, the slope of a line, the cosine of an angle, and the tangent to an ellipse, and may be looked at from several other interesting perspectives.},
	Author = {Rodgers, Joseph L. and Nicewander, Alan W.},
	Citeulike-Article-Id = {361042},
	Date-Added = {2009-02-16 10:15:46 +0100},
	Date-Modified = {2009-02-16 10:15:46 +0100},
	Doi = {http://dx.doi.org/10.2307/2685263},
	Journal = {The American Statistician},
	Keywords = {correlation, review, statistics, tutorial},
	Number = {1},
	Pages = {59--66},
	Posted-At = {2008-07-11 18:18:14},
	Priority = {3},
	Title = {Thirteen Ways to Look at the Correlation Coefficient},
	Url = {http://dx.doi.org/10.2307/2685263},
	Volume = {42},
	Year = {1988},
	Bdsk-Url-1 = {http://dx.doi.org/10.2307/2685263}}

@article{dahlmanwright2006international,
	Address = {Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden. karin.dahlman-wright@biosci.ki.se},
	Au = {Dahlman-Wright, K and Cavailles, V and Fuqua, SA and Jordan, VC and Katzenellenbogen, JA and Korach, KS and Maggi, A and Muramatsu, M and Parker, MG and Gustafsson, JA},
	Author = {Dahlman-Wright, Karin and Cavailles, Vincent and Fuqua, Suzanne A and Jordan, V Craig and Katzenellenbogen, John A and Korach, Kenneth S and Maggi, Adriana and Muramatsu, Masami and Parker, Malcolm G and Gustafsson, Jan-Ake},
	Crdt = {2006/11/30 09:00},
	Da = {20061129},
	Date-Added = {2009-02-15 12:01:03 +0100},
	Date-Modified = {2009-02-15 12:01:25 +0100},
	Dcom = {20070226},
	Doi = {10.1124/pr.58.4.8},
	Edat = {2006/11/30 09:00},
	Issn = {0031-6997 (Print)},
	Jid = {0421737},
	Journal = {Pharmacol Rev},
	Jt = {Pharmacological reviews},
	Language = {eng},
	Mh = {Animals; Breast Neoplasms/genetics/physiopathology/prevention \& control; Estrogen Receptor alpha/genetics/physiology; Estrogen Receptor beta/genetics/physiology; Female; Gene Expression; Humans; Mutation; Receptors, Estrogen/genetics/*physiology; Selective Estrogen Receptor Modulators/therapeutic use},
	Mhda = {2007/02/27 09:00},
	Number = {4},
	Own = {NLM},
	Pages = {773--781},
	Pii = {58/4/773},
	Pl = {United States},
	Pmid = {17132854},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Rf = {69},
	Rn = {0 (Estrogen Receptor alpha); 0 (Estrogen Receptor beta); 0 (Receptors, Estrogen); 0 (Selective Estrogen Receptor Modulators)},
	Sb = {IM},
	So = {Pharmacol Rev. 2006 Dec;58(4):773-81.},
	Stat = {MEDLINE},
	Title = {International Union of Pharmacology. LXIV. Estrogen receptors.},
	Volume = {58},
	Year = {2006 Dec},
	Bdsk-Url-1 = {http://dx.doi.org/10.1124/pr.58.4.8}}

@article{chudin2001assessment,
	Abstract = {BACKGROUND:Affymetrix microarrays have become increasingly popular in gene-expression studies; however, limitations of the technology have not been well established for commercially available arrays. The hybridization signal has been shown to be proportional to actual transcript concentration for specialized arrays containing hundreds of distinct probe pairs per gene. Additionally, the technology has been described as capable of distinguishing concentration levels within a factor of 2, and of detecting transcript frequencies as low as 1 in 2,000,000. Using commercially available arrays, we assessed these representations directly through a series of 'spike-in' hybridizations involving four prokaryotic transcripts in the absence and presence of fixed eukaryotic background. The contribution of probe-target interactions to the mismatch signal was quantified under various analyte concentrations.RESULTS:A linear relationship between transcript abundance and signal was consistently observed between 1 pM and 10 pM transcripts. The signal ceased to be linear above the 10 pM level and commenced saturating around the 100 pM level. The 0.1 pM transcripts were virtually undetectable in the presence of eukaryotic background. Our measurements show that preponderance of the signal for mismatch probes derives from interactions with the target transcripts.CONCLUSIONS:Landmark studies outlining an observed linear relationship between signal and transcript concentration were carried out under highly specialized conditions and may not extend to commercially available arrays under routine operating conditions. Additionally, alternative metrics that are not based on the difference in the signal of members of a probe pair may further improve the quantitative utility of the Affymetrix GeneChip(R) array.},
	Author = {Chudin, Eugene and Walker, Randal and Kosaka, Alan and Wu, Sue and Rabert, Douglas and Chang, Thomas and Kreder, Dirk},
	Date-Added = {2009-02-14 09:44:13 +0100},
	Date-Modified = {2009-02-14 09:44:20 +0100},
	Doi = {10.1186/gb-2001-3-1-research0005},
	Issn = {1465-6906},
	Journal = {Genome Biology},
	Number = {1},
	Pages = {research0005.1-research0005.10},
	Pubmedid = {11806828},
	Title = {Assessment of the relationship between signal intensities and transcript concentration for Affymetrix GeneChip(R) arrays},
	Url = {http://genomebiology.com/2001/3/1/research/0005},
	Volume = {3},
	Year = {2001},
	Bdsk-Url-1 = {http://genomebiology.com/2001/3/1/research/0005},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/gb-2001-3-1-research0005}}

@article{hartigan1979kmeans,
	Author = {J. A. Hartigan and M. A. Wong},
	Date-Added = {2009-02-13 08:53:48 +0100},
	Date-Modified = {2009-02-13 08:54:24 +0100},
	Journal = {Applied Statistics},
	Pages = {100--108},
	Title = {A {K}-Means Clustering Algorithm},
	Volume = 28,
	Year = 1979}

@article{huang2008systematic,
	Annote = {10.1038/nprot.2008.211},
	Author = {Huang, Da Wei and Sherman, Brad T and Lempicki, Richard A},
	Date-Added = {2009-02-12 14:40:59 +0100},
	Date-Modified = {2009-02-12 14:40:59 +0100},
	Isbn = {1754-2189},
	Journal = {Nat. Protocols},
	L3 = {http://www.nature.com/nprot/journal/v4/n1/suppinfo/nprot.2008.211_S1.html},
	M3 = {10.1038/nprot.2008.211},
	Month = {12},
	Number = {1},
	Pages = {44--57},
	Publisher = {Nature Publishing Group},
	Title = {Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nprot.2008.211},
	Volume = {4},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nprot.2008.211}}

@article{engle2006using,
	Author = {Engle, L J and Simpson, C L and Landers, J E},
	Date-Added = {2009-02-11 09:45:39 +0100},
	Date-Modified = {2009-02-11 09:45:39 +0100},
	Isbn = {0950-9232},
	Journal = {Oncogene},
	Number = {11},
	Pages = {1594--1601},
	Title = {Using high-throughput SNP technologies to study cancer},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/sj.onc.1209368},
	Volume = {25},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.onc.1209368}}

@book{sprites2000causation,
	Author = {Sprites, P. and Glymour, C. and Scheines, R.},
	Date-Added = {2009-02-10 18:25:05 +0100},
	Date-Modified = {2009-02-10 18:31:30 +0100},
	Edition = {second},
	Publisher = {{MIT Press}},
	Title = {Causation, prediction, and search: Adaptive computation and machine learning},
	Year = {2000}}

@article{owen2003gene,
	Abstract = {One of the most important uses of whole-genome expression data is for the discovery of new genes with similar function to a given list of genes (the query) already known to have closely related function. We have developed an algorithm, called the gene recommender, that ranks genes according to how strongly they correlate with a set of query genes in those experiments for which the query genes are most strongly coregulated. We used the gene recommender to find other genes coexpressed with several sets of query genes, including genes known to function in the retinoblastoma complex. Genetic experiments confirmed that one gene (JC8.6) identified by the gene recommender acts with lin-35 Rb to regulate vulval cell fates, and that another gene (wrm-1) acts antagonistically. We find that the gene recommender returns lists of genes with better precision, for fixed levels of recall, than lists generated using the C. elegans expression topomap.},
	Address = {Department of Statistics, Stanford University, Stanford, California 94305, USA. art@stat.stanford.edu},
	Au = {Owen, AB and Stuart, J and Mach, K and Villeneuve, AM and Kim, S},
	Author = {Owen, Art B and Stuart, Josh and Mach, Kathy and Villeneuve, Anne M and Kim, Stuart},
	Crdt = {2003/08/07 05:00},
	Da = {20030806},
	Date-Added = {2009-02-10 17:20:49 +0100},
	Date-Modified = {2009-02-10 17:21:29 +0100},
	Dcom = {20030904},
	Doi = {10.1101/gr.1125403},
	Edat = {2003/08/07 05:00},
	Issn = {1088-9051 (Print)},
	Jid = {9518021},
	Journal = {Genome Res},
	Jt = {Genome research},
	Language = {eng},
	Lr = {20081120},
	Mh = {*Algorithms; Animals; Caenorhabditis elegans/*genetics; Computational Biology; DNA, Helminth/analysis; Databases, Genetic/statistics \& numerical data; Gene Expression Profiling/*methods/statistics \& numerical data; Gene Expression Regulation/*genetics; Genes, Helminth/*genetics; Genes, Retinoblastoma/genetics; Oligonucleotide Array Sequence Analysis/methods/statistics \& numerical data; RNA Interference; Software},
	Mhda = {2003/09/05 05:00},
	Month = {August},
	Number = {8},
	Oid = {NLM: PMC403774},
	Own = {NLM},
	Pages = {1828--1837},
	Pii = {13/8/1828},
	Pl = {United States},
	Pmc = {PMC403774},
	Pmid = {12902378},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (DNA, Helminth)},
	Sb = {IM},
	So = {Genome Res. 2003 Aug;13(8):1828-37.},
	Stat = {MEDLINE},
	Title = {A gene recommender algorithm to identify coexpressed genes in C. elegans.},
	Volume = {13},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1101/gr.1125403}}

@article{steven2008meaning,
	Author = {Woolf, Steven H.},
	Date-Added = {2009-02-09 12:46:22 +0100},
	Date-Modified = {2009-02-09 12:46:22 +0100},
	Doi = {10.1001/jama.2007.26},
	Eprint = {http://jama.ama-assn.org/cgi/reprint/299/2/211.pdf},
	Journal = {JAMA},
	Number = {2},
	Pages = {211-213},
	Title = {{The Meaning of Translational Research and Why It Matters}},
	Url = {http://jama.ama-assn.org},
	Volume = {299},
	Year = {2008},
	Bdsk-Url-1 = {http://jama.ama-assn.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1001/jama.2007.26}}

@article{miller2002optimal,
	Author = {Miller, Lance D. and Long, Philip M. and Wong, Limsoon and Mukherjee, Sayan and McShane, Lisa M. and Liu, Edison T.},
	Date-Added = {2009-02-09 12:16:11 +0100},
	Date-Modified = {2009-02-09 12:16:11 +0100},
	Id = {S1535-6108(02)00181-2},
	Isbn = {1535-6108},
	Month = {11},
	Number = {5},
	Pages = {353--361},
	Title = {Optimal gene expression analysis by microarrays},
	Ty = {ABST},
	Url = {http://linkinghub.elsevier.com/retrieve/pii/S1535610802001812},
	Volume = {2},
	Year = {2002},
	Bdsk-Url-1 = {http://linkinghub.elsevier.com/retrieve/pii/S1535610802001812}}

@url{cran,
	Author = {{CRAN}},
	Date-Added = {2009-02-09 11:17:42 +0100},
	Date-Modified = {2009-02-09 11:24:20 +0100},
	Title = {Comprehensive {R} Archive Network},
	Url = {http://cran.r-project.org/},
	Urldate = {2009},
	Bdsk-Url-1 = {http://cran.r-project.org/}}

@book{everitt2002cambridge,
	Author = {B. S. Everitt},
	Date-Added = {2009-02-05 19:21:47 +0100},
	Date-Modified = {2009-02-05 19:23:27 +0100},
	Isbn = {052181099X},
	Publisher = {Cambridge University Press},
	Title = {The Cambridge Dictionary of Statistics},
	Year = {2002},
	Bdsk-Url-1 = {http://www.amazon.com/Cambridge-Dictionary-Statistics-B-Everitt/dp/052181099X}}

@article{kane2000assessment,
	Abstract = {To examine the utility and performance of 50mer oligonucleotide (oligonucleotide probe) microarrays, gene-specific oligonucleotide probes were spotted along with PCR probes onto glass microarrays and the performance of each probe type was evaluated. The specificity of oligonucleotide probes was studied using target RNAs that shared various degrees of sequence similarity. Sensitivity was defined as the ability to detect a 3-fold change in mRNA. No significant difference in sensitivity between oligonucleotide probes and PCR probes was observed and both had a minimum reproducible detection limit of approximately 10 mRNA copies/cell. Specificity studies showed that for a given oligonucleotide probe any 'non-target' transcripts (cDNAs) >75% similar over the 50 base target may show cross-hybridization. Thus non-target sequences which have >75-80% sequence similarity with target sequences (within the oligonucleotide probe 50 base target region) will contribute to the overall signal intensity. In addition, if the 50 base target region is marginally similar, it must not include a stretch of complementary sequence >15 contiguous bases. Therefore, knowledge about the target sequence, as well as its similarity to other mRNAs in the target tissue or RNA sample, is required to design successful oligonucleotide probes for quality microarray results. Together these results validate the utility of oligonucleotide probe (50mer) glass microarrays.},
	Address = {Department of Molecular Biology and Genomics and Department of Infectious Diseases, Pfizer Global Research and Development, Ann Arbor, MI 48105, USA.},
	Au = {Kane, MD and Jatkoe, TA and Stumpf, CR and Lu, J and Thomas, JD and Madore, SJ},
	Author = {Kane, M D and Jatkoe, T A and Stumpf, C R and Lu, J and Thomas, J D and Madore, S J},
	Crdt = {2000/11/10 11:00},
	Da = {20001114},
	Date-Added = {2009-02-05 17:00:10 +0100},
	Date-Modified = {2009-02-05 17:09:18 +0100},
	Dcom = {20001207},
	Edat = {2000/11/10 11:00},
	Issn = {1362-4962 (Electronic)},
	Jid = {0411011},
	Journal = {Nucleic Acids Res},
	Jt = {Nucleic acids research},
	Language = {eng},
	Lr = {20081120},
	Mh = {Animals; Bacillus subtilis/genetics; Base Sequence; DNA Probes; Gene Expression Regulation, Bacterial; Genes, Bacterial/genetics; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis/*methods; Oligonucleotides/*genetics; RNA, Messenger/genetics/metabolism; Rats; Sensitivity and Specificity},
	Mhda = {2001/02/28 10:01},
	Month = {November},
	Number = {22},
	Oid = {NLM: PMC113865},
	Own = {NLM},
	Pages = {4552--4557},
	Pl = {ENGLAND},
	Pmc = {PMC113865},
	Pmid = {11071945},
	Pst = {ppublish},
	Pt = {Comparative Study; Journal Article},
	Rn = {0 (DNA Probes); 0 (Oligonucleotides); 0 (RNA, Messenger)},
	Sb = {IM},
	So = {Nucleic Acids Res. 2000 Nov 15;28(22):4552-7.},
	Stat = {MEDLINE},
	Title = {Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays.},
	Volume = {28},
	Year = {2000}}

@article{adams1991complementary,
	Abstract = {Automated partial DNA sequencing was conducted on more than 600 randomly selected human brain complementary DNA (cDNA) clones to generate expressed sequence tags (ESTs). ESTs have applications in the discovery of new human genes, mapping of the human genome, and identification of coding regions in genomic sequences. Of the sequences generated, 337 represent new genes, including 48 with significant similarity to genes from other organisms, such as a yeast RNA polymerase II subunit; Drosophila kinesin, Notch, and Enhancer of split; and a murine tyrosine kinase receptor. Forty-six ESTs were mapped to chromosomes after amplification by the polymerase chain reaction. This fast approach to cDNA characterization will facilitate the tagging of most human genes in a few years at a fraction of the cost of complete genomic sequencing, provide new genetic markers, and serve as a resource in diverse biological research fields.
},
	Author = {Adams, MD and Kelley, JM and Gocayne, JD and Dubnick, M and Polymeropoulos, MH and Xiao, H and Merril, CR and Wu, A and Olde, B and Moreno, RF and et, al.},
	Date-Added = {2009-02-05 16:14:33 +0100},
	Date-Modified = {2009-02-05 16:14:33 +0100},
	Doi = {10.1126/science.2047873},
	Eprint = {http://www.sciencemag.org/cgi/reprint/252/5013/1651.pdf},
	Journal = {Science},
	Number = {5013},
	Pages = {1651-1656},
	Title = {{Complementary DNA sequencing: expressed sequence tags and human genome project}},
	Url = {http://www.sciencemag.org/cgi/content/abstract/252/5013/1651},
	Volume = {252},
	Year = {1991},
	Bdsk-Url-1 = {http://www.sciencemag.org/cgi/content/abstract/252/5013/1651},
	Bdsk-Url-2 = {http://dx.doi.org/10.1126/science.2047873}}

@article{murphy2002gene,
	Abstract = {Anumber of mammalian genomes having been sequenced, an important next step is to catalog the expression patterns of all transcription units in health and disease by use of microarrays. Such discovery programs are crucial to our understanding of the gene networks that control developmental, physiological, and pathological processes. However, despite the excitement, the full promise of microarray technology has yet to be realized, as the superficial simplicity of the concept belies considerable problems. Microarray technology is very new; methodologies are still evolving, common standards have yet to be established, and many problems with experimental design and variability have still to be fully understood and overcome. This review will describe the time course of a microarray experiment--RNA isolation from sample, target preparation, hybridization to the microarray probe, data capture, and bioinformatic analysis. For each stage, the advantages and disadvantages of competing techniques are compared, and inherent sources of error are identified and discussed.
},
	Author = {Murphy, David},
	Date-Added = {2009-02-05 13:02:32 +0100},
	Date-Modified = {2009-02-05 13:02:42 +0100},
	Eprint = {http://advan.physiology.org/cgi/reprint/26/4/256.pdf},
	Journal = {Advan. Physiol. Edu.},
	Number = {4},
	Pages = {256-270},
	Title = {{Gene Expression Studies Using Microarrays: Principles, Problems and Prospects}},
	Url = {http://advan.physiology.org/cgi/content/abstract/26/4/256},
	Volume = {26},
	Year = {2002},
	Bdsk-Url-1 = {http://advan.physiology.org/cgi/content/abstract/26/4/256}}

@url{affymetrix,
	Author = {Affymetrix},
	Date-Added = {2009-02-05 12:22:53 +0100},
	Date-Modified = {2009-02-05 12:25:36 +0100},
	Title = {Affymetrix, Inc.},
	Url = {http://affymetrix.com},
	Urldate = {2009},
	Bdsk-Url-1 = {http://affymetrix.com}}

@url{wikipedia,
	Author = {Wikipedia},
	Date-Added = {2009-02-05 12:14:09 +0100},
	Date-Modified = {2009-02-05 12:16:24 +0100},
	Title = {The Free Encyclopedia},
	Url = {http://www.wikipedia.org/},
	Urldate = {2009},
	Bdsk-Url-1 = {http://www.wikipedia.org/}}

@article{lonning2007breast,
	Abstract = {Expanding knowledge, together with implementation of new techniques, has fuelled the area of translational medical research aiming at improving prognostication as well as prediction in cancer therapy. At the same time, new discoveries have revealed a biological complexity we were unaware of only a decade ago. Thus, we are faced with novel challenges with respect to how we may explore issues such as prognostication and predict drug resistance in vivo. While microarray analysis exploring expression of thousands of genes in concert represents a major methodological advancement, discoveries such as the finding of different mechanisms of epigenetic silencing, intronic mutations, that most gene transcripts in the human genome are subject to alternative splicing and that hypersplicing seems to be a tumour-related phenomenon, exemplifies a complex pathology that may not be explored with use of single analytical methods only. This paper discusses clinical settings for studying drug resistance in vivo together with a discussion of contemporary biology in this field. Notably, each individual parameter which has been found correlated to drug resistance in vivo so far represents either a direct drug target or a factor involved in DNA repair or apoptosis. On the basis of these findings, we suggest drug resistance may be explored on the basis of upfront biological hypotheses.
},
	Author = {Lonning, PE and Knappskog, S and Staalesen, V and Chrisanthar, R and Lillehaug, JR},
	Date-Added = {2009-02-05 09:43:33 +0100},
	Date-Modified = {2009-02-05 09:43:33 +0100},
	Doi = {10.1093/annonc/mdm013},
	Eprint = {http://annonc.oxfordjournals.org/cgi/reprint/18/8/1293.pdf},
	Journal = {Ann Oncol},
	Number = {8},
	Pages = {1293-1306},
	Title = {{Breast cancer prognostication and prediction in the postgenomic era}},
	Url = {http://annonc.oxfordjournals.org/cgi/content/abstract/18/8/1293},
	Volume = {18},
	Year = {2007},
	Bdsk-Url-1 = {http://annonc.oxfordjournals.org/cgi/content/abstract/18/8/1293},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/annonc/mdm013}}

@article{subramanian2005gene,
	Abstract = {Although genomewide RNA expression analysis has become a routine tool in biomedical research, extracting biological insight from such information remains a major challenge. Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data. The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation. We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer. Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common. The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biologically defined gene sets.
},
	Author = {Subramanian, Aravind and Tamayo, Pablo and Mootha, Vamsi K. and Mukherjee, Sayan and Ebert, Benjamin L. and Gillette, Michael A. and Paulovich, Amanda and Pomeroy, Scott L. and Golub, Todd R. and Lander, Eric S. and Mesirov, Jill P.},
	Date-Added = {2009-02-02 10:50:28 +0100},
	Date-Modified = {2009-02-02 10:50:45 +0100},
	Doi = {10.1073/pnas.0506580102},
	Eprint = {http://www.pnas.org/content/102/43/15545.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {43},
	Pages = {15545-15550},
	Title = {{Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles}},
	Url = {http://www.pnas.org/content/102/43/15545.abstract},
	Volume = {102},
	Year = {2005},
	Bdsk-Url-1 = {http://www.pnas.org/content/102/43/15545.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0506580102}}

@article{efron1981censored,
	Author = {Efron, Brad},
	Date-Added = {2009-01-31 09:45:07 +0100},
	Date-Modified = {2009-01-31 09:46:17 +0100},
	Journal = {Journal of American Statistical Asscoiation},
	Number = {312-319},
	Title = {Censored data and the bootstrap},
	Volume = {76},
	Year = {1981}}

@article{desouto2008clustering,
	Abstract = {BACKGROUND:The use of clustering methods for the discovery of cancer subtypes has drawn a great deal of attention in the scientific community. While bioinformaticians have proposed new clustering methods that take advantage of characteristics of the gene expression data, the medical community has a preference for using "classic" clustering methods. There have been no studies thus far performing a large-scale evaluation of different clustering methods in this context.RESULTS/CONCLUSION:We present the first large-scale analysis of seven different clustering methods and four proximity measures for the analysis of 35 cancer gene expression data sets. Our results reveal that the finite mixture of Gaussians, followed closely by k-means, exhibited the best performance in terms of recovering the true structure of the data sets. These methods also exhibited, on average, the smallest difference between the actual number of classes in the data sets and the best number of clusters as indicated by our validation criteria. Furthermore, hierarchical methods, which have been widely used by the medical community, exhibited a poorer recovery performance than that of the other methods evaluated. Moreover, as a stable basis for the assessment and comparison of different clustering methods for cancer gene expression data, this study provides a common group of data sets (benchmark data sets) to be shared among researchers and used for comparisons with new methods. The data sets analyzed in this study are available at http://algorithmics.molgen.mpg.de/Supplements/CompCancer/.},
	Author = {{de Souto}, Marcilio and Costa, Ivan and de Araujo, Daniel and Ludermir, Teresa and Schliep, Alexander},
	Date-Added = {2009-01-30 12:43:31 +0100},
	Date-Modified = {2009-01-30 12:43:31 +0100},
	Doi = {10.1186/1471-2105-9-497},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {497},
	Pubmedid = {19038021},
	Title = {Clustering cancer gene expression data: a comparative study},
	Url = {http://www.biomedcentral.com/1471-2105/9/497},
	Volume = {9},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/9/497},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-9-497}}

@article{tamayo1999Interpreting,
	Abstract = {Array technologies have made it straightforward to monitor simultaneously the expression pattern of thousands of genes. The challenge now is to interpret such massive data sets. The first step is to extract the fundamental patterns of gene expression inherent in the data. This paper describes the application of self-organizing maps, a type of mathematical cluster analysis that is particularly well suited for recognizing and classifying features in complex, multidimensional data. The method has been implemented in a publicly available computer package, GENECLUSTER, that performs the analytical calculations and provides easy data visualization. To illustrate the value of such analysis, the approach is applied to hematopoietic differentiation in four well studied models (HL-60, U937, Jurkat, and NB4 cells). Expression patterns of some 6,000 human genes were assayed, and an online database was created. GENECLUSTER was used to organize the genes into biologically relevant clusters that suggest novel hypotheses about hematopoietic differentiation-for example, highlighting certain genes and pathways involved in "differentiation therapy" used in the treatment of acute promyelocytic leukemia.},
	Address = {Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.},
	Au = {Tamayo, P and Slonim, D and Mesirov, J and Zhu, Q and Kitareewan, S and Dmitrovsky, E and Lander, ES and Golub, TR},
	Author = {Tamayo, P and Slonim, D and Mesirov, J and Zhu, Q and Kitareewan, S and Dmitrovsky, E and Lander, E S and Golub, T R},
	Crdt = {1999/03/17 00:00},
	Da = {19990520},
	Date-Added = {2009-01-30 12:31:59 +0100},
	Date-Modified = {2009-01-30 12:32:22 +0100},
	Dcom = {19990520},
	Edat = {1999/03/17},
	Issn = {0027-8424 (Print)},
	Jid = {7505876},
	Journal = {Proc Natl Acad Sci U S A},
	Jt = {Proceedings of the National Academy of Sciences of the United States of America},
	Language = {eng},
	Lr = {20081120},
	Mh = {Animals; Cluster Analysis; *Gene Expression Regulation; HL-60 Cells; Hematopoiesis/*genetics; Humans; Jurkat Cells; Saccharomyces cerevisiae; Software},
	Mhda = {1999/03/17 00:01},
	Month = {March},
	Number = {6},
	Oid = {NLM: PMC15868},
	Own = {NLM},
	Pages = {2907--2912},
	Pl = {UNITED STATES},
	Pmc = {PMC15868},
	Pmid = {10077610},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Sb = {IM},
	So = {Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2907-12.},
	Stat = {MEDLINE},
	Title = {Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation.},
	Volume = {96},
	Year = {1999}}

@article{cheng2000biclustering,
	Abstract = {An efficient node-deletion algorithm is introduced to find submatrices in expression data that have low mean squared residue scores and it is shown to perform well in finding co-regulation patterns in yeast and human. This introduces "biclustering", or simultaneous clustering of both genes and conditions, to knowledge discovery from expression data. This approach overcomes some problems associated with traditional clustering methods, by allowing automatic discovery of similarity based on a subset of attributes, simultaneous clustering of genes and conditions, and overlapped grouping that provides a better representation for genes with multiple functions or regulated by many factors.},
	Address = {Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. yizong.cheng@uc.edu},
	Au = {Cheng, Y and Church, GM},
	Author = {Cheng, Y and Church, G M},
	Crdt = {2000/09/08 11:00},
	Da = {20010123},
	Date-Added = {2009-01-30 12:27:00 +0100},
	Date-Modified = {2009-01-30 12:27:18 +0100},
	Dcom = {20010126},
	Edat = {2000/09/08 11:00},
	Issn = {1553-0833 (Print)},
	Jid = {9509125},
	Journal = {Proc Int Conf Intell Syst Mol Biol},
	Jt = {Proceedings / ... International Conference on Intelligent Systems for Molecular Biology ; ISMB. International Conference on Intelligent Systems for Molecular Biology},
	Language = {eng},
	Lr = {20041117},
	Mh = {*Algorithms; Animals; Gene Expression Profiling/*methods; Humans; *Multigene Family; Oligonucleotide Array Sequence Analysis/*methods},
	Mhda = {2001/02/28 10:01},
	Own = {NLM},
	Pages = {93--103},
	Pl = {UNITED STATES},
	Pmid = {10977070},
	Pst = {ppublish},
	Pt = {Journal Article},
	Sb = {IM},
	So = {Proc Int Conf Intell Syst Mol Biol. 2000;8:93-103.},
	Stat = {MEDLINE},
	Title = {Biclustering of expression data.},
	Volume = {8},
	Year = {2000}}

@book{kuncheva2004combining,
	Author = {Ludmila I. Kuncheva},
	Date-Added = {2009-01-30 11:53:27 +0100},
	Date-Modified = {2009-01-30 11:55:44 +0100},
	Doi = {10.1002/0471660264.refs},
	Editor = {Bangor, Gwynedd},
	Isbn = {978047121078},
	Publisher = {John Wiley \& Sons},
	Title = {Combining Pattern Classifiers},
	Year = {2004},
	Bdsk-Url-1 = {http://www3.interscience.wiley.com/cgi-bin/summary/109584049/SUMMARY?CRETRY=1&SRETRY=0}}

@article{hashem1996effects,
	Author = {Hashem, Sherif},
	Date-Added = {2009-01-30 11:52:59 +0100},
	Date-Modified = {2009-01-30 11:52:59 +0100},
	Isbn = {0954-0091},
	Journal = {Connection Science},
	Number = {3},
	Pages = {315--336},
	Publisher = {Taylor \& Francis},
	Title = {Effects of Collinearity on Combining Neural Networks},
	Ty = {JOUR},
	Url = {http://www.informaworld.com/10.1080/095400996116794},
	Volume = {8},
	Year = {1996},
	Bdsk-Url-1 = {http://www.informaworld.com/10.1080/095400996116794}}

@book{good2006resampling,
	Author = {Philippe Good},
	Date-Added = {2009-01-30 09:25:34 +0100},
	Date-Modified = {2009-01-30 09:27:12 +0100},
	Edition = {Third},
	Isbn = {1-8176-4386-9},
	Publisher = {Birkhauser},
	Title = {Resampling Methods},
	Year = {2006}}

@article{efron1981nonparametric,
	Abstract = {We discuss several nonparametric methods for attaching a standard error to a point estimate: the jackknife, the bootstrap, half-sampling, subsampling, balanced repeated replications, the infinitesimal jackknife, influence function techniques and the delta method. The last three methods are shown to be identical. All the methods derive from the same basic idea, which is also the idea underlying the common parametric methods. Extended numerical comparisons are made for the special case of the correlation coefficient.
},
	Author = {Bradley Efron},
	Date-Added = {2009-01-30 09:14:37 +0100},
	Date-Modified = {2009-01-30 10:20:47 +0100},
	Doi = {10.1093/biomet/68.3.589},
	Eprint = {http://biomet.oxfordjournals.org/cgi/reprint/68/3/589.pdf},
	Journal = {Biometrika},
	Number = {3},
	Pages = {589-599},
	Title = {{Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods}},
	Url = {http://biomet.oxfordjournals.org/cgi/content/abstract/68/3/589},
	Volume = {68},
	Year = {1981},
	Bdsk-Url-1 = {http://biomet.oxfordjournals.org/cgi/content/abstract/68/3/589},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/biomet/68.3.589}}

@phdthesis{meyer2008information,
	Author = {Patrick Emmanual Meyer},
	Date-Added = {2009-01-29 19:45:54 +0100},
	Date-Modified = {2009-01-29 19:48:51 +0100},
	Month = {December},
	School = {Universit\'{e} Libre de Bruxelles},
	Title = {Information-Theoretic Variable Selection and Network Inference from Microarray Data},
	Year = {2008},
	Bdsk-Url-1 = {http://theses.ulb.ac.be/ETD-db/collection/available/ULBetd-12162008-093634/}}

@article{sheng2003biclustering,
	Abstract = {Motivation: Gibbs sampling has become a method of choice for the discovery of noisy patterns, known as motifs, in DNA and protein sequences. Because handling noise in microarray data presents similar challenges, we have adapted this strategy to the biclustering of discretized microarray data.  Results: In contrast with standard clustering that reveals genes   that behave similarly over all the conditions, biclustering groups genes over only a subset of conditions for which those genes have a sharp probability distribution. We have opted for a simple probabilistic model of the biclusters because it has the key advantage of providing a transparent probabilistic interpretation of the biclusters in the form of an easily interpretable fingerprint. Furthermore, Gibbs sampling does not suffer from the problem of local minima that often characterizes   Expectation-Maximization. We demonstrate the effectiveness of our approach on two synthetic data sets as well as a data set from leukemia patients.  Contact: qizheng.sheng@esat.kuleuven.ac.be
},
	Author = {Sheng, Qizheng and Moreau, Yves and De Moor, Bart},
	Date-Added = {2009-01-29 19:00:27 +0100},
	Date-Modified = {2009-01-30 13:03:24 +0100},
	Doi = {10.1093/bioinformatics/btg1078},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/19/suppl_2/ii196.pdf},
	Journal = {Bioinformatics},
	Number = {suppl 2},
	Pages = {ii196-205},
	Title = {{Biclustering microarray data by Gibbs sampling}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/19/suppl_2/ii196},
	Volume = {19},
	Year = {2003},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/19/suppl_2/ii196},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btg1078}}

@book{wasserman2007nonparametric,
	Author = {Larry Wasserman},
	Date-Added = {2009-01-29 11:51:30 +0100},
	Date-Modified = {2009-01-29 11:53:07 +0100},
	Isbn = {0387251456},
	Publisher = {Springer},
	Title = {All of Nonparametric Statistics},
	Year = {2007},
	Bdsk-Url-1 = {http://www.amazon.com/All-Nonparametric-Statistics-Springer-Texts/dp/0387251456}}

@article{green1977multivariate,
	Author = {Green, Bert F.},
	Date-Added = {2009-01-26 17:13:44 +0100},
	Date-Modified = {2009-01-26 17:13:44 +0100},
	Isbn = {0027-3171},
	Journal = {Multivariate Behavioral Research},
	Number = {3},
	Pages = {263--287},
	Publisher = {Psychology Press},
	Title = {Parameter Sensitivity In Multivariate Methods},
	Ty = {JOUR},
	Url = {http://www.informaworld.com/10.1207/s15327906mbr1203_1},
	Volume = {12},
	Year = {1977},
	Bdsk-Url-1 = {http://www.informaworld.com/10.1207/s15327906mbr1203_1}}

@article{wainer1976estimating,
	Author = {Howard Wainer},
	Date-Added = {2009-01-26 15:36:35 +0100},
	Date-Modified = {2009-01-26 15:38:31 +0100},
	Journal = {Psychological Bulletin},
	Number = {2},
	Pages = {213--217},
	Title = {Estimating Coefficients in Linear Models: It Don't Make No Nevermind},
	Volume = {83},
	Year = {1976},
	Bdsk-Url-1 = {http://www-stat.wharton.upenn.edu/~hwainer/Readings/Wainer_Estimating%20Coefficients%20in%20Linear%20Models.pdf}}

@techreport{bishop1994mixture,
	Author = {Christopher M. Bishop},
	Date-Added = {2009-01-26 12:22:54 +0100},
	Date-Modified = {2009-01-26 12:23:57 +0100},
	Institution = {Astom Univeristy},
	Month = {February},
	Title = {Mixture density networks},
	Year = {1994},
	Bdsk-Url-1 = {http://www.ncrg.aston.ac.uk/publications/cgi-bin/tr_avail.pl?trnumber=NCRG/94/004}}

@article{bendor1999clustering,
	Abstract = {Recent advances in biotechnology allow researchers to measure expression levels for thousands of genes simultaneously, across different conditions and over time. Analysis of data produced by such experiments offers potential insight into gene function and regulatory mechanisms. A key step in the analysis of gene expression data is the detection of groups of genes that manifest similar expression patterns. The corresponding algorithmic problem is to cluster multicondition gene expression patterns. In this paper we describe a novel clustering algorithm that was developed for analysis of gene expression data. We define an appropriate stochastic error model on the input, and prove that under the conditions of the model, the algorithm recovers the cluster structure with high probability. The running time of the algorithm on an n-gene dataset is O[n2[log(n)]c]. We also present a practical heuristic based on the same algorithmic ideas. The heuristic was implemented and its performance is demonstrated on simulated data and on real gene expression data, with very promising results.},
	Address = {Department of Computer Science and Engineering, University of Washington, Seattle 98105, USA. amirbd@cs.washington.edu},
	Au = {Ben-Dor, A and Shamir, R and Yakhini, Z},
	Author = {Ben-Dor, A and Shamir, R and Yakhini, Z},
	Crdt = {1999/12/03 00:00},
	Da = {19991230},
	Date-Added = {2009-01-25 10:55:06 +0100},
	Date-Modified = {2009-01-25 10:55:28 +0100},
	Dcom = {19991230},
	Doi = {10.1089/106652799318274},
	Edat = {1999/12/03},
	Issn = {1066-5277 (Print)},
	Jid = {9433358},
	Journal = {J Comput Biol},
	Jt = {Journal of computational biology : a journal of computational molecular cell biology},
	Language = {eng},
	Lr = {20061115},
	Mh = {*Algorithms; Animals; Caenorhabditis elegans/genetics; *Cluster Analysis; Computer Simulation; Data Interpretation, Statistical; *Gene Expression; Humans; Models, Statistical; Stochastic Processes},
	Mhda = {1999/12/03 00:01},
	Number = {3-4},
	Own = {NLM},
	Pages = {281--297},
	Pl = {UNITED STATES},
	Pmid = {10582567},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Sb = {IM},
	So = {J Comput Biol. 1999 Fall-Winter;6(3-4):281-97.},
	Stat = {MEDLINE},
	Title = {Clustering gene expression patterns.},
	Volume = {6},
	Year = {1999},
	Bdsk-Url-1 = {http://dx.doi.org/10.1089/106652799318274}}

@article{rhodes2007oncomine,
	Abstract = {DNA microarrays have been widely applied to cancer transcriptome analysis; however, the majority of such data are not easily accessible or comparable. Furthermore, several important analytic approaches have been applied to microarray analysis; however, their application is often limited. To overcome these limitations, we have developed Oncomine, a bioinformatics initiative aimed at collecting, standardizing, analyzing, and delivering cancer transcriptome data to the biomedical research community. Our analysis has identified the genes, pathways, and networks deregulated across 18,000 cancer gene expression microarrays, spanning the majority of cancer types and subtypes. Here, we provide an update on the initiative, describe the database and analysis modules, and highlight several notable observations. Results from this comprehensive analysis are available at http://www.oncomine.org.},
	Address = {Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0940, USA.},
	Au = {Rhodes, DR and Kalyana-Sundaram, S and Mahavisno, V and Varambally, R and Yu, J and Briggs, BB and Barrette, TR and Anstet, MJ and Kincead-Beal, C and Kulkarni, P and Varambally, S and Ghosh, D and Chinnaiyan, AM},
	Author = {Rhodes, Daniel R and Kalyana-Sundaram, Shanker and Mahavisno, Vasudeva and Varambally, Radhika and Yu, Jianjun and Briggs, Benjamin B and Barrette, Terrence R and Anstet, Matthew J and Kincead-Beal, Colleen and Kulkarni, Prakash and Varambally, Sooryanaryana and Ghosh, Debashis and Chinnaiyan, Arul M},
	Crdt = {2007/03/16 09:00},
	Da = {20070314},
	Date-Added = {2009-01-23 18:18:13 +0100},
	Date-Modified = {2009-01-23 18:32:27 +0100},
	Dcom = {20070412},
	Edat = {2007/03/16 09:00},
	Gr = {5P30 CA46592/CA/NCI NIH HHS/United States; U01 CA111275-01/CA/NCI NIH HHS/United States; U54 DA021519-01A1/DA/NIDA NIH HHS/United States},
	Issn = {1476-5586 (Electronic)},
	Jid = {100886622},
	Journal = {Neoplasia},
	Jt = {Neoplasia (New York, N.Y.)},
	Language = {eng},
	Lr = {20081120},
	Mh = {Antineoplastic Agents/pharmacology; Automatic Data Processing; Chromosome Mapping; Chromosomes, Human/genetics; Computational Biology/*organization \& administration; Data Collection; Data Display; Data Interpretation, Statistical; *Databases, Genetic; Drug Design; *Gene Expression Profiling/statistics \& numerical data; *Gene Expression Regulation, Neoplastic; *Genes, Neoplasm; Humans; Internet; Models, Biological; Neoplasm Proteins/biosynthesis/chemistry/*genetics; Neoplasms/classification/genetics/metabolism; *Oligonucleotide Array Sequence Analysis; Subtraction Technique; Transcription, Genetic},
	Mhda = {2007/04/14 09:00},
	Month = {February},
	Number = {2},
	Oid = {NLM: PMC1813932},
	Own = {NLM},
	Pages = {166--180},
	Pl = {Canada},
	Pmc = {PMC1813932},
	Pmid = {17356713},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't},
	Rn = {0 (Antineoplastic Agents); 0 (Neoplasm Proteins)},
	Sb = {IM},
	So = {Neoplasia. 2007 Feb;9(2):166-80.},
	Stat = {MEDLINE},
	Title = {Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.},
	Volume = {9},
	Year = {2007}}

@techreport{leborgne2005bias,
	Author = {Yann-Ael {Le Borgne}},
	Date-Added = {2009-01-23 09:42:56 +0100},
	Date-Modified = {2009-01-23 09:44:30 +0100},
	Institution = {Universit\'{e} Libre de Bruxelles},
	Month = {January},
	Number = {534},
	Title = {Bias variance trade-off characterization in a classification. What differences with regression?},
	Year = {2005},
	Bdsk-Url-1 = {http://www.ulb.ac.be/di/map/yleborgn/pub/bv.pdf}}

@article{stone1985additive,
	Author = {J. C. Stone},
	Date-Added = {2009-01-23 09:07:31 +0100},
	Date-Modified = {2009-01-23 09:08:49 +0100},
	Journal = {Annals of Statistics},
	Pages = {689--705},
	Title = {Additive Regression and Other Nonparametric Models},
	Volume = {13},
	Year = {1985},
	Bdsk-Url-1 = {http://projecteuclid.org/DPubS?service=UI&version=1.0&verb=Display&handle=euclid.aos/1176349548}}

@incollection{perrone1993when,
	Author = {Michael P. Perrone and Leon N Cooper},
	Booktitle = {Artificial Neural Networks for Speech and Vision},
	Date-Added = {2009-01-22 17:19:07 +0100},
	Date-Modified = {2009-01-22 17:20:51 +0100},
	Editor = {R. J. Mammone},
	Pages = {126--142},
	Publisher = {Chapman and Hall},
	Title = {When networks disagree: Ensemble methods for hybrid neural networks},
	Year = {1993}}

@book{sheng2005advances,
	Author = {Qizheng Sheng and Yves Moreau and Frank {De Smet} and Kathleen Marchal and Bart {De Moor}},
	Date-Added = {2009-01-22 08:19:53 +0100},
	Date-Modified = {2009-01-22 08:24:39 +0100},
	Editor = {Francisco Azuaje and Joaqu{\'\i}n Dopazo},
	Isbn = {9780470094396},
	Publisher = {John Wiley \& Sons},
	Title = {Data Analysis and Visualization in Genomics and Proteomics},
	Url = {http://www3.interscience.wiley.com/cgi-bin/summary/110528999/SUMMARY},
	Year = {2005},
	Bdsk-Url-1 = {http://www3.interscience.wiley.com/cgi-bin/summary/110528999/SUMMARY}}

@article{jakulin2004quantifying,
	Author = {Aleks Jakulin and Ivan Bratko},
	Date-Added = {2009-01-21 19:03:17 +0100},
	Date-Modified = {2009-01-21 19:03:17 +0100},
	Journal = {http://arxiv.org/abs/cs.AI/0308002 v3},
	Pages = {3},
	Title = {Quantifying and visualizing attribute interactions: An approach based on entropy},
	Volume = {308002},
	Year = {2004}}

@misc{wienholt1996how,
	Author = {W. Wienholt and B. Sendhoff},
	Date-Added = {2009-01-21 18:41:15 +0100},
	Date-Modified = {2009-01-21 18:41:35 +0100},
	Text = {W. Wienholt and B. Sendhoff. How to determine the redundancy of noisy chaotic time series. Int. J. of Bifurcation and Chaos, 6(1), January 1996.},
	Title = {How to determine the redundancy of noisy chaotic time series},
	Url = {citeseer.comp.nus.edu.sg/150922.html},
	Year = {1996},
	Bdsk-Url-1 = {citeseer.comp.nus.edu.sg/150922.html}}

@book{ye2007bioinformatics,
	Author = {Ye, Shui Qing},
	Date-Added = {2009-01-21 12:40:50 +0100},
	Date-Modified = {2009-01-21 12:43:51 +0100},
	Isbn = {1584888105},
	Publisher = {Chapman \& Hall/CRC},
	Title = {Bioinformatics: A Practical Approach},
	Year = {2007},
	Bdsk-Url-1 = {http://books.google.com/books?id=JWD7f-cc9acC&dq=kmeans+gene+microarray&source=gbs_summary_s&cad=0}}

@article{liedtke2008pik3caactivating,
	Abstract = {INTRODUCTION:In vitro evidence suggests that PIK3CA (phosphatidylinositol 3-kinase, catalytic, alpha polypeptide) activation may be associated with altered chemotherapy sensitivity in cancer.METHODS:Tumor DNA from 140 patients with stage II-III breast cancer undergoing neoadjuvant chemotherapy was sequenced for PIK3CA mutations on exons 1, 9, and 20. Mutation status was correlated with clinical/pathological parameters and chemotherapy response as (a) pathological complete response (pCR) versus residual cancer or (b) quantitative residual cancer burden (RCB) scores, including stratification for estrogen receptor (ER) expression status, type of chemotherapy, and by exons.RESULTS:Twenty-three patients (16.4%) harbored a PIK3CA mutation, with 12, 11, and 0 mutations located in exons 9, 20, and 1, respectively. PIK3CA exon 9 mutations were more frequent among node-negative (52% versus 25%; P = 0.012) than node-positive tumors, particularly among ER-positive tumors. pCR rates and RCB scores were similar among patients with the wild-type and mutant PIK3CA genes, even after stratification by ER status, chemotherapy regimen (anthracycline versus anthracycline plus paclitaxel), or exon.CONCLUSION:PIK3CA mutations are not associated with altered sensitivity to preoperative anthracycline-based or taxane-based chemotherapies in ER-positive and ER-negative breast tumors. In this study, PIK3CA mutation was associated with a decreased rate of node-positive disease, particularly among ER-positive tumors.},
	Author = {Liedtke, Cornelia and Cardone, Luca and Tordai, Attila and Yan, Kai and Gomez, Henry and Figureoa, Luis and Hubbard, Rebekah and Valero, Vicente and Souchon, Eduardo and Symmans, W Fraser and Hortobagyi, Gabriel and Bardelli, Alberto and Pusztai, Lajos},
	Date-Added = {2009-01-20 12:16:40 +0100},
	Date-Modified = {2009-01-20 12:17:04 +0100},
	Doi = {10.1186/bcr1984},
	Issn = {1465-5411},
	Journal = {Breast Cancer Research},
	Number = {2},
	Pages = {R27},
	Pubmedid = {18371219},
	Title = {PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer},
	Url = {http://breast-cancer-research.com/content/10/2/R27},
	Volume = {10},
	Year = {2008},
	Bdsk-Url-1 = {http://breast-cancer-research.com/content/10/2/R27},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr1984}}

@book{jolliffe2002principal,
	Author = {I. T. Jolliffe},
	Date-Added = {2009-01-19 11:41:50 +0100},
	Date-Modified = {2009-01-19 11:45:33 +0100},
	Editor = {I. T. Jolliffe},
	Isbn = {978-0-387-95442-4},
	Publisher = {Springer},
	Series = {Springer Series in Statistics},
	Title = {Principal Component Analysis},
	Url = {http://www.springer.com/statistics/statistical+theory+and+methods/book/978-0-387-95442-4},
	Year = {2002},
	Bdsk-Url-1 = {http://www.springer.com/statistics/statistical+theory+and+methods/book/978-0-387-95442-4}}

@article{bach2003kernel,
	Address = {Cambridge, MA, USA},
	Author = {Francis R. Bach and Michael I. Jordan},
	Date-Added = {2009-01-19 11:38:17 +0100},
	Date-Modified = {2009-01-19 11:38:17 +0100},
	Issn = {1533-7928},
	Journal = {J. Mach. Learn. Res.},
	Pages = {1--48},
	Publisher = {MIT Press},
	Title = {Kernel independent component analysis},
	Volume = {3},
	Year = {2003}}

@article{werner2005genome,
	Abstract = {Genomes with their complexity and size present what appears to be an impossible challenge. Scientists speak in terms of decades or even centuries before we will understand how genomes and their hosts the cell and the city of cells that make up the multicellular context function. We believe that there will be surprisingly quick progress made in our understanding of genomes. The key is to stop taking the Central Dogma as the only direction in which genome research can scale the semantics of genomes. Instead a top-down approach coupled with a bottom-up approach may snare the unwieldy beast and make sense of genomes. The method we propose is to take in silico biology seriously. By developing in silico models of genomes cells and multicellular systems, we position ourselves to develop a theory of meaning for artificial genomes. Then using that develop a natural semantics of genomes.},
	Address = {Cellnomica, Inc., P.O. Box 1422, Fort Myers, FL 33928-1422, USA. eric.werner@cellnomica.com},
	Au = {Werner, E},
	Author = {Werner, Eric},
	Crdt = {2005/03/15 09:00},
	Da = {20050314},
	Date-Added = {2009-01-19 10:19:09 +0100},
	Date-Modified = {2009-01-19 10:24:32 +0100},
	Dcom = {20050405},
	Doi = {10.1016/j.febslet.2005.02.011},
	Edat = {2005/03/15 09:00},
	Issn = {0014-5793 (Print)},
	Jid = {0155157},
	Journal = {FEBS Lett},
	Jt = {FEBS letters},
	Language = {eng},
	Lr = {20051116},
	Mh = {*Cells; Computational Biology; *Computer Simulation; *Genome; Models, Biological; Research/methods; *Semantics},
	Mhda = {2005/04/06 09:00},
	Month = {March},
	Number = {8},
	Own = {NLM},
	Pages = {1779--1782},
	Phst = {2005/01/11 {$[$}received{$]$}; 2005/01/11 {$[$}revised{$]$}; 2005/02/01 {$[$}accepted{$]$}},
	Pii = {S0014-5793(05)00184-5},
	Pl = {Netherlands},
	Pmid = {15763551},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Rf = {10},
	Sb = {IM},
	So = {FEBS Lett. 2005 Mar 21;579(8):1779-82.},
	Stat = {MEDLINE},
	Title = {Genome semantics, in silico multicellular systems and the Central Dogma.},
	Volume = {579},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.febslet.2005.02.011}}

@article{goetz2006twogene,
	Abstract = {Purpose: In the adjuvant treatment of estrogen receptor (ER)-positive breast cancer, additional markers are needed to identify women at high risk for recurrence.  Experimental Design: We examined the association between the ratio of the homeobox 13 (HOXB13) to interleukin-17B receptor (IL-17BR) expression and the clinical outcomes of relapse and survival in women with ER-positive breast cancer enrolled onto a North Central Cancer Treatment Group adjuvant tamoxifen trial (NCCTG 89-30-52).  Results: Tumor blocks were obtained from 211 of 256 eligible patients, and quantitative reverse transcription-PCR profiles for HOXB13 and IL-17BR were obtained from 206 patients. The cut point for the two-gene log 2(expression ratio) that best discriminated clinical outcome (recurrence and survival) was selected and identified women with significantly worse relapse-free survival (RFS), disease-free survival (DFS), and overall survival (OS), independent of standard prognostic markers. The cut point differed as a function of nodal status [node negative (59th percentile) versus node positive (90th percentile)]. In the node-positive cohort (n = 86), the HOXB13/IL-17BR ratio was not associated with relapse or survival. In contrast, in the node-negative cohort (n = 130), a high HOXB13/IL-17BR ratio was associated with significantly worse RFS [hazard ratio (HR), 1.98; P = 0.031], DFS (HR, 2.03; P = 0.015), and OS (HR, 2.4; P = 0.014), independent of standard prognostic markers.  Conclusion: A high HOXB13/IL-17BR expression ratio is associated with increased relapse and death in patients with resected node-negative, ER-positive breast cancer treated with tamoxifen and may identify patients in whom alternative therapies should be studied.
},
	Author = {Goetz, Matthew P. and Suman, Vera J. and Ingle, James N. and Nibbe, Andrea M. and Visscher, Dan W. and Reynolds, Carol A. and Lingle, Wilma L. and Erlander, Mark and Ma, Xiao-Jun and Sgroi, Dennis C. and Perez, Edith A. and Couch, Fergus J.},
	Date-Added = {2009-01-18 11:07:17 +0100},
	Date-Modified = {2009-01-18 11:07:17 +0100},
	Doi = {10.1158/1078-0432.CCR-05-1263},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/12/7/2080.pdf},
	Journal = {Clin Cancer Res},
	Number = {7},
	Pages = {2080-2087},
	Title = {{A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/12/7/2080},
	Volume = {12},
	Year = {2006},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/12/7/2080},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-05-1263}}

@article{hubble2009implementation,
	Author = {Hubble, Jeremy and Demeter, Janos and Jin, Heng and Mao, Maria and Nitzberg, Michael and Reddy, T. B. K. and Wymore, Farrell and Zachariah, Zachariah K. and Sherlock, Gavin and Ball, Catherine A.},
	Date-Added = {2009-01-15 14:07:37 +0100},
	Date-Modified = {2009-01-15 18:12:24 +0100},
	Doi = {10.1093/nar/gkn786},
	Eprint = {http://nar.oxfordjournals.org/cgi/reprint/37/suppl_1/D898.pdf},
	Journal = {Nucl. Acids Res.},
	Number = {suppl 1},
	Pages = {D898-901},
	Title = {{Implementation of GenePattern within the Stanford Microarray Database}},
	Url = {http://nar.oxfordjournals.org/cgi/content/abstract/37/suppl_1/D898},
	Volume = {37},
	Year = {2009},
	Bdsk-Url-1 = {http://nar.oxfordjournals.org/cgi/content/abstract/37/suppl_1/D898},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/nar/gkn786}}

@article{konecny2004association,
	Abstract = {PURPOSE: Activation or overexpression of HER-2/neu is associated with up-regulation of vascular endothelial growth factor (VEGF) in human breast cancer cells in vitro. Preclinical experiments indicate that increased expression of VEGF may in part mediate the biologically aggressive phenotype of HER-2/neu-overexpressing human breast cancer. It was the purpose of this study to: (a). evaluate the association between HER-2/neu and VEGF expression in a large clinical cohort of primary breast cancer patients; (b). compare the prognostic significance of VEGF isoforms; and (c). analyze the combined effects of HER-2/neu and VEGF on clinical outcome. EXPERIMENTAL DESIGN: HER-2/neu and VEGF were measured by ELISA in primary breast tumor tissue lysates from 611 unselected patients with a median clinical follow-up of 50 months. At least six VEGF isoforms consisting of 121, 145, 165, 183, 189, or 206 amino acids are generated as a result of alternative splicing. The VEGF(121-206) ELISA uses antibodies that bind to VEGF(121) and, therefore, detects all of the VEGF isoforms with 121 and more amino acids. The VEGF(165-206) ELISA uses antibodies that bind to VEGF(165) and, therefore, detects all of the VEGF isoforms with 165 and more amino acids. VEGF(121-206) and VEGF(165-206) were analyzed both as continuous and categorical variables, using detectable expression as a cutoff for positivity. Cell lines with defined HER-2/neu expression levels were used to establish a cutoff point for HER-2/neu overexpression in breast tumor samples. RESULTS: Our findings indicate a significant positive association between HER-2/neu and VEGF expression. VEGF(121-206) and VEGF(165-206) expression was detectable in 88 (77.2%) and 100 (87.7%), respectively, of the 114 patients with HER-2/neu-overexpressing tumors, in contrast to 271 (54.5%) and 353 (71.0%), respectively, of the 497 patients with nonoverexpressing tumors (chi(2) test: P < 0.001 for both VEGF(121-206) and VEGF(165-206)). VEGF(121-206) and VEGF(165-206) demonstrate a comparable prognostic significance for survival in unselected primary breast cancer patients (univariate analysis: VEGF(121-206), P = 0.0068; VEGF(165-206), P = 0.0046; multivariate analysis: VEGF(121-206), P = 0.1475; VEGF(165-206), P = 0.1483). When the analyses were performed separately for node-negative and node-positive patients, VEGF(121-206) and VEGF(165-206) were of prognostic significance for survival only in node-positive patients (univariate analysis: VEGF(121-206), P = 0.0003; VEGF(165-206), P = 0.0038; multivariate analysis: VEGF(121-206), P = 0.0103; VEGF(165-206), P = 0.0150). A biological concentration-effect relationship between VEGF expression and survival (VEGF(121-206), P = 0.0280; VEGF(165-206,) P = 0.0097) suggests that VEGF levels, as determined by ELISA, could be of importance as a predictive marker for therapeutic strategies that target VEGF. Combining HER-2/neu and VEGF(121-206)/VEGF(165-206) results in additional prognostic information for survival (VEGF(121-206), P = 0.0133; VEGF(165-206), P = 0.0092). CONCLUSION: The positive association between HER-2/neu and VEGF expression implicates VEGF in the aggressive phenotype exhibited by HER-2/neu overexpression, and supports the use of combination therapies directed against both HER-2/neu and VEGF for treatment of breast cancers that overexpress HER-2/neu.},
	Address = {Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095-1678, USA.},
	Au = {Konecny, GE and Meng, YG and Untch, M and Wang, HJ and Bauerfeind, I and Epstein, M and Stieber, P and Vernes, JM and Gutierrez, J and Hong, K and Beryt, M and Hepp, H and Slamon, DJ and Pegram, MD},
	Author = {Konecny, Gottfried E and Meng, Y Gloria and Untch, Michael and Wang, He-Jing and Bauerfeind, Ingo and Epstein, Melinda and Stieber, Petra and Vernes, Jean-Michel and Gutierrez, Johnny and Hong, Kyu and Beryt, Malgorzata and Hepp, Hermann and Slamon, Dennis J and Pegram, Mark D},
	Cin = {Clin Cancer Res. 2004 Dec 15;10(24):8752-3. PMID: 15623662},
	Crdt = {2004/03/12 05:00},
	Da = {20040311},
	Date-Added = {2009-01-14 20:52:57 +0100},
	Date-Modified = {2009-01-14 20:53:18 +0100},
	Dcom = {20041005},
	Edat = {2004/03/12 05:00},
	Issn = {1078-0432 (Print)},
	Jid = {9502500},
	Journal = {Clin Cancer Res},
	Jt = {Clinical cancer research : an official journal of the American Association for Cancer Research},
	Language = {eng},
	Lr = {20061115},
	Mh = {Adult; Aged; Aged, 80 and over; Analysis of Variance; Breast Neoplasms/*genetics/mortality/pathology; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic/genetics; Genes, erbB-2/*genetics; Humans; Lymphatic Metastasis; Middle Aged; Receptor, erbB-2/*genetics; Survival Analysis; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A/*genetics},
	Mhda = {2004/10/06 09:00},
	Month = {March},
	Number = {5},
	Own = {NLM},
	Pages = {1706--1716},
	Pl = {United States},
	Pmid = {15014023},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.},
	Rn = {0 (Vascular Endothelial Growth Factor A); EC 2.7.1.112 (Receptor, erbB-2)},
	Sb = {IM},
	So = {Clin Cancer Res. 2004 Mar 1;10(5):1706-16.},
	Stat = {MEDLINE},
	Title = {Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.},
	Volume = {10},
	Year = {2004}}

@article{mcshane2005reporting,
	Abstract = {Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often, initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent conclusions or stand in direct contradiction to the promising results. It is imperative that we attempt to understand the reasons that multiple studies of the same marker lead to differing conclusions. A variety of methodologic problems have been cited to explain these discrepancies. Unfortunately, many tumor marker studies have not been reported in a rigorous fashion, and published articles often lack sufficient information to allow adequate assessment of the quality of the study or the generalizability of study results. The development of guidelines for the reporting of tumor marker studies was a major recommendation of the National Cancer Institute-European Organisation for Research and Treatment of Cancer (NCI-EORTC) First International Meeting on Cancer Diagnostics in 2000. As for the successful CONSORT initiative for randomized trials and for the STARD statement for diagnostic studies, we suggest guidelines to provide relevant information about the study design, preplanned hypotheses, patient and specimen characteristics, assay methods, and statistical analysis methods. In addition, the guidelines suggest helpful presentations of data and important elements to include in discussions. The goal of these guidelines is to encourage transparent and complete reporting so that the relevant information will be available to others to help them to judge the usefulness of the data and understand the context in which the conclusions apply.
},
	Author = {McShane, Lisa M. and Altman, Douglas G. and Sauerbrei, Willi and Taube, Sheila E. and Gion, Massimo and Clark, Gary M.},
	Date-Added = {2009-01-14 20:50:19 +0100},
	Date-Modified = {2009-03-28 13:38:28 +0100},
	Doi = {10.1093/jnci/dji237},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;97/16/1180.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {16},
	Pages = {1180-1184},
	Title = {{Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/16/1180},
	Volume = {97},
	Year = {2005},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/16/1180},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/dji237}}

@article{mauri2005neoadjuvant,
	Abstract = {Background: Interest in the use of preoperative systemic treatment in the management of breast cancer has increased because such neoadjuvant therapy appears to reduce the extent of local surgery required. We compared the clinical end points of patients with breast cancer treated preoperatively with systemic therapy (neoadjuvant therapy) and of those treated postoperatively with the same regimen (adjuvant therapy) in a meta-analysis of randomized trials. Methods: We evaluated nine randomized studies, including a total of 3946 patients with breast cancer, that compared neoadjuvant therapy with adjuvant therapy regardless of what additional surgery and/or radiation treatment was used. Fixed and random effects methods were used to combine data. Primary outcomes were death, disease progression, distant disease recurrence, and loco-regional disease recurrence. Secondary outcomes were local response and conservative local treatment. All statistical tests were two-sided. Results: We found no statistically or clinically significant difference between neoadjuvant therapy and adjuvant therapy arms associated with death (summary risk ratio [RR] = 1.00, 95% confidence interval [CI] = 0.90 to 1.12), disease progression (summary RR = 0.99, 95% CI = 0.91 to 1.07), or distant disease recurrence (summary RR = 0.94, 95% CI = 0.83 to 1.06). However, neoadjuvant therapy was statistically significantly associated with an increased risk of loco-regional disease recurrences (RR = 1.22, 95% CI = 1.04 to 1.43), compared with adjuvant therapy, especially in trials where more patients in the neoadjuvant, than the adjuvant, arm received radiation therapy without surgery (RR = 1.53, 95% CI = 1.11 to 2.10). Across trials, we observed heterogeneity in the rates of complete clinical response (range = 7%-65%; P for heterogeneity of <.001), pathologic response (range = 4%-29%; P for heterogeneity of <.001), and adoption of conservative local treatment (range = 28%-89% in neoadjuvant arms, P for heterogeneity of <.001). Conclusions: Neoadjuvant therapy was apparently equivalent to adjuvant therapy in terms of survival and overall disease progression. Neoadjuvant therapy, compared with adjuvant therapy, was associated with a statistically significant increased risk of loco-regional recurrence when radiotherapy without surgery was adopted.
},
	Author = {Mauri, Davide and Pavlidis, Nicholas and Ioannidis, John P. A.},
	Date-Added = {2009-01-14 20:14:27 +0100},
	Date-Modified = {2009-01-14 20:14:27 +0100},
	Doi = {10.1093/jnci/dji021},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;97/3/188.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {3},
	Pages = {188-194},
	Title = {{Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/3/188},
	Volume = {97},
	Year = {2005},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/3/188},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/dji021}}

@article{ebctg2005effects,
	Abstract = {BACKGROUND: Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year effects. METHODS: Collaborative meta-analyses were undertaken of 194 unconfounded randomised trials of adjuvant chemotherapy or hormonal therapy that began by 1995. Many trials involved CMF (cyclophosphamide, methotrexate, fluorouracil), anthracycline-based combinations such as FAC (fluorouracil, doxorubicin, cyclophosphamide) or FEC (fluorouracil, epirubicin, cyclophosphamide), tamoxifen, or ovarian suppression: none involved taxanes, trastuzumab, raloxifene, or modern aromatase inhibitors. FINDINGS: Allocation to about 6 months of anthracycline-based polychemotherapy (eg, with FAC or FEC) reduces the annual breast cancer death rate by about 38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4) for those of age 50-69 years when diagnosed, largely irrespective of the use of tamoxifen and of oestrogen receptor (ER) status, nodal status, or other tumour characteristics. Such regimens are significantly (2p=0.0001 for recurrence, 2p<0.00001 for breast cancer mortality) more effective than CMF chemotherapy. Few women of age 70 years or older entered these chemotherapy trials. For ER-positive disease only, allocation to about 5 years of adjuvant tamoxifen reduces the annual breast cancer death rate by 31% (SE 3), largely irrespective of the use of chemotherapy and of age (<50, 50-69, > or =70 years), progesterone receptor status, or other tumour characteristics. 5 years is significantly (2p<0.00001 for recurrence, 2p=0.01 for breast cancer mortality) more effective than just 1-2 years of tamoxifen. For ER-positive tumours, the annual breast cancer mortality rates are similar during years 0-4 and 5-14, as are the proportional reductions in them by 5 years of tamoxifen, so the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis. These results combine six meta-analyses: anthracycline-based versus no chemotherapy (8000 women); CMF-based versus no chemotherapy (14,000); anthracycline-based versus CMF-based chemotherapy (14,000); about 5 years of tamoxifen versus none (15,000); about 1-2 years of tamoxifen versus none (33,000); and about 5 years versus 1-2 years of tamoxifen (18,000). Finally, allocation to ovarian ablation or suppression (8000 women) also significantly reduces breast cancer mortality, but appears to do so only in the absence of other systemic treatments. For middle-aged women with ER-positive disease (the commonest type of breast cancer), the breast cancer mortality rate throughout the next 15 years would be approximately halved by 6 months of anthracycline-based chemotherapy (with a combination such as FAC or FEC) followed by 5 years of adjuvant tamoxifen. For, if mortality reductions of 38% (age <50 years) and 20% (age 50-69 years) from such chemotherapy were followed by a further reduction of 31% from tamoxifen in the risks that remain, the final mortality reductions would be 57% and 45%, respectively (and, the trial results could well have been somewhat stronger if there had been full compliance with the allocated treatments). Overall survival would be comparably improved, since these treatments have relatively small effects on mortality from the aggregate of all other causes. INTERPRETATION: Some of the widely practicable adjuvant drug treatments that were being tested in the 1980s, which substantially reduced 5-year recurrence rates (but had somewhat less effect on 5-year mortality rates), also substantially reduce 15-year mortality rates. Further improvements in long-term survival could well be available from newer drugs, or better use of older drugs.},
	Author = {{EBCTG}},
	Cin = {ACP J Club. 2005 Nov-Dec;143(3):58. PMID: 16262215; Lancet. 2005 May 14-20;365(9472):1665-6. PMID: 15894082},
	Cn = {Early Breast Cancer Trialists' Collaborative Group (EBCTCG)},
	Crdt = {2005/05/17 09:00},
	Da = {20050516},
	Date-Added = {2009-01-14 19:23:03 +0100},
	Date-Modified = {2009-01-21 14:24:18 +0100},
	Dcom = {20050906},
	Doi = {10.1016/S0140-6736(05)66544-0},
	Edat = {2005/05/17 09:00},
	Issn = {1474-547X (Electronic)},
	Jid = {2985213R},
	Journal = {Lancet},
	Jt = {Lancet},
	Language = {eng},
	Lr = {20071115},
	Mh = {Aged; Anthracyclines/therapeutic use; Antineoplastic Agents, Hormonal/*therapeutic use; Antineoplastic Combined Chemotherapy Protocols/*therapeutic use; Breast Neoplasms/drug therapy/mortality/pathology/*therapy; Cause of Death; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; *Ovariectomy; Ovary/drug effects; Randomized Controlled Trials as Topic; Receptors, Estrogen/analysis; Survival Rate; Tamoxifen/*therapeutic use},
	Mhda = {2005/09/07 09:00},
	Month = {May},
	Number = {9472},
	Own = {NLM},
	Pages = {1687--1717},
	Pii = {S0140-6736(05)66544-0},
	Pl = {England},
	Pmid = {15894097},
	Pst = {ppublish},
	Pt = {Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't},
	Rn = {0 (Anthracyclines); 0 (Antineoplastic Agents, Hormonal); 0 (Receptors, Estrogen); 10540-29-1 (Tamoxifen)},
	Sb = {AIM; IM},
	So = {Lancet. 2005 May 14-20;365(9472):1687-717.},
	Stat = {MEDLINE},
	Title = {Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.},
	Volume = {365},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0140-6736(05)66544-0}}

@article{parkin2001estimating,
	Address = {Descriptive Epidemiology Unit, International Agency for Research on Cancer, Lyon, France. parkin@iarc.fr},
	Au = {Parkin, DM and Bray, F and Ferlay, J and Pisani, P},
	Author = {Parkin, D M and Bray, F and Ferlay, J and Pisani, P},
	Crdt = {2001/10/23 10:00},
	Da = {20011022},
	Date-Added = {2009-01-14 19:19:13 +0100},
	Date-Modified = {2009-01-21 14:26:22 +0100},
	Dcom = {20011101},
	Edat = {2001/10/23 10:00},
	Issn = {0020-7136 (Print)},
	Jid = {0042124},
	Journal = {Int J Cancer},
	Jt = {International journal of cancer. Journal international du cancer},
	Language = {eng},
	Lr = {20070724},
	Mh = {Female; Humans; Incidence; Male; Neoplasms/*epidemiology/mortality; Prevalence; Time Factors},
	Mhda = {2001/11/03 10:01},
	Month = {October},
	Number = {2},
	Own = {NLM},
	Pages = {153--156},
	Pii = {10.1002/ijc.1440},
	Pl = {United States},
	Pmid = {11668491},
	Pst = {ppublish},
	Pt = {Journal Article},
	Sb = {IM},
	So = {Int J Cancer. 2001 Oct 15;94(2):153-6.},
	Stat = {MEDLINE},
	Title = {Estimating the world cancer burden: Globocan 2000.},
	Volume = {94},
	Year = {2001}}

@article{veronesi2005breast,
	Abstract = {Breast cancer remains a public-health issue on a global scale. We report new information about the disease from the past 5 years. Early age at first birth, increasing parity, and tamoxifen use are related to long-term lifetime reduction in breast-cancer risk. Ductal carcinomas in situ has been suggested to be renamed ductal intraepithelial neoplasia to emphasise its non-life-threatening nature. An alternative approach, the progenitor/stem cell theory, predicts that only some tumour cells cause cancer progression and that these should be targeted by treatment. Mammography and ultrasonography are still the most effective for women with non-dense and dense breast tissues, respectively. Additionally, MRI, lymphatic mapping, the nipple-sparing mastectomy, partial breast irradiation, neoadjuvant systemic therapy, and adjuvant treatments are promising for subgroups of breast-cancer patients. Although tamoxifen can be offered for endocrine-responsive disease, aromatase inhibitors are increasingly used. Assessment of potential molecular targets is now important in primary diagnosis. Tyrosine-kinase inhibitors and other drugs with anti-angiogenesis properties are currently undergoing preclinical investigations.},
	Address = {European Institute of Oncology, Milan, Italy. umberto.veronesi{\char64}ieo.it},
	Au = {Veronesi, U and Boyle, P and Goldhirsch, A and Orecchia, R and Viale, G},
	Author = {Veronesi, Umberto and Boyle, Peter and Goldhirsch, Aron and Orecchia, Roberto and Viale, Giuseppe},
	Cin = {Lancet. 2005 Nov 5;366(9497):1605-6; author reply 1606. PMID: 16271638},
	Crdt = {2005/05/17 09:00},
	Da = {20050516},
	Date-Added = {2009-01-14 19:17:16 +0100},
	Date-Modified = {2009-01-21 14:22:30 +0100},
	Dcom = {20050906},
	Doi = {10.1016/S0140-6736(05)66546-4},
	Edat = {2005/05/17 09:00},
	Issn = {1474-547X (Electronic)},
	Jid = {2985213R},
	Journal = {Lancet},
	Jt = {Lancet},
	Language = {eng},
	Lr = {20061115},
	Mh = {*Breast Neoplasms/diagnosis/etiology/prevention \& control/therapy; Chemoprevention; Female; Humans; Risk Factors},
	Mhda = {2005/09/07 09:00},
	Month = {May},
	Number = {9472},
	Own = {NLM},
	Pages = {1727--1741},
	Pii = {S0140-6736(05)66546-4},
	Pl = {England},
	Pmid = {15894099},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	Rf = {160},
	Sb = {AIM; IM},
	So = {Lancet. 2005 May 14-20;365(9472):1727-41.},
	Stat = {MEDLINE},
	Title = {Breast cancer},
	Volume = {365},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0140-6736(05)66546-4}}

@article{colozza2005proliferative,
	Abstract = {In the last few decades, proliferative markers have been broadly evaluated as prognostic and predictive factors for early stage breast cancer patients. Several papers evaluating one or more markers have been published, often with contradictory results. As a consequence, there is still uncertainty about the role of these proliferative markers. The present paper critically reviews the current knowledge about the following markers: thymidine labeling index, S phase fraction/flow cytometry, Ki 67, thymidine kinase (TK), cyclins E, cyclin D, the cyclin inhibitors p27 and p21, and topoisomerase II{alpha}. For each marker, the prognostic and predictive role was separately analyzed. Only papers published in English in peer-reviewed journals before June 2004 that include at least 100 evaluable patients were selected. In addition, the prognostic and predictive role of the proliferative markers had to be assessed through multivariate analyses. One hundred and thirty-two papers fulfilled these criteria and 159 516 patients were analyzed. Unfortunately, several methodological problems in the research to date prevent us from including any one of these proliferative markers among the standard prognostic and predictive factors. Early incorporation of translational research and new technologies with clinical trials are needed to prospectively validate biological markers and allow their use in clinical practice.
},
	Author = {Colozza, M. and Azambuja, E. and Cardoso, F. and Sotiriou, C. and Larsimont, D. and Piccart, M. J.},
	Date-Added = {2009-01-11 15:31:24 +0100},
	Date-Modified = {2009-01-11 15:31:24 +0100},
	Doi = {10.1093/annonc/mdi352},
	Eprint = {http://annonc.oxfordjournals.org/cgi/reprint/16/11/1723.pdf},
	Journal = {Ann Oncol},
	Number = {11},
	Pages = {1723-1739},
	Title = {{Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?}},
	Url = {http://annonc.oxfordjournals.org/cgi/content/abstract/16/11/1723},
	Volume = {16},
	Year = {2005},
	Bdsk-Url-1 = {http://annonc.oxfordjournals.org/cgi/content/abstract/16/11/1723},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/annonc/mdi352}}

@article{seungsang2007significance,
	Abstract = {We conducted this study to examine whether the expression of c-erbB-2 and p53 is the prognostic indicator for patients with early-stage breast cancer in which axillary lymph node metastasis is absent. We examined 326 patients with early-stage breast cancer in which axillary lymph node metastasis is absent. Tissue microarrays were constructed. Following this, immunohistochemical staining was done for estrogen receptor (ER), progesterone receptor (PR), c-erbB2, and p53. The results were as follows: (1) expression of c-erbB-2 was correlated with other clinicopathologic factors (eg, patient's age, presence of menopause, tumor size, histologic and nuclear grade, and presence of hormone receptors such as ER and PR); and (2) expression of p53 was correlated with survival rate, patient's age, presence of menopause, and tumor size. However, these results were not statistically significant. In conclusion, our results indicate that expression of c-erbB-2 and p53 did not have any prognostic value in patients with early-stage breast cancer in which axillary lymph node metastasis is absent.},
	Address = {Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, Korea. drkoss@skku.edu},
	Au = {Ko, SS and Na, YS and Yoon, CS and Park, JY and Kim, HS and Hur, MH and Lee, HK and Chun, YK and Kang, SS and Park, BW and Lee, JH},
	Author = {Ko, Seung-Sang and Na, Youn-Sun and Yoon, Chan-Seok and Park, Ji-Young and Kim, Hye-Sun and Hur, Min-Hee and Lee, Hae-Kyung and Chun, Yi-Kyung and Kang, Sung-Soo and Park, Byeong-Woo and Lee, Jee-Hyun},
	Crdt = {2007/05/05 09:00},
	Da = {20070504},
	Date-Added = {2009-01-11 08:43:07 +0100},
	Date-Modified = {2009-01-11 08:43:47 +0100},
	Dcom = {20070524},
	Doi = {10.1177/1066896906299124},
	Edat = {2007/05/05 09:00},
	Issn = {1066-8969 (Print)},
	Jid = {9314927},
	Journal = {Int J Surg Pathol},
	Jt = {International journal of surgical pathology},
	Language = {eng},
	Mh = {Adult; Axilla; Breast Neoplasms/*metabolism/mortality/pathology; Carcinoma, Ductal, Breast/*metabolism/mortality/pathology; Combined Modality Therapy; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prognosis; Receptor, erbB-2/*metabolism; Retrospective Studies; Survival Rate; Tissue Array Analysis; Tumor Markers, Biological/metabolism; Tumor Suppressor Protein p53/*metabolism},
	Mhda = {2007/05/26 09:00},
	Month = {April},
	Number = {2},
	Own = {NLM},
	Pages = {98--109},
	Pii = {15/2/98},
	Pl = {United States},
	Pmid = {17478762},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Tumor Markers, Biological); 0 (Tumor Suppressor Protein p53); EC 2.7.1.112 (Receptor, erbB-2)},
	Sb = {IM},
	So = {Int J Surg Pathol. 2007 Apr;15(2):98-109.},
	Stat = {MEDLINE},
	Title = {The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.},
	Volume = {15},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1177/1066896906299124}}

@article{tsutsui2003prognostic,
	Abstract = {BACKGROUND: The expressions of p53 protein and c-erbB2 have been thoroughly analyzed as prognostic factors for breast cancer. However, the prognostic significance of the coexpression of p53 protein and c-erbB2 remains controversial. METHODS: The immunohistochemical expression of p53 protein and c-erbB2 was evaluated in 242 women with breast cancer. RESULTS: According to the combination of p53 protein and c-erbB2, a group negative for both (125 cases), a group positive for either one of these two parameters (99 cases) and a group positive for both (18 cases) were identified. The group positive for one factor had a significantly (P = 0.0045) worse disease-free survival (DFS) than the group negative for both, while the group positive for both had a significantly (P = 0.0023) worse DFS than the group positive for one factor. A multivariate analysis indicated that the relative risk of p53 protein alone and cerbB2 alone was 2.18 and 2.93, respectively, while the relative risk of the group positive for one factor and the group positive for both was 2.29 and 6.37, respectively . CONCLUSIONS: Breast cancer with a coexpression of p53 protein and c-erbB2 was thus found to have a more significant prognostic value than those with a positive expression for either of these two biological parameters, while the prognostic significance of these two parameters themselves remained independent of each other.},
	Address = {Department of Breast Surgery, Beppu National Hospital, 1473 Oaza-Uchikamado, Beppu 874-0011, Japan. tsutsui@lime.ocn.ne.jp},
	Au = {Tsutsui, S and Ohno, S and Murakami, S and Kataoka, A and Kinoshita, J and Hachitanda, Y},
	Author = {Tsutsui, Shinichi and Ohno, Shinji and Murakami, Shigeru and Kataoka, Akemi and Kinoshita, Junko and Hachitanda, Yoichi},
	Crdt = {2003/02/01 04:00},
	Da = {20030131},
	Date-Added = {2009-01-11 08:42:13 +0100},
	Date-Modified = {2009-01-11 08:42:39 +0100},
	Dcom = {20030310},
	Edat = {2003/02/01 04:00},
	Issn = {0002-9610 (Print)},
	Jid = {0370473},
	Journal = {Am J Surg},
	Jt = {American journal of surgery},
	Language = {eng},
	Lr = {20051117},
	Mh = {Adult; Aged; Aged, 80 and over; Breast Neoplasms/*metabolism; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Prognosis; Receptor, erbB-2/*biosynthesis; Tumor Suppressor Protein p53/*biosynthesis},
	Mhda = {2003/03/11 04:00},
	Month = {February},
	Number = {2},
	Own = {NLM},
	Pages = {165--167},
	Pii = {S0002961002012035},
	Pl = {United States},
	Pmid = {12559449},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Tumor Suppressor Protein p53); EC 2.7.1.112 (Receptor, erbB-2)},
	Sb = {AIM; IM},
	So = {Am J Surg. 2003 Feb;185(2):165-7.},
	Stat = {MEDLINE},
	Title = {Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer.},
	Volume = {185},
	Year = {2003}}

@article{lonn1995prognostic,
	Abstract = {BACKGROUND. Amplification of erb-B2 and myc shows prognostic value in patients with operable breast cancer. Amplification is usually detected in tumor samples remaining after pathologic work-up, preventing the examination of small tumors. METHODS. Tumor imprints that contained low numbers of contaminating normal cells were obtained from small tumors. The prognostic value of erb-B2 and myc amplification in imprint breast preparations was examined, using the polymerase chain reaction (PCR) to determine gene copy number. Tumor material was obtained from 162 patients with breast cancer operated 1975-1976. RESULTS. Amplification of erb-B2 existed in 21% and myc in 16% of the patients. Both erb-B2 and myc amplification showed prognostic significance in univariate analysis for survival and relapse free survival. In multivariate analysis, erb-B2 was a significant factor. In small tumors less than 13 mm in greatest dimension, erb-B2 showed prognostic significance for survival but not for relapse free survival. CONCLUSIONS. The use of imprints/PCR allows the detection of gene amplification in breast cancer. The procedure is suitable for the analysis of small tumors and can be used to examine very small tumors, such as those detected mammographically.},
	Address = {Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.},
	Au = {Lonn, U and Lonn, S and Nilsson, B and Stenkvist, B},
	Author = {Lonn, U and Lonn, S and Nilsson, B and Stenkvist, B},
	Crdt = {1995/06/01 00:00},
	Da = {19950615},
	Date-Added = {2009-01-11 08:39:23 +0100},
	Date-Modified = {2009-01-11 08:39:53 +0100},
	Dcom = {19950615},
	Edat = {1995/06/01},
	Gs = {erb-B2; myc},
	Issn = {0008-543X (Print)},
	Jid = {0374236},
	Journal = {Cancer},
	Jt = {Cancer},
	Language = {eng},
	Lr = {20061115},
	Mh = {Analysis of Variance; Base Sequence; Breast Neoplasms/*genetics/pathology; Follow-Up Studies; *Gene Amplification; *Genes, erbB; *Genes, myc; Humans; Lymph Nodes/pathology; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; Tumor Cells, Cultured},
	Mhda = {1995/06/01 00:01},
	Number = {11},
	Own = {NLM},
	Pages = {2681--2687},
	Pl = {UNITED STATES},
	Pmid = {7743470},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Sb = {AIM; IM},
	So = {Cancer. 1995 Jun 1;75(11):2681-7.},
	Stat = {MEDLINE},
	Title = {Prognostic value of erb-B2 and myc amplification in breast cancer imprints.},
	Volume = {75},
	Year = {1995 Jun 1}}

@article{revillion1998erbb2,
	Abstract = {We reveiwed the relationships between ERBB2 amplification and/or overexpression in human breast cancer and the clinicopathological parameters described in the literature (97 studies involving 22,616 patients) in order to draw conclusions regarding its clinical interest. The mean of ERBB2 positivity (26%, ranging from 5 to 55%) is not dependent on the method used to evaluate ERBB2 amplification or overexpression. Despite the discrepancies observed between the different studies, several associations between ERBB2 positivity and the classical clinicopathological parameters were noted. There are clear relationships between ERBB2 positivity and the lack of steroid receptors, the histological subtypes of mammary tumours (ductal invasive and in situ), worse histological and nuclear grades, aneuploidy and high rate of proliferation. In univariate analyses, ERBB2 is strongly associated with poor prognosis. All these data indicate that ERBB2 is a marker of aggressiveness of the tumour. However, ERBB2 does not retain a clinical prognostic significance in multivariate analyses, since it is associated with several strong prognostic parameters. When considering the prognostic value of ERBB2 in relation to treatment, a significantly worse survival of the treated patients is noted in ERBB2 positive patients. This suggest that ERBB2 could be a marker of reduced response to chemotherapy and hormonal treatment. With respect to the tumour response to treatment, the results, provided as yet by pilot studies, remain controversial and further investigations are necessary to evaluate the predictive value of ERBB2. Finally, new therapeutic approaches targeting the cells overexpressing ERBB2 have been developed.},
	Address = {Laboratoire d'Oncologie Moleculaire Humaine, Centre Oscar Lambret, Lille, France.},
	Au = {Revillion, F and Bonneterre, J and Peyrat, JP},
	Author = {Revillion, F and Bonneterre, J and Peyrat, J P},
	Crdt = {1998/11/03 00:00},
	Da = {19981106},
	Date-Added = {2009-01-11 08:30:57 +0100},
	Date-Modified = {2009-01-11 08:31:26 +0100},
	Dcom = {19981106},
	Edat = {1998/11/03},
	Issn = {0959-8049 (Print)},
	Jid = {9005373},
	Journal = {Eur J Cancer},
	Jt = {European journal of cancer (Oxford, England : 1990)},
	Language = {eng},
	Lr = {20061115},
	Mh = {Age of Onset; Antineoplastic Agents/therapeutic use; Breast Neoplasms/*genetics/pathology/therapy; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; *Genes, erbB-2; Humans; Lymphatic Metastasis; Receptors, Estrogen/metabolism},
	Mhda = {1998/11/03 00:01},
	Month = {May},
	Number = {6},
	Own = {NLM},
	Pages = {791--808},
	Pii = {S0959-8049(97)10157-5},
	Pl = {ENGLAND},
	Pmid = {9797688},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	Rf = {187},
	Rn = {0 (Antineoplastic Agents); 0 (Receptors, Estrogen)},
	Sb = {IM},
	So = {Eur J Cancer. 1998 May;34(6):791-808.},
	Stat = {MEDLINE},
	Title = {ERBB2 oncogene in human breast cancer and its clinical significance.},
	Volume = {34},
	Year = {1998}}

@book{devroye1997probabilistic,
	Abstract = {{Pattern recognition presents one of the most significant challenges for scientists and engineers, and many different approaches have been proposed. The aim of this book is to provide a self-contained account of probabilistic analysis of these approaches. The book includes a discussion of distance measures, nonparametric methods based on kernels or nearest neighbors, Vapnik-Chervonenkis theory, epsilon entropy, parametric classification, error estimation, free classifiers, and neural networks. Wherever possible, distribution-free properties and inequalities are derived. A substantial portion of the results or the analysis is new. Over 430 problems and exercises complement the material.}},
	Author = {Devroye, Luc and Gy\"{o}rfi, Laszlo and Lugosi, Gabor},
	Citeulike-Article-Id = {134351},
	Date-Added = {2009-01-10 11:06:09 +0100},
	Date-Modified = {2009-01-10 11:06:09 +0100},
	Howpublished = {Hardcover},
	Isbn = {0387946187},
	Keywords = {pattern-recognition},
	Month = {February},
	Posted-At = {2007-12-19 21:19:52},
	Priority = {2},
	Publisher = {Springer},
	Title = {A Probabilistic Theory of Pattern Recognition (Stochastic Modelling and Applied Probability)},
	Url = {http://www.amazon.ca/exec/obidos/redirect?tag=citeulike09-20\&amp;path=ASIN/0387946187},
	Year = {1997},
	Bdsk-Url-1 = {http://www.amazon.ca/exec/obidos/redirect?tag=citeulike09-20%5C&amp;path=ASIN/0387946187}}

@inproceedings{davies1994npcompleteness,
	Author = {Scott Davies and Stuart Russell},
	Booktitle = {AAAI Symposium on Intelligent Relevance},
	Date-Added = {2009-01-10 10:59:06 +0100},
	Date-Modified = {2009-01-10 10:59:20 +0100},
	Pages = {37--39},
	Publisher = {AAAI Press},
	Title = {NP-Completeness of Searches for Smallest Possible Feature Sets},
	Year = {1994}}

@article{ruspini1969new,
	Author = {Ruspini, E. H.},
	Citeulike-Article-Id = {2870000},
	Date-Added = {2009-01-09 19:10:39 +0100},
	Date-Modified = {2009-01-09 19:10:39 +0100},
	Journal = {Information and Control},
	Keywords = {fuzzy},
	Number = {1},
	Pages = {22--32},
	Posted-At = {2008-06-06 17:16:22},
	Priority = {2},
	Title = {A new approach to clustering},
	Volume = {15},
	Year = {1969}}

@article{rouzier2005breast,
	Abstract = {Purpose: Molecular classification of breast cancer has been proposed based on gene expression profiles of human tumors. Luminal, basal-like, normal-like, and erbB2+ subgroups were identified and were shown to have different prognoses. The goal of this research was to determine if these different molecular subtypes of breast cancer also respond differently to preoperative chemotherapy.  Experimental Design: Fine needle aspirations of 82 breast cancers were obtained before starting preoperative paclitaxel followed by 5-fluorouracil, doxorubicin, and cyclophosphamide chemotherapy. Gene expression profiling was done with Affymetrix U133A microarrays and the previously reported "breast intrinsic" gene set was used for hierarchical clustering and multidimensional scaling to assign molecular class.  Results: The basal-like and erbB2+ subgroups were associated with the highest rates of pathologic complete response (CR), 45% [95% confidence interval (95% CI), 24-68] and 45% (95% CI, 23-68), respectively, whereas the luminal tumors had a pathologic CR rate of 6% (95% CI, 1-21). No pathologic CR was observed among the normal-like cancers (95% CI, 0-31). Molecular class was not independent of conventional cliniocopathologic predictors of response such as estrogen receptor status and nuclear grade. None of the 61 genes associated with pathologic CR in the basal-like group were associated with pathologic CR in the erbB2+ group, suggesting that the molecular mechanisms of chemotherapy sensitivity may vary between these two estrogen receptor-negative subtypes.  Conclusions: The basal-like and erbB2+ subtypes of breast cancer are more sensitive to paclitaxel- and doxorubicin-containing preoperative chemotherapy than the luminal and normal-like cancers.
},
	Author = {Rouzier, Roman and Perou, Charles M. and Symmans, W. Fraser and Ibrahim, Nuhad and Cristofanilli, Massimo and Anderson, Keith and Hess, Kenneth R. and Stec, James and Ayers, Mark and Wagner, Peter and Morandi, Paolo and Fan, Chang and Rabiul, Islam and Ross, Jeffrey S. and Hortobagyi, Gabriel N. and Pusztai, Lajos},
	Date-Added = {2009-01-09 15:34:06 +0100},
	Date-Modified = {2009-01-09 15:34:20 +0100},
	Doi = {10.1158/1078-0432.CCR-04-2421},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/11/16/5678.pdf},
	Journal = {Clin Cancer Res},
	Number = {16},
	Pages = {5678-5685},
	Title = {{Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/11/16/5678},
	Volume = {11},
	Year = {2005},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/11/16/5678},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-04-2421}}

@article{rouzier2005nomograms,
	Abstract = {PURPOSE: To combine clinical variables associated with pathologic complete response (pCR) and distant metastasis-free survival (DMFS) after preoperative chemotherapy (PC) into a prediction nomogram.  PATIENTS AND METHODS: Data from 496 patients treated with anthracycline PC at the Institut Gustave Roussy were used to develop and calibrate a nomogram for pCR based on multivariate logistic regression. This nomogram was tested on two independent cohorts of patients treated at the M.D. Anderson Cancer Center. The first cohort (n = 337) received anthracycline; the second cohort (n = 237) received a combination of paclitaxel and anthracycline PC. A separate nomogram to predict DMFS was developed using Cox proportional hazards regression model.  RESULTS: The pCR nomogram based on clinical stage, estrogen receptor status, histologic grade, and number of preoperative chemotherapy cycles had good discrimination and calibration in the training and the anthracycline-treated validation sets (concordance indices, 0.77, 0.79). In the paclitaxel plus anthracycline group, when the predicted pCR rate was less than 14%, the observed rate was 7.5%; for a predicted rate of [&ge;] 38%, the actual rate was 85%. For a predicted rate between 14% to 38%, the observed rates were 50% with weekly and 27% with 3-weekly paclitaxel. This indicates that patients with intermediate chemotherapy sensitivity benefit the most from the optimized schedule of paclitaxel. Patients unlikely to achieve pCR to anthracylines remain at low probability for pCR, even after inclusion of paclitaxel. The nomogram for DMFS had a concordance index of 0.72 in the validation set and outperformed other prediction tools (P = .02).  CONCLUSION: Our nomograms predict pCR accurately and can serve as a basis to integrate future molecular markers into a clinical prediction model.
},
	Author = {Rouzier, Roman and Pusztai, Lajos and Delaloge, Suzette and Gonzalez-Angulo, Ana M. and Andre, Fabrice and Hess, Kenneth R. and Buzdar, Aman U. and Garbay, Jean-Remi and Spielmann, Marc and Mathieu, Marie-Christine and Symmans, W. Fraser and Wagner, Peter and Atallah, David and Valero, Vicente and Berry, Donald A. and Hortobagyi, Gabriel N.},
	Date-Added = {2009-01-09 15:33:25 +0100},
	Date-Modified = {2009-01-09 15:33:25 +0100},
	Doi = {10.1200/JCO.2005.01.2898},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/23/33/8331.pdf},
	Journal = {J Clin Oncol},
	Number = {33},
	Pages = {8331-8339},
	Title = {{Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/23/33/8331},
	Volume = {23},
	Year = {2005},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/23/33/8331},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2005.01.2898}}

@article{turner2004tamoxifen,
	Abstract = {The process of cancer invasion involves a complex interplay between cell-cell and cell-medium adhesion, proteolytic enzyme secretion, cell birth and death processes, random and directed motility, and immune response, as well as many other factors. The growth factor TGF beta is known to have a complex effect on this process. It inhibits mitosis and promotes apoptosis in a concentration-dependent manner in vitro, and it is for this reason that its secretion is thought to be helpful in inhibiting tumour growth. However, recent in vitro and in vivo results have shown a significant effect of this growth factor in promoting the sensitivity of malignantly transformed cells to gradients of extracellular matrix proteins--an effect which tends to increase invasiveness. The drug tamoxifen has been demonstrated to be therapeutically effective in the treatment of patients with breast cancer; however, it is known also that many patients become resistant to the effect of this drug after a few years, and the reasons for this remain controversial. In this work we take our established model of cancer invasion (J. Theor. Biol. 216(1) (2002) 85), and extend it to include the effect of TGF beta. In so doing we demonstrate that a tamoxifen-stimulated upregulation of the secretion of TGF beta may give rise to a tumour which has a smaller number of cells but which has a greater invasiveness, greater metastatic potential, and a tumour histology which is known to correlate with a poorer prognosis. These data suggest that tamoxifen-stimulated secretion of TGF beta might explain treatment failure in some patients.},
	Address = {Centre for Theoretical Modelling in Medicine, Department of Mathematics, Heriot-Watt University, Edinburgh EH14 4AS, Scotland, UK. stephen@ma.hw.ac.uk, stephen.turner@pet.hw.ac.uk},
	Au = {Turner, S and A Sherratt, J and Cameron, D},
	Author = {Turner, Stephen and A Sherratt, Jonathan and Cameron, David},
	Ci = {Copyright 2004 Elsevier Ltd.},
	Crdt = {2004/06/05 05:00},
	Da = {20040604},
	Date-Added = {2009-01-08 20:03:03 +0100},
	Date-Modified = {2009-01-08 20:10:18 +0100},
	Dcom = {20040927},
	Doi = {10.1016/j.jtbi.2004.03.008},
	Edat = {2004/06/05 05:00},
	Issn = {0022-5193 (Print)},
	Jid = {0376342},
	Journal = {J Theor Biol},
	Jt = {Journal of theoretical biology},
	Language = {eng},
	Lr = {20041117},
	Mh = {Anticarcinogenic Agents/*therapeutic use; Breast Neoplasms/*drug therapy/metabolism/pathology; Dose-Response Relationship, Drug; *Drug Resistance, Neoplasm; Extracellular Matrix/metabolism; Female; Humans; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Tamoxifen/*therapeutic use; Transforming Growth Factor beta/metabolism},
	Mhda = {2004/09/28 05:00},
	Month = {July},
	Number = {1},
	Own = {NLM},
	Pages = {101--111},
	Phst = {2003/09/24 {$[$}received{$]$}; 2004/02/20 {$[$}revised{$]$}; 2004/03/03 {$[$}accepted{$]$}},
	Pii = {S0022519304001079},
	Pl = {England},
	Pmid = {15178188},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Anticarcinogenic Agents); 0 (Transforming Growth Factor beta); 10540-29-1 (Tamoxifen)},
	Sb = {IM},
	So = {J Theor Biol. 2004 Jul 7;229(1):101-11.},
	Stat = {MEDLINE},
	Title = {Tamoxifen treatment failure in cancer and the nonlinear dynamics of TGFbeta.},
	Volume = {229},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jtbi.2004.03.008}}

@article{prasad2004slit,
	Abstract = {Slit, which mediates its function by binding to the Roundabout (Robo) receptor, has been shown to regulate neuronal and CXCR4-mediated leukocyte migration. Slit-2 was shown to be frequently inactivated in lung and breast cancers because of hypermethylation of its promoter region. Furthermore, the CXCR4/CXCL12 axis has been reported recently to be actively involved in breast cancer metastasis to target organs such as lymph nodes, lung, and bone. In this study, we sought to characterize the effect of Slit (=Slit-2) on the CXCL12/CXCR4-mediated metastatic properties of breast cancer cells. We demonstrate here that breast cancer cells and tissues derived from breast cancer patients express Robo 1 and 2 receptors. We also show that Slit treatment inhibits CXCL12/CXCR4-induced breast cancer cell chemotaxis, chemoinvasion, and adhesion, the fundamental components that promote metastasis. Slit had no significant effect on the CXCL12-induced internalization process of CXCR4. In addition, characterization of signaling events revealed that Slit inhibits CXCL12-induced tyrosine phosphorylation of focal adhesion components such as RAFTK/Pyk2 at residues 580 and 881, focal adhesion kinase at residue 576, and paxillin. We found that Slit also inhibits CXCL12-induced phosphatidylinositol 3-kinase, p44/42 MAP kinase, and metalloproteinase 2 and 9 activities. However, it showed no effect on JNK and p38 MAP kinase activities. To our knowledge, this is the first report to analyze in detail the effect of Slit on breast cancer cell motility as well as its effect on the critical components of the cancer cell chemotactic machinery. Studies of the Slit-Robo complex may foster new anti-chemotactic approaches to block cancer cell metastasis.},
	Address = {Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.},
	Au = {Prasad, A and Fernandis, AZ and Rao, Y and Ganju, RK},
	Author = {Prasad, Anil and Fernandis, Aaron Z and Rao, Yi and Ganju, Ramesh K},
	Crdt = {2003/12/03 05:00},
	Da = {20040301},
	Date-Added = {2009-01-08 19:49:19 +0100},
	Date-Modified = {2009-01-26 06:52:39 +0100},
	Dcom = {20040706},
	Dep = {20031126},
	Doi = {10.1074/jbc.M308083200},
	Edat = {2003/12/03 05:00},
	Issn = {0021-9258 (Print)},
	Jid = {2985121R},
	Journal = {J Biol Chem},
	Jt = {The Journal of biological chemistry},
	Language = {eng},
	Lr = {20071115},
	Mh = {Breast Neoplasms/*metabolism/pathology; Cell Line, Tumor; Chemotaxis/drug effects; Female; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System/drug effects; Nerve Tissue Proteins/*metabolism/pharmacology; Receptors, CCR4; Receptors, Chemokine/*metabolism; Receptors, Immunologic/metabolism; Signal Transduction/drug effects},
	Mhda = {2004/07/09 05:00},
	Month = {March},
	Number = {10},
	Own = {NLM},
	Pages = {9115--9124},
	Phst = {2003/11/26 {$[$}aheadofprint{$]$}},
	Pii = {M308083200},
	Pl = {United States},
	Pmid = {14645233},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (CCR4 protein, human); 0 (Intercellular Signaling Peptides and Proteins); 0 (Nerve Tissue Proteins); 0 (Receptors, CCR4); 0 (Receptors, Chemokine); 0 (Receptors, Immunologic); 0 (Slit homolog 2 protein); 0 (roundabout protein)},
	Sb = {IM},
	So = {J Biol Chem. 2004 Mar 5;279(10):9115-24. Epub 2003 Nov 26.},
	Stat = {MEDLINE},
	Title = {Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells.},
	Volume = {279},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1074/jbc.M308083200}}

@article{liu2003reck,
	Author = {Liu, Li-Teh and Peng, Jyh-Ping and Chang, Hui-Chiu and Hung, Wen-Chun},
	Date-Added = {2009-01-08 19:47:46 +0100},
	Date-Modified = {2009-01-08 19:48:39 +0100},
	Isbn = {0950-9232},
	Journal = {Oncogene},
	Number = {51},
	Pages = {8263-8270},
	Publisher = {Nature Publishing Group},
	Title = {RECK is a target of Epstein-Barr virus latent membrane protein 1},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/sj.onc.1207157},
	Volume = {22},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.onc.1207157}}

@article{reid2005limits,
	Abstract = {Data from microarray studies have been used to develop predictive models for treatment outcome in breast cancer, such as a recently proposed predictive model for antiestrogen response after tamoxifen treatment that was based on the expression ratio of two genes. We attempted to validate this model on an independent cohort of 58 patients with resectable estrogen receptor-positive breast cancer. We measured expression of the genes HOXB13 and IL17BR with real time-quantitative polymerase chain reaction and assessed the association between their expression and outcome by use of univariate logistic regression, area under the receiver-operating-characteristic curve (AUC), a two-sample t test, and a Mann-Whitney test. We also applied standard supervised methods to the original microarray dataset and to another independent dataset from similar patients to estimate the classification accuracy obtainable by using more than two genes in a microarray-based predictive model. We could not validate the performance of the two-gene predictor on our cohort of samples (relation between outcome and the following genes estimated by logistic regression: for HOXB13, odds ratio [OR] = 1.04, 95% confidence interval [CI] = 0.92 to 1.16, P = .54; for IL17BR, OR = 0.69, 95% CI = 0.40 to 1.20, P = .18; and for HOXB13/IL17BR, OR = 1.30, 95% CI = 0.88 to 1.93, P = .18). Similar results were obtained with the AUC, a two-sample two-sided t test, and a Mann-Whitney test. In addition, estimates of classification accuracies applied to two independent microarray datasets highlighted the poor performance of treatment-response predictive models that can be achieved with the sample sizes of patients and informative genes to date.
},
	Author = {Reid, James F. and Lusa, Lara and De Cecco, Loris and Coradini, Danila and Veneroni, Silvia and Daidone, Maria Grazia and Gariboldi, Manuela and Pierotti, Marco A.},
	Date-Added = {2009-01-08 18:20:44 +0100},
	Date-Modified = {2009-01-08 18:20:44 +0100},
	Doi = {10.1093/jnci/dji153},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;97/12/927.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {12},
	Pages = {927-930},
	Title = {{Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/12/927},
	Volume = {97},
	Year = {2005},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;97/12/927},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/dji153}}

@article{elston2002pathological,
	Address = {Department of Histopathology, City Hospital, Nottingham, UK},
	Au = {Elston, CW and Ellis, IO},
	Author = {Elston, C W and Ellis, I O},
	Crdt = {2002/10/31 04:00},
	Da = {20021030},
	Date-Added = {2009-01-07 18:10:27 +0100},
	Date-Modified = {2009-01-07 18:34:29 +0100},
	Dcom = {20080221},
	Edat = {2002/10/31 04:00},
	Issn = {1365-2559 (Electronic)},
	Jid = {7704136},
	Journal = {Histopathology},
	Jt = {Histopathology},
	Language = {eng},
	Mhda = {2002/10/31 04:01},
	Month = {September},
	Number = {3A},
	Own = {NLM},
	Pages = {154--161},
	Pii = {1489{\_}2},
	Pl = {England},
	Pmid = {12405947},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rpf = {Histopathology. 1991 Nov;19(5):403-10. PMID: 1757079},
	So = {Histopathology. 2002 Sep;41(3A):154-61.},
	Stat = {PubMed-not-MEDLINE},
	Title = {Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.},
	Volume = {41},
	Year = {2002}}

@article{plackett1983karl,
	Author = {R. L. Plackett},
	Date-Added = {2009-01-07 12:20:26 +0100},
	Date-Modified = {2009-01-07 12:21:55 +0100},
	Journal = {International Statistical Review},
	Number = {1},
	Pages = {59-72},
	Title = {Karl Pearson and the Chi-squared Test},
	Volume = {51},
	Year = {1983},
	Bdsk-Url-1 = {http://www.jstor.org/pss/1402731}}

@article{cheang2007gene,
	Author = {Cheang, Maggie C.U. and van de Rijn, Matt and Nielsen, Torsten O.},
	Date-Added = {2009-01-07 11:11:41 +0100},
	Date-Modified = {2009-01-07 11:11:41 +0100},
	Doi = {10.1146/annurev.pathmechdis.3.121806.151505},
	Eprint = {http://arjournals.annualreviews.org/doi/pdf/10.1146/annurev.pathmechdis.3.121806.151505},
	Journal = {Annual Review of Pathology: Mechanisms of Disease},
	Note = {PMID: 18039137},
	Number = {1},
	Pages = {67-97},
	Title = {Gene Expression Profiling of Breast Cancer},
	Url = {http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathmechdis.3.121806.151505},
	Volume = {3},
	Year = {2008},
	Bdsk-Url-1 = {http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathmechdis.3.121806.151505},
	Bdsk-Url-2 = {http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151505}}

@article{calabro2008effects,
	Abstract = {Abstract~~The involvement of the immune system for the course of breast cancer, as evidenced by varying degrees of lymphocyte infiltration (LI) into the tumor is still poorly understood. The aim of this study was to evaluate the prognostic value of LI in breast cancer samples using microarray-based screening for LI-associated genes. Starting from the observation that most published ER gene signatures are heavily influenced by the LI effect, we developed and applied a novel approach to dissect molecular signatures. Further, a meta-analysis encompassing 1,044 hybridizations showed that LI alone is not sufficient to highlight breast cancer patients with different prognosis. However, for ER positive patients, high LI was associated with shorter survival times, whereas for ER negative patients, high LI is significantly associated with longer survival. Annotation of LI, in addition to ER status, is important for breast cancer patient prognosis and may have implications for the future treatment of breast cancer. },
	Author = {Calabr{\`o}, Alberto and Beissbarth, Tim and Kuner, Ruprecht and Stojanov, Michael and Benner, Axel and Asslaber, Martin and Ploner, Ferdinand and Zatloukal, Kurt and Samonigg, Hellmut and Poustka, Annemarie and S{\"u}ltmann, Holger},
	Date-Added = {2009-01-04 09:25:37 +0100},
	Date-Modified = {2009-01-04 11:01:52 +0100},
	Doi = {10.1007/s10549-008-0105-3},
	Journal = {Breast Cancer Research and Treatment},
	Title = {Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer},
	Url = {http://dx.doi.org/10.1007/s10549-008-0105-3},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-008-0105-3}}

@article{campone2007prediction,
	Abstract = {Abstract~~Breast cancer is a very heterogeneous disease, and markers for disease subtypes and therapy response remain poorly defined. For that reason, we employed a retrospective study in node-positive breast cancer to identify molecular signatures of gene expression correlating with metastatic free survival. Patients were primarily included in FEC100 (5-fluorouracil 500&nbsp;mg/m2, epirubicin 100&nbsp;mg/m2 and cyclophosphamide 500 mg/m2) arms of two multicentric prospective adjuvant clinical trials (PACS01 and PEGASE01---FNCLCC cooperative group). Data from nylon microarrays containing 8,032 cDNA unique sequences, representing 5,776 distinct genes, have been used to develop a predictive model for treatment outcome. We obtained the gene expression profiles for 150 of these patients, and used stringent univariate selection techniques based on Cox regression combined with principal component analysis to identify a genomic signature of metastatic relapse after adjuvant FEC100 regimen. Most of the 14 selected genes have a clear role in breast cancer, carcinogenesis or chemotherapy resistance. Six genes have been previously described in other genomic studies (UBE2C, CENPF, C16orf61 [DC13], STMN1, CCT5 and BCL2A1). Furthermore, we showed the interest of combining transcriptomic data with clinical data into a clinicogenomic model for patients subtyping. The described model adds predictive accuracy to that provided by the well-established Nottingham prognostic index or by our genomic signature alone. },
	Author = {Campone, Mario and Campion, Lo{\"\i}c and Roch{\'e}, Henry and Gouraud, Wilfried and Charbonnel, Catherine and Magrangeas, Florence and Minvielle, St{\'e}phane and Gen{\`e}ve, Jean and Martin, Anne-Laure and Bataille, R{\'e}gis and J{\'e}z{\'e}quel, Pascal},
	Date-Added = {2009-01-03 20:01:21 +0100},
	Date-Modified = {2009-01-03 20:01:21 +0100},
	Day = {01},
	Journal = {Breast Cancer Research and Treatment},
	M3 = {10.1007/s10549-007-9673-x},
	Month = {06},
	Number = {3},
	Pages = {491--501},
	Title = {Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1007/s10549-007-9673-x},
	Volume = {109},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10549-007-9673-x}}

@article{dalgin2007portraits,
	Abstract = {BACKGROUND:Clustering analysis of microarray data is often criticized for giving ambiguous results because of sensitivity to data perturbation or clustering techniques used. In this paper, we describe a new method based on principal component analysis and ensemble consensus clustering that avoids these problems.RESULTS:We illustrate the method on a public microarray dataset from 36 breast cancer patients of whom 31 were diagnosed with at least two of three pathological stages of disease (atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). Our method identifies an optimum set of genes and divides the samples into stable clusters which correlate with clinical classification into Luminal, Basal-like and Her2+ subtypes. Our analysis reveals a hierarchical portrait of breast cancer progression and identifies genes and pathways for each stage, grade and subtype. An intriguing observation is that the disease phenotype is distinguishable in ADH and progresses along distinct pathways for each subtype. The genetic signature for disease heterogeneity across subtypes is greater than the heterogeneity of progression from DCIS to IDC within a subtype, suggesting that the disease subtypes have distinct progression pathways.Our method identifies six disease subtype and one normal clusters. The first split separates the normal samples from the cancer samples. Next, the cancer cluster splits into low grade (pathological grades 1 and 2) and high grade (pathological grades 2 and 3) while the normal cluster is unchanged. Further, the low grade cluster splits into two subclusters and the high grade cluster into four. The final six disease clusters are mapped into one Luminal A, three Luminal B, one Basal-like and one Her2+.CONCLUSION:We confirm that the cancer phenotype can be identified in early stage because the genes altered in this stage progressively alter further as the disease progresses through DCIS into IDC. We identify six subtypes of disease which have distinct genetic signatures and remain separated in the clustering hierarchy. Our findings suggest that the heterogeneity of disease across subtypes is higher than the heterogeneity of the disease progression within a subtype, indicating that the subtypes are in fact distinct diseases.},
	Author = {Dalgin, Gul and Alexe, Gabriela and Scanfeld, Daniel and Tamayo, Pablo and Mesirov, Jill and Ganesan, Shridar and DeLisi, Charles and Bhanot, Gyan},
	Date-Added = {2008-12-30 18:47:21 +0100},
	Date-Modified = {2008-12-30 18:47:21 +0100},
	Doi = {10.1186/1471-2105-8-291},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {291},
	Pubmedid = {17683614},
	Title = {Portraits of breast cancer progression},
	Url = {http://www.biomedcentral.com/1471-2105/8/291},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/8/291},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-8-291}}

@article{ramaswamy2001multiclass,
	Abstract = {The optimal treatment of patients with cancer depends on
 establishing accurate diagnoses by using a complex combination of
 clinical and histopathological data. In some instances, this task is
 difficult or impossible because of atypical clinical presentation or
 histopathology. To determine whether the diagnosis of multiple common
 adult malignancies could be achieved purely by molecular
 classification, we subjected 218 tumor samples, spanning 14
 common tumor types, and 90 normal tissue samples to oligonucleotide
 microarray gene expression analysis. The expression levels of 16,063
 genes and expressed sequence tags were used to evaluate the accuracy of
 a multiclass classifier based on a support vector machine algorithm.
 Overall classification accuracy was 78%, far exceeding the accuracy of
 random classification (9%). Poorly differentiated cancers resulted in
 low-confidence predictions and could not be accurately classified
 according to their tissue of origin, indicating that they are
 molecularly distinct entities with dramatically different gene
 expression patterns compared with their well differentiated
 counterparts. Taken together, these results demonstrate the feasibility
 of accurate, multiclass molecular cancer classification and suggest a
 strategy for future clinical implementation of molecular cancer
 diagnostics.
},
	Author = {Ramaswamy, Sridhar and Tamayo, Pablo and Rifkin, Ryan and Mukherjee, Sayan and Yeang, Chen-Hsiang and Angelo, Michael and Ladd, Christine and Reich, Michael and Latulippe, Eva and Mesirov, Jill P. and Poggio, Tomaso and Gerald, William and Loda, Massimo and Lander, Eric S. and Golub, Todd R.},
	Date-Added = {2008-12-30 18:34:35 +0100},
	Date-Modified = {2008-12-30 18:34:35 +0100},
	Doi = {10.1073/pnas.211566398},
	Eprint = {http://www.pnas.org/content/98/26/15149.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {26},
	Pages = {15149-15154},
	Title = {{Multiclass cancer diagnosis using tumor gene expression signatures}},
	Url = {http://www.pnas.org/content/98/26/15149.abstract},
	Volume = {98},
	Year = {2001},
	Bdsk-Url-1 = {http://www.pnas.org/content/98/26/15149.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.211566398}}

@article{alexe2007high,
	Abstract = {Gene expression analysis has identified biologically relevant subclasses of breast cancer. However, most classification schemes do not robustly cluster all HER2+ breast cancers, in part due to limitations and bias of clustering techniques used. In this article, we propose an alternative approach that first separates the HER2+ tumors using a gene amplification signal for Her2/neu amplicon genes and then applies consensus ensemble clustering separately to the HER2+ and HER2- clusters to look for further substructure. We applied this procedure to a microarray data set of 286 early-stage breast cancers treated only with surgery and radiation and identified two basal and four luminal subtypes in the HER2- tumors, as well as two novel and robust HER2+ subtypes. HER2+ subtypes had median distant metastasis-free survival of 99 months [95% confidence interval (95% CI), 83-118 months] and 33 months (95% CI, 11-54 months), respectively, and recurrence rates of 11% and 58%, respectively. The low recurrence subtype had a strong relative overexpression of lymphocyte-associated genes and was also associated with a prominent lymphocytic infiltration on histologic analysis. These data suggest that early-stage HER2+ cancers associated with lymphocytic infiltration are a biologically distinct subtype with an improved natural history. [Cancer Res 2007;67(22):10669-76]
},
	Author = {Alexe, Gabriela and Dalgin, Gul S. and Scanfeld, Daniel and Tamayo, Pablo and Mesirov, Jill P. and DeLisi, Charles and Harris, Lyndsay and Barnard, Nicola and Martel, Maritza and Levine, Arnold J. and Ganesan, Shridar and Bhanot, Gyan},
	Date-Added = {2008-12-30 18:20:31 +0100},
	Date-Modified = {2008-12-30 18:20:31 +0100},
	Doi = {10.1158/0008-5472.CAN-07-0539},
	Eprint = {http://cancerres.aacrjournals.org/cgi/reprint/67/22/10669.pdf},
	Journal = {Cancer Res},
	Number = {22},
	Pages = {10669-10676},
	Title = {{High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates}},
	Url = {http://cancerres.aacrjournals.org/cgi/content/abstract/67/22/10669},
	Volume = {67},
	Year = {2007},
	Bdsk-Url-1 = {http://cancerres.aacrjournals.org/cgi/content/abstract/67/22/10669},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/0008-5472.CAN-07-0539}}

@article{chen1989orthogonal,
	Author = {Chen, S. and Billings, S. A. and Luo, W.},
	Date-Added = {2008-12-29 08:49:55 +0100},
	Date-Modified = {2008-12-29 08:49:55 +0100},
	Isbn = {0020-7179},
	Journal = {International Journal of Control},
	Number = {5},
	Pages = {1873--1896},
	Publisher = {Taylor \& Francis},
	Title = {Orthogonal least squares methods and their application to non-linear system identification},
	Ty = {JOUR},
	Url = {http://www.informaworld.com/10.1080/00207178908953472},
	Volume = {50},
	Year = {1989},
	Bdsk-Url-1 = {http://www.informaworld.com/10.1080/00207178908953472}}

@article{toledano2003three,
	Author = {Toledano, Alicia T.},
	Date-Added = {2008-12-26 11:54:15 +0100},
	Date-Modified = {2008-12-26 11:56:00 +0100},
	Doi = {10.1002/sim.1518},
	Journal = {Statistics in Medicine},
	Number = {18},
	Pages = {2919)2933},
	Title = {Three methods for analysing correlated ROC curves: a comparison in real data sets from multi-reader, multi-case studies with a factorial design},
	Volume = {22},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.1518}}

@article{hanley1983method,
	Author = {Hanley, JA and McNeil, BJ},
	Date-Added = {2008-12-26 09:14:36 +0100},
	Date-Modified = {2008-12-26 09:14:52 +0100},
	Eprint = {http://radiology.rsnajnls.org/cgi/reprint/148/3/839.pdf},
	Journal = {Radiology},
	Number = {3},
	Pages = {839-843},
	Title = {{A method of comparing the areas under receiver operating characteristic curves derived from the same cases}},
	Url = {http://radiology.rsnajnls.org/cgi/content/abstract/148/3/839},
	Volume = {148},
	Year = {1983},
	Bdsk-Url-1 = {http://radiology.rsnajnls.org/cgi/content/abstract/148/3/839}}

@book{davison1997bootstrap,
	Author = {A. C. Davison and D. V. Hinkley},
	Date-Added = {2008-12-26 07:00:00 +0100},
	Date-Modified = {2008-12-26 07:04:50 +0100},
	Doi = {10.2277/0521574714},
	Publisher = {Cambridge University Pres},
	Series = {Cambridge Series in Statistical and Probabilistic Mathematics},
	Title = {Bootstrap Methods and their Application},
	Url = {http://www.cup.cam.ac.uk/uk/catalogue/catalogue.asp?isbn=9780521574716},
	Year = {1997},
	Bdsk-Url-1 = {http://www.cup.cam.ac.uk/uk/catalogue/catalogue.asp?isbn=9780521574716}}

@article{gui2005penalized,
	Abstract = {Motivation: An important application of microarray technology is to relate gene expression profiles to various clinical phenotypes of patients. Success has been demonstrated in molecular classification of cancer in which the gene expression data serve as predictors and different types of cancer serve as a categorical outcome variable. However, there has been less research in linking gene expression profiles to the censored survival data such as patients' overall survival time or time to cancer relapse. It would be desirable to have models with good prediction accuracy and parsimony property.  Results: We propose to use the L1 penalized estimation for the Cox model to select genes that are relevant to patients' survival and to build a predictive model for future prediction. The computational difficulty associated with the estimation in the high-dimensional and low-sample size settings can be efficiently solved by using the recently developed least-angle regression (LARS) method. Our simulation studies and application to real datasets on predicting survival after chemotherapy for patients with diffuse large B-cell lymphoma demonstrate that the proposed procedure, which we call the LARS-Cox procedure, can be used for identifying important genes that are related to time to death due to cancer and for building a parsimonious model for predicting the survival of future patients. The LARS-Cox regression gives better predictive performance than the L2 penalized regression and a few other dimension-reduction based methods.  Conclusions: We conclude that the proposed LARS-Cox procedure can be very useful in identifying genes relevant to survival phenotypes and in building a parsimonious predictive model that can be used for classifying future patients into clinically relevant high- and low-risk groups based on the gene expression profile and survival times of previous patients.  Supplementary information: http://dna.ucdavis.edu/~hli/LARSCox-Appendix.pdf  Contact: hli@ucdavis.edu
},
	Author = {Gui, Jiang and Li, Hongzhe},
	Date-Added = {2008-12-23 15:11:04 +0100},
	Date-Modified = {2008-12-23 15:11:29 +0100},
	Doi = {10.1093/bioinformatics/bti422},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/21/13/3001.pdf},
	Journal = {Bioinformatics},
	Number = {13},
	Pages = {3001-3008},
	Title = {{Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/13/3001},
	Volume = {21},
	Year = {2005},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/13/3001},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/bti422}}

@article{kattan2004evaluating,
	Author = {Kattan, Michael W.},
	Date-Added = {2008-12-22 18:57:03 +0100},
	Date-Modified = {2008-12-22 18:57:03 +0100},
	Doi = {10.1158/1078-0432.CCR-03-0061},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/10/3/822.pdf},
	Journal = {Clin Cancer Res},
	Number = {3},
	Pages = {822-824},
	Title = {{Evaluating a New Marker's Predictive Contribution}},
	Url = {http://clincancerres.aacrjournals.org},
	Volume = {10},
	Year = {2004},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-03-0061}}

@article{ma2007populationbased,
	Abstract = {Purpose: The purpose of this study is to predict breast cancer recurrence and metastases and to identify gene signatures indicative of clinicopathologic characteristics using gene expression patterns derived from cDNA microarray.  Experimental Design: Expression profiles of 7,650 genes were investigated on an unselected group of 99 node-negative and node-positive breast cancer patients to identify prognostic gene signature of recurrence and metastases. The identified gene signature was validated on independent 78 patients with primary invasive carcinoma (T1/T2 and N0) and on 58 patients with locally advanced breast cancer (T3/T4 and/or N2). The gene predictors were identified using a combination of random forests and linear discriminant analysis function.  Results: This study identified a new 28-gene signature that achieved highly accurate disease-free survival and overall survival (both at P < 0.001, time-dependent receiver operating characteristic analysis) in individual breast cancer patients. Patients categorized into high-risk, intermediate-risk, and low-risk groups had distinct disease-free survival (P < 0.005, Kaplan-Meier analysis, log-rank test) in three patient cohorts. A strong association (P < 0.05) was identified between risk groups and tumor size, tumor grade, estrogen receptor and progesterone receptor status, and HER2/neu overexpression in the studied cohorts. We also identified 14-gene predictors of nodal status and 9-gene predictors of tumor grade.  Conclusions: This study has established a population-based approach to predicting breast cancer outcomes at the individual level exclusively based on gene expression patterns. The 28-gene recurrence signature has been validated as quantifying the probability of recurrence and metastases in patients with heterogeneous histology and disease stage.
},
	Author = {Ma, Yan and Qian, Yong and Wei, Liang and Abraham, Jame and Shi, Xianglin and Castranova, Vincent and Harner, E. James and Flynn, Daniel C. and Guo, Lan},
	Date-Added = {2008-12-22 18:33:33 +0100},
	Date-Modified = {2008-12-22 18:33:33 +0100},
	Doi = {10.1158/1078-0432.CCR-06-2222},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/13/7/2014.pdf},
	Journal = {Clin Cancer Res},
	Number = {7},
	Pages = {2014-2022},
	Title = {{Population-Based Molecular Prognosis of Breast Cancer by Transcriptional Profiling}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/7/2014},
	Volume = {13},
	Year = {2007},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/7/2014},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-06-2222}}

@article{eden2004good,
	Abstract = {We compared the power of gene expression measurements with that of conventional prognostic markers, i.e., clinical, histopathological, and cell biological parameters, for predicting distant metastases in breast cancer patients using both established prognostic indices (e.g., the Nottingham Prognostic Index (NPI)) and novel combinations of conventional markers. We used publicly available data on 97 patients, and the performance of metastasis prediction was represented by receiver operating characteristic (ROC) areas and Kaplan-Meier plots. The gene expression profiler did not perform noticeably better than indices constructed from the clinical variables, e.g., the well established NPI. When analysing separately subgroups, according to the oestrogen receptor (ER) status both approaches could predict clinical outcome more easily for the ER-positive than for the ER-negative cohort. Given the time it may take before microarray processing is used worldwide, particularly due to the costs and the lack of standards, it is important to pursue research using conventional markers. Our analysis suggests that it might be possible to improve the combination of different conventional prognostic markers into one prognostic index.},
	Address = {Complex Systems Division, Department of Theoretical Physics, Lund University, Solvegatan 14A, SE-22362 Lund, Sweden.},
	Au = {Eden, P and Ritz, C and Rose, C and Ferno, M and Peterson, C},
	Author = {Eden, Patrik and Ritz, Cecilia and Rose, Carsten and Ferno, Marten and Peterson, Carsten},
	Crdt = {2004/08/04 05:00},
	Da = {20040803},
	Date-Added = {2008-12-22 16:13:16 +0100},
	Date-Modified = {2008-12-22 16:22:07 +0100},
	Dcom = {20041012},
	Doi = {10.1016/j.ejca.2004.02.025},
	Edat = {2004/08/04 05:00},
	Issn = {0959-8049 (Print)},
	Jid = {9005373},
	Journal = {Eur J Cancer},
	Jt = {European journal of cancer (Oxford, England : 1990)},
	Language = {eng},
	Lr = {20061115},
	Mh = {Adult; Breast Neoplasms/*diagnosis/metabolism; Female; Humans; Middle Aged; Neoplasm Metastasis/diagnosis; Odds Ratio; Oligonucleotide Array Sequence Analysis/methods; Prognosis; Receptors, Estrogen/metabolism; Tumor Markers, Biological/*blood},
	Mhda = {2004/10/13 09:00},
	Month = {August},
	Number = {12},
	Own = {NLM},
	Pages = {1837--1841},
	Phst = {2003/11/12 {$[$}received{$]$}; 2004/02/24 {$[$}revised{$]$}; 2004/02/25 {$[$}accepted{$]$}},
	Pii = {S0959804904002138},
	Pl = {England},
	Pmid = {15288284},
	Pst = {ppublish},
	Pt = {Comparative Study; Journal Article},
	Rn = {0 (Receptors, Estrogen); 0 (Tumor Markers, Biological)},
	Sb = {IM},
	So = {Eur J Cancer. 2004 Aug;40(12):1837-41.},
	Stat = {MEDLINE},
	Title = {"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.},
	Volume = {40},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ejca.2004.02.025}}

@article{truntzer2008comparative,
	Abstract = {BACKGROUND:In cancer research, most clinical variables have already been investigated and are now well established. The use of transcriptomic variables has raised two problems: restricting their number and validating their significance. Thus, their contribution to prognosis is currently thought to be overestimated. The aim of this study was to determine to what extent optimism concerning current transcriptomic models may lead to overestimation of the contribution of transcriptomic variables to survival prognosis.RESULTS:To achieve this goal, Cox proportional hazards models that adjust for clinical and transcriptomic variables were built. As the relevance of the clinical variables had already been established, they were not submitted to selection. As for genes, they were selected using both univariate and multivariate methods. Optimism and the contribution of clinical and transcriptomic variables to prognosis were compared through simulations and by using the Kent and O'Quigley rho2 measure of dependence. We showed that the optimism relative to clinical variables was low because these are no longer submitted to selection of relevant variables. In contrast, for genes, the selection process introduced high optimism, which increased when the proportion of genes of interest decreased. However, this optimism can be decreased by increasing the number of samples.CONCLUSION:Two phenomena have to be taken into account by comparing the predictive power and optimism of clinical variables and those of genes: overestimation for genes due to the selection process and underestimation for clinical variables due to the omission of relevant genes. In comparison with genes, the predictive value of validated clinical variables is not overestimated, which should be kept in mind in future studies involving both clinical and transcriptomic variables.},
	Author = {Truntzer, Caroline and Maucort-Boulch, Delphine and Roy, Pascal},
	Date-Added = {2008-12-22 16:04:38 +0100},
	Date-Modified = {2008-12-22 16:04:38 +0100},
	Doi = {10.1186/1471-2105-9-434},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {434},
	Pubmedid = {18854055},
	Title = {Comparative optimism in models involving both classical clinical and gene expression information},
	Url = {http://www.biomedcentral.com/1471-2105/9/434},
	Volume = {9},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/9/434},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-9-434}}

@article{royston2006dichotomizing,
	Abstract = {In medical research, continuous variables are often converted into categorical variables by grouping values into two or more categories. We consider in detail issues pertaining to creating just two groups, a common approach in clinical research. We argue that the simplicity achieved is gained at a cost; dichotomization may create rather than avoid problems, notably a considerable loss of power and residual confounding. In addition, the use of a data-derived 'optimal' cutpoint leads to serious bias. We illustrate the impact of dichotomization of continuous predictor variables using as a detailed case study a randomized trial in primary biliary cirrhosis. Dichotomization of continuous data is unnecessary for statistical analysis and in particular should not be applied to explanatory variables in regression models.},
	Address = {MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK. patrick.royston@ctu.mrc.ac.uk},
	Au = {Royston, P and Altman, DG and Sauerbrei, W},
	Author = {Royston, Patrick and Altman, Douglas G and Sauerbrei, Willi},
	Ci = {Copyright 2005 John Wiley \& Sons, Ltd.},
	Crdt = {2005/10/12 09:00},
	Da = {20051219},
	Date-Added = {2008-12-22 14:48:54 +0100},
	Date-Modified = {2009-01-19 18:41:09 +0100},
	Dcom = {20060321},
	Doi = {10.1002/sim.2331},
	Edat = {2005/10/12 09:00},
	Issn = {0277-6715 (Print)},
	Jid = {8215016},
	Journal = {Stat Med},
	Jt = {Statistics in medicine},
	Language = {eng},
	Lr = {20071115},
	Mh = {Age Factors; Albumins/analysis; Antimetabolites/pharmacology; Azathioprine/pharmacology; Bilirubin/analysis; Cholestasis/drug therapy; *Data Interpretation, Statistical; Humans; Liver Cirrhosis, Biliary/drug therapy; Randomized Controlled Trials as Topic/*methods; *Regression Analysis},
	Mhda = {2006/03/22 09:00},
	Month = {January},
	Number = {1},
	Own = {NLM},
	Pages = {127--141},
	Pl = {England},
	Pmid = {16217841},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Albumins); 0 (Antimetabolites); 446-86-6 (Azathioprine); 635-65-4 (Bilirubin)},
	Sb = {IM},
	So = {Stat Med. 2006 Jan 15;25(1):127-41.},
	Stat = {MEDLINE},
	Title = {Dichotomizing continuous predictors in multiple regression: a bad idea.},
	Volume = {25},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.2331}}

@article{parmigiani2002statistical,
	Author = {Parmigiani, Giovanni and Garret, Elizabeth S. and Ramaswamy, Anbazhagan and Gabrielson, Edward},
	Date-Added = {2008-12-22 09:34:08 +0100},
	Date-Modified = {2008-12-22 09:37:30 +0100},
	Journal = {Journal of the Royal Statistical Society B},
	Pages = {717-736},
	Title = {A statistical framework for expression--based molecular classification in cancer},
	Volume = {64},
	Year = {2002}}

@article{reese1997her2neu,
	Abstract = {The HER-2/neu proto-oncogene encodes a 185 kDa transmembrane receptor tyrosine kinase with significant sequence homology to other members of the class I receptor tyrosine kinase family. The HER-2/neu gene is amplified and/or overexpressed in 25%-30% of human breast and ovarian cancers, and overexpression of the receptor is associated with poor prognosis. Tyrosine phosphorylation and activation of the HER-2 receptor lead to activation of specific signal transduction pathways in breast and ovarian cancer cells, including the ras/MAP kinase cascade, phosphatidylinositol 3-kinase, and phospholipase C-{gamma}. HER-2/neu signal transduction pathways ultimately converge on the cell nucleus, where the expression of diverse genes is induced after activation of the receptor. A more complete understanding of HER-2/neu signal transduction pathways may allow the development of specific therapeutics for the treatment of those human breast and ovarian cancers containing this alteration.
},
	Author = {Reese, David M. and Slamon, Dennis J.},
	Date-Added = {2008-12-21 18:41:14 +0100},
	Date-Modified = {2008-12-21 18:41:37 +0100},
	Eprint = {http://stemcells.alphamedpress.org/cgi/reprint/15/1/1.pdf},
	Journal = {Stem Cells},
	Number = {1},
	Pages = {1-8},
	Title = {{HER-2/neu Signal Transduction in Human Breast and Ovarian Cancer}},
	Url = {http://stemcells.alphamedpress.org/cgi/content/abstract/15/1/1},
	Volume = {15},
	Year = {1997},
	Bdsk-Url-1 = {http://stemcells.alphamedpress.org/cgi/content/abstract/15/1/1}}

@article{teschendorff2006consensus,
	Abstract = {BACKGROUND:A consensus prognostic gene expression classifier is still elusive in heterogeneous diseases such as breast cancer.RESULTS:Here we perform a combined analysis of three major breast cancer microarray data sets to hone in on a universally valid prognostic molecular classifier in estrogen receptor (ER) positive tumors. Using a recently developed robust measure of prognostic separation, we further validate the prognostic classifier in three external independent cohorts, confirming the validity of our molecular classifier in a total of 877 ER positive samples. Furthermore, we find that molecular classifiers may not outperform classical prognostic indices but that they can be used in hybrid molecular-pathological classification schemes to improve prognostic separation.CONCLUSION:The prognostic molecular classifier presented here is the first to be valid in over 877 ER positive breast cancer samples and across three different microarray platforms. Larger multi-institutional studies will be needed to fully determine the added prognostic value of molecular classifiers when combined with standard prognostic factors.},
	Author = {Teschendorff, Andrew and Naderi, Ali and Barbosa-Morais, Nuno and Pinder, Sarah and Ellis, Ian and Aparicio, Sam and Brenton, James and Caldas, Carlos},
	Date-Added = {2008-12-21 17:59:07 +0100},
	Date-Modified = {2008-12-21 17:59:07 +0100},
	Doi = {10.1186/gb-2006-7-10-r101},
	Issn = {1465-6906},
	Journal = {Genome Biology},
	Number = {10},
	Pages = {R101},
	Pubmedid = {17076897},
	Title = {A consensus prognostic gene expression classifier for ER positive breast cancer},
	Url = {http://genomebiology.com/2006/7/10/R101},
	Volume = {7},
	Year = {2006},
	Bdsk-Url-1 = {http://genomebiology.com/2006/7/10/R101},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/gb-2006-7-10-r101}}

@article{saal2007poor,
	Abstract = {Pathway-specific therapy is the future of cancer management. The oncogenic phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in solid tumors; however, currently, no reliable test for PI3K pathway activation exists for human tumors. Taking advantage of the observation that loss of PTEN, the negative regulator of PI3K, results in robust activation of this pathway, we developed and validated a microarray gene expression signature for immunohistochemistry (IHC)-detectable PTEN loss in breast cancer (BC). The most significant signature gene was  itself, indicating that  mRNA levels are the primary determinant of PTEN protein levels in BC. Some PTEN IHC-positive BCs exhibited the signature of PTEN loss, which was associated to moderately reduced  mRNA levels cooperating with specific types of  mutations and/or amplification of . This demonstrates that the signature is more sensitive than PTEN IHC for identifying tumors with pathway activation. In independent data sets of breast, prostate, and bladder carcinoma, prediction of pathway activity by the signature correlated significantly to poor patient outcome. Stathmin, encoded by the signature gene , was an accurate IHC marker of the signature and had prognostic significance in BC. Stathmin was also pathway-pharmacodynamic  and . Thus, the signature or its components such as stathmin may be clinically useful tests for stratification of patients for anti-PI3K pathway therapy and monitoring therapeutic efficacy. This study indicates that aberrant PI3K pathway signaling is strongly associated with metastasis and poor survival across carcinoma types, highlighting the enormous potential impact on patient survival that pathway inhibition could achieve.
},
	Author = {Saal, Lao H. and Johansson, Peter and Holm, Karolina and Gruvberger-Saal, Sofia K. and She, Qing-Bai and Maurer, Matthew and Koujak, Susan and Ferrando, Adolfo A. and Malmstrom, Per and Memeo, Lorenzo and Isola, Jorma and Bendahl, Par-Ola and Rosen, Neal and Hibshoosh, Hanina and Ringner, Markus and Borg, Ake and Parsons, Ramon},
	Date-Added = {2008-12-15 12:00:07 +0100},
	Date-Modified = {2009-01-08 20:27:12 +0100},
	Doi = {10.1073/pnas.0702507104},
	Eprint = {http://www.pnas.org/content/104/18/7564.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {18},
	Pages = {7564-7569},
	Title = {{Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity}},
	Url = {http://www.pnas.org/content/104/18/7564.abstract},
	Volume = {104},
	Year = {2007},
	Bdsk-Url-1 = {http://www.pnas.org/content/104/18/7564.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0702507104}}

@article{vanderlaan2003new,
	Author = {M. J. {van der Laan} and K. S. Pollard and J. Bryan},
	Date-Added = {2008-12-11 11:59:28 +0100},
	Date-Modified = {2008-12-11 12:01:20 +0100},
	Journal = {Journal of Statistical Computation and Simulation},
	Number = {8},
	Pages = {575-584},
	Title = {A new partitioning around medoids algorithm},
	Volume = {73},
	Year = {2003}}

@article{crick1970central,
	Author = {Crick, Francis},
	Date-Added = {2008-12-09 12:49:34 +0100},
	Date-Modified = {2008-12-09 12:51:15 +0100},
	Journal = {Nature},
	Month = {August},
	Pages = {561-563},
	Title = {Central Dogma of Molecular Biology},
	Volume = {227},
	Year = {1970},
	Bdsk-Url-1 = {http://www.nature.com/nature/focus/crick/}}

@conference{suzuki2004application,
	Author = {Suzuki, R. and Shimodaira, H.},
	Booktitle = {The Fifteenth International Conference on Genome Informatics 2004},
	Date-Added = {2008-12-08 17:23:16 +0100},
	Date-Modified = {2008-12-08 17:25:20 +0100},
	Pages = {P034},
	Title = {An application of multiscale bootstrap resampling to hierarchical clustering of microarray data: How accurate are these clusters?},
	Year = {2004},
	Bdsk-Url-1 = {http://www.jsbi.org/journal/GIW04/GIW04Poster.html}}

@article{singletary2002revision,
	Abstract = {PURPOSE: To revise the American Joint Committee on Cancer staging system for breast carcinoma.  MATERIALS AND METHODS: A Breast Task Force submitted recommended changes and additions to the existing staging system that were (1) evidence-based and/or consistent with widespread clinical consensus about appropriate diagnostic and treatment standards and (2) useful for the uniform accrual of outcome information in national databases.  RESULTS: Major changes included the following: size-based discrimination between micrometastases and isolated tumor cells; identifiers to indicate usage of innovative technical approaches; classification of lymph node status by number of involved axillary lymph nodes; and new classifications for metastasis to the infraclavicular, internal mammary, and supraclavicular lymph nodes.  CONCLUSION: This revised staging system will be officially adopted for use in tumor registries in January 2003.
},
	Author = {Singletary, S. Eva and Allred, Craig and Ashley, Pandora and Bassett, Lawrence W. and Berry, Donald and Bland, Kirby I. and Borgen, Patrick I. and Clark, Gary and Edge, Stephen B. and Hayes, Daniel F. and Hughes, Lorie L. and Hutter, Robert V.P. and Morrow, Monica and Page, David L. and Recht, Abram and Theriault, Richard L. and Thor, Ann and Weaver, Donald L. and Wieand, H. Samuel and Greene, Frederick L.},
	Date-Added = {2008-12-07 16:11:19 +0100},
	Date-Modified = {2008-12-07 16:11:19 +0100},
	Doi = {10.1200/JCO.2002.02.026},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/20/17/3628.pdf},
	Journal = {J Clin Oncol},
	Number = {17},
	Pages = {3628-3636},
	Title = {{Revision of the American Joint Committee on Cancer Staging System for Breast Cancer}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/20/17/3628},
	Volume = {20},
	Year = {2002},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/20/17/3628},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2002.02.026}}

@article{perez2006her2,
	Abstract = {PURPOSE: To evaluate concordance between local and central laboratory HER2 testing results in patients from the North Central Cancer Treatment Group (NCCTG) N9831 adjuvant trial of trastuzumab.  PATIENTS AND METHODS: NCCTG N9831 is a randomized, phase III clinical trial comparing three drug regimens: doxorubicin/cyclophosphamide followed by paclitaxel with trastuzumab added concurrently, sequentially, or not at all as adjuvant therapy for women with HER2-positive resected breast cancer. Originally, patients were eligible if their tumors were HER2 positive by either local laboratory immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH). A protocol modification in 2002 made central laboratory testing mandatory, with additional testing of discordant cases conducted by a reference laboratory. Concordance between local and central laboratory, and level of agreement between central and reference laboratory HER2 findings in discordant cases were examined.  RESULTS: HER2 positivity was confirmed in 85.8% of 2,535 patients registered since March 2002. When local and central evaluation used the same methodology, concordance was 88.1% for FISH and 81.6% for a diagnostic test for presence of the HER2 protein. Among discordant cases examined at the reference laboratory, there was 94.3% agreement for IHC (0, 1+, 2+) and 95.2% agreement for FISH (not gene amplified).  CONCLUSION: There was a high degree of discordance between local and central testing for IHC and FISH, but a high degree of agreement between central and reference laboratories. These findings support the importance of using high-volume, experienced laboratories for HER2 testing to improve the process of selecting patients likely to benefit from trastuzumab therapy.
},
	Author = {Perez, Edith A. and Suman, Vera J. and Davidson, Nancy E. and Martino, Silvana and Kaufman, Peter A. and Lingle, Wilma L. and Flynn, Patrick J. and Ingle, James N. and Visscher, Daniel and Jenkins, Robert B.},
	Date-Added = {2008-12-07 16:08:32 +0100},
	Date-Modified = {2008-12-07 16:08:32 +0100},
	Doi = {10.1200/JCO.2005.03.4744},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/24/19/3032.pdf},
	Journal = {J Clin Oncol},
	Number = {19},
	Pages = {3032-3038},
	Title = {{HER2 Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/24/19/3032},
	Volume = {24},
	Year = {2006},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/24/19/3032},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2005.03.4744}}

@article{saeys2007review,
	Abstract = {Feature selection techniques have become an apparent need in many bioinformatics applications. In addition to the large pool of techniques that have already been developed in the machine learning and data mining fields, specific applications in bioinformatics have led to a wealth of newly proposed techniques.  In this article, we make the interested reader aware of the possibilities of feature selection, providing a basic taxonomy of feature selection techniques, and discussing their use, variety and potential in a number of both common as well as upcoming bioinformatics applications.  Contact: yvan.saeys@psb.ugent.be  Supplementary information: http://bioinformatics.psb.ugent.be/supplementary_data/yvsae/fsreview
},
	Author = {Saeys, Yvan and Inza, Inaki and Larranaga, Pedro},
	Date-Added = {2008-12-04 15:43:56 +0100},
	Date-Modified = {2008-12-04 15:43:56 +0100},
	Doi = {10.1093/bioinformatics/btm344},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/23/19/2507.pdf},
	Journal = {Bioinformatics},
	Number = {19},
	Pages = {2507-2517},
	Title = {{A review of feature selection techniques in bioinformatics}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/23/19/2507},
	Volume = {23},
	Year = {2007},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/23/19/2507},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btm344}}

@article{jain1999data,
	Author = {A. K. Jain and M. N. Murty and P. J. Flynn},
	Date-Added = {2008-12-04 13:59:45 +0100},
	Date-Modified = {2008-12-04 14:01:27 +0100},
	Journal = {ACM Computing Surveys},
	Month = {September},
	Number = {3},
	Pages = {264-323},
	Title = {Data Clustering: A Review},
	Volume = {31},
	Year = {1999},
	Bdsk-Url-1 = {http://www.cs.rutgers.edu/~mlittman/courses/lightai03/jain99data.pdf}}

@manual{affymetrix2004manual,
	Author = {Affymetrix},
	Date-Added = {2008-12-04 13:01:02 +0100},
	Date-Modified = {2008-12-04 13:05:16 +0100},
	Title = {GeneChip Expression Analysis: Data Analysis Fundamentals},
	Url = {http://www.affymetrix.com/support/downloads/manuals/data_analysis_fundamentals_manual.pdf},
	Year = {2004},
	Bdsk-Url-1 = {http://www.affymetrix.com/support/downloads/manuals/data_analysis_fundamentals_manual.pdf}}

@article{tabpwg2004expression,
	Annote = {10.1038/nrg1297},
	Author = {{The Tumor Analysis Best Practices Working Group}},
	Date-Added = {2008-12-04 12:50:49 +0100},
	Date-Modified = {2008-12-04 12:50:49 +0100},
	Isbn = {1471-0056},
	Journal = {Nat Rev Genet},
	M3 = {10.1038/nrg1297},
	Month = {03},
	Number = {3},
	Pages = {229--237},
	Title = {Expression profiling - best practices for data generation and interpretation in clinical trials},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nrg1297},
	Volume = {5},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrg1297}}

@url{ingenuity,
	Author = {Ingenuity Systems, Mountain View, CA},
	Date-Added = {2008-12-02 11:21:41 +0100},
	Date-Modified = {2008-12-02 11:24:32 +0100},
	Title = {Ingenuity Pathway Analysis},
	Url = {http://www.ingenuity.com},
	Urldate = {2008},
	Bdsk-Url-1 = {http://www.ingenuity.com}}

@article{davis2006reliable,
	Abstract = {Motivation: Two important questions for the analysis of gene expression measurements from different sample classes are (1) how to classify samples and (2) how to identify meaningful gene signatures (ranked gene lists) exhibiting the differences between classes and sample subsets. Solutions to both questions have immediate biological and biomedical applications. To achieve optimal classification performance, a suitable combination of classifier and gene selection method needs to be specifically selected for a given dataset. The selected gene signatures can be unstable and the resulting classification accuracy unreliable, particularly when considering different subsets of samples. Both unstable gene signatures and overestimated classification accuracy can impair biological conclusions.  Methods: We address these two issues by repeatedly evaluating the classification performance of all models, i.e. pairwise combinations of various gene selection and classification methods, for random subsets of arrays (sampling). A model score is used to select the most appropriate model for the given dataset. Consensus gene signatures are constructed by extracting those genes frequently selected over many samplings. Sampling additionally permits measurement of the stability of the classification performance for each model, which serves as a measure of model reliability.  Results: We analyzed a large gene expression dataset with 78 measurements of four different cartilage sample classes. Classifiers trained on subsets of measurements frequently produce models with highly variable performance. Our approach provides reliable classification performance estimates via sampling. In addition to reliable classification performance, we determined stable consensus signatures (i.e. gene lists) for sample classes. Manual literature screening showed that these genes are highly relevant to our gene expression experiment with osteoarthritic cartilage. We compared our approach to others based on a publicly available dataset on breast cancer.  Availability: R package at http://www.bio.ifi.lmu.de/~davis/edaprakt  Contact: ralf.zimmer@bio.ifi.lmu.de
},
	Author = {Davis, Chad A. and Gerick, Fabian and Hintermair, Volker and Friedel, Caroline C. and Fundel, Katrin and Kuffner, Robert and Zimmer, Ralf},
	Date-Added = {2008-11-20 16:47:33 +0100},
	Date-Modified = {2008-11-20 16:47:33 +0100},
	Doi = {10.1093/bioinformatics/btl400},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/22/19/2356.pdf},
	Journal = {Bioinformatics},
	Number = {19},
	Pages = {2356-2363},
	Title = {{Reliable gene signatures for microarray classification: assessment of stability and performance}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/19/2356},
	Volume = {22},
	Year = {2006},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/19/2356},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btl400}}

@book{blom1958statistical,
	Author = {Blom, Gunnar},
	Date-Added = {2008-11-18 12:38:51 +0100},
	Date-Modified = {2008-11-18 12:42:11 +0100},
	Publisher = {John Wiley and Sons},
	Title = {Statistical Estimates and Transformed Beta Variables},
	Year = {1958}}

@article{starmans2008robust,
	Author = {Starmans, M H W and Krishnapuram, B and Steck, H and Horlings, H and Nuyten, D S A and van de Vijver, M J and Seigneuric, R and Buffa, F M and Harris, A L and Wouters, B G and Lambin, P},
	Date-Added = {2008-11-17 12:12:48 +0100},
	Date-Modified = {2008-11-17 12:12:48 +0100},
	Isbn = {1532-1827},
	Journal = {Br J Cancer},
	L3 = {http://www.nature.com/bjc/journal/vaop/ncurrent/suppinfo/6604746s1.html},
	Pages = {--},
	Publisher = {Cancer Research UK},
	Title = {Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/sj.bjc.6604746},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.bjc.6604746}}

@article{elston1991value,
	Author = {C. W. Elston and I. O. Ellis},
	Date-Added = {2008-11-12 18:41:55 +0100},
	Date-Modified = {2008-11-12 18:43:44 +0100},
	Journal = {Histopathology},
	Pages = {403-410},
	Title = {The value of histological grade in breast cancer: experience from a large study with long-term follow-up},
	Volume = {19},
	Year = {1991}}

@article{dabney2007optimality,
	Abstract = {Nearest-centroid classifiers have recently been successfully employed in high-dimensional applications, such as in genomics. A necessary step when building a classifier for high-dimensional data is feature selection. Feature selection is frequently carried out by computing univariate scores for each feature individually, without consideration for how a subset of features performs as a whole. We introduce a new feature selection approach for high-dimensional nearest centroid classifiers that instead is based on the theoretically optimal choice of a given number of features, which we determine directly here. This allows us to develop a new greedy algorithm to estimate this optimal nearest-centroid classifier with a given number of features. In addition, whereas the centroids are usually formed from maximum likelihood estimates, we investigate the applicability of high-dimensional shrinkage estimates of centroids. We apply the proposed method to clinical classification based on gene-expression microarrays, demonstrating that the proposed method can outperform existing nearest centroid classifiers. },
	Author = {Dabney, Alan R. AND Storey, John D.},
	Date-Added = {2008-11-12 10:50:45 +0100},
	Date-Modified = {2008-11-12 10:50:45 +0100},
	Doi = {10.1371/journal.pone.0001002},
	Journal = {PLoS ONE},
	Month = {Oct},
	Number = {10},
	Pages = {e1002},
	Publisher = {Public Library of Science},
	Title = {Optimality Driven Nearest Centroid Classification from Genomic Data},
	Url = {http://dx.doi.org/10.1371%2Fjournal.pone.0001002},
	Volume = {2},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0001002}}

@article{hu2006molecular,
	Abstract = {BACKGROUND:Validation of a novel gene expression signature in independent data sets is a critical step in the development of a clinically useful test for cancer patient risk-stratification. However, validation is often unconvincing because the size of the test set is typically small. To overcome this problem we used publicly available breast cancer gene expression data sets and a novel approach to data fusion, in order to validate a new breast tumor intrinsic list.RESULTS:A 105-tumor training set containing 26 sample pairs was used to derive a new breast tumor intrinsic gene list. This intrinsic list contained 1300 genes and a proliferation signature that was not present in previous breast intrinsic gene sets. We tested this list as a survival predictor on a data set of 311 tumors compiled from three independent microarray studies that were fused into a single data set using Distance Weighted Discrimination. When the new intrinsic gene set was used to hierarchically cluster this combined test set, tumors were grouped into LumA, LumB, Basal-like, HER2+/ER-, and Normal Breast-like tumor subtypes that we demonstrated in previous datasets. These subtypes were associated with significant differences in Relapse-Free and Overall Survival. Multivariate Cox analysis of the combined test set showed that the intrinsic subtype classifications added significant prognostic information that was independent of standard clinical predictors. From the combined test set, we developed an objective and unchanging classifier based upon five intrinsic subtype mean expression profiles (i.e. centroids), which is designed for single sample predictions (SSP). The SSP approach was applied to two additional independent data sets and consistently predicted survival in both systemically treated and untreated patient groups.CONCLUSION:This study validates the "breast tumor intrinsic" subtype classification as an objective means of tumor classification that should be translated into a clinical assay for further retrospective and prospective validation. In addition, our method of combining existing data sets can be used to robustly validate the potential clinical value of any new gene expression profile.},
	Author = {Hu, Zhiyuan and Fan, Cheng and Oh, Daniel and Marron, JS and He, Xiaping and Qaqish, Bahjat and Livasy, Chad and Carey, Lisa and Reynolds, Evangeline and Dressler, Lynn and Nobel, Andrew and Parker, Joel and Ewend, Matthew and Sawyer, Lynda and Wu, Junyuan and Liu, Yudong and Nanda, Rita and Tretiakova, Maria and Orrico, Alejandra and Dreher, Donna and Palazzo, Juan and Perreard, Laurent and Nelson, Edward and Mone, Mary and Hansen, Heidi and Mullins, Michael and Quackenbush, John and Ellis, Matthew and Olopade, Olufunmilayo and Bernard, Philip and Perou, Charles},
	Date-Added = {2008-11-11 12:31:12 +0100},
	Date-Modified = {2009-11-29 15:56:12 +0100},
	Doi = {10.1186/1471-2164-7-96},
	Issn = {1471-2164},
	Journal = {BMC Genomics},
	Number = {96},
	Pubmedid = {16643655},
	Title = {The molecular portraits of breast tumors are conserved across microarray platforms},
	Url = {http://www.biomedcentral.com/1471-2164/7/96},
	Volume = {7},
	Year = {2006},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/7/96},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-7-96}}

@article{hofling2008prevalidation,
	Abstract = {Given a predictor of outcome derived from a high-dimensional dataset, pre-validation is a useful technique for comparing it to competing predictors on the same dataset. For microarray data, it allows one to compare a newly derived predictor for disease outcome to standard clinical predictors on the same dataset. We study pre-validation analytically to determine if the inferences drawn from it are valid. We show that while pre-validation generally works well, the straightforward "one degree of freedom" analytical test from pre-validation can be biased and we propose a permutation test to remedy this problem. In simulation studies, we show that the permutation test has the nominal level and achieves roughly the same power as the analytical test.},
	Author = {Holger H{\"o}fling and Robert Tibshirani},
	Date-Added = {2008-11-11 08:17:16 +0100},
	Date-Modified = {2008-11-11 08:18:06 +0100},
	Doi = {doi:10.1214/07-AOAS152},
	Journal = {Annals of Applied Statistics},
	Month = jul,
	Number = {2},
	Pages = {643-664},
	Title = {A study of pre-validation},
	Url = {http://arxiv.org/abs/0807.4105},
	Volume = {2},
	Year = {2008},
	Bdsk-Url-1 = {http://arxiv.org/abs/0807.4105},
	Bdsk-Url-2 = {http://dx.doi.org/10.1214/07-AOAS152}}

@article{tibshirani2002prevalidation,
	Abstract = {In microarray studies, an important problem is to compare a predictor of disease outcome derived from gene expression levels to standard clinical predictors. Comparing them on the same dataset that was used to derive the microarray predictor can lead to results strongly biased in favor of the microarray predictor. We propose a new technique called "pre-validation'' for making a fairer comparison between the two sets of predictors. We study the method analytically and explore its application in a recent study on breast cancer.},
	Address = {Stanford University, USA. tibs{\char64}stat.stanford.edu},
	Au = {Tibshirani, RJ and Efron, B},
	Author = {Tibshirani, Robert J and Efron, Brad},
	Da = {20060501},
	Date-Added = {2008-11-10 16:58:23 +0100},
	Date-Modified = {2008-11-10 16:58:52 +0100},
	Dcom = {20060518},
	Dep = {20020822},
	Doi = {10.2202/1544-6115.1000},
	Edat = {2006/05/02 09:00},
	Issn = {1544-6115 (Electronic)},
	Jid = {101176023},
	Journal = {Stat Appl Genet Mol Biol},
	Jt = {Statistical applications in genetics and molecular biology},
	Language = {eng},
	Lr = {20061204},
	Mhda = {2006/05/02 09:01},
	Own = {NLM},
	Pages = {Article1},
	Phst = {2002/08/22 {$[$}epublish{$]$}},
	Pl = {United States},
	Pmid = {16646777},
	Pst = {ppublish},
	Pt = {Journal Article},
	Pubm = {Print-Electronic},
	So = {Stat Appl Genet Mol Biol. 2002;1:Article1. Epub 2002 Aug 22.},
	Stat = {PubMed-not-MEDLINE},
	Title = {Pre-validation and inference in microarrays.},
	Volume = {1},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.2202/1544-6115.1000}}

@article{nimeusmalmstrom2008gene,
	Abstract = {INTRODUCTION:Some patients with breast cancer develop local recurrence after breast-conservation surgery despite postoperative radiotherapy, whereas others remain free of local recurrence even in the absence of radiotherapy. As clinical parameters are insufficient for identifying these two groups of patients, we investigated whether gene expression profiling would add further information.METHODS:We performed gene expression analysis (oligonucleotide arrays, 26,824 reporters) on 143 patients with lymph node-negative disease and tumor-free margins. A support vector machine was employed to build classifiers using leave-one-out cross-validation.RESULTS:Within the estrogen receptor-positive (ER+) subgroup, the gene expression profile clearly distinguished patients with local recurrence after radiotherapy (n = 20) from those without local recurrence (n = 80 with or without radiotherapy). The receiver operating characteristic (ROC) area was 0.91, and 5,237 of 26,824 reporters had a P value of less than 0.001 (false discovery rate = 0.005). This gene expression profile provides substantially added value to conventional clinical markers (for example, age, histological grade, and tumor size) in predicting local recurrence despite radiotherapy. Within the ER- subgroup, a weaker, but still significant, signal was found (ROC area = 0.74). The ROC area for distinguishing patients who develop local recurrence from those who remain local recurrence-free in the absence of radiotherapy was 0.66 (combined ER+/ER-).CONCLUSION:A highly distinct gene expression profile for patients developing local recurrence after breast-conservation surgery despite radiotherapy has been identified. If verified in further studies, this profile might be a most important tool in the decision making for surgery and adjuvant therapy.},
	Author = {Nimeus-Malmstrom, Emma and Krogh, Morten and Malmstrom, Per and Strand, Carina and Fredriksson, Irma and Karlsson, Per and Nordenskjold, Bo and Stal, Olle and Ostberg, Gorel and Peterson, Carsten and Ferno, Marten},
	Date-Added = {2008-11-10 14:41:06 +0100},
	Date-Modified = {2008-11-10 14:41:47 +0100},
	Doi = {10.1186/bcr1997},
	Issn = {1465-5411},
	Journal = {Breast Cancer Research},
	Number = {2},
	Pages = {R34},
	Pubmedid = {18430221},
	Title = {Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy},
	Url = {http://breast-cancer-research.com/content/10/2/R34},
	Volume = {10},
	Year = {2008},
	Bdsk-Url-1 = {http://breast-cancer-research.com/content/10/2/R34},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr1997}}

@article{weigelt2008refinement,
	Author = {B. Weigelt and H. M. Horlings and B. Kreike and M. M. Hayes and M. Hauptmann and L. F. A. Wessels and D. {de Jong} and M. J. {Van de Vijver} and L. J. {Van't Veer} and J. L. Peterse},
	Date-Added = {2008-11-04 07:48:08 +0100},
	Date-Modified = {2008-11-04 07:51:09 +0100},
	Doi = {10.1002/path.2407},
	Journal = {Journal of Pathology},
	Number = {2},
	Pages = {141-150},
	Title = {Refinement of breast cancer classification by molecular characterization of histological special types},
	Volume = {216},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/path.2407}}

@article{viswanathan2008getting,
	Author = {Viswanathan, Ganesh A AND Seto, Jeremy AND Patil, Sonali AND Nudelman, German AND Sealfon, Stuart C},
	Date-Added = {2008-11-03 19:51:40 +0100},
	Date-Modified = {2008-11-03 19:51:40 +0100},
	Doi = {10.1371/journal.pcbi.0040016},
	Journal = {PLoS Comput Biol},
	Month = {Feb},
	Number = {2},
	Pages = {e16},
	Publisher = {Public Library of Science},
	Title = {Getting Started in Biological Pathway Construction and Analysis},
	Url = {http://dx.doi.org/10.1371%2Fjournal.pcbi.0040016},
	Volume = {4},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pcbi.0040016}}

@article{wang2005cellular,
	Annote = {10.1038/nrd1691},
	Author = {Wang, Dong and Lippard, Stephen J.},
	Date-Added = {2008-11-03 19:41:50 +0100},
	Date-Modified = {2008-11-03 19:41:50 +0100},
	Isbn = {1474-1776},
	Journal = {Nat Rev Drug Discov},
	M3 = {10.1038/nrd1691},
	Number = {4},
	Pages = {307--320},
	Title = {Cellular processing of platinum anticancer drugs},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nrd1691},
	Volume = {4},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrd1691}}

@manual{R2008,
	Address = {Vienna, Austria},
	Author = {{R Development Core Team}},
	Date-Added = {2008-11-03 19:08:54 +0100},
	Date-Modified = {2008-11-03 19:10:17 +0100},
	Isbn = {{ISBN} 3-900051-07-0},
	Organization = {R Foundation for Statistical Computing},
	Title = {R: A language and environment for statistical computing},
	Url = {http://www.R-project.org},
	Bdsk-Url-1 = {http://www.R-project.org}}

@phdthesis{sugar1998techniques,
	Author = {Sugar, C.},
	Date-Added = {2008-10-24 12:02:52 +0200},
	Date-Modified = {2008-10-24 12:04:01 +0200},
	School = {Stanford University},
	Title = {Techniques for clustering and classification with applications to medical problems},
	Year = {1998}}

@article{fraley1998how,
	Author = {Fraley, C. and Raftery, A. E.},
	Date-Added = {2008-10-24 11:56:43 +0200},
	Date-Modified = {2008-10-24 11:58:51 +0200},
	Journal = {Computational Journal},
	Pages = {578-588},
	Title = {How many clusters? Which clustering method? -- Answers via model-based cluster analysis},
	Volume = {41},
	Year = {1998}}

@inproceedings{wessels2002representation,
	Address = {San Jose, California, USA},
	Author = {Wessels, Lodewyk F. A. and Reinders, Marcel J. T. and {van Welsem}, T. and Nederlof, P. M.},
	Booktitle = {Proceedings of SPIE},
	Date-Added = {2008-10-24 09:59:25 +0200},
	Date-Modified = {2008-12-11 14:26:00 +0100},
	Organization = {BIOS2002},
	Title = {Representation and classification for high-throughput data},
	Volume = {4626},
	Year = {2002}}

@article{ripley2004nonlinear,
	Author = {Ripley, Ruth M. and Harris, Adrian L. and Tarassenko, Lionel},
	Date-Added = {2008-10-23 15:57:52 +0200},
	Date-Modified = {2008-10-23 16:00:30 +0200},
	Doi = {10.1002/sim.1655},
	Journal = {Statistics in Medicine},
	Pages = {825-842},
	Title = {Non-linear survival analysis using neural networks},
	Volume = {23},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.1655}}

@article{molinaro2004treebased,
	Author = {Molinaro, A. M. and Dudoit, S. and {van der Laan} M. J.},
	Date-Added = {2008-10-23 15:55:26 +0200},
	Date-Modified = {2008-10-23 15:57:44 +0200},
	Journal = {Journal of Multivariate Analaysis},
	Pages = {154-177},
	Title = {Tree-based multivariate regresion and density estimation with right-censored data},
	Volume = {90},
	Year = {2004}}

@article{verweij1993crossvalidation,
	Author = {Verweij, P. J. M. and {van Houwelingen}, J. C.},
	Date-Added = {2008-10-23 10:36:50 +0200},
	Date-Modified = {2008-10-23 10:38:35 +0200},
	Journal = {Statistics in Medicine},
	Pages = {2305-2314},
	Title = {Cross-validation in survival analysis},
	Volume = {12},
	Year = {1993}}

@article{teschendorff2008robust,
	Abstract = {INTRODUCTION:Patients with primary operable oestrogen receptor (ER) negative (-) breast cancer account for about 30% of all cases and generally have a worse prognosis than ER-positive (+) patients. Nevertheless, a significant proportion of ER- cases have favourable outcomes and could potentially benefit from a less aggressive course of therapy. However, identification of such patients with a good prognosis remains difficult and at present is only possible through examining histopathological factors.METHODS:Building on a previously identified seven-gene prognostic immune response module for ER- breast cancer, we developed a novel statistical tool based on Mixture Discriminant Analysis in order to build a classifier that could accurately identify ER- patients with a good prognosis.RESULTS:We report the construction of a seven-gene expression classifier that accurately predicts, across a training cohort of 183 ER- tumours and six independent test cohorts (a total of 469 ER- tumours), ER- patients of good prognosis (in test sets, average predictive value = 94% [range 85 to 100%], average hazard ratio = 0.15 [range 0.07 to 0.36] p < 0.000001) independently of lymph node status and treatment.CONCLUSIONS:This seven-gene classifier could be used in a polymerase chain reaction-based clinical assay to identify ER- patients with a good prognosis, who may therefore benefit from less aggressive treatment regimens.},
	Author = {Teschendorff, Andrew and Caldas, Carlos},
	Date-Added = {2008-10-11 23:13:12 +0200},
	Date-Modified = {2008-10-11 23:13:24 +0200},
	Doi = {10.1186/bcr2138},
	Issn = {1465-5411},
	Journal = {Breast Cancer Research},
	Number = {4},
	Pages = {R73},
	Pubmedid = {18755024},
	Title = {A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer},
	Url = {http://breast-cancer-research.com/content/10/4/R73},
	Volume = {10},
	Year = {2008},
	Bdsk-Url-1 = {http://breast-cancer-research.com/content/10/4/R73},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr2138}}

@article{teschendorff2007immune,
	Abstract = {BACKGROUND:Estrogen receptor (ER)-negative breast cancer specimens are predominantly of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and basal subtypes. Although ER-negative disease has overall worse prognosis than does ER-positive breast cancer, not all ER-negative breast cancer patients have poor clinical outcome. Reliable identification of ER-negative tumors that have a good prognosis is not yet possible.RESULTS:We apply a recently proposed feature selection method in an integrative analysis of three major microarray expression datasets to identify molecular subclasses and prognostic markers in ER-negative breast cancer. We find a subclass of basal tumors, characterized by over-expression of immune response genes, which has a better prognosis than the rest of ER-negative breast cancers. Moreover, we show that, in contrast to ER-positive tumours, the majority of prognostic markers in ER-negative breast cancer are over-expressed in the good prognosis group and are associated with activation of complement and immune response pathways. Specifically, we identify an immune response related seven-gene module and show that downregulation of this module confers greater risk for distant metastasis (hazard ratio 2.02, 95% confidence interval 1.2-3.4; P = 0.009), independent of lymph node status and lymphocytic infiltration. Furthermore, we validate the immune response module using two additional independent datasets.CONCLUSION:We show that ER-negative basal breast cancer is a heterogeneous disease with at least four main subtypes. Furthermore, we show that the heterogeneity in clinical outcome of ER-negative breast cancer is related to the variability in expression levels of complement and immune response pathway genes, independent of lymphocytic infiltration.},
	Author = {Teschendorff, Andrew and Miremadi, Ahmad and Pinder, Sarah and Ellis, Ian and Caldas, Carlos},
	Date-Added = {2008-10-11 23:12:37 +0200},
	Date-Modified = {2008-10-11 23:12:49 +0200},
	Doi = {10.1186/gb-2007-8-8-r157},
	Issn = {1465-6906},
	Journal = {Genome Biology},
	Number = {8},
	Pages = {R157},
	Pubmedid = {17683518},
	Title = {An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer},
	Url = {http://genomebiology.com/2007/8/8/R157},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://genomebiology.com/2007/8/8/R157},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/gb-2007-8-8-r157}}

@article{kapp2006discovery,
	Abstract = {BACKGROUND:Previous studies demonstrated breast cancer tumor tissue samples could be classified into different subtypes based upon DNA microarray profiles. The most recent study presented evidence for the existence of five different subtypes: normal breast-like, basal, luminal A, luminal B, and ERBB2+.RESULTS:Based upon the analysis of 599 microarrays (five separate cDNA microarray datasets) using a novel approach, we present evidence in support of the most consistently identifiable subtypes of breast cancer tumor tissue microarrays being: ESR1+/ERBB2-, ESR1-/ERBB2-, and ERBB2+ (collectively called the ESR1/ERBB2 subtypes). We validate all three subtypes statistically and show the subtype to which a sample belongs is a significant predictor of overall survival and distant-metastasis free probability.CONCLUSION:As a consequence of the statistical validation procedure we have a set of centroids which can be applied to any microarray (indexed by UniGene Cluster ID) to classify it to one of the ESR1/ERBB2 subtypes. Moreover, the method used to define the ESR1/ERBB2 subtypes is not specific to the disease. The method can be used to identify subtypes in any disease for which there are at least two independent microarray datasets of disease samples.},
	Author = {Kapp, Amy and Jeffrey, Stefanie and Langerod, Anita and Borresen-Dale, Anne-Lise and Han, Wonshik and Noh, Dong-Young and Bukholm, Ida and Nicolau, Monica and Brown, Patrick and Tibshirani, Robert},
	Date-Added = {2008-10-10 16:17:36 +0200},
	Date-Modified = {2008-10-10 16:17:54 +0200},
	Doi = {10.1186/1471-2164-7-231},
	Issn = {1471-2164},
	Journal = {BMC Genomics},
	Number = {1},
	Pages = {231},
	Pubmedid = {16965636},
	Title = {Discovery and validation of breast cancer subtypes},
	Url = {http://www.biomedcentral.com/1471-2164/7/231},
	Volume = {7},
	Year = {2006},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/7/231},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-7-231}}

@article{ambrogi2006molecular,
	Abstract = {Purpose: Recent small-sized genomic studies on the identification of breast cancer bioprofiles have led to profoundly dishomogeneous results. Thus, we sought to identify distinct tumor profiles with possible clinical relevance based on clusters of immunohistochemical molecular markers measured on a large, single institution, case series.  Experimental Design: Tumor biological profiles were explored on 633 archival tissue samples analyzed by immunohistochemistry. Five validated markers were considered, i.e., estrogen receptors (ER), progesterone receptors (PR), Ki-67/MIB1 as a proliferation marker, HER2/NEU, and p53 in their original scale of measurement. The results obtained were analyzed by three different clustering algorithms. Four different indices were then used to select the different profiles (number of clusters).  Results: The best classification was obtained creating four clusters. Notably, three clusters were identified according to low, intermediate, and high ER/PR levels. A further subdivision in two biologically distinct subtypes was determined by the presence/absence of HER2/NEU and of p53. As expected, the cluster with high ER/PR levels was characterized by a much better prognosis and response to hormone therapy compared to that with the lowest ER/PR values. Notably, the cluster characterized by high HER2/NEU levels showed intermediate prognosis, but a rather poor response to hormone therapy.  Conclusions: Our results show the possibility of profiling breast cancers by means of traditional markers, and have novel clinical implications on the definition of the prognosis of cancer patients. These findings support the existence of a tumor subtype that responds poorly to hormone therapy, characterized by HER2/NEU overexpression.
},
	Author = {Ambrogi, Federico and Biganzoli, Elia and Querzoli, Patrizia and Ferretti, Stefano and Boracchi, Patrizia and Alberti, Saverio and Marubini, Ettore and Nenci, Italo},
	Date-Added = {2008-10-08 17:15:28 +0200},
	Date-Modified = {2008-10-08 17:15:28 +0200},
	Doi = {10.1158/1078-0432.CCR-05-0763},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/12/3/781.pdf},
	Journal = {Clin Cancer Res},
	Number = {3},
	Pages = {781-790},
	Title = {{Molecular Subtyping of Breast Cancer from Traditional Tumor Marker Profiles Using Parallel Clustering Methods}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/12/3/781},
	Volume = {12},
	Year = {2006},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/12/3/781},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-05-0763}}

@article{isaacs2001new,
	Abstract = {Decisions regarding the use of adjuvant therapy for breast cancer are strongly influenced by the risk of disease recurrence and death. These risks are now determined by examining the currently recognized breast cancer prognostic factors including clinical stage, axillary nodal status, tumor size and grade, hormone receptor status, and presence of lymphovascular involvement. Newer factors are being evaluated in an attempt to more precisely define disease-related prognosis. This article provides an overview of issues that need to be considered when analyzing studies of prognostic factors, as well as a review of the currently recognized and the newer candidate prognostic factors.},
	Address = {Breast Cancer Program, Lombardi Cancer Center, Georgetown University, Washington, DC, USA.},
	Au = {Isaacs, C and Stearns, V and Hayes, DF},
	Author = {Isaacs, C and Stearns, V and Hayes, D F},
	Da = {20010301},
	Date-Added = {2008-10-01 12:10:58 +0200},
	Date-Modified = {2008-10-09 10:21:37 +0200},
	Dcom = {20010329},
	Edat = {2001/03/20 10:00},
	Issn = {0093-7754 (Print)},
	Jid = {0420432},
	Journal = {Semin Oncol},
	Jt = {Seminars in oncology},
	Language = {eng},
	Lr = {20061115},
	Mh = {Breast Neoplasms/classification/drug therapy/*pathology; Chemotherapy, Adjuvant; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local/*prevention \& control; Neoplasm Staging; Patient Selection; Prognosis; Tumor Markers, Biological},
	Mhda = {2001/04/03 10:01},
	Month = {February},
	Number = {1},
	Own = {NLM},
	Pages = {53--67},
	Pii = {S0093775401000872},
	Pl = {United States},
	Pmid = {11254867},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	Pubm = {Print},
	Rf = {88},
	Rn = {0 (Tumor Markers, Biological)},
	Sb = {IM},
	So = {Semin Oncol. 2001 Feb;28(1):53-67.},
	Stat = {MEDLINE},
	Title = {New prognostic factors for breast cancer recurrence.},
	Volume = {28},
	Year = {2001}}

@article{thalamuthu2006evaluation,
	Abstract = {Motivation: Microarray technology has been widely applied in biological and clinical studies for simultaneous monitoring of gene expression in thousands of genes. Gene clustering analysis is found useful for discovering groups of correlated genes potentially co-regulated or associated to the disease or conditions under investigation. Many clustering methods including hierarchical clustering, K-means, PAM, SOM, mixture model-based clustering and tight clustering have been widely used in the literature. Yet no comprehensive comparative study has been performed to evaluate the effectiveness of these methods.  Results: In this paper, six gene clustering methods are evaluated by simulated data from a hierarchical log-normal model with various degrees of perturbation as well as four real datasets. A weighted Rand index is proposed for measuring similarity of two clustering results with possible scattered genes (i.e. a set of noise genes not being clustered). Performance of the methods in the real data is assessed by a predictive accuracy analysis through verified gene annotations. Our results show that tight clustering and model-based clustering consistently outperform other clustering methods both in simulated and real data while hierarchical clustering and SOM perform among the worst. Our analysis provides deep insight to the complicated gene clustering problem of expression profile and serves as a practical guideline for routine microarray cluster analysis.  Contact: ctseng@pitt.edu  Supplementary information: Supplementary data are available at Bioinformatics online.
},
	Author = {Thalamuthu, Anbupalam and Mukhopadhyay, Indranil and Zheng, Xiaojing and Tseng, George C.},
	Date-Added = {2008-09-30 16:08:06 +0200},
	Date-Modified = {2008-09-30 16:08:23 +0200},
	Doi = {10.1093/bioinformatics/btl406},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/22/19/2405.pdf},
	Journal = {Bioinformatics},
	Number = {19},
	Pages = {2405-2412},
	Title = {{Evaluation and comparison of gene clustering methods in microarray analysis}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/19/2405},
	Volume = {22},
	Year = {2006},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/19/2405},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btl406}}

@article{tseng2005tight,
	Abstract = {In this article, we propose a method for clustering that produces tight and stable clusters without forcing all points into clusters. The methodology is general but was initially motivated from cluster analysis of microarray experiments. Most current algorithms aim to assign all genes into clusters. For many biological studies, however, we are mainly interested in identifying the most informative, tight, and stable clusters of sizes, say, 20-60 genes for further investigation. We want to avoid the contamination of tightly regulated expression patterns of biologically relevant genes due to other genes whose expressions are only loosely compatible with these patterns. "Tight clustering" has been developed specifically to address this problem. It applies K-means clustering as an intermediate clustering engine. Early truncation of a hierarchical clustering tree is used to overcome the local minimum problem in K-means clustering. The tightest and most stable clusters are identified in a sequential manner through an analysis of the tendency of genes to be grouped together under repeated resampling. We validated this method in a simulated example and applied it to analyze a set of expression profiles in the study of embryonic stem cells.},
	Address = {Department of Biostatistics and Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. ctseng@pitt.edu},
	Au = {Tseng, GC and Wong, WH},
	Author = {Tseng, George C and Wong, Wing H},
	Da = {20050301},
	Date-Added = {2008-09-30 15:10:56 +0200},
	Date-Modified = {2009-01-26 06:51:54 +0100},
	Dcom = {20050630},
	Doi = {10.1111/j.0006-341X.2005.031032.x},
	Edat = {2005/03/02 09:00},
	Issn = {0006-341X (Print)},
	Jid = {0370625},
	Journal = {Biometrics},
	Jt = {Biometrics},
	Language = {eng},
	Lr = {20061115},
	Mh = {*Algorithms; *Cluster Analysis; Computer Graphics; Genomics/methods; Oligonucleotide Array Sequence Analysis; Pattern Recognition, Automated},
	Mhda = {2005/07/01 09:00},
	Month = {March},
	Number = {1},
	Own = {NLM},
	Pages = {10--16},
	Pii = {BIOM031032},
	Pl = {United States},
	Pmid = {15737073},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.},
	Pubm = {Print},
	Sb = {IM},
	So = {Biometrics. 2005 Mar;61(1):10-6.},
	Stat = {MEDLINE},
	Title = {Tight clustering: a resampling-based approach for identifying stable and tight patterns in data.},
	Volume = {61},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1111/j.0006-341X.2005.031032.x}}

@article{lusa2007challenges,
	Abstract = {BackgroundGene expression microarray studies for several types of cancer have been reported to identify previously unknown subtypes of tumors. For breast cancer, a molecular classification consisting of five subtypes based on gene expression microarray data has been proposed. These subtypes have been reported to exist across several breast cancer microarray studies, and they have demonstrated some association with clinical outcome. A classification rule based on the method of centroids has been proposed for identifying the subtypes in new collections of breast cancer samples; the method is based on the similarity of the new profiles to the mean expression profile of the previously identified subtypes.  MethodsPreviously identified centroids of five breast cancer subtypes were used to assign 99 breast cancer samples, including a subset of 65 estrogen receptor-positive (ER+) samples, to five breast cancer subtypes based on microarray data for the samples. The effect of mean centering the genes (i.e., transforming the expression of each gene so that its mean expression is equal to 0) on subtype assignment by method of centroids was assessed. Further studies of the effect of mean centering and of class prevalence in the test set on the accuracy of method of centroids classifications of ER status were carried out using training and test sets for which ER status had been independently determined by ligand-binding assay and for which the proportion of ER+ and ER- samples were systematically varied.  ResultsWhen all 99 samples were considered, mean centering before application of the method of centroids appeared to be helpful for correctly assigning samples to subtypes, as evidenced by the expression of genes that had previously been used as markers to identify the subtypes. However, when only the 65 ER+ samples were considered for classification, many samples appeared to be misclassified, as evidenced by an unexpected distribution of ER+ samples among the resultant subtypes. When genes were mean centered before classification of samples for ER status, the accuracy of the ER subgroup assignments was highly dependent on the proportion of ER+ samples in the test set; this effect of subtype prevalence was not seen when gene expression data were not mean centered.  ConclusionsSimple corrections such as mean centering of genes aimed at microarray platform or batch effect correction can have undesirable consequences because patient population effects can easily be confused with these assay-related effects. Careful thought should be given to the comparability of the patient populations before attempting to force data comparability for purposes of assigning subtypes to independent subjects.
},
	Author = {Lusa, Lara and McShane, Lisa M. and Reid, James F. and De Cecco, Loris and Ambrogi, Federico and Biganzoli, Elia and Gariboldi, Manuela and Pierotti, Marco A.},
	Date-Added = {2008-09-23 13:27:56 +0200},
	Date-Modified = {2008-09-23 13:27:56 +0200},
	Doi = {10.1093/jnci/djm216},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;99/22/1715.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {22},
	Pages = {1715-1723},
	Title = {{Challenges in Projecting Clustering Results Across Gene Expression Profiling Datasets}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;99/22/1715},
	Volume = {99},
	Year = {2007},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;99/22/1715},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/djm216}}

@article{buyse2006validation,
	Abstract = {Background: A 70-gene signature was previously shown to have prognostic value in patients with node-negative breast cancer. Our goal was to validate the signature in an independent group of patients. Methods: Patients (n = 307, with 137 events after a median follow-up of 13.6 years) from five European centers were divided into high- and low-risk groups based on the gene signature classification and on clinical risk classifications. Patients were assigned to the gene signature low-risk group if their 5-year distant metastasis-free survival probability as estimated by the gene signature was greater than 90%. Patients were assigned to the clinicopathologic low-risk group if their 10-year survival probability, as estimated by Adjuvant! software, was greater than 88% (for estrogen receptor [ER]-positive patients) or 92% (for ER-negative patients). Hazard ratios (HRs) were estimated to compare time to distant metastases, disease-free survival, and overall survival in high- versus low-risk groups. Results: The 70-gene signature outperformed the clinicopathologic risk assessment in predicting all endpoints. For time to distant metastases, the gene signature yielded HR = 2.32 (95% confidence interval [CI] = 1.35 to 4.00) without adjustment for clinical risk and hazard ratios ranging from 2.13 to 2.15 after adjustment for various estimates of clinical risk; clinicopathologic risk using Adjuvant! software yielded an unadjusted HR = 1.68 (95% CI = 0.92 to 3.07). For overall survival, the gene signature yielded an unadjusted HR = 2.79 (95% CI = 1.60 to 4.87) and adjusted hazard ratios ranging from 2.63 to 2.89; clinicopathologic risk yielded an unadjusted HR = 1.67 (95% CI = 0.93 to 2.98). For patients in the gene signature high-risk group, 10-year overall survival was 0.69 for patients in both the low- and high-clinical risk groups; for patients in the gene signature low-risk group, the 10-year survival rates were 0.88 and 0.89, respectively. Conclusions: The 70-gene signature adds independent prognostic information to clinicopathologic risk assessment for patients with early breast cancer.
},
	Author = {Buyse, Marc and Loi, Sherene and van't Veer, Laura and Viale, Giuseppe and Delorenzi, Mauro and Glas, Annuska M. and Saghatchian d'Assignies, Mahasti and Bergh, Jonas and Lidereau, Rosette and Ellis, Paul and Harris, Adrian and Bogaerts, Jan and Therasse, Patrick and Floore, Arno and Amakrane, Mohamed and Piette, Fanny and Rutgers, Emiel and Sotiriou, Christos and Cardoso, Fatima and Piccart, Martine J.},
	Date-Added = {2008-09-20 13:11:14 +0200},
	Date-Modified = {2008-09-20 13:11:14 +0200},
	Doi = {10.1093/jnci/djj329},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;98/17/1183.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {17},
	Pages = {1183-1192},
	Title = {{Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;98/17/1183},
	Volume = {98},
	Year = {2006},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;98/17/1183},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/djj329}}

@article{conforti2007breast,
	Abstract = {Background: The purpose of this study was to determine the predictive value of breast cancer molecular subclassification regarding the benefit of adjuvant anthracycline-based chemotherapy.  Patients and methods: Tumor samples from 823 patients included in two randomized trials that compared an anthracycline-based chemotherapy with no treatment were used to construct a tissue array. Estrogen receptor (ER), Her2, epidermal growth factor receptor, cytokeratine 5/6 expressions were determined by immunohistochemistry (IHC). The potential predictive factors of treatment effect on disease-free survival (DFS) were assessed by interaction tests and multivariate analysis.  Results: Sixty-four (8%), 98 (12%), 109 (14%) and 527 (66%) patients presented a Her2+/ER-, basal-like, Her2-/ER-/nonbasal and luminal-like breast cancer. ER expression, when assessed by IHC, was an independent predictive factor for the benefit of chemotherapy on DFS (test for interaction, P = 0.0015). The molecular subclassification significantly predicted the efficacy of chemotherapy (test for interaction, P = 0.01), but had no significant added value (P = 0.32) as compared to the ER by treatment interaction. Adjuvant chemotherapy was associated with an adjusted hazard ratio for relapse or death of 0.42 [95% confidence interval (CI): 0.17-1.05], 0.54 (95% CI: 0.27-1.08), 0.35 (95% CI: 0.18-0.68), 1.07 (95% CI: 0.81-1.41) for patients with Her2+/ER-, basal-like, Her2-/ER-/nonbasal and luminal-like tumors, respectively.  Conclusion: The breast cancer molecular subclassification was predictive for chemotherapy efficacy in adjuvant setting, but did not provide significant additional information to ER.
},
	Author = {Conforti, R and Boulet, T and Tomasic, G and Taranchon, E and Arriagada, R and Spielmann, M and Ducourtieux, M and Soria, JC and Tursz, T and Delaloge, S and Michiels, S and Andre, F},
	Date-Added = {2008-09-19 11:49:52 +0200},
	Date-Modified = {2008-09-19 11:49:52 +0200},
	Doi = {10.1093/annonc/mdm209},
	Eprint = {http://annonc.oxfordjournals.org/cgi/reprint/18/9/1477.pdf},
	Journal = {Ann Oncol},
	Number = {9},
	Pages = {1477-1483},
	Title = {{Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials}},
	Url = {http://annonc.oxfordjournals.org/cgi/content/abstract/18/9/1477},
	Volume = {18},
	Year = {2007},
	Bdsk-Url-1 = {http://annonc.oxfordjournals.org/cgi/content/abstract/18/9/1477},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/annonc/mdm209}}

@article{sihto2008molecular,
	Abstract = {Purpose: The frequency and significance of gene expression profile-derived molecular subtypes of breast cancers found in mammography screening are unknown.  Experimental Design: We identified breast cancers diagnosed in women of any age living in defined geographic regions in Finland in 1991 to 1992 and collected clinical and pathologic data. Surrogates for the molecular subtypes were determined for 247 cancers found in organized mammography screening and 989 cancers detected outside of screening using immunohistochemistry or in situ hybridization. Molecular subtypes were defined as luminal A [estrogen receptor (ER) positive and/or progesterone receptor (PR) positive, HER2-], luminal B (ER+ and/or PR+, HER2+), basal-like (ER-, PR-, HER2-, cytokeratin 5+, and/or HER1+), HER2+/ER- (ER-, PR-, and HER2+), and unclassified. The median follow-up time was 9.4 years.  Results: The luminal type A was common (73.7%) and the HER2+/ER- type is rare (5.7%) in screen-detected cancer, and only 16% were HER2 positive. Women with cancer diagnosed in screening at ages 50 to 69 years had similar molecular subtype distribution as women whose cancer was found outside of screening at age >69 years. In a multivariate model, cancer detection at screening independently predicted favorable distant disease-free survival when the molecular subtype was included as a covariate in addition to age, histologic grade, and cancer size. Women with small (pT1N0M0) HER2-positive cancer had similar outcome regardless of the method of detection.  Conclusions: Molecular subtype distribution of screen-detected breast cancer differs from that of cancers found outside of screening and accounts in part for the better outcome of screen-detected cancer.
},
	Author = {Sihto, Harri and Lundin, Johan and Lehtimaki, Tiina and Sarlomo-Rikala, Maarit and Butzow, Ralf and Holli, Kaija and Sailas, Liisa and Kataja, Vesa and Lundin, Mikael and Turpeenniemi-Hujanen, Taina and Isola, Jorma and Heikkila, Paivi and Joensuu, Heikki},
	Date-Added = {2008-09-19 11:40:11 +0200},
	Date-Modified = {2008-09-19 11:40:11 +0200},
	Doi = {10.1158/1078-0432.CCR-07-5003},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/14/13/4103.pdf},
	Journal = {Clin Cancer Res},
	Number = {13},
	Pages = {4103-4110},
	Title = {{Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/13/4103},
	Volume = {14},
	Year = {2008},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/13/4103},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-07-5003}}

@article{calza2006intrinsic,
	Abstract = {BACKGROUND:Molecular markers and the rich biological information they contain have great potential for cancer diagnosis, prognostication and therapy prediction. So far, however, they have not superseded routine histopathology and staging criteria, partly because the few studies performed on molecular subtyping have had little validation and limited clinical characterization.METHODS:We obtained gene expression and clinical data for 412 breast cancers obtained from population-based cohorts of patients from Stockholm and Uppsala, Sweden. Using the intrinsic set of approximately 500 genes derived in the Norway/Stanford breast cancer data, we validated the existence of five molecular subtypes - basal-like, ERBB2, luminal A/B and normal-like - and characterized these subtypes extensively with the use of conventional clinical variables.RESULTS:We found an overall 77.5% concordance between the centroid prediction of the Swedish cohort by using the Norway/Stanford signature and the k-means clustering performed internally within the Swedish cohort. The highest rate of discordant assignments occurred between the luminal A and luminal B subtypes and between the luminal B and ERBB2 subtypes. The subtypes varied significantly in terms of grade (p < 0.001), p53 mutation (p < 0.001) and genomic instability (p = 0.01), but surprisingly there was little difference in lymph-node metastasis (p = 0.31). Furthermore, current users of hormone-replacement therapy were strikingly over-represented in the normal-like subgroup (p < 0.001). Separate analyses of the patients who received endocrine therapy and those who did not receive any adjuvant therapy supported the previous hypothesis that the basal-like subtype responded to adjuvant treatment, whereas the ERBB2 and luminal B subtypes were poor responders.CONCLUSION:We found that the intrinsic molecular subtypes of breast cancer are broadly present in a diverse collection of patients from a population-based cohort in Sweden. The intrinsic gene set, originally selected to reveal stable tumor characteristics, was shown to have a strong correlation with progression-related properties such as grade, p53 mutation and genomic instability.},
	Author = {Calza, Stefano and Hall, Per and Auer, Gert and Bjohle, Judith and Klaar, Sigrid and Kronenwett, Ulrike and Liu, Edison and Miller, Lance and Ploner, Alexander and Smeds, Johanna and Bergh, Jonas and Pawitan, Yudi},
	Date-Added = {2008-09-19 11:32:37 +0200},
	Date-Modified = {2008-09-19 11:32:37 +0200},
	Doi = {10.1186/bcr1517},
	Issn = {1465-5411},
	Journal = {Breast Cancer Research},
	Number = {4},
	Pages = {R34},
	Pubmedid = {16846532},
	Title = {Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients},
	Url = {http://breast-cancer-research.com/content/8/4/R34},
	Volume = {8},
	Year = {2006},
	Bdsk-Url-1 = {http://breast-cancer-research.com/content/8/4/R34},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr1517}}

@article{pusztai2006molecular,
	Abstract = {Reverse transcription polymerase chain reaction and DNA microarrays are increasingly used in the clinic and in clinical research as prognostic or predictive tests. Results from these tests led to novel risk stratification methods and to new molecular classification of breast cancer. Some of these tools already complement existing diagnostic tests and can aid medical decision making in some situations. Better understanding of the molecular classes of breast cancer, independent of their prognostic and predictive values, may also lead to new biological insights and eventually to better therapies that are directed toward particular molecular subsets. However, there is substantially less experience with these emerging technologies than with the more established methods, the accuracy of which is often overestimated. This review discusses some of the limitations and strengths of current gene expression-based molecular classification of breast cancer. To provide context for this discussion, we also briefly examine the performance of estrogen receptor immunohistochemistry, which represents an essential part of the routine diagnostic workup for all breast cancer patients.
},
	Author = {Pusztai, Lajos and Mazouni, Chafika and Anderson, Keith and Wu, Yun and Symmans, W. Fraser},
	Date-Added = {2008-09-19 10:58:59 +0200},
	Date-Modified = {2008-09-19 10:58:59 +0200},
	Doi = {10.1634/theoncologist.11-8-868},
	Eprint = {http://theoncologist.alphamedpress.org/cgi/reprint/11/8/868.pdf},
	Journal = {Oncologist},
	Number = {8},
	Pages = {868-877},
	Title = {{Molecular Classification of Breast Cancer: Limitations and Potential}},
	Url = {http://theoncologist.alphamedpress.org/cgi/content/abstract/11/8/868},
	Volume = {11},
	Year = {2006},
	Bdsk-Url-1 = {http://theoncologist.alphamedpress.org/cgi/content/abstract/11/8/868},
	Bdsk-Url-2 = {http://dx.doi.org/10.1634/theoncologist.11-8-868}}

@article{ambroise2002selection,
	Abstract = {In the context of cancer diagnosis and treatment, we consider the problem of constructing an accurate prediction rule on the basis of a relatively small number of tumor tissue samples of known type containing the expression data on very many (possibly thousands) genes. Recently, results have been presented in the literature suggesting that it is possible to construct a prediction rule from only a few genes such that it has a negligible prediction error rate. However, in these results the test error or the leave-one-out cross-validated error is calculated without allowance for the selection bias. There is no allowance because the rule is either tested on tissue samples that were used in the first instance to select the genes being used in the rule or because the cross-validation of the rule is not external to the selection process; that is, gene selection is not performed in training the rule at each stage of the cross-validation process. We describe how in practice the selection bias can be assessed and corrected for by either performing a cross-validation or applying the bootstrap external to the selection process. We recommend using 10-fold rather than leave-one-out cross-validation, and concerning the bootstrap, we suggest using the so-called .632+ bootstrap error estimate designed to handle overfitted prediction rules. Using two published data sets, we demonstrate that when correction is made for the selection bias, the cross-validated error is no longer zero for a subset of only a few genes.
},
	Author = {Ambroise, Christophe and McLachlan, Geoffrey J.},
	Date-Added = {2008-09-16 18:27:34 +0200},
	Date-Modified = {2008-09-16 18:27:34 +0200},
	Doi = {10.1073/pnas.102102699},
	Eprint = {http://www.pnas.org/content/99/10/6562.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {10},
	Pages = {6562-6566},
	Title = {{Selection bias in gene extraction on the basis of microarray gene-expression data}},
	Url = {http://www.pnas.org/content/99/10/6562.abstract},
	Volume = {99},
	Year = {2002},
	Bdsk-Url-1 = {http://www.pnas.org/content/99/10/6562.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.102102699}}

@article{wessels2005protocol,
	Abstract = {Motivation: Microarray gene expression data are increasingly employed to identify sets of marker genes that accurately predict disease development and outcome in cancer. Many computational approaches have been proposed to construct such predictors. However, there is, as yet, no objective way to evaluate whether a new approach truly improves on the current state of the art. In addition no  standard' computational approach has emerged which enables robust outcome prediction.  Results: An important contribution of this work is the description of a principled training and validation protocol, which allows objective evaluation of the complete methodology for constructing a predictor. We review the possible choices of computational approaches, with specific emphasis on predictor choice and reporter selection strategies. Employing this training-validation protocol, we evaluated different reporter selection strategies and predictors on six gene expression datasets of varying degrees of difficulty. We demonstrate that simple reporter selection strategies (forward filtering and shrunken centroids) work surprisingly well and outperform partial least squares in four of the six datasets. Similarly, simple predictors, such as the nearest mean classifier, outperform more complex classifiers. Our training-validation protocol provides a robust methodology to evaluate the performance of new computational approaches and to objectively compare outcome predictions on different datasets.  Contact: l.f.a.wessels@ewi.tudelft.nl  Supplementary information: http://ict.ewi.tudelft.nl/index.php?option=com_pub&task=view&id=1983
},
	Author = {Wessels, Lodewyk F. A. and Reinders, Marcel J. T. and Hart, Augustinus A. M. and Veenman, Cor J. and Dai, Hongyue and He, Yudong D. and {van't Veer}, Laura J.},
	Date-Added = {2008-09-16 18:25:42 +0200},
	Date-Modified = {2009-04-24 10:45:47 +0200},
	Doi = {10.1093/bioinformatics/bti429},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/21/19/3755.pdf},
	Journal = {Bioinformatics},
	Number = {19},
	Pages = {3755-3762},
	Title = {{A protocol for building and evaluating predictors of disease state based on microarray data}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/19/3755},
	Volume = {21},
	Year = {2005},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/19/3755},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/bti429}}

@article{schmidt2008humoral,
	Abstract = {Estrogen receptor (ER) expression and proliferative activity are established prognostic factors in breast cancer. In a search for additional prognostic motifs, we analyzed the gene expression patterns of 200 tumors of patients who were not treated by systemic therapy after surgery using a discovery approach. After performing hierarchical cluster analysis, we identified coregulated genes related to the biological process of proliferation, steroid hormone receptor expression, as well as B-cell and T-cell infiltration. We calculated metagenes as a surrogate for all genes contained within a particular cluster and visualized the relative expression in relation to time to metastasis with principal component analysis. Distinct patterns led to the hypothesis of a prognostic role of the immune system in tumors with high expression of proliferation-associated genes. In multivariate Cox regression analysis, the proliferation metagene showed a significant association with metastasis-free survival of the whole discovery cohort [hazard ratio (HR), 2.20; 95% confidence interval (95% CI), 1.40-3.46]. The B-cell metagene showed additional independent prognostic information in carcinomas with high proliferative activity (HR, 0.66; 95% CI, 0.46-0.97). A prognostic influence of the B-cell metagene was independently confirmed by multivariate analysis in a first validation cohort enriched for high-grade tumors (n = 286; HR, 0.78; 95% CI, 0.62-0.98) and a second validation cohort enriched for younger patients (n = 302; HR, 0.83; 95% CI, 0.7-0.97). Thus, we could show in three cohorts of untreated, node-negative breast cancer patients that the humoral immune system plays a pivotal role in metastasis-free survival of carcinomas of the breast. [Cancer Res 2008;68(13):5405-13]
},
	Author = {Schmidt, Marcus and Bohm, Daniel and von Torne, Christian and Steiner, Eric and Puhl, Alexander and Pilch, Henryk and Lehr, Hans-Anton and Hengstler, Jan G. and Kolbl, Heinz and Gehrmann, Mathias},
	Date-Added = {2008-09-14 18:41:06 +0200},
	Date-Modified = {2008-09-14 18:41:06 +0200},
	Doi = {10.1158/0008-5472.CAN-07-5206},
	Eprint = {http://cancerres.aacrjournals.org/cgi/reprint/68/13/5405.pdf},
	Journal = {Cancer Res},
	Number = {13},
	Pages = {5405-5413},
	Title = {{The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer}},
	Url = {http://cancerres.aacrjournals.org/cgi/content/abstract/68/13/5405},
	Volume = {68},
	Year = {2008},
	Bdsk-Url-1 = {http://cancerres.aacrjournals.org/cgi/content/abstract/68/13/5405},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/0008-5472.CAN-07-5206}}

@article{dupuy2007critical,
	Abstract = {BACKGROUND: Both the validity and the reproducibility of microarray-based clinical research have been challenged. There is a need for critical review of the statistical analysis and reporting in published microarray studies that focus on cancer-related clinical outcomes.  METHODS: Studies published through 2004 in which microarray-based gene expression profiles were analyzed for their relation to a clinical cancer outcome were identified through a Medline search followed by hand screening of abstracts and full text articles. Studies that were eligible for our analysis addressed one or more outcomes that were either an event occurring during follow-up, such as death or relapse, or a therapeutic response. We recorded descriptive characteristics for all the selected studies. A critical review of outcome-related statistical analyses was undertaken for the articles published in 2004.  RESULTS: Ninety studies were identified, and their descriptive characteristics are presented. Sixty-eight (76%) were published in journals of impact factor greater than 6. A detailed account of the 42 studies (47%) published in 2004 is reported. Twenty-one (50%) of them contained at least one of the following three basic flaws: 1) in outcome-related gene finding, an unstated, unclear, or inadequate control for multiple testing; 2) in class discovery, a spurious claim of correlation between clusters and clinical outcome, made after clustering samples using a selection of outcome-related differentially expressed genes; or 3) in supervised prediction, a biased estimation of the prediction accuracy through an incorrect cross-validation procedure.  CONCLUSIONS: The most common and serious mistakes and misunderstandings recorded in published studies are described and illustrated. Based on this analysis, a proposal of guidelines for statistical analysis and reporting for clinical microarray studies, presented as a checklist of "Do's and Don'ts," is provided.
},
	Author = {Dupuy, Alain and Simon, Richard M.},
	Date-Added = {2008-09-12 16:12:07 +0200},
	Date-Modified = {2008-09-12 16:12:21 +0200},
	Doi = {10.1093/jnci/djk018},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;99/2/147.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {2},
	Pages = {147-157},
	Title = {{Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and Reporting}},
	Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;99/2/147},
	Volume = {99},
	Year = {2007},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;99/2/147},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/djk018}}

@article{zupan1999machine,
	Abstract = {This paper deals with the problem of learning prognostic models from medical survival data, where the sole prediction of probability of event (and not its probability dependency on time) is of interest. To appropriately consider the follow-up time and censoring --- both characteristic for survival data --- we propose a weighting technique that lessens the impact of data from patients for which the event did not occur and have short follow-up times. A case study on prostate cancer recurrence shows that by incorporating this weighting technique the machine learning tools stand beside or even outperform modern statistical methods and may, by inducing symbolic recurrence models, provide further insight to relationships within the modeled data. },
	Author = {Zupan, Bla{\v z} and Dem{\v s}ar, Janez and Kattan, Michael and Beck, J. and Bratko, I.},
	Date-Added = {2008-09-11 17:31:43 +0200},
	Date-Modified = {2008-09-11 17:31:43 +0200},
	Journal = {Artificial Intelligence in Medicine},
	M3 = {10.1007/3-540-48720-4{\_}37},
	Pages = {346--355},
	Title = {Machine Learning for Survival Analysis: A Case Study on Recurrence of Prostate Cancer},
	Ty = {CHAPTER},
	Url = {http://dx.doi.org/10.1007/3-540-48720-4_37},
	Year = {1999},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/3-540-48720-4_37}}

@article{weston2004systems,
	Affiliation = {Institute for Systems Biology, 1441 North 34th Street, Seattle, Washington, 98103-8904},
	Author = {Weston, A.D. and Hood, L.},
	Date-Added = {2008-09-11 16:56:40 +0200},
	Date-Modified = {2008-09-11 16:56:40 +0200},
	Issn = {1535-3893},
	Journal = {Journal of Proteome Research},
	Number = {2},
	Pages = {179-196},
	Title = {Systems Biology, Proteomics, and the Future of Health Care: Toward Predictive, Preventative, and Personalized Medicine},
	Url = {http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/pr0499693},
	Volume = {3},
	Year = {2004},
	Bdsk-Url-1 = {http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/pr0499693}}

@article{cruz2006applications,
	Author = {J. A. Cruz and D. S. Wishart},
	Date-Added = {2008-09-11 16:51:57 +0200},
	Date-Modified = {2008-09-11 16:53:24 +0200},
	Journal = {Cancer Informatics},
	Pages = {59-78},
	Title = {Applications of Machine Learning in Cancer Prediction and Prognosis},
	Volume = {2},
	Year = {2006},
	Bdsk-Url-1 = {http://la-press.com/article.php?article_id=110}}

@article{gentleman2004bioconductor,
	Abstract = {The Bioconductor project is an initiative for the collaborative creation of extensible software for computational biology and bioinformatics. The goals of the project include: fostering collaborative development and widespread use of innovative software, reducing barriers to entry into interdisciplinary scientific research, and promoting the achievement of remote reproducibility of research results. We describe details of our aims and methods, identify current challenges, compare Bioconductor to other open bioinformatics projects, and provide working examples.},
	Author = {Gentleman, Robert and Carey, Vincent and Bates, Douglas and Bolstad, Ben and Dettling, Marcel and Dudoit, Sandrine and Ellis, Byron and Gautier, Laurent and Ge, Yongchao and Gentry, Jeff and Hornik, Kurt and Hothorn, Torsten and Huber, Wolfgang and Iacus, Stefano and Irizarry, Rafael and Leisch, Friedrich and Li, Cheng and Maechler, Martin and Rossini, Anthony and Sawitzki, Gunther and Smith, Colin and Smyth, Gordon and Tierney, Luke and Yang, Jean and Zhang, Jianhua},
	Date-Added = {2008-09-10 07:01:59 +0200},
	Date-Modified = {2008-09-10 07:02:19 +0200},
	Doi = {10.1186/gb-2004-5-10-r80},
	Issn = {1465-6906},
	Journal = {Genome Biology},
	Number = {10},
	Pages = {R80},
	Pubmedid = {15461798},
	Title = {Bioconductor: open software development for computational biology and bioinformatics},
	Url = {http://genomebiology.com/2004/5/10/R80},
	Volume = {5},
	Year = {2004},
	Bdsk-Url-1 = {http://genomebiology.com/2004/5/10/R80},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/gb-2004-5-10-r80}}

@article{tibshirani2001estimating,
	Author = {Robert Tibshirani and Guenther Walther and Trevor Hastie},
	Date-Added = {2008-09-09 14:46:14 +0200},
	Date-Modified = {2008-09-09 14:48:20 +0200},
	Doi = {10.1111/1467-9868.00293},
	Journal = {Journal of the Royal Statistical Society: Series B (Statistical Methodology)},
	Number = {2},
	Pages = {411-423},
	Title = {Estimating the number of clusters in a data set via the gap statistic},
	Volume = {63},
	Year = {2001},
	Bdsk-Url-1 = {http://www3.interscience.wiley.com/journal/118994756/abstract}}

@article{fraley2002modelbased,
	Author = {C. Fraley and A. E. Raftery},
	Date-Added = {2008-09-09 11:54:32 +0200},
	Date-Modified = {2008-09-09 11:56:24 +0200},
	Journal = {Journal of American Statistical Asscoiation},
	Month = {June},
	Number = {458},
	Pages = {611-631},
	Title = {Model-Based Clustering, Discriminant Analysis, and Density Estimation},
	Volume = {97},
	Year = {2002},
	Bdsk-Url-1 = {http://www.ingentaconnect.com/content/asa/jasa/2002/00000097/00000458/art00022}}

@article{celeux1995gaussian,
	Author = {G. Celeux and G. Govaert},
	Date-Added = {2008-09-09 11:39:54 +0200},
	Date-Modified = {2008-09-09 11:41:35 +0200},
	Journal = {Pattern Recognition},
	Number = {5},
	Pages = {781-793},
	Title = {Gaussian parsimonious clustering models},
	Volume = {28},
	Year = {1995}}

@article{everitt1996introduction,
	Abstract = {Finite mixture densities can be used to model data from populations known or suspected to contain a number of separate subpopulations. Most commonly used are mixture densities with Gaussian (univariate or multivariate) components, but mixtures with other types of component are also increas ingly used to model, for example, survival times. This paper gives a general introduction to the topic which should help when considering the other more specialized papers in this issue.
},
	Author = {Everitt, BS},
	Date-Added = {2008-09-09 11:31:31 +0200},
	Date-Modified = {2008-09-09 11:31:31 +0200},
	Doi = {10.1177/096228029600500202},
	Eprint = {http://smm.sagepub.com/cgi/reprint/5/2/107.pdf},
	Journal = {Statistical Methods in Medical Research},
	Number = {2},
	Pages = {107-127},
	Title = {{An introduction to finite mixture distributions}},
	Url = {http://smm.sagepub.com/cgi/content/abstract/5/2/107},
	Volume = {5},
	Year = {1996},
	Bdsk-Url-1 = {http://smm.sagepub.com/cgi/content/abstract/5/2/107},
	Bdsk-Url-2 = {http://dx.doi.org/10.1177/096228029600500202}}

@book{everitt1981finite,
	Author = {B. S. Everitt and D. J. Hand},
	Date-Added = {2008-09-09 11:15:32 +0200},
	Date-Modified = {2008-09-09 11:28:32 +0200},
	Isbn = {0-412-22420-8},
	Publisher = {Chapman and Hall (London)},
	Title = {Finite Mixture Distributions},
	Year = {1981}}

@article{theissig1990histological,
	Abstract = {A study was conducted to assess the reproducibility and prognostic significance of the histopathological grading by using the criteria of Bloom and Richardson. 166 breast carcinomas of the invasive ductal type (NOS - not otherwise specified) according to the WHO criteria, selected from the biopsy material of the years 1980 to 1988 were investigated. 85 of the patients presented axillary lymph node metastases in the mastectomy specimens. A satisfactory correlation of histopathological grades assessed by three pathologists was found in 72.3% of all cases. Fifteen cases (9%) were over- and 31 cases (18.7%) were underestimated compared with an expert's grade. A disagreement of two grades occurred in one case only. In comparison of grade 1 and grade 3 tumours as well as of grade 2 and grade 3 tumours significant differences in the overall survival could be found. Irrespective of statistically significant differences between the three grades in actuarial survival, the histopathological grading is of rather low value for the prediction of prognosis of individual patients.},
	Address = {Medical Academy Carl Gustav Carus Dresden, Institute of Pathological Anatomy, GDR.},
	Au = {Theissig, F and Kunze, KD and Haroske, G and Meyer, W},
	Author = {Theissig, F and Kunze, K D and Haroske, G and Meyer, W},
	Da = {19910516},
	Date-Added = {2008-09-02 17:16:46 +0200},
	Date-Modified = {2008-09-02 17:16:59 +0200},
	Dcom = {19910516},
	Edat = {1990/12/01},
	Issn = {0344-0338 (Print)},
	Jid = {7806109},
	Journal = {Pathol Res Pract},
	Jt = {Pathology, research and practice},
	Language = {eng},
	Lr = {20071115},
	Mh = {Breast Neoplasms/classification/*pathology; Carcinoma, Intraductal, Noninfiltrating/classification/*pathology; Female; Humans; Prognosis; Terminology as Topic},
	Mhda = {1990/12/01 00:01},
	Number = {6},
	Own = {NLM},
	Pages = {732--736},
	Pl = {GERMANY},
	Pmid = {1964730},
	Pst = {ppublish},
	Pt = {Journal Article},
	Pubm = {Print},
	Sb = {IM},
	So = {Pathol Res Pract. 1990 Dec;186(6):732-6.},
	Stat = {MEDLINE},
	Title = {Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance.},
	Volume = {186},
	Year = {1990 Dec}}

@article{hopton1989observer,
	Abstract = {A multicentre study was conducted to assess the degree of agreement between pathologists grading breast tumours using the WHO criteria. Satisfactory correlation of grades was found to occur with observer variation of 21.9% on 874 tumours.},
	Address = {York District Hospital, UK.},
	Au = {Hopton, DS and Thorogood, J and Clayden, AD and MacKinnon, D},
	Author = {Hopton, D S and Thorogood, J and Clayden, A D and MacKinnon, D},
	Da = {19890327},
	Date-Added = {2008-09-02 17:13:37 +0200},
	Date-Modified = {2008-09-02 17:13:57 +0200},
	Dcom = {19890327},
	Edat = {1989/02/01},
	Issn = {0748-7983 (Print)},
	Jid = {8504356},
	Journal = {Eur J Surg Oncol},
	Jt = {European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
	Language = {eng},
	Lr = {20071115},
	Mh = {Breast Neoplasms/*pathology; Cell Transformation, Neoplastic/pathology; England; Female; Humans; Mitosis; Multicenter Studies as Topic; World Health Organization},
	Mhda = {1989/02/01 00:01},
	Number = {1},
	Own = {NLM},
	Pages = {21--23},
	Pl = {ENGLAND},
	Pmid = {2645174},
	Pst = {ppublish},
	Pt = {Clinical Trial; Journal Article; Multicenter Study},
	Pubm = {Print},
	Sb = {IM},
	So = {Eur J Surg Oncol. 1989 Feb;15(1):21-3.},
	Stat = {MEDLINE},
	Title = {Observer variation in histological grading of breast cancer.},
	Volume = {15},
	Year = {1989 Feb}}

@article{pease1994lightgenerated,
	Abstract = {In many areas of molecular biology there is a need to rapidly extract and analyze genetic information; however, current technologies for DNA sequence analysis are slow and labor intensive. We report here how modern photolithographic techniques can be used to facilitate sequence analysis by generating miniaturized arrays of densely packed oligonucleotide probes. These probe arrays, or DNA chips, can then be applied to parallel DNA hybridization analysis, directly yielding sequence information. In a preliminary experiment, a 1.28 x 1.28 cm array of 256 different octanucleotides was produced in 16 chemical reaction cycles, requiring 4 hr to complete. The hybridization pattern of fluorescently labeled oligonucleotide targets was then detected by epifluorescence microscopy. The fluorescence signals from complementary probes were 5-35 times stronger than those with single or double base-pair hybridization mismatches, demonstrating specificity in the identification of complementary sequences. This method should prove to be a powerful tool for rapid investigations in human genetics and diagnostics, pathogen detection, and DNA molecular recognition.},
	Address = {Affymetrix, Santa Clara, CA 95051.},
	Au = {Pease, AC and Solas, D and Sullivan, EJ and Cronin, MT and Holmes, CP and Fodor, SP},
	Author = {Pease, A C and Solas, D and Sullivan, E J and Cronin, M T and Holmes, C P and Fodor, S P},
	Da = {19940627},
	Date-Added = {2008-09-02 11:38:41 +0200},
	Date-Modified = {2008-09-02 11:44:45 +0200},
	Dcom = {19940627},
	Edat = {1994/05/24},
	Gr = {HG 00060/HG/United States NHGRI; HG 00813/HG/United States NHGRI},
	Issn = {0027-8424 (Print)},
	Jid = {7505876},
	Journal = {Proc Natl Acad Sci USA},
	Jt = {Proceedings of the National Academy of Sciences of the United States of America},
	Language = {eng},
	Lr = {20071114},
	Mh = {Base Sequence; Humans; *Light; Microscopy, Fluorescence; Molecular Sequence Data; Molecular Structure; Nucleic Acid Hybridization; Oligodeoxyribonucleotides/radiation effects; Oligonucleotide Probes; Sequence Analysis, DNA/*methods},
	Mhda = {1994/05/24 00:01},
	Month = {May},
	Number = {11},
	Own = {NLM},
	Pages = {5022--5026},
	Pl = {UNITED STATES},
	Pmc = {PMC43922},
	Pmid = {8197176},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Pubm = {Print},
	Rn = {0 (Oligodeoxyribonucleotides); 0 (Oligonucleotide Probes)},
	Sb = {IM},
	So = {Proc Natl Acad Sci U S A. 1994 May 24;91(11):5022-6.},
	Stat = {MEDLINE},
	Title = {Light-generated oligonucleotide arrays for rapid DNA sequence analysis.},
	Volume = {91},
	Year = {1994}}

@article{bammler2005standardizing,
	Abstract = {To facilitate collaborative research efforts between multi-investigator teams using DNA microarrays, we identified sources of error and data variability between laboratories and across microarray platforms, and methods to accommodate this variability. RNA expression data were generated in seven laboratories, which compared two standard RNA samples using 12 microarray platforms. At least two standard microarray types (one spotted, one commercial) were used by all laboratories. Reproducibility for most platforms within any laboratory was typically good, but reproducibility between platforms and across laboratories was generally poor. Reproducibility between laboratories increased markedly when standardized protocols were implemented for RNA labeling, hybridization, microarray processing, data acquisition and data normalization. Reproducibility was highest when analysis was based on biological themes defined by enriched Gene Ontology (GO) categories. These findings indicate that microarray results can be comparable across multiple laboratories, especially when a common platform and set of procedures are used.},
	Au = {Bammler, T and Beyer, RP and Bhattacharya, S and Boorman, GA and Boyles, A and Bradford, BU and Bumgarner, RE and Bushel, PR and Chaturvedi, K and Choi, D and Cunningham, ML and Deng, S and Dressman, HK and Fannin, RD and Farin, FM and Freedman, JH and Fry, RC and Harper, A and Humble, MC and Hurban, P and Kavanagh, TJ and Kaufmann, WK and Kerr, KF and Jing, L and Lapidus, JA and Lasarev, MR and Li, J and Li, YJ and Lobenhofer, EK and Lu, X and Malek, RL and Milton, S and Nagalla, SR and O'malley, JP and Palmer, VS and Pattee, P and Paules, RS and Perou, CM and Phillips, K and Qin, LX and Qiu, Y and Quigley, SD and Rodland, M and Rusyn, I and Samson, LD and Schwartz, DA and Shi, Y and Shin, JL and Sieber, SO and Slifer, S and Speer, MC and Spencer, PS and Sproles, DI and Swenberg, JA and Suk, WA and Sullivan, RC and Tian, R and Tennant, RW and Todd, SA and Tucker, CJ and Van Houten, B and Weis, BK and Xuan, S and Zarbl, H},
	Author = {Bammler, Theodore and Beyer, Richard P and Bhattacharya, Sanchita and Boorman, Gary A and Boyles, Abee and Bradford, Blair U and Bumgarner, Roger E and Bushel, Pierre R and Chaturvedi, Kabir and Choi, Dongseok and Cunningham, Michael L and Deng, Shibing and Dressman, Holly K and Fannin, Rickie D and Farin, Fredrico M and Freedman, Jonathan H and Fry, Rebecca C and Harper, Angel and Humble, Michael C and Hurban, Patrick and Kavanagh, Terrance J and Kaufmann, William K and Kerr, Kathleen F and Jing, Li and Lapidus, Jodi A and Lasarev, Michael R and Li, Jianying and Li, Yi-Ju and Lobenhofer, Edward K and Lu, Xinfang and Malek, Renae L and Milton, Sean and Nagalla, Srinivasa R and O'malley, Jean P and Palmer, Valerie S and Pattee, Patrick and Paules, Richard S and Perou, Charles M and Phillips, Ken and Qin, Li-Xuan and Qiu, Yang and Quigley, Sean D and Rodland, Matthew and Rusyn, Ivan and Samson, Leona D and Schwartz, David A and Shi, Yan and Shin, Jung-Lim and Sieber, Stella O and Slifer, Susan and Speer, Marcy C and Spencer, Peter S and Sproles, Dean I and Swenberg, James A and Suk, William A and Sullivan, Robert C and Tian, Ru and Tennant, Raymond W and Todd, Signe A and Tucker, Charles J and Van Houten, Bennett and Weis, Brenda K and Xuan, Shirley and Zarbl, Helmut},
	Cin = {Nat Methods. 2005 May;2(5):329-30. PMID: 15846357},
	Cn = {Members of the Toxicogenomics Research Consortium},
	Da = {20050506},
	Date-Added = {2008-09-02 11:30:16 +0200},
	Date-Modified = {2008-09-02 11:44:55 +0200},
	Dcom = {20050516},
	Dep = {20050421},
	Doi = {10.1038/nmeth754},
	Edat = {2005/04/23 09:00},
	Ein = {Nat Methods. 2005 Jun;2(6):477},
	Gr = {ES11375/ES/United States NIEHS; ES11384/ES/United States NIEHS; ES11387/ES/United States NIEHS; ES11391/ES/United States NIEHS; ES11399/ES/United States NIEHS},
	Issn = {1548-7091 (Print)},
	Jid = {101215604},
	Journal = {Nat Methods},
	Jt = {Nature methods},
	Language = {eng},
	Lr = {20071114},
	Mh = {Gene Expression Profiling/*standards; Laboratories/standards; Oligonucleotide Array Sequence Analysis/*standards; Reproducibility of Results},
	Mhda = {2005/05/17 09:00},
	Month = {May},
	Number = {5},
	Own = {NLM},
	Pages = {351--356},
	Phst = {2004/12/14 {$[$}received{$]$}; 2005/03/25 {$[$}accepted{$]$}; 2005/04/21 {$[$}aheadofprint{$]$}},
	Pii = {nmeth754},
	Pl = {United States},
	Pmid = {15846362},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, P.H.S.},
	Pubm = {Print-Electronic},
	Sb = {IM},
	So = {Nat Methods. 2005 May;2(5):351-6. Epub 2005 Apr 21.},
	Stat = {MEDLINE},
	Title = {Standardizing global gene expression analysis between laboratories and across platforms.},
	Volume = {2},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nmeth754}}

@article{simon2003diagnostic,
	Author = {R. Simon},
	Date-Added = {2008-09-01 16:02:31 +0200},
	Date-Modified = {2008-09-01 16:03:38 +0200},
	Journal = {British Journal of Cancer},
	Pages = {1599-1604},
	Title = {Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data},
	Volume = {89},
	Year = {2003},
	Bdsk-Url-1 = {http://www.nature.com/bjc/journal/v89/n9/full/6601326a.html#references}}

@article{johnson2007adjusting,
	Abstract = {Non-biological experimental variation or "batch effects" are commonly observed across multiple batches of microarray experiments, often rendering the task of combining data from these batches difficult. The ability to combine microarray data sets is advantageous to researchers to increase statistical power to detect biological phenomena from studies where logistical considerations restrict sample size or in studies that require the sequential hybridization of arrays. In general, it is inappropriate to combine data sets without adjusting for batch effects. Methods have been proposed to filter batch effects from data, but these are often complicated and require large batch sizes ([IMG]f1.gif" ALT="Formula" BORDER="0">) to implement. Because the majority of microarray studies are conducted using much smaller sample sizes, existing methods are not sufficient. We propose parametric and non-parametric empirical Bayes frameworks for adjusting data for batch effects that is robust to outliers in small sample sizes and performs comparable to existing methods for large samples. We illustrate our methods using two example data sets and show that our methods are justifiable, easy to apply, and useful in practice. Software for our method is freely available at: http://biosun1.harvard.edu/complab/batch/.
},
	Author = {Johnson, W. Evan and Li, Cheng and Rabinovic, Ariel},
	Date-Added = {2008-09-01 15:17:47 +0200},
	Date-Modified = {2008-09-01 15:17:47 +0200},
	Doi = {10.1093/biostatistics/kxj037},
	Eprint = {http://biostatistics.oxfordjournals.org/cgi/reprint/8/1/118.pdf},
	Journal = {Biostat},
	Number = {1},
	Pages = {118-127},
	Title = {{Adjusting batch effects in microarray expression data using empirical Bayes methods}},
	Url = {http://biostatistics.oxfordjournals.org/cgi/content/abstract/8/1/118},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://biostatistics.oxfordjournals.org/cgi/content/abstract/8/1/118},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/biostatistics/kxj037}}

@article{rhodes2005integrative,
	Author = {Rhodes, Daniel R and Chinnaiyan, Arul M},
	Date-Added = {2008-09-01 08:27:58 +0200},
	Date-Modified = {2008-09-01 08:28:22 +0200},
	Journal = {Nat Genet},
	Title = {Integrative analysis of the cancer transcriptome},
	Bdsk-Url-1 = {http://www.nature.com/ng/journal/v37/n6s/full/ng1570.html}}

@article{gevaert2006predicting,
	Abstract = {Motivation: Clinical data, such as patient history, laboratory analysis, ultrasound parameters--which are the basis of day-to-day clinical decision support--are often underused to guide the clinical management of cancer in the presence of microarray data. We propose a strategy based on Bayesian networks to treat clinical and microarray data on an equal footing. The main advantage of this probabilistic model is that it allows to integrate these data sources in several ways and that it allows to investigate and understand the model structure and parameters. Furthermore using the concept of a Markov Blanket we can identify all the variables that shield off the class variable from the influence of the remaining network. Therefore Bayesian networks automatically perform feature selection by identifying the (in)dependency relationships with the class variable.  Results: We evaluated three methods for integrating clinical and microarray data: decision integration, partial integration and full integration and used them to classify publicly available data on breast cancer patients into a poor and a good prognosis group. The partial integration method is most promising and has an independent test set area under the ROC curve of 0.845. After choosing an operating point the classification performance is better than frequently used indices.  Contact: olivier.gevaert@esat.kuleuven.be
},
	Author = {Gevaert, Olivier and Smet, Frank De and Timmerman, Dirk and Moreau, Yves and Moor, Bart De},
	Date-Added = {2008-08-29 16:00:53 +0200},
	Date-Modified = {2008-08-29 16:00:53 +0200},
	Doi = {10.1093/bioinformatics/btl230},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/22/14/e184.pdf},
	Journal = {Bioinformatics},
	Number = {14},
	Pages = {e184-190},
	Title = {{Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/14/e184},
	Volume = {22},
	Year = {2006},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/22/14/e184},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btl230}}

@article{boulesteix2008microarraybased,
	Abstract = {Motivation: In the context of clinical bioinformatics methods are needed for assessing the additional predictive value of microarray data compared to simple clinical parameters alone. Such methods should also provide an optimal prediction rule making use of all potentialities of both types of data: they should ideally be able to catch subtypes which are not identified by clinical parameters alone. Moreover, they should address the question of the additional predictive value of microarray data in a fair framework.  Results: We propose a novel but simple two-step approach based on random forests and partial least squares (PLS) dimension reduction embedding the idea of pre-validation suggested by Tibshirani and colleagues, which is based on an internal cross-validation for avoiding overfitting. Our approach is fast, flexible and can be used both for assessing the overall additional significance of the microarray data and for building optimal hybrid classification rules. Its efficiency is demonstrated through simulations and an application to breast cancer and colorectal cancer data.  Availability: Our method is implemented in the freely available R package  MAclinical' which can be downloaded from http://www.stat.uni-muenchen.de/~socher/MAclinical  Contact: boulesteix@slcmsr.org
},
	Author = {Boulesteix, Anne-Laure and Porzelius, Christine and Daumer, Martin},
	Date-Added = {2008-08-29 15:59:18 +0200},
	Date-Modified = {2008-08-29 15:59:36 +0200},
	Doi = {10.1093/bioinformatics/btn262},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/24/15/1698.pdf},
	Journal = {Bioinformatics},
	Number = {15},
	Pages = {1698-1706},
	Title = {{Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/24/15/1698},
	Volume = {24},
	Year = {2008},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/24/15/1698},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btn262}}

@article{boulesteix2007wilcoxcv,
	Abstract = {Summary: In the last few years, numerous methods have been proposed for microarray-based class prediction. Although many of them have been designed especially for the case n << p (much more variables than observations), preliminary variable selection is almost always necessary when the number of genes reaches several tens of thousands, as usual in recent data sets. In the two-class setting, the Wilcoxon rank sum test statistic is, with the t-statistic, one of the standard approaches for variable selection. It is well known that the variable selection step must be seen as a part of classifier construction and, as such, be performed based on training data only. When classifier accuracy is evaluated via cross-validation or Monte-Carlo cross-validation, it means that we have to perform p Wilcoxon or t-tests for each iteration, which becomes a daunting task for increasing p. As a consequence, many authors often perform variable selection only once using all the available data, which can induce a dramatic underestimation of error rate and thus lead to misleadingly reporting predictive power. We propose a very fast implementation of variable selection based on the Wilcoxon test for use in cross-validation and Monte Carlo cross-validation (also known as random splitting into learning and test sets). This implementation is based on a simple mathematical formula using only the ranks calculated from the original data set.  Availability: Our method is implemented in the freely available R package WilcoxCV which can be downloaded from the Comprehensive R Archive Network at http://cran.r-project.org/src/contrib/Descriptions/WilcoxCV.html  Contact: boulesteix@slcmsr.org
},
	Author = {Boulesteix, Anne-Laure},
	Date-Added = {2008-07-31 08:24:17 +0200},
	Date-Modified = {2008-07-31 08:24:17 +0200},
	Doi = {10.1093/bioinformatics/btm162},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/23/13/1702.pdf},
	Journal = {Bioinformatics},
	Number = {13},
	Pages = {1702-1704},
	Title = {{WilcoxCV: an R package for fast variable selection in cross-validation}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/23/13/1702},
	Volume = {23},
	Year = {2007},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/23/13/1702},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btm162}}

@article{braganeto2004crossvalidation,
	Abstract = {Motivation: Microarray classification typically possesses two striking attributes: (1) classifier design and error estimation are based on remarkably small samples and (2) cross-validation error estimation is employed in the majority of the papers. Thus, it is necessary to have a quantifiable understanding of the behavior of cross-validation in the context of very small samples.  Results: An extensive simulation study has been performed comparing cross-validation, resubstitution and bootstrap estimation for three popular classification rules--linear discriminant analysis, 3-nearest-neighbor and decision trees (CART)--using both synthetic and real breast-cancer patient data. Comparison is via the distribution of differences between the estimated and true errors. Various statistics for the deviation distribution have been computed: mean (for estimator bias), variance (for estimator precision), root-mean square error (for composition of bias and variance) and quartile ranges, including outlier behavior. In general, while cross-validation error estimation is much less biased than resubstitution, it displays excessive variance, which makes individual estimates unreliable for small samples. Bootstrap methods provide improved performance relative to variance, but at a high computational cost and often with increased bias (albeit, much less than with resubstitution).  Availability and Supplementary information: A companion web site can be accessed at the URL http://ee.tamu.edu/~edward/cv_paper. The companion web site contains: (1) the complete set of tables and plots regarding the simulation study; (2) additional figures; (3) a compilation of references for microarray classification studies and (4) the source code used, with full documentation and examples.
},
	Author = {Braga-Neto, Ulisses M. and Dougherty, Edward R.},
	Date-Added = {2008-07-31 08:03:39 +0200},
	Date-Modified = {2008-07-31 08:03:51 +0200},
	Doi = {10.1093/bioinformatics/btg419},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/20/3/374.pdf},
	Journal = {Bioinformatics},
	Number = {3},
	Pages = {374-380},
	Title = {{Is cross-validation valid for small-sample microarray classification?}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/20/3/374},
	Volume = {20},
	Year = {2004},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/20/3/374},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btg419}}

@article{statnikov2005comprehensive,
	Abstract = {Motivation: Cancer diagnosis is one of the most important emerging clinical applications of gene expression microarray technology. We are seeking to develop a computer system for powerful and reliable cancer diagnostic model creation based on microarray data. To keep a realistic perspective on clinical applications we focus on multicategory diagnosis. To equip the system with the optimum combination of classifier, gene selection and cross-validation methods, we performed a systematic and comprehensive evaluation of several major algorithms for multicategory classification, several gene selection methods, multiple ensemble classifier methods and two cross-validation designs using 11 datasets spanning 74 diagnostic categories and 41 cancer types and 12 normal tissue types.  Results: Multicategory support vector machines (MC-SVMs) are the most effective classifiers in performing accurate cancer diagnosis from gene expression data. The MC-SVM techniques by Crammer and Singer, Weston and Watkins and one-versus-rest were found to be the best methods in this domain. MC-SVMs outperform other popular machine learning algorithms, such as k-nearest neighbors, backpropagation and probabilistic neural networks, often to a remarkable degree. Gene selection techniques can significantly improve the classification performance of both MC-SVMs and other non-SVM learning algorithms. Ensemble classifiers do not generally improve performance of the best non-ensemble models. These results guided the construction of a software system GEMS (Gene Expression Model Selector) that automates high-quality model construction and enforces sound optimization and performance estimation procedures. This is the first such system to be informed by a rigorous comparative analysis of the available algorithms and datasets.  Availability: The software system GEMS is available for download from http://www.gems-system.org for non-commercial use.  Contact: alexander.statnikov@vanderbilt.edu
},
	Author = {Statnikov, Alexander and Aliferis, Constantin F. and Tsamardinos, Ioannis and Hardin, Douglas and Levy, Shawn},
	Date-Added = {2008-07-30 14:47:54 +0200},
	Date-Modified = {2008-07-30 14:47:54 +0200},
	Doi = {10.1093/bioinformatics/bti033},
	Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/21/5/631.pdf},
	Journal = {Bioinformatics},
	Number = {5},
	Pages = {631-643},
	Title = {{A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis}},
	Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/5/631},
	Volume = {21},
	Year = {2005},
	Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/21/5/631},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/bti033}}

@article{quackenbush2006microarray,
	Author = {Quackenbush, John},
	Date-Added = {2008-07-28 15:27:55 +0200},
	Date-Modified = {2008-07-28 15:27:55 +0200},
	Doi = {10.1056/NEJMra042342},
	Eprint = {http://content.nejm.org/cgi/reprint/354/23/2463.pdf},
	Journal = {N Engl J Med},
	Number = {23},
	Pages = {2463-2472},
	Title = {{Microarray Analysis and Tumor Classification}},
	Url = {http://content.nejm.org},
	Volume = {354},
	Year = {2006},
	Bdsk-Url-1 = {http://content.nejm.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1056/NEJMra042342}}

@article{simon2005development,
	Author = {Simon, Richard},
	Date-Added = {2008-07-23 13:53:19 +0200},
	Date-Modified = {2008-07-23 13:53:19 +0200},
	Doi = {10.1093/jnci/dji168},
	Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;97/12/866.pdf},
	Journal = {J. Natl. Cancer Inst.},
	Number = {12},
	Pages = {866-867},
	Title = {{Development and Validation of Therapeutically Relevant Multi-Gene Biomarker Classifiers}},
	Url = {http://jnci.oxfordjournals.org},
	Volume = {97},
	Year = {2005},
	Bdsk-Url-1 = {http://jnci.oxfordjournals.org},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/dji168}}

@article{bendor2000tissue,
	Author = {Ben-Dor,Amir and Bruhn,Laurakay and Friedman,Nir and Nachman,Iftach and Schummer,Michel and Yakhini,Zohar},
	Date-Added = {2008-07-23 12:13:24 +0200},
	Date-Modified = {2008-09-01 16:05:42 +0200},
	Doi = {10.1089/106652700750050943},
	Eprint = {http://www.liebertonline.com/doi/pdf/10.1089/106652700750050943},
	Journal = {Journal of Computational Biology},
	Number = {3-4},
	Pages = {559-583},
	Title = {Tissue Classification with Gene Expression Profiles},
	Url = {http://www.liebertonline.com/doi/abs/10.1089/106652700750050943},
	Volume = {7},
	Year = {2000},
	Bdsk-Url-1 = {http://www.liebertonline.com/doi/abs/10.1089/106652700750050943},
	Bdsk-Url-2 = {http://dx.doi.org/10.1089/106652700750050943}}

@article{brown2000knowledgebased,
	Abstract = {We introduce a method of functionally classifying genes by using gene expression data from DNA microarray hybridization experiments. The method is based on the theory of support vector machines (SVMs). SVMs are considered a supervised computer learning method because they exploit prior knowledge of gene function to identify unknown genes of similar function from expression data. SVMs avoid several problems associated with unsupervised clustering methods, such as hierarchical clustering and self-organizing maps. SVMs have many mathematical features that make them attractive for gene expression analysis, including their flexibility in choosing a similarity function, sparseness of solution when dealing with large data sets, the ability to handle large feature spaces, and the ability to identify outliers. We test several SVMs that use different similarity metrics, as well as some other supervised learning methods, and find that the SVMs best identify sets of genes with a common function using expression data. Finally, we use SVMs to predict functional roles for uncharacterized yeast ORFs based on their expression data.
},
	Author = {Brown, Michael P. S. and Grundy, William Noble and Lin, David and Cristianini, Nello and Sugnet, Charles Walsh and Furey, Terrence S. and Ares, Manuel and Haussler, David},
	Eprint = {http://www.pnas.org/content/97/1/262.abstract.pdf},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {1},
	Pages = {262-267},
	Title = {{Knowledge-based analysis of microarray gene expression data by using support vector machines}},
	Url = {http://www.pnas.org/content/97/1/262.abstract},
	Volume = {97},
	Year = {2000},
	Bdsk-Url-1 = {http://www.pnas.org/content/97/1/262.abstract}}

@article{khan2001classification,
	Annote = {10.1038/89044},
	Author = {Khan, Javed and Wei, Jun S. and Ringner, Markus and Saal, Lao H. and Ladanyi, Marc and Westermann, Frank and Berthold, Frank and Schwab, Manfred and Antonescu, Cristina R. and Peterson, Carsten and Meltzer, Paul S.},
	Date-Added = {2008-07-23 10:41:51 +0200},
	Date-Modified = {2008-07-23 10:41:51 +0200},
	Isbn = {1078-8956},
	Journal = {Nat Med},
	L3 = {http://www.nature.com/nm/journal/v7/n6/suppinfo/nm0601_673_S1.html},
	M3 = {10.1038/89044},
	Number = {6},
	Pages = {673--679},
	Title = {Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/89044},
	Volume = {7},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/89044}}

@article{alizadeh2000distinct,
	Author = {Alizadeh, Ash A. and Eisen, Michael B. and Davis, R. Eric and Ma, Chi and Lossos, Izidore S. and Rosenwald, Andreas and Boldrick, Jennifer C. and Sabet, Hajeer and Tran, Truc and Yu, Xin and Powell, John I. and Yang, Liming and Marti, Gerald E. and Moore, Troy and Hudson, James, and Lu, Lisheng and Lewis, David B. and Tibshirani, Robert and Sherlock, Gavin and Chan, Wing C. and Greiner, Timothy C. and Weisenburger, Dennis D. and Armitage, James O. and Warnke, Roger and Levy, Ronald and Wilson, Wyndham and Grever, Michael R. and Byrd, John C. and Botstein, David and Brown, Patrick O. and Staudt, Louis M.},
	Date-Added = {2008-07-23 10:38:14 +0200},
	Date-Modified = {2008-07-23 10:38:14 +0200},
	Doi = {10.1038/35000501},
	Isbn = {0028-0836},
	Journal = {Nature},
	Number = {6769},
	Pages = {503--511},
	Title = {Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling},
	Url = {http://dx.doi.org/10.1038/35000501},
	Volume = {403},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/35000501}}

@article{radmacher2002paradigm,
	Author = {Radmacher,Michael D. and McShane,Lisa M. and Simon,Richard},
	Doi = {10.1089/106652702760138592},
	Eprint = {http://www.liebertonline.com/doi/pdf/10.1089/106652702760138592},
	Journal = {Journal of Computational Biology},
	Number = {3},
	Pages = {505-511},
	Title = {A Paradigm for Class Prediction Using Gene Expression Profiles},
	Url = {http://www.liebertonline.com/doi/abs/10.1089/106652702760138592},
	Volume = {9},
	Year = {2002},
	Bdsk-Url-1 = {http://www.liebertonline.com/doi/abs/10.1089/106652702760138592},
	Bdsk-Url-2 = {http://dx.doi.org/10.1089/106652702760138592}}

@article{khan1998gene,
	Abstract = {Several forms of human sarcoma, lymphoma, and leukemia are characterized by somatically acquired chromosome translocations that result in fusion genes that encode chimeric transcription factors with oncogenic properties. We have used cDNA microarrays containing 1238 cDNAs to investigate the gene expression profile of a group of seven alveolar rhabdomyosarcoma (ARMS) cell lines characterized by the presence of the PAX3-FKHR fusion gene. Using the method of multidimensional scaling to represent the relationships among the cell lines in two-dimensional Euclidean space, we determined that ARMS cells show a consistent pattern of gene expression, which allows the cells to be clustered together. By searching across the seven ARMS cell lines, we found that 37 of 1238 genes were most consistently expressed in ARMS relative to a reference cell line. Only three of these genes have been previously reported to be expressed in ARMS. Among these 37 were genes related to both primary (PAX3-FKHR) and secondary (CDK4) genetic alterations in ARMS. These results in ARMS demonstrate the potential of cDNA microarray technology to elucidate tumor-specific gene expression profiles in human cancers.
},
	Author = {Khan, Javed and Simon, Richard and Bittner, Michael and Chen, Yidong and Leighton, Stephen B. and Pohida, Thomas and Smith, Paul D. and Jiang, Yuan and Gooden, Gerald C. and Trent, Jeffrey M. and Meltzer, Paul S.},
	Date-Added = {2008-07-23 09:58:46 +0200},
	Date-Modified = {2008-07-23 09:58:46 +0200},
	Eprint = {http://cancerres.aacrjournals.org/cgi/reprint/58/22/5009.pdf},
	Journal = {Cancer Res},
	Number = {22},
	Pages = {5009-5013},
	Title = {{Gene Expression Profiling of Alveolar Rhabdomyosarcoma with cDNA Microarrays}},
	Url = {http://cancerres.aacrjournals.org/cgi/content/abstract/58/22/5009},
	Volume = {58},
	Year = {1998},
	Bdsk-Url-1 = {http://cancerres.aacrjournals.org/cgi/content/abstract/58/22/5009}}

@article{derisi1996cdna,
	Annote = {10.1038/ng1296-457},
	Author = {DeRisi, Joseph and Penland, Lolita and Brown, Patrick O. and Bittner, Michael L. and Meltzer, Paul S. and Ray, Michael and Chen, Yidong and Su, Yan A. and Trent, Jeffrey M.},
	Date-Added = {2008-07-23 09:49:55 +0200},
	Date-Modified = {2008-07-23 10:41:09 +0200},
	Journal = {Nat Genet},
	M3 = {10.1038/ng1296-457},
	Number = {4},
	Pages = {457--460},
	Title = {Use of a cDNA microarray to analyse gene expression patterns in human cancer},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/ng1296-457},
	Volume = {14},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ng1296-457}}

@article{golub1999molecular,
	Author = {Golub, T. R. and Slonim, D. K. and Tamayo, P. and Huard, C. and Gaasenbeek, M. and Mesirov, J. P. and Coller, H. and Loh, M. L. and Downing, J. R. and Caligiuri, M. A. and Bloomfield, C. D. and Lander, E. S.},
	Doi = {10.1126/science.286.5439.531},
	Eprint = {http://www.sciencemag.org/cgi/reprint/286/5439/531.pdf},
	Journal = {Science},
	Number = {5439},
	Pages = {531-537},
	Title = {{Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring}},
	Url = {http://www.sciencemag.org/cgi/content/abstract/286/5439/531},
	Volume = {286},
	Year = {1999},
	Bdsk-Url-1 = {http://www.sciencemag.org/cgi/content/abstract/286/5439/531},
	Bdsk-Url-2 = {http://dx.doi.org/10.1126/science.286.5439.531}}

@url{wikipedia2008machine,
	Author = {Wikipedia},
	Date-Added = {2008-07-22 11:04:14 +0200},
	Date-Modified = {2008-07-22 11:10:49 +0200},
	Title = {Machine Learning},
	Url = {http://en.wikipedia.org/wiki/Machine_Learning},
	Urldate = {2008},
	Bdsk-Url-1 = {http://en.wikipedia.org/wiki/Machine_Learning}}

@article{chang2005patterns,
	Abstract = {PURPOSE: Chemotherapy for operable breast cancer decreases the risk of death. Docetaxel is one of the most active agents in breast cancer, but resistance or incomplete response is frequent.  PATIENTS AND METHODS: Core biopsies from 24 patients were obtained before treatment with neoadjuvant docetaxel (four cycles, 100 mg/m2 every 3 weeks), and response was assessed after chemotherapy. After 3 months of neoadjuvant chemotherapy, surgical specimens (n = 13) were obtained, and laser capture microdissection (LCM; n = 8) was performed to enrich for tumor cells. From each core, surgical, and LCM specimen, sufficient total RNA (3 to 6 {micro}g) was extracted for cDNA array analysis using the Affymetrix HgU95-Av2 GeneChip (Affymetrix, Santa Clara, CA).  RESULTS: From the initial core biopsies, differential patterns of expression of 92 genes correlated with docetaxel response (P = .001). However, the molecular patterns of the residual cancers after 3 months of docetaxel treatment were strikingly similar, independent of initial sensitivity or resistance. This relative genetic homogeneity after treatment was observed in both LCM and non-LCM surgical specimens. The residual tumor after treatment in tumors that were initially sensitive indicates selection of a residual and resistant subpopulation of cells. The gene expression pattern was populated by genes involved in cell cycle arrest at G2M (eg, mitotic cyclins and cdc2) and survival pathways involving the mammalian target of rapamycin.  CONCLUSION: A specific and consistent gene expression pattern was found in residual tumors after docetaxel treatment. These profiles provide therapeutic targets that could lead to improved treatment.
},
	Author = {Chang, Jenny C. and Wooten, Eric C. and Tsimelzon, Anna and Hilsenbeck, Susan G. and Gutierrez, M. Carolina and Tham, Yee-Lu and Kalidas, Mamta and Elledge, Richard and Mohsin, Syed and Osborne, C. Kent and Chamness, Gary C. and Allred, D. Craig and Lewis, Michael T. and Wong, Helen and O'Connell, Peter},
	Date-Modified = {2008-07-18 11:51:32 +0200},
	Doi = {10.1200/JCO.2005.03.156},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/23/6/1169.pdf},
	Journal = {J Clin Oncol},
	Number = {6},
	Pages = {1169-1177},
	Title = {{Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/23/6/1169},
	Volume = {23},
	Year = {2005},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/23/6/1169},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2005.03.156}}

@article{ayers2004gene,
	Abstract = {PURPOSE: The goal of this study was to examine the feasibility of developing a multigene predictor of pathologic complete response (pCR) to sequential weekly paclitaxel and fluorouracil + doxorubicin + cyclophosphamide (T/FAC) neoadjuvant chemotherapy regimen for breast cancer.  PATIENTS AND METHODS: All patients underwent one-time pretreatment fine-needle aspiration to obtain RNA from the cancer for transcriptional profiling using cDNA arrays containing 30,721 human sequence clones. Analysis was performed after profiling, and 42 patients' clinical results were available, 24 of which were used for predictive marker discovery; 18 patients' results were used as an independent validation set.  RESULTS: Thirty-one percent of patients had pCR (six discovery and seven validation), defined as disappearance of all invasive cancer in the breast after completion of chemotherapy. We could identify no single marker that was sufficiently associated with pCR to be used as an individual predictor. A multigene model with 74 markers (P [&le;] .09) was built using data from the discovery samples and tested on the validation samples. Overall, a 78% (14 of 18) predictive accuracy was observed, with a 100% (three of three) positive predictive value for pCR, a 73% (11 of 15) negative predictive value, a sensitivity of 43% (three of seven), and a specificity of 100% (11 of 11). The expected response rate to T/FAC neoadjuvant therapy in unselected patients is 28%.  CONCLUSION: Our results suggest that transcriptional profiling has the potential to identify a gene expression pattern in breast cancer that may lead to clinically useful predictors of pCR to T/FAC neoadjuvant therapy.
},
	Author = {Ayers, M. and Symmans, W.F. and Stec, J. and Damokosh, A.I. and Clark, E. and Hess, K. and Lecocke, M. and Metivier, J. and Booser, D. and Ibrahim, N. and Valero, V. and Royce, M. and Arun, B. and Whitman, G. and Ross, J. and Sneige, N. and Hortobagyi, G.N. and Pusztai, L.},
	Date-Added = {2008-07-18 11:32:10 +0200},
	Date-Modified = {2008-07-18 11:32:10 +0200},
	Doi = {10.1200/JCO.2004.05.166},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/22/12/2284.pdf},
	Journal = {J Clin Oncol},
	Number = {12},
	Pages = {2284-2293},
	Title = {{Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/22/12/2284},
	Volume = {22},
	Year = {2004},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/22/12/2284},
	Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2004.05.166}}

@article{fisher1998effect,
	Author = {Fisher, B and Bryant, J and Wolmark, N and Mamounas, E and Brown, A and Fisher, ER and Wickerham, DL and Begovic, M and DeCillis, A and Robidoux, A and Margolese, RG and Cruz, AB, Jr and Hoehn, JL and Lees, AW and Dimitrov, NV and Bear, HD},
	Date-Modified = {2008-07-18 11:29:02 +0200},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/16/8/2672.pdf},
	Journal = {J Clin Oncol},
	Number = {8},
	Pages = {2672-2685},
	Title = {{Effect of preoperative chemotherapy on the outcome of women with operable breast cancer}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/16/8/2672},
	Volume = {16},
	Year = {1998},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/16/8/2672}}

@article{ma2008fivegene,
	Abstract = {Purpose: Histologic tumor grade is a well-established prognostic factor for breast cancer, and tumor grade-associated genes are the common denominator of many prognostic gene signatures. The objectives of this study are as follows: (a) to develop a simple gene expression index for tumor grade (molecular grade index or MGI), and (b) to determine whether MGI and our previously described HOXB13:IL17BR index together provide improved prognostic information.  Experimental Design: From our previously published list of genes whose expression correlates with both tumor grade and tumor stage progression, we selected five cell cycle-related genes to build MGI and evaluated MGI in two publicly available microarray data sets totaling 410 patients. Using two additional cohorts (n = 323), we developed a real-time reverse transcription PCR assay for MGI, validated its prognostic utility, and examined its interaction with HOXB13:IL17BR.  Results: MGI performed consistently as a strong prognostic factor and was comparable with a more complex 97-gene genomic grade index in multiple data sets. In patients treated with endocrine therapy, MGI and HOXB13:IL17BR modified each other's prognostic performance. High MGI was associated with significantly worse outcome only in combination with high HOXB13:IL17BR, and likewise, high HOXB13:IL17BR was significantly associated with poor outcome only in combination with high MGI.  Conclusions: We developed and validated a five-gene reverse transcription PCR assay for MGI suitable for analyzing routine formalin-fixed paraffin-embedded clinical samples. The combination of MGI and HOXB13:IL17BR outperforms either alone and identifies a subgroup ([~]30%) of early stage estrogen receptor-positive breast cancer patients with very poor outcome despite endocrine therapy.
},
	Author = {Ma, Xiao-Jun and Salunga, Ranelle and Dahiya, Sonika and Wang, Wilson and Carney, Erin and Durbecq, Virginie and Harris, Adrian and Goss, Paul and Sotiriou, Christos and Erlander, Mark and Sgroi, Dennis},
	Date-Added = {2008-07-15 10:41:25 +0200},
	Date-Modified = {2008-07-15 10:42:41 +0200},
	Doi = {10.1158/1078-0432.CCR-07-5026},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/14/9/2601.pdf},
	Journal = {Clin Cancer Res},
	Number = {9},
	Pages = {2601-2608},
	Title = {{A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/9/2601},
	Volume = {14},
	Year = {2008},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/9/2601},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-07-5026}}

@article{altman1994dangers,
	Author = {Altman, DG and Lausen, B and Sauerbrei, W and Schumacher, M},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1093/jnci/86.11.829},
	Journal = {J Natl Cancer Inst},
	Number = {11},
	Pages = {829-835},
	Pubmedid = {8182763},
	Title = {Dangers of using "optimal" cutpoints in the evaluation of prognostic factors},
	Volume = {86},
	Year = {1994},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/jnci/86.11.829}}

@article{cantor1994dangers,
	Author = {Cantor, AB},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1093/jnci/86.23.1798-a},
	Journal = {J Natl Cancer Inst},
	Number = {23},
	Pages = {1798},
	Pubmedid = {7966421},
	Title = {Re: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors},
	Volume = {86},
	Year = {1994},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/jnci/86.23.1798-a}}

@article{cantor1999comparison,
	Author = {Cantor, SB and Sun, CC and Tortolero-Luna, G and Richards-Kortum, R and Follen, M},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1016/S0895-4356(99)00075-X},
	Journal = {J Clin Epidemiol},
	Pages = {885-892},
	Pubmedid = {10529029},
	Title = {A comparison of C/B ratios from studies using receiver operating characteristic curve analysis},
	Volume = {52},
	Year = {1999},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0895-4356(99)00075-X}}

@article{faraggi1996simulation,
	Author = {Faraggi, D and Simon, R},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.0.CO;2-G},
	Journal = {Stat Med},
	Pages = {2203-2213},
	Pubmedid = {8910964},
	Title = {A simulation study of cross-validation for selecting an optimal cutpoint in univariable survival analysis},
	Volume = {15},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/(SICI)1097-0258(19961030)15:20%3C2203::AID-SIM357%3E3.0.CO;2-G}}

@article{faraggi2002estimation,
	Author = {Faraggi, D and Reiser, B},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1002/sim.1228},
	Journal = {Stat Med},
	Number = {20},
	Pages = {3093-3106},
	Pubmedid = {12369084},
	Title = {Estimation of the area under the ROC curve},
	Volume = {21},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.1228}}

@article{gail1976generalization,
	Author = {Gail, MH and Green, SB},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.2307/2529745},
	Journal = {Biometrics},
	Pages = {561-570},
	Pubmedid = {963171},
	Title = {A generalization of the one-sided two-sample Kolmogorov-Smirnov statistics for evaluating diagnostic tests},
	Volume = {32},
	Year = {1976},
	Bdsk-Url-1 = {http://dx.doi.org/10.2307/2529745}}

@article{hanley1982meaning,
	Author = {Hanley, JA and McNeil, BJ},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {Radiology},
	Number = {1},
	Pages = {29-36},
	Pubmedid = {7063747},
	Title = {The meaning and use of the area under the receiver operating characteristic (ROC) curve},
	Volume = {143},
	Year = {1982}}

@article{harrell1982evaluating,
	Author = {Harrell FE, Jr and Califf, RM and Pryor, DB and Lee, KL and Rosati, RA},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2009-01-26 21:38:40 +0100},
	Doi = {10.1001/jama.247.18.2543},
	Journal = {JAMA},
	Number = {18},
	Pages = {2543-2546},
	Pubmedid = {7069920},
	Title = {Evaluating the yield of medical tests},
	Volume = {247},
	Year = {1982},
	Bdsk-Url-1 = {http://dx.doi.org/10.1001/jama.247.18.2543}}

@article{harrell1996multivariate,
	Author = {Harrell, FE Jr and Lee, KL and Mark, DB},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2009-01-26 21:38:32 +0100},
	Doi = {10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4},
	Journal = {Stat Med},
	Number = {4},
	Pages = {361-387},
	Pubmedid = {8668867},
	Title = {Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors},
	Volume = {15},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/(SICI)1097-0258(19960229)15:4%3C361::AID-SIM168%3E3.0.CO;2-4}}

@article{hilsenbeck1992why,
	Author = {Hilsenbeck, SG and Clark, GM and McGuire, WL},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1007/BF01840833},
	Journal = {Breast Cancer Res Treat},
	Pages = {197-206},
	Pubmedid = {1391986},
	Title = {Why do so many prognostic factors fail to pan out?},
	Volume = {22},
	Year = {1992},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/BF01840833}}

@article{hilsenbeck1996practical,
	Author = {Hilsenbeck, SG and Clark, GM},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1002/(SICI)1097-0258(19960115)15:1<103::AID-SIM156>3.0.CO;2-Y},
	Journal = {Stat Med},
	Pages = {103-112},
	Pubmedid = {8614741},
	Title = {Practical p-value adjustment for optimally selected cutpoints},
	Volume = {15},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/(SICI)1097-0258(19960115)15:1%3C103::AID-SIM156%3E3.0.CO;2-Y}}

@article{kristjansson1996optimal,
	Author = {Kristjansson, B and Hill, G and McDowell, I and Lindsay, J},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1016/S0895-4356(96)00272-7},
	Journal = {J Clin Epidemiol},
	Number = {12},
	Pages = {1423-28},
	Pubmedid = {8970493},
	Title = {Optimal cut-points when screening for more than one disease state: an example from the Canadian study of health and aging},
	Volume = {49},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0895-4356(96)00272-7}}

@article{lemeshow1982review,
	Author = {Lemeshow, S and Hosmer, DW},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {Am J Epidemiol},
	Number = {1},
	Pages = {92-106},
	Pubmedid = {7055134},
	Title = {A review of goodness of fit statistics for use in the development of logistic regression models},
	Volume = {115},
	Year = {1982}}

@article{linnet1986assessing,
	Author = {Linnet, K and Brandt, E},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {Clin Chem},
	Number = {7},
	Pages = {1341-1346},
	Pubmedid = {3719943},
	Title = {Assessing diagnostic tests once an optimal cutoff point has been selected},
	Volume = {32},
	Year = {1986}}

@article{long1993comparison,
	Author = {Long, WJ and Griffith, JL and Selker, HP and D'Agostino, RB},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1006/cbmr.1993.1005},
	Journal = {Comput Biomed Res},
	Pages = {74-97},
	Pubmedid = {8444029},
	Title = {A comparison of logistic regression to decision-tree induction in a medical domain},
	Volume = {26},
	Year = {1993},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/cbmr.1993.1005}}

@article{matzumdar2003methods,
	Author = {Mazumdar, M and Smith, A and Bacik, J},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1002/sim.1333},
	Journal = {Stat Med},
	Pages = {559-571},
	Pubmedid = {12590414},
	Title = {Methods for categorizing a prognostic variable in a multivariable setting},
	Volume = {22},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.1333}}

@article{mazumdar2000categorizing,
	Author = {Mazumdar, M and Glassman, J},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O},
	Journal = {Stat Med},
	Pages = {113-132},
	Pubmedid = {10623917},
	Title = {Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer-treatments},
	Volume = {19},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/(SICI)1097-0258(20000115)19:1%3C113::AID-SIM245%3E3.0.CO;2-O}}

@article{metz1978basic,
	Author = {Metz, CE},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {Semin Nucl Med},
	Number = {4},
	Pages = {283-298},
	Pubmedid = {112681},
	Title = {Basic principles of ROC analysis},
	Volume = {8},
	Year = {1978}}

@article{miettinen2001modern,
	Author = {Miettinen, OS},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {CMAJ},
	Number = {6},
	Pages = {781-2},
	Pubmedid = {11584568},
	Title = {The modern scientific physician: 3. Scientific diagnosis},
	Volume = {165},
	Year = {2001}}

@article{schafer1989constructing,
	Author = {Schafer, H},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Journal = {Stat Med},
	Pages = {1381-1391},
	Pubmedid = {2692111},
	Title = {Constructing a cut-off point for a quantitative diagnostic test},
	Volume = {8},
	Year = {1989}}

@article{tsuruta2006polychotomization,
	Abstract = {BACKGROUND:When developing multivariable regression models for diagnosis or prognosis, continuous independent variables can be categorized to make a prediction table instead of a prediction formula. Although many methods have been proposed to dichotomize prognostic variables, to date there has been no integrated method for polychotomization. The latter is necessary when dichotomization results in too much loss of information or when central values refer to normal states and more dispersed values refer to less preferable states, a situation that is not unusual in medical settings (e.g. body temperature, blood pressure). The goal of our study was to develop a theoretical and practical method for polychotomization.METHODS:We used the overall discrimination index C, introduced by Harrel, as a measure of the predictive ability of an independent regressor variable and derived a method for polychotomization mathematically. Since the naive application of our method, like some existing methods, gives rise to positive bias, we developed a parametric method that minimizes this bias and assessed its performance by the use of Monte Carlo simulation.RESULTS:The overall C is closely related to the area under the ROC curve and the produced di(poly)chotomized variable's predictive performance is comparable to the original continuous variable. The simulation shows that the parametric method is essentially unbiased for both the estimates of performance and the cutoff points. Application of our method to the predictor variables of a previous study on rhabdomyolysis shows that it can be used to make probability profile tables that are applicable to the diagnosis or prognosis of individual patient status.CONCLUSION:We propose a polychotomization (including dichotomization) method for independent continuous variables in regression models based on the overall discrimination index C and clarified its meaning mathematically. To avoid positive bias in application, we have proposed and evaluated a parametric method. The proposed method for polychotomizing continuous regressor variables performed well and can be used to create probability profile tables.},
	Author = {Tsuruta, Harukazu and Bax, Leon},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.1186/1472-6947-6-41},
	Issn = {1472-6947},
	Journal = {BMC Medical Informatics and Decision Making},
	Number = {1},
	Pages = {41},
	Pubmedid = {17169154},
	Title = {Polychotomization of continuous variables in regression models based on the overall C index},
	Url = {http://www.biomedcentral.com/1472-6947/6/41},
	Volume = {6},
	Year = {2006},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1472-6947/6/41},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1472-6947-6-41}}

@article{walker1967estimation,
	Author = {Walker, SH and Duncan, DB},
	Date-Added = {2008-07-14 17:29:08 +0200},
	Date-Modified = {2008-07-14 17:29:08 +0200},
	Doi = {10.2307/2333860},
	Journal = {Biometrika},
	Number = {1 and 2},
	Pages = {167-179},
	Pubmedid = {6049533},
	Title = {Estimation of the probability of an event as a function of several independent variables},
	Volume = {54},
	Year = {1967},
	Bdsk-Url-1 = {http://dx.doi.org/10.2307/2333860}}

@article{pencina2004overall,
	Author = {Pencina, MJ and D'Agostino, RB},
	Date-Added = {2008-07-14 17:22:12 +0200},
	Date-Modified = {2008-07-14 17:22:12 +0200},
	Doi = {10.1002/sim.1802},
	Journal = {Stat Med},
	Number = {13},
	Pages = {2109-2123},
	Pubmedid = {15211606},
	Title = {Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation},
	Volume = {23},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.1802}}

@article{bonnefoi2007validation,
	Author = {H. Bonnefoi and A. Potti and M. Delorenzi and L. Mauriac and M. Campone and M. Tubiana-Hulin and T. Petit and P. Rouanet and J. Jassem and E. Blot and V. Becette and P. Farmer and S. Andr{\'e} and C. R. Acharya and S. Mukherjee and D. Cameron and J. Bergh and J. R. Nevins and R.D. Iggo},
	Date-Added = {2008-07-10 15:44:53 +0200},
	Date-Modified = {2008-07-10 15:47:58 +0200},
	Journal = {Lancet Oncology},
	Number = {12},
	Pages = {1071-1078},
	Title = {Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial},
	Volume = {8},
	Year = {2007}}

@article{ravdin2001computer,
	Abstract = {PURPOSE: The goal of the computer program Adjuvant! is to allow health professionals and their patients with early breast cancer to make more informed decisions about adjuvant therapy.  METHODS: Actuarial analysis was used to project outcomes of patients with and without adjuvant therapy based on estimates of prognosis largely derived from Surveillance, Epidemiology, and End-Results data and estimates of the efficacy of adjuvant therapy based on the 1998 overviews of randomized trials of adjuvant therapy. These estimates can be refined using the Prognostic Factor Impact Calculator, which uses a Bayesian method to make adjustments based on relative risks conferred and prevalence of positive test results.  RESULTS: From the entries of patient information (age, menopausal status, comorbidity estimate) and tumor staging and characteristics (tumor size, number of positive axillary nodes, estrogen receptor status), baseline prognostic estimates are made. Estimates for the efficacy of endocrine therapy (5 years of tamoxifen) and of polychemotherapy (cyclophosphamide/methotrexate/fluorouracil-like regimens, or anthracycline-based therapy, or therapy based on both an anthracycline and a taxane) can then be used to project outcomes presented in both numerical and graphical formats. Outcomes for overall survival and disease-free survival and the improvement seen in clinical trials, are reasonably modeled by Adjuvant!, although an ideal validation for all patient subsets with all treatment options is not possible. Additional speculative estimates of years of remaining life expectancy and long-term survival curves can also be produced. Help files supply general information about breast cancer. The program's Internet links supply national treatment guidelines, cooperative group trial options, and other related information.  CONCLUSION: The computer program Adjuvant! can play practical and educational roles in clinical settings.
},
	Author = {Ravdin, Peter M. and Siminoff, Laura A. and Davis, Greg J. and Mercer, Mary Beth and Hewlett, Joan and Gerson, Nancy and Parker, Helen L.},
	Date-Added = {2008-07-04 10:43:10 +0200},
	Date-Modified = {2008-07-04 10:43:10 +0200},
	Eprint = {http://jco.ascopubs.org/cgi/reprint/19/4/980.pdf},
	Journal = {J Clin Oncol},
	Number = {4},
	Pages = {980-991},
	Title = {{Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer}},
	Url = {http://jco.ascopubs.org/cgi/content/abstract/19/4/980},
	Volume = {19},
	Year = {2001},
	Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/19/4/980}}

@article{todd1987confirmation,
	Author = {J. H. Todd and C. Dowle and M. R. Wiliam and C. W. Elston and I. O. Ellis and C. P. Hinton and R. W. Blamey and J. L. Haybittle},
	Date-Added = {2008-07-04 10:34:47 +0200},
	Date-Modified = {2008-07-04 10:37:02 +0200},
	Journal = {British Journal of Cancer},
	Number = {4},
	Pages = {489-492},
	Title = {Confirmation of a prognostic index in primary breast cancer},
	Volume = {56},
	Year = {1987}}

@article{finak2008stromal,
	Annote = {10.1038/nm1764},
	Author = {Finak, Greg and Bertos, Nicholas and Pepin, Francois and Sadekova, Svetlana and Souleimanova, Margarita and Zhao, Hong and Chen, Haiying and Omeroglu, Gulbeyaz and Meterissian, Sarkis and Omeroglu, Atilla and Hallett, Michael and Park, Morag},
	Date-Added = {2008-06-25 09:36:40 +0200},
	Date-Modified = {2008-06-25 09:36:40 +0200},
	Isbn = {1078-8956},
	Journal = {Nat Med},
	L3 = {http://www.nature.com/nm/journal/v14/n5/suppinfo/nm1764_S1.html},
	M3 = {10.1038/nm1764},
	Number = {5},
	Pages = {518--527},
	Publisher = {Nature Publishing Group},
	Title = {Stromal gene expression predicts clinical outcome in breast cancer},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nm1764},
	Volume = {14},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nm1764}}

@article{shi2006maqc,
	Annote = {10.1038/nbt1239},
	Author = {{MAQC Consortium}},
	Date-Added = {2008-06-25 09:28:32 +0200},
	Date-Modified = {2008-11-16 09:55:11 +0100},
	Isbn = {1087-0156},
	Journal = {Nat Biotech},
	L3 = {http://www.nature.com/nbt/journal/v24/n9/suppinfo/nbt1239_S1.html},
	M3 = {10.1038/nbt1239},
	Number = {9},
	Pages = {1151--1161},
	Title = {The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nbt1239},
	Volume = {24},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt1239}}

@article{maglot2007genecentered,
	Abstract = {Entrez Gene (www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene) is NCBI's database for gene-specific information. It does not include all known or predicted genes; instead Entrez Gene focuses on the genomes that have been completely sequenced, that have an active research community to contribute gene-specific information, or that are scheduled for intense sequence analysis. The content of Entrez Gene represents the result of curation and automated integration of data from NCBI's Reference Sequence project (RefSeq), from collaborating model organism databases, and from many other databases available from NCBI. Records are assigned unique, stable and tracked integers as identifiers. The content (nomenclature, map location, gene products and their attributes, markers, phenotypes, and links to citations, sequences, variation details, maps, expression, homologs, protein domains and external databases) is updated as new information becomes available. Entrez Gene is a step forward from NCBI's LocusLink, with both a major increase in taxonomic scope and improved access through the many tools associated with NCBI Entrez.
},
	Author = {Maglott, Donna and Ostell, Jim and Pruitt, Kim D. and Tatusova, Tatiana},
	Date-Added = {2008-06-25 09:24:42 +0200},
	Date-Modified = {2008-06-25 09:24:42 +0200},
	Doi = {10.1093/nar/gki031},
	Eprint = {http://nar.oxfordjournals.org/cgi/reprint/33/suppl_1/D54.pdf},
	Journal = {Nucl. Acids Res.},
	Number = {suppl_1},
	Pages = {D54-58},
	Title = {{Entrez Gene: gene-centered information at NCBI}},
	Url = {http://nar.oxfordjournals.org/cgi/content/abstract/33/suppl_1/D54},
	Volume = {33},
	Year = {2005},
	Bdsk-Url-1 = {http://nar.oxfordjournals.org/cgi/content/abstract/33/suppl_1/D54},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/nar/gki031}}

@article{minn2005genes,
	Annote = {10.1038/nature03799},
	Author = {Minn, Andy J. and Gupta, Gaorav P. and Siegel, Peter M. and Bos, Paula D. and Shu, Weiping and Giri, Dilip D. and Viale, Agnes and Olshen, Adam B. and Gerald, William L. and Massague, Joan},
	Date-Added = {2008-06-05 12:29:40 +0200},
	Date-Modified = {2008-06-05 12:29:40 +0200},
	Isbn = {0028-0836},
	Journal = {Nature},
	L3 = {http://www.nature.com/nature/journal/v436/n7050/suppinfo/nature03799_S1.html},
	M3 = {10.1038/nature03799},
	Number = {7050},
	Pages = {518--524},
	Title = {Genes that mediate breast cancer metastasis to lung},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/nature03799},
	Volume = {436},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature03799}}

@article{xu2008merging,
	Abstract = {BACKGROUND:There is an urgent need for new prognostic markers of breast cancer metastases to ensure that newly diagnosed patients receive appropriate therapy. Recent studies have demonstrated the potential value of gene expression signatures in assessing the risk of developing distant metastases. However, due to the small sample sizes of individual studies, the overlap among signatures is almost zero and their predictive power is often limited. Integrating microarray data from multiple studies in order to increase sample size is therefore a promising approach to the development of more robust prognostic tests.RESULTS:In this study, by using a highly stable data aggregation procedure based on expression comparisons, we have integrated three independent microarray gene expression data sets for breast cancer and identified a structured prognostic signature consisting of 112 genes organized into 80 pair-wise expression comparisons. A classical likelihood ratio test based on these comparisons, essentially weighted voting, achieves 88.6% sensitivity and 54.6% specificity in an independent external test set of 154 samples. The test is highly informative in assessing the risk of developing distant metastases within five years (hazard ratio 9.3 with 95% CI 2.9-29.9).CONCLUSION:Rank-based features provide a stable way to integrate patient data from separate microarray studies due to invariance to data normalization, and such features can be combined into a useful predictor of distant metastases in breast cancer within a statistical modeling framework which begins to capture gene-gene interactions. Upon further confirmation on large-scale independent data, such prognostic signatures and tests could provide a powerful tool to guide adjuvant systemic treatment that could greatly reduce the cost of breast cancer treatment, both in terms of toxic side effects and health care expenditures.},
	Author = {Xu, Lei and Tan, Aik and Winslow, Raimond and Geman, Donald},
	Date-Added = {2008-05-29 16:48:11 +0200},
	Date-Modified = {2008-05-29 16:48:23 +0200},
	Doi = {10.1186/1471-2105-9-125},
	Issn = {1471-2105},
	Journal = {BMC Bioinformatics},
	Number = {1},
	Pages = {125},
	Pubmedid = {18304324},
	Title = {Merging microarray data from separate breast cancer studies provides a robust prognostic test},
	Url = {http://www.biomedcentral.com/1471-2105/9/125},
	Volume = {9},
	Year = {2008},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2105/9/125},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2105-9-125}}

@article{ntzani2003predictive,
	Author = {E. E. Ntzani and J. P. A. Ioannidis},
	Date-Added = {2008-05-29 10:03:19 +0200},
	Date-Modified = {2008-05-29 10:04:26 +0200},
	Journal = {Lancet},
	Number = {1439-1444},
	Title = {Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment},
	Volume = {362},
	Year = {2003}}

@article{perou2000molecular,
	Annote = {10.1038/35021093},
	Author = {Perou, Charles M. and Sorlie, Therese and Eisen, Michael B. and van de Rijn, Matt and Jeffrey, Stefanie S. and Rees, Christian A. and Pollack, Jonathan R. and Ross, Douglas T. and Johnsen, Hilde and Akslen, Lars A. and Fluge, Oystein and Pergamenschikov, Alexander and Williams, Cheryl and Zhu, Shirley X. and Lonning, Per E. and Borresen-Dale, Anne-Lise and Brown, Patrick O. and Botstein, David},
	Date-Added = {2008-05-29 09:37:54 +0200},
	Date-Modified = {2008-05-29 09:37:54 +0200},
	Isbn = {0028-0836},
	Journal = {Nature},
	L3 = {http://www.nature.com/nature/journal/v406/n6797/suppinfo/406747a0_S1.html},
	M3 = {10.1038/35021093},
	Number = {6797},
	Pages = {747--752},
	Title = {Molecular portraits of human breast tumours},
	Ty = {JOUR},
	Url = {http://dx.doi.org/10.1038/35021093},
	Volume = {406},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/35021093}}

@article{chin2006genomic,
	Author = {Chin, Koei and Devries, Sandy and Fridlyand, Jane and Spellman, Paul and Roydasgupta, Ritu and Kuo, Wen L. and Lapuk, Anna and Neve, Richard and Qian, Zuwei and Ryder, Tom and Chen, Fanqing and Feiler, Heidi and Tokuyasu, Taku and Kingsley, Chris and Dairkee, Shanaz and Meng, Zhenhang and Chew, Karen and Pinkel, Daniel and Jain, Ajay and Ljung, Britt and Esserman, Laura and Albertson, Donna and Waldman, Frederic and Gray, Joe},
	Citeulike-Article-Id = {1465610},
	Date-Modified = {2008-05-19 12:29:30 +0200},
	Journal = {Cancer cell},
	Keywords = {copy-number-variation, genomics},
	Month = {Dec},
	Pages = {529--41},
	Posted-At = {2007-07-18 21:04:38},
	Priority = {0},
	Title = {Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.},
	Url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve\&db=pubmed\&dopt=Abstract\&list\_uids=17157792},
	Volume = {10},
	Year = {2006},
	Bdsk-Url-1 = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%5C&db=pubmed%5C&dopt=Abstract%5C&list%5C_uids=17157792}}

@article{chanrion2008gene,
	Abstract = {Purpose: The identification of a molecular signature predicting the relapse of tamoxifen-treated primary breast cancers should help the therapeutic management of estrogen receptor-positive cancers.  Experimental Design: A series of 132 primary tumors from patients who received adjuvant tamoxifen were analyzed for expression profiles at the whole-genome level by 70-mer oligonucleotide microarrays. A supervised analysis was done to identify an expression signature.  Results: We defined a 36-gene signature that correctly classified 78% of patients with relapse and 80% of relapse-free patients (79% accuracy). Using 23 independent tumors, we confirmed the accuracy of the signature (78%) whose relevance was further shown by using published microarray data from 60 tamoxifen-treated patients (63% accuracy). Univariate analysis using the validation set of 83 tumors showed that the 36-gene classifier is more efficient in predicting disease-free survival than the traditional histopathologic prognostic factors and is as effective as the Nottingham Prognostic Index or the "Adjuvant!" software. Multivariate analysis showed that the molecular signature is the only independent prognostic factor. A comparison with several already published signatures demonstrated that the 36-gene signature is among the best to classify tumors from both training and validation sets. Kaplan-Meier analyses emphasized its prognostic power both on the whole cohort of patients and on a subgroup with an intermediate risk of recurrence as defined by the St. Gallen criteria.  Conclusion: This study identifies a molecular signature specifying a subgroup of patients who do not gain benefits from tamoxifen treatment. These patients may therefore be eligible for alternative endocrine therapies and/or chemotherapy.
},
	Author = {Chanrion, Maia and Negre, Vincent and Fontaine, Helene and Salvetat, Nicolas and Bibeau, Frederic and Grogan, Gaetan Mac and Mauriac, Louis and Katsaros, Dionyssios and Molina, Franck and Theillet, Charles and Darbon, Jean-Marie},
	Date-Modified = {2008-05-19 08:27:30 +0200},
	Doi = {10.1158/1078-0432.CCR-07-1833},
	Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/14/6/1744.pdf},
	Journal = {Clin Cancer Res},
	Number = {6},
	Pages = {1744-1752},
	Title = {{A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer}},
	Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/6/1744},
	Volume = {14},
	Year = {2008},
	Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/6/1744},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-07-1833}}

@article{hoadley2007egfr,
	Abstract = {BACKGROUND:The epidermal growth factor receptor (EGFR/HER1) and its downstream signaling events are important for regulating cell growth and behavior in many epithelial tumors types. In breast cancer, the role of EGFR is complex and appears to vary relative to important clinical features including estrogen receptor (ER) status. To investigate EGFR-signaling using a genomics approach, several breast basal-like and luminal epithelial cell lines were examined for sensitivity to EGFR inhibitors. An EGFR-associated gene expression signature was identified in the basal-like SUM102 cell line and was used to classify a diverse set of sporadic breast tumors.RESULTS:In vitro, breast basal-like cell lines were more sensitive to EGFR inhibitors compared to luminal cell lines. The basal-like tumor derived lines were also the most sensitive to carboplatin, which acted synergistically with cetuximab. An EGFR-associated signature was developed in vitro, evaluated on 241 primary breast tumors; three distinct clusters of genes were evident in vivo, two of which were predictive of poor patient outcomes. These EGFR-associated poor prognostic signatures were highly expressed in almost all basal-like tumors and many of the HER2+/ER- and Luminal B tumors.CONCLUSION:These results suggest that breast basal-like cell lines are sensitive to EGFR inhibitors and carboplatin, and this combination may also be synergistic. In vivo, the EGFR-signatures were of prognostic value, were associated with tumor subtype, and were uniquely associated with the high expression of distinct EGFR-RAS-MEK pathway genes.},
	Author = {Hoadley, Katherine and Weigman, Victor and Fan, Cheng and Sawyer, Lynda and He, Xiaping and Troester, Melissa and Sartor, Carolyn and Rieger-House, Thais and Bernard, Philip and Carey, Lisa and Perou, Charles},
	Date-Modified = {2008-05-19 07:31:51 +0200},
	Doi = {10.1186/1471-2164-8-258},
	Issn = {1471-2164},
	Journal = {BMC Genomics},
	Number = {1},
	Pages = {258},
	Pubmedid = {17663798},
	Title = {EGFR associated expression profiles vary with breast tumor subtype},
	Url = {http://www.biomedcentral.com/1471-2164/8/258},
	Volume = {8},
	Year = {2007},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/8/258},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-8-258}}

@article{kreike2007gene,
	Abstract = {INTRODUCTION:Breast cancer is a heterogeneous group of tumors, and can be subdivided on the basis of histopathological features, genetic alterations and gene-expression profiles. One well-defined subtype of breast cancer is characterized by a lack of HER2 gene amplification and estrogen and progesterone receptor expression ('triple-negative tumors'). We examined the histopathological and gene-expression profile of triple-negative tumors to define subgroups with specific characteristics, including risk of developing distant metastases.METHODS:97 triple-negative tumors were selected from the fresh-frozen tissue bank of the Netherlands Cancer Institute, and gene-expression profiles were generated using 35K oligonucleotide microarrays. In addition, histopathological and immunohistochemical characterization was performed, and the findings were associated to clinical features.RESULTS:All triple-negative tumors were classified as basal-like tumors on the basis of their overall gene-expression profile. Hierarchical cluster analysis revealed five distinct subgroups of triple-negative breast cancers. Multivariable analysis showed that a large amount of lymphocytic infiltrate (HR = 0.30, 95% CI 0.09-0.96) and absence of central fibrosis in the tumors (HR = 0.14, 95% CI 0.03-0.62) were associated with distant metastasis-free survival.CONCLUSION:Triple-negative tumors are synonymous with basal-like tumors, and can be identified by immunohistochemistry. Based on gene-expression profiling, basal-like tumors are still heterogeneous and can be subdivided into at least five distinct subgroups. The development of distant metastasis in basal-like tumors is associated with the presence of central fibrosis and a small amount of lymphocytic infiltrate.},
	Author = {Kreike, Bas and van Kouwenhove, Marieke and Horlings, Hugo and Weigelt, Britta and Peterse, Hans and Bartelink, Harry and van de Vijver, Marc},
	Date-Modified = {2008-05-16 16:21:08 +0200},
	Doi = {10.1186/bcr1771},
	Issn = {1465-5411},
	Journal = {Breast Cancer Research},
	Note = {See related letters by Rakha et al., http://breast-cancer-research.com/content/9/6/404 and Kreike et al., http://breast-cancer-research.com/content/9/6/405},
	Number = {5},
	Pages = {R65},
	Pubmedid = {17910759},
	Title = {Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas},
	Url = {http://breast-cancer-research.com/content/9/5/R65},
	Volume = {9},
	Year = {2007},
	Bdsk-Url-1 = {http://breast-cancer-research.com/content/9/5/R65},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr1771}}

@article{brenton2005molecular,
	Abstract = {Profiling breast cancer with expression arrays has become common, and it has been suggested that the results from early studies will lead to understanding of the molecular differences between clinical cases and allow individualization of care. We critically review two main applications of expression profiling; studies unraveling novel breast cancer classifications and those that aim to identify novel markers for prediction of clinical outcome. Breast cancer may now be subclassified into luminal, basal, and HER2 subtypes with distinct differences in prognosis and response to therapy. However, profiling studies to identify predictive markers have suffered from methodologic problems that prevent general application of their results. Future work will need to reanalyze existing microarray data sets to identify more representative sets of candidate genes for use as prognostic signatures and will need to take into account the new knowledge of molecular subtypes of breast cancer when assessing predictive effects.},
	Address = {Cancer Genomics Program, Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, United Kingdom CB22XZ.},
	Au = {Brenton, JD and Carey, LA and Ahmed, AA and Caldas, C},
	Author = {Brenton, James D and Carey, Lisa A and Ahmed, Ahmed Ashour and Caldas, Carlos},
	Cin = {J Clin Oncol. 2006 Feb 1;24(4):721-2; author reply 722-3. PMID: 16446348},
	Da = {20051007},
	Date-Added = {2008-05-06 15:12:31 +0200},
	Date-Modified = {2008-05-06 15:12:52 +0200},
	Dcom = {20051221},
	Dep = {20050906},
	Doi = {10.1200/JCO.2005.03.3845},
	Edat = {2005/09/08 09:00},
	Issn = {0732-183X (Print)},
	Jid = {8309333},
	Journal = {J Clin Oncol},
	Jt = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
	Language = {eng},
	Lr = {20060213},
	Mh = {Breast Neoplasms/classification/*genetics; Female; Forecasting; *Gene Expression Profiling; Genetic Markers; Humans; Outcome Assessment (Health Care); Predictive Value of Tests; Tumor Markers, Biological/*genetics},
	Mhda = {2005/12/22 09:00},
	Number = {29},
	Own = {NLM},
	Pages = {7350--7360},
	Phst = {2005/09/06 {$[$}aheadofprint{$]$}},
	Pii = {JCO.2005.03.3845},
	Pl = {United States},
	Pmid = {16145060},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Pubm = {Print-Electronic},
	Rf = {66},
	Rn = {0 (Genetic Markers); 0 (Tumor Markers, Biological)},
	Sb = {IM},
	So = {J Clin Oncol. 2005 Oct 10;23(29):7350-60. Epub 2005 Sep 6.},
	Stat = {MEDLINE},
	Title = {Molecular classification and molecular forecasting of breast cancer: ready for clinical application?},
	Volume = {23},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1200/JCO.2005.03.3845}}

@article{royston2004new,
	Author = {P. Royston and W. Sauerbrei},
	Date-Added = {2008-05-02 10:25:45 +0200},
	Date-Modified = {2008-05-02 10:27:15 +0200},
	Journal = {Statistics in Medicine},
	Pages = {723-748},
	Title = {A new measure of prognostic separation in survival data},
	Volume = {23},
	Year = {2004}}

@article{scarff1968histological,
	Author = {R. W. Scarff and H. Torloni},
	Date-Added = {2008-04-21 11:40:16 +0200},
	Date-Modified = {2008-04-21 11:41:38 +0200},
	Journal = {International histological classification of tumours},
	Number = {2},
	Pages = {13-20},
	Title = {Histological Typing of Breast Tumors},
	Volume = {2},
	Year = {1968}}

@article{student1908probable,
	Author = {Student},
	Date-Added = {2008-04-20 18:55:48 +0200},
	Date-Modified = {2008-04-20 18:57:10 +0200},
	Journal = {Biometrika},
	Number = {1},
	Pages = {1-25},
	Title = {The Probable Error of a Mean},
	Volume = {6},
	Year = {1908}}

@article{eindor2006thousands,
	Abstract = {Predicting at the time of discovery the prognosis and metastatic potential of cancer is a major challenge in current clinical research. Numerous recent studies searched for gene expression signatures that outperform traditionally used clinical parameters in outcome prediction. Finding such a signature will free many patients of the suffering and toxicity associated with adjuvant chemotherapy given to them under current protocols, even though they do not need such treatment. A reliable set of predictive genes also will contribute to a better understanding of the biological mechanism of metastasis. Several groups have published lists of predictive genes and reported good predictive performance based on them. However, the gene lists obtained for the same clinical types of patients by different groups differed widely and had only very few genes in common. This lack of agreement raised doubts about the reliability and robustness of the reported predictive gene lists, and the main source of the problem was shown to be the small number of samples that were used to generate the gene lists. Here, we introduce a previously undescribed mathematical method, probably approximately correct (PAC) sorting, for evaluating the robustness of such lists. We calculate for several published data sets the number of samples that are needed to achieve any desired level of reproducibility. For example, to achieve a typical overlap of 50% between two predictive lists of genes, breast cancer studies would need the expression profiles of several thousand early discovery patients.
},
	Author = {L. Ein-Dor and O. Zuk and E. Domany},
	Date-Added = {2008-04-17 08:28:37 +0200},
	Date-Modified = {2008-04-17 08:29:25 +0200},
	Doi = {10.1073/pnas.0601231103},
	Eprint = {http://www.pnas.org/cgi/reprint/103/15/5923.pdf},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {15},
	Pages = {5923-5928},
	Title = {{Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer}},
	Url = {http://www.pnas.org/cgi/content/abstract/103/15/5923},
	Volume = {103},
	Year = {2006},
	Bdsk-Url-1 = {http://www.pnas.org/cgi/content/abstract/103/15/5923},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0601231103}}

@article{galea1992nottingham,
	Author = {Marcus H. Galea and Roger W. Blamey and Christopher E. Elston and Ian O. Ellis},
	Date-Added = {2008-04-16 17:57:52 +0200},
	Date-Modified = {2008-04-16 18:01:55 +0200},
	Journal = {Breast Cancer Research and Treatment},
	Number = {3},
	Pages = {207-219},
	Title = {The Nottingham prognostic index in primary breast cancer},
	Volume = {22},
	Year = {1992},
	Bdsk-Url-1 = {http://www.springerlink.com/content/34614t545370502k/}}

@article{kattan2006validating,
	Author = {M. Kattan},
	Date-Added = {2008-04-15 19:11:38 +0200},
	Date-Modified = {2008-04-15 19:13:29 +0200},
	Journal = {Cancer},
	Number = {11},
	Pages = {2523-2524},
	Title = {Validating a Prognostic Model},
	Volume = {107},
	Year = {2006}}

@article{minn2007lung,
	Abstract = {The association between large tumor size and metastatic risk in a majority of clinical cancers has led to questions as to whether these observations are causally related or whether one is simply a marker for the other. This is partly due to an uncertainty about how metastasis-promoting gene expression changes can arise in primary tumors. We investigated this question through the analysis of a previously defined "lung metastasis gene-expression signature" (LMS) that mediates experimental breast cancer metastasis selectively to the lung and is expressed by primary human breast cancer with a high risk for developing lung metastasis. Experimentally, we demonstrate that the LMS promotes primary tumor growth that enriches for LMS+ cells, and it allows for intravasation after reaching a critical tumor size. Clinically, this corresponds to LMS+ tumors being larger at diagnosis compared with LMS- tumors and to a marked rise in the incidence of metastasis after LMS+ tumors reach 2 cm. Patients with LMS-expressing primary tumors selectively fail in the lung compared with the bone or other visceral sites and have a worse overall survival. The mechanistic linkage between metastasis gene expression, accelerated tumor growth, and likelihood of metastatic recurrence provided by the LMS may help to explain observations of prognostic gene signatures in primary cancer and how tumor growth can both lead to metastasis and be a marker for cells destined to metastasize.
},
	Author = {Minn, Andy J. and Gupta, Gaorav P. and Padua, David and Bos, Paula and Nguyen, Don X. and Nuyten, Dimitry and Kreike, Bas and Zhang, Yi and Wang, Yixin and Ishwaran, Hemant and Foekens, John A. and van de Vijver, Marc and Massague, Joan},
	Date-Added = {2008-02-20 12:34:02 +0100},
	Date-Modified = {2008-02-20 12:34:02 +0100},
	Doi = {10.1073/pnas.0701138104},
	Eprint = {http://www.pnas.org/cgi/reprint/104/16/6740.pdf},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {16},
	Pages = {6740-6745},
	Title = {{Lung metastasis genes couple breast tumor size and metastatic spread}},
	Url = {http://www.pnas.org/cgi/content/abstract/104/16/6740},
	Volume = {104},
	Year = {2007},
	Bdsk-Url-1 = {http://www.pnas.org/cgi/content/abstract/104/16/6740},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0701138104}}

@article{chang2005robustness,
	Abstract = {Based on the hypothesis that features of the molecular program of normal wound healing might play an important role in cancer metastasis, we previously identified consistent features in the transcriptional response of normal fibroblasts to serum, and used this "wound-response signature" to reveal links between wound healing and cancer progression in a variety of common epithelial tumors. Here, in a consecutive series of 295 early breast cancer patients, we show that both overall survival and distant metastasis-free survival are markedly diminished in patients whose tumors expressed this wound-response signature compared to tumors that did not express this signature. A gene expression centroid of the wound-response signature provides a basis for prospectively assigning a prognostic score that can be scaled to suit different clinical purposes. The wound-response signature improves risk stratification independently of known clinico-pathologic risk factors and previously established prognostic signatures based on unsupervised hierarchical clustering ("molecular subtypes") or supervised predictors of metastasis ("70-gene prognosis signature").
},
	Author = {Chang, Howard Y. and Nuyten, Dimitry S. A. and Sneddon, Julie B. and Hastie, Trevor and Tibshirani, Robert and Sorlie, Therese and Dai, Hongyue and He, Yudong D. and van't Veer, Laura J. and Bartelink, Harry and van de Rijn, Matt and Brown, Patrick O. and van de Vijver, Marc J.},
	Date-Added = {2008-02-18 09:45:52 +0100},
	Date-Modified = {2008-02-18 09:45:52 +0100},
	Doi = {10.1073/pnas.0409462102},
	Eprint = {http://www.pnas.org/cgi/reprint/102/10/3738.pdf},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {10},
	Pages = {3738-3743},
	Title = {{From The Cover: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival}},
	Url = {http://www.pnas.org/cgi/content/abstract/102/10/3738},
	Volume = {102},
	Year = {2005},
	Bdsk-Url-1 = {http://www.pnas.org/cgi/content/abstract/102/10/3738},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0409462102}}

@article{yu2004molecular,
	Abstract = {The Nottingham prognostic index (NPI) is a widely used clinicopathological staging system for breast cancer prognostication. Using a step-wise classification approach where breast tumor expression profiles were first divided into general "molecular subtypes" [estrogen receptor (ER)+, ER-, ERBB2+], followed by an independent analysis of each subtype, we identified a 62-gene expression signature (NPI-ES) highly correlated to the NPI in ER+ tumors. The NPI-ES classified the majority of ER+ tumors into two distinct groups with high confidence and was significantly correlated to NPI status in two independent sets of ER+ tumors derived from different centers. The NPI-ES is comparable to the classical NPI in identifying patients likely to exhibit a poor clinical prognosis, as well as to a recently described "prognosis signature" for breast cancer. Our findings demonstrate how expression profiling can complement classical staging systems employing histopathological parameters scored over a continuous range of values.
},
	Author = {Yu, Kun and Lee, Chee How and Tan, Puay Hoon and Hong, Ga Sze and Wee, Siew Bok and Wong, Chow Yin and Tan, Patrick},
	Date-Added = {2008-02-05 11:02:19 +0100},
	Date-Modified = {2008-02-05 11:02:40 +0100},
	Doi = {10.1158/0008-5472.CAN-03-2430},
	Eprint = {http://cancerres.aacrjournals.org/cgi/reprint/64/9/2962.pdf},
	Journal = {Cancer Res},
	Number = {9},
	Pages = {2962-2968},
	Title = {{A Molecular Signature of the Nottingham Prognostic Index in Breast Cancer}},
	Url = {http://cancerres.aacrjournals.org/cgi/content/abstract/64/9/2962},
	Volume = {64},
	Year = {2004},
	Bdsk-Url-1 = {http://cancerres.aacrjournals.org/cgi/content/abstract/64/9/2962},
	Bdsk-Url-2 = {http://dx.doi.org/10.1158/0008-5472.CAN-03-2430}}

@article{yu2007pathway,
	Abstract = {BACKGROUND:Published prognostic gene signatures in breast cancer have few genes in common. Here we provide a rationale for this observation by studying the prognostic power and the underlying biological pathways of different gene signatures.METHODS:Gene signatures to predict the development of metastases in estrogen receptor-positive and estrogen receptor-negative tumors were identified using 500 re-sampled training sets and mapping to Gene Ontology Biological Process to identify over-represented pathways. The Global Test program confirmed that gene expression profilings in the common pathways were associated with the metastasis of the patients.RESULTS:The apoptotic pathway and cell division, or cell growth regulation and G-protein coupled receptor signal transduction, were most significantly associated with the metastatic capability of estrogen receptor-positive or estrogen-negative tumors, respectively. A gene signature derived of the common pathways predicted metastasis in an independent cohort. Mapping of the pathways represented by different published prognostic signatures showed that they share 53% of the identified pathways.CONCLUSION:We show that divergent gene sets classifying patients for the same clinical endpoint represent similar biological processes and that pathway-derived signatures can be used to predict prognosis. Furthermore, our study reveals that the underlying biology related to aggressiveness of estrogen receptor subgroups of breast cancer is quite different.},
	Author = {Yu, Jack and Sieuwerts, Anieta and Zhang, Yi and Martens, John and Smid, Marcel and Klijn, Jan and Wang, Yixin and Foekens, John},
	Date-Added = {2008-02-05 10:59:56 +0100},
	Date-Modified = {2008-02-05 11:00:32 +0100},
	Doi = {10.1186/1471-2407-7-182},
	Issn = {1471-2407},
	Journal = {BMC Cancer},
	Number = {1},
	Pages = {182},
	Pubmedid = {17894856},
	Title = {Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer},
	Url = {http://www.biomedcentral.com/1471-2407/7/182},
	Volume = {7},
	Year = {2007},
	Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2407/7/182},
	Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2407-7-182}}

@article{hummel2006biologic,
	Author = {Michael Hummel and Stefan Bentink and M.S. and Hilmar Berger and Wolfram Klapper and Swen Wessendorf and Thomas F.E. Barth and Heinz-Wolfram Bernd and Sergio B. Cogliatti and Judith Dierlamm and Alfred C. Feller and Martin-Leo Hansmann and Eugenia Haralambieva and Lana Harder and Dirk Hasenclever and Michael K{\"u}hn and Dido Lenze and Peter Lichter and Jose Ignacio Martin-Subero and Peter M{\"o}ller and Hans-Konrad M{\"u}ller-Hermelink and German Ott and Reza M. Parwaresch and Christiane Pott and Andreas Rosenwald and Maciej Rosolowski and Carsten Schwaenen and Benjamin St{\"u}rzenhofecker and Monika Szczepanowski and Heiko Trautmann and M.S. and Hans-Heinrich Wacker and Rainer Spang and Markus Loeffler and Lorenz Tr{\"u}mper and Harald Stein and Reiner Siebert},
	Date-Added = {2008-02-04 13:53:39 +0100},
	Date-Modified = {2008-02-04 13:57:47 +0100},
	Journal = {The New England Journal of Medicine},
	Number = {23},
	Pages = {2419-2430},
	Title = {A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling},
	Volume = {354},
	Year = {2006},
	Bdsk-File-1 = {YnBsaXN0MDDUAQIDBAUIJidUJHRvcFgkb2JqZWN0c1gkdmVyc2lvblkkYXJjaGl2ZXLRBgdUcm9vdIABqAkKFRYXGyIjVSRudWxs0wsMDQ4RFFpOUy5vYmplY3RzV05TLmtleXNWJGNsYXNzog8QgASABqISE4ACgAOAB1lhbGlhc0RhdGFccmVsYXRpdmVQYXRo0hgNGRpXTlMuZGF0YU8RAioAAAAAAioAAgAADE1hY2ludG9zaCBIRAAAAAAAAAAAAAAAAAAAAMPjDF1IKwAAAAvwARZodW1tZWwyMDA2YmlvbG9naWMucGRmAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAC/AFw6IdoQAAAAAAAAAAAAEABwAACSAAAAAAAAAAAAAAAAAAAAASaHVtbWVsMjAwNmJpb2xvZ2ljABAACAAAw+NSrQAAABEACAAAw6Jj8QAAAAEAJAAL8AEAC+/6AAvsEAAL7A4BZK61AAvSEgALwssACu9qAAB63AACAHFNYWNpbnRvc2ggSEQ6VXNlcnM6YmhhaWJla2E6TXlXb3JrOnJlc2VhcmNoOklKQjpseW1waG9tYTphbmFseXNpczpwYXJ0NTpodW1tZWwyMDA2YmlvbG9naWM6aHVtbWVsMjAwNmJpb2xvZ2ljLnBkZgAADgAuABYAaAB1AG0AbQBlAGwAMgAwADAANgBiAGkAbwBsAG8AZwBpAGMALgBwAGQAZgAPABoADABNAGEAYwBpAG4AdABvAHMAaAAgAEgARAASAGRVc2Vycy9iaGFpYmVrYS9NeVdvcmsvcmVzZWFyY2gvSUpCL2x5bXBob21hL2FuYWx5c2lzL3BhcnQ1L2h1bW1lbDIwMDZiaW9sb2dpYy9odW1tZWwyMDA2YmlvbG9naWMucGRmABMAAS8AABUAAgAP//8AAIAF0hwdHh9YJGNsYXNzZXNaJGNsYXNzbmFtZaMfICFdTlNNdXRhYmxlRGF0YVZOU0RhdGFYTlNPYmplY3RfEFEuLi9yZXNlYXJjaC9JSkIvbHltcGhvbWEvYW5hbHlzaXMvcGFydDUvaHVtbWVsMjAwNmJpb2xvZ2ljL2h1bW1lbDIwMDZiaW9sb2dpYy5wZGbSHB0kJaIlIVxOU0RpY3Rpb25hcnkSAAGGoF8QD05TS2V5ZWRBcmNoaXZlcgAIABEAFgAfACgAMgA1ADoAPABFAEsAUgBdAGUAbABvAHEAcwB2AHgAegB8AIYAkwCYAKACzgLQAtUC3gLpAu0C+wMCAwsDXwNkA2cDdAN5AAAAAAAAAgEAAAAAAAAAKAAAAAAAAAAAAAAAAAAAA4s=}}

@article{glas2006converting,
	Author = {A. M. Glas and A. Floore and L. J. Delahaye and A. T. Witeveen and R. C. Pover and N. Bakx and J. S. Lahti-Domenici and T. J. Bruinsma and M. O. Warmoes and R. Bernards and L. F. Wessels and L. {van't Veer}},
	Date-Added = {2008-01-29 17:57:53 +0100},
	Date-Modified = {2008-01-29 18:03:00 +0100},
	Journal = {BMC Genomics},
	Number = {278},
	Pages = {10},
	Title = {Converting a breast cancer microarray signature into a high-throughput diagnostic test},
	Volume = {7},
	Year = {2006}}

@article{zhang2007integrated,
	Author = {Z. Zhang and D. Chen and D. A. Fenstermacher},
	Date-Added = {2008-01-29 16:43:10 +0100},
	Date-Modified = {2008-01-30 08:05:45 +0100},
	Journal = {BMC Genomics},
	Number = {331},
	Pages = {13},
	Title = {Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome},
	Volume = {8},
	Year = {2007}}

@article{sweets1988measuring,
	Author = {J. A. Sweets},
	Date-Added = {2007-12-24 16:20:22 +0100},
	Date-Modified = {2007-12-24 16:21:21 +0100},
	Journal = {Science},
	Number = {4857},
	Pages = {1285-1293},
	Title = {Measuring the accuracy of diagnostic systems},
	Volume = {240},
	Year = {1988}}

@article{bontempi2007blocking,
	Author = {G. Bontempi},
	Date-Added = {2007-12-24 12:02:38 +0100},
	Date-Modified = {2007-12-24 12:03:42 +0100},
	Journal = {IEEE/ACM Transactions on Computational Biology and Bioinformatics},
	Number = {2},
	Pages = {293-300},
	Title = {A blocking strategy to improve gene selection for classification of gene expression data},
	Volume = {4},
	Year = {2007}}

@techreport{zeger2004cox,
	Author = {S. L. Zeger and P. J. Diggle and K-Y. Liang},
	Date-Added = {2007-12-11 16:36:47 +0100},
	Date-Modified = {2007-12-11 16:39:46 +0100},
	Institution = {Johns Hopkins University, Dept. of Biostatistics},
	Number = {32},
	Title = {A Cox model for biostatistics of the future},
	Type = {Working Paper},
	Url = {http://www.bepress.com/jhubiostat/paper32},
	Year = {2004},
	Bdsk-Url-1 = {http://www.bepress.com/jhubiostat/paper32}}

@article{simon2005roadmap,
	Author = {R. Simon},
	Date-Added = {2007-12-11 16:03:04 +0100},
	Date-Modified = {2007-12-11 16:04:33 +0100},
	Journal = {Journal of Clinical Oncology},
	Pages = {7332-7341},
	Title = {Roadmap for developing and validating therapeutically relevant genomic classifiers},
	Volume = {23},
	Year = {2005}}

@article{thomassen2007comparison,
	Author = {M. Thomassen and Q. Tan and F. Eiriksdottir and M. Bak and S. Cold and T. A. Kruse},
	Date-Added = {2007-12-03 14:08:03 +0100},
	Date-Modified = {2007-12-03 14:10:01 +0100},
	Journal = {Clinical Cancer Research},
	Number = {18},
	Pages = {5355-5360},
	Title = {Comparison of Gene Sets for Expression Profiling: Prediction of Metastasis from Low-Malignant Breast Cancer},
	Volume = {13},
	Year = {2007}}

@article{fan2006concordance,
	Author = {C. Fan and D. S. Oh and L. Wessels and B. Weigelt and D. S. Buyten and A. B. Nobel and L. J. {van't Veer} and C. M. Perou},
	Date-Added = {2007-12-03 14:04:01 +0100},
	Date-Modified = {2007-12-03 14:07:08 +0100},
	Journal = {New England Journal of Medicine},
	Pages = {560-569},
	Title = {Concordance among Gene-Expression--Based Predictors for Breast Cancer},
	Volume = {355},
	Year = {2006}}

@conference{raykar2007ranking,
	Author = {V. C. Raykar and H. Steck and B. Krishnapuram and C. Dehing-Oberije and P. Lambin},
	Booktitle = {Neural Information Processing Systems Conference},
	Date-Added = {2007-12-03 09:38:27 +0100},
	Date-Modified = {2007-12-03 09:43:35 +0100},
	Title = {On Ranking in Survival Analysis: Bounds on the Concordance Index},
	Year = {2007}}

@article{freiman1978importance,
	Author = {J. A. Freiman and T. C. Chalmers and H. Smith and R. R. Kuebler},
	Date-Added = {2007-11-29 10:30:35 +0100},
	Date-Modified = {2007-11-29 10:33:18 +0100},
	Journal = {New England Journal of Medicine},
	Pages = {690-694},
	Title = {The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: survey of 71 "negative" trials},
	Volume = {299},
	Year = {1978}}

@article{lewis2001forest,
	Author = {S. Lewis and M. Clarke},
	Date-Added = {2007-11-29 10:25:18 +0100},
	Date-Modified = {2007-11-29 10:27:49 +0100},
	Journal = {British Medical Journal},
	Number = {7300},
	Pages = {1479-1480},
	Title = {Forest plots: trying to see the wood and the trees},
	Volume = {322},
	Year = {2001}}

@article{brier1950verification,
	Author = {G. W. Brier},
	Date-Added = {2007-11-28 18:28:56 +0100},
	Date-Modified = {2007-11-28 18:33:15 +0100},
	Journal = {Monthly Weather Review},
	Pages = {1-3},
	Title = {Verification of forecasts expressed in terms of probabilities},
	Volume = {78},
	Year = {1950}}

@article{bild2006oncogenic,
	Author = {A. H. Bild and G. Yao and J. T. Chang and Q. Wang and A. Potti and D. Chasse and M-B. Joshi and >D. Harpole and J. M. Lancaster and A. Berschuk and J. A. {Olson Jr} and J. R. Marks and H. K. Dressman and M. West and J. R. Nevins},
	Date-Added = {2007-11-28 10:22:32 +0100},
	Date-Modified = {2007-11-28 10:27:02 +0100},
	Journal = {Nature},
	Pages = {353-356},
	Title = {Oncogenic pathway signatures in human cancers as a guide to targeted therapies},
	Volume = {439},
	Year = {2006}}

@book{andersen1993statistical,
	Author = {P. K. Andersen and O. Borgan and R. D. Gill and N. Keiding},
	Date-Added = {2007-11-26 23:44:46 +0100},
	Date-Modified = {2007-11-26 23:46:49 +0100},
	Publisher = {Springer},
	Title = {Statistical Models Based on Counting Processes},
	Year = {1993}}

@article{gerds2001functional,
	Author = {T. A. Gerds and M. Schumacher},
	Date-Added = {2007-11-26 23:26:44 +0100},
	Date-Modified = {2007-11-26 23:28:21 +0100},
	Journal = {Biometrika},
	Number = {2},
	Pages = {572-580},
	Title = {On functional misspecification of covariates in teh Cox regression model},
	Volume = {88},
	Year = {2001}}

@article{schumacher2007assessment,
	Author = {M. Schumacher and H. Binder and T. A. Gerds},
	Date-Added = {2007-11-22 18:33:34 +0100},
	Date-Modified = {2007-11-22 18:34:51 +0100},
	Journal = {Bioinformatics},
	Number = {14},
	Pages = {1768-1774},
	Title = {Assessment of survival prediction models based on microarray data},
	Volume = {23},
	Year = {2007}}

@article{bovelstad2007predicting,
	Author = {H. M. Bovelstad and S. Nygard and H. L. Storvold and M. Aldrin and O. Borgan and A. Frigessi and O. C. Lingjaerde},
	Date-Added = {2007-11-22 18:31:29 +0100},
	Date-Modified = {2007-11-22 18:33:21 +0100},
	Journal = {Bioinformatics},
	Number = {16},
	Pages = {2080-2087},
	Title = {Predicting survival from microarray data---a comparative study},
	Volume = {23},
	Year = {2007}}

@article{gerds2006consistent,
	Author = {T. A. Gerds and M. Schumacher},
	Date-Added = {2007-11-22 18:29:36 +0100},
	Date-Modified = {2007-11-22 18:30:49 +0100},
	Journal = {Biometrical Journal},
	Pages = {1029-1040},
	Title = {Consistent Estimation of the Expected Brier Score in General Survival Models with Right-Censored Event Times},
	Volume = {6},
	Year = {2006}}

@article{parkinson2005arrayexpress,
	Author = {H. Parkinson and U. Sarkans and M. Shojatalab, andN. Abeygunawardena and S. Contrino and R. Coulson and A. Farne and G. G. Lara and E. Holloway and M. Kapushesky and P. Lilja and G. Mukherjee and A. Oezcimen and T. Rayner and P. Rocca-Serra and A. Sharma and S. Sansone and A. Brazma},
	Date-Added = {2007-11-22 16:48:07 +0100},
	Date-Modified = {2009-01-15 14:05:05 +0100},
	Journal = {Nucleic Acids Research},
	Pages = {D553-D555},
	Title = {ArrayExpress: a public repository for microarray gene expression data at the EBI},
	Volume = {33},
	Year = {2005}}

@article{park2007l1,
	Author = {M. Y. Park and T. Hastie},
	Date-Added = {2007-11-22 15:16:32 +0100},
	Date-Modified = {2007-11-22 15:17:58 +0100},
	Journal = {Journal of the Royal Statistical Society},
	Pages = {659-677},
	Title = {L1 regularization path algorithm for generalized linear models},
	Volume = {69},
	Year = {2007}}

@article{vanhouwelingen2006crossvalidated,
	Author = {H. {van Houwelingen} and T. Bruinsma and A. A. Hart and L. J. {van't Veer} and L. F. A. Wessels},
	Date-Added = {2007-11-22 15:10:10 +0100},
	Date-Modified = {2007-11-22 15:12:44 +0100},
	Journal = {Statistics in Medicine},
	Pages = {3201-3216},
	Title = {Cross-validated Cox regression on microarray gene expression data},
	Volume = {25},
	Year = {2006}}

@article{segal2006microarray,
	Author = {M. R. Segal},
	Date-Added = {2007-11-22 15:04:18 +0100},
	Date-Modified = {2007-11-22 15:05:07 +0100},
	Journal = {Biostatistics},
	Number = {2},
	Pages = {268-285},
	Title = {Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited},
	Volume = {7},
	Year = {2006}}

@book{schumacher2006prognostic,
	Author = {M. Schumacher and N. Hollander and G. Schwarzer and W. Sauerbrei},
	Date-Added = {2007-11-22 14:31:37 +0100},
	Date-Modified = {2007-11-22 14:34:45 +0100},
	Edition = {2},
	Editor = {J. Crowley and D. P. Ankerst},
	Publisher = {Chapman and Hall/crc},
	Series = {andbook of Statistics in Clinical Oncology},
	Title = {Prognostic factor studies},
	Year = {2006}}

@article{olivotto2005populationbased,
	Author = {I. A. Olivotto and C. D. Bajdik and P. M. Ravdin and C. H. Speers and A. J. Coldman and B. D. Norris and G. J. Davis and S. K. Chia and K. A. Gelmon},
	Date-Added = {2007-11-22 14:00:39 +0100},
	Date-Modified = {2007-11-22 14:03:59 +0100},
	Journal = {Journal of Clinical Oncology},
	Number = {12},
	Pages = {2716-2725},
	Title = {Population-based validation of the prognostic model Adjuvant! for early breast cancer},
	Volume = {23},
	Year = {2005}}

@article{segal1997features,
	Author = {M. R. Segal},
	Date-Added = {2007-09-26 15:35:08 +0200},
	Date-Modified = {2007-11-22 15:43:36 +0100},
	Journal = {Journal of Epidemiology},
	Number = {4},
	Pages = {344-346},
	Title = {Features of Tree-Strucured Survival Analysis},
	Volume = {8},
	Year = {1997}}

@article{graf1999assessment,
	Author = {E. Graf and C. Schmoor and W. Sauerbrei and M. Schumacher},
	Date-Added = {2007-09-26 14:25:05 +0200},
	Date-Modified = {2007-09-26 14:27:02 +0200},
	Journal = {Statistics in Medicine},
	Pages = {2529-2545},
	Title = {Assessment and comparison of prognostic classification schemes for survival data},
	Volume = {18},
	Year = {1999}}

@article{haybittle1982prognostic,
	Author = {J. L. Haybittle and R. W. Blamey and C. W. Elston and J. Johnson and P. J. Doyle and F. C. Campbell and R. I. Nicholson and K. Griffiths},
	Date-Added = {2007-09-26 14:12:31 +0200},
	Date-Modified = {2007-09-26 14:20:06 +0200},
	Journal = {British Journal of Cancer},
	Pages = {361-366},
	Title = {A prognostic index in primary breast cancer},
	Volume = {45},
	Year = {1982}}

@article{pang2007classification,
	Author = {S. Pang and I. Havukkala and Y. Hu and N. Kasabov},
	Date-Added = {2007-09-24 16:20:16 +0200},
	Date-Modified = {2007-09-24 16:22:51 +0200},
	Journal = {Neural Computing and Applications},
	Month = {October},
	Number = {6},
	Pages = {527-539},
	Title = {Classification consistency analysis for bootstrapping gene selection},
	Volume = {18},
	Year = {2007}}

@article{nicolau2007diseasespecific,
	Author = {M. Nicolau and R. Tibshirani and A-L. Borresen-Dale and S. S. Jeffrey},
	Date-Added = {2007-09-24 14:42:39 +0200},
	Date-Modified = {2007-09-24 14:44:21 +0200},
	Journal = {Bioinformatics},
	Number = {8},
	Pages = {957-965},
	Title = {Disease-specific genomic analysis: identifying the signature of pathologic biology},
	Volume = {23},
	Year = {2007}}

@article{ransohoff2004rules,
	Author = {D. F. Ransohoff},
	Date-Added = {2007-09-21 10:29:01 +0200},
	Date-Modified = {2007-09-24 10:32:28 +0200},
	Journal = {Nature Cancer Review},
	Pages = {309-314},
	Title = {Rules of evidence for cancer molecular marker discovery and validation},
	Volume = {4},
	Year = {2004}}

@inproceedings{vanbelle2007support,
	Author = {V. {van Belle} and K. Pelckmans and J. A. Suykens and S. {van Huffel}},
	Booktitle = {Third International Conference on Computational Intelligence in Medicine and Healthcare},
	Date-Added = {2007-09-07 11:11:33 +0200},
	Date-Modified = {2007-09-07 11:19:36 +0200},
	Title = {Support Vector Machines for Survival Analysis},
	Year = {2007}}

@article{hubert1985comparing,
	Author = {L. Hubert and P. Arabie},
	Date-Added = {2007-09-03 10:48:31 +0200},
	Date-Modified = {2007-09-03 10:49:33 +0200},
	Journal = {Journal of Classification},
	Pages = {193-218},
	Title = {Comparing Partitions},
	Year = {1985}}

@article{yeung2001modelbased,
	Author = {K. Y. Yeung and C. Fraley and A. Murua an A. E. Raftery and W. L. Ruzzo},
	Date-Added = {2007-09-03 10:39:21 +0200},
	Date-Modified = {2007-09-03 10:48:21 +0200},
	Journal = {Bioinformatics},
	Number = {10},
	Pages = {977-987},
	Title = {Model-based clustering and data transformations for gene expression data},
	Volume = {17},
	Year = {2001}}

@article{kapp2007are,
	Author = {A. V. Kapp and R. Tibshirani},
	Date-Added = {2007-09-03 10:33:43 +0200},
	Date-Modified = {2007-09-03 10:35:12 +0200},
	Journal = {Biostatistics},
	Pages = {9-31},
	Title = {Are clusters found in one dataset present in another dataset?},
	Volume = {8},
	Year = {2007}}

@article{tibshirani2005cluster,
	Author = {R. Tibshirani and G. Walther},
	Date-Added = {2007-09-03 10:30:01 +0200},
	Date-Modified = {2007-09-03 10:57:20 +0200},
	Journal = {Journal of Computational and Graphical Statistics},
	Number = {3},
	Pages = {511-528},
	Title = {Cluster Validation by Prediction Strength},
	Volume = {14},
	Year = {2005}}

@article{pritchard2005aromatase,
	Author = {K. I. Pritchard},
	Date-Added = {2007-06-30 11:10:32 +0200},
	Date-Modified = {2007-06-30 11:11:44 +0200},
	Journal = {Journal of Clinical Oncology},
	Number = {22},
	Pages = {4858-4852},
	Title = {Aromatase Inhibitors in Adjuvant Therapy of Breast Cancer: Before, Instead of, or Beyond Tamoxifen},
	Volume = {23},
	Year = {2005}}

@article{sotiriou2007taking,
	Author = {C. Sotiriou and M. J. Piccart},
	Date-Added = {2007-06-27 08:51:12 +0200},
	Date-Modified = {2007-06-28 17:33:29 +0200},
	Journal = {Nature Cancer Review},
	Month = {July},
	Pages = {545-553},
	Title = {Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?},
	Volume = {7},
	Year = {2007}}

@book{cramer1999mathematical,
	Author = {H. Cramer},
	Date-Added = {2007-06-21 13:35:54 +0200},
	Date-Modified = {2007-06-21 13:36:52 +0200},
	Publisher = {Princeton University Press},
	Title = {Mathematical Methods of Statistics},
	Year = {1999}}

@article{chernoff1954maximum,
	Author = {H. Chernoff and E. L. Lehmann},
	Date-Added = {2007-06-21 13:29:36 +0200},
	Date-Modified = {2007-06-21 13:31:33 +0200},
	Journal = {The Annals of Mathematical Statistics},
	Pages = {579-586},
	Title = {The use of maximum likelihood estimates in chi-square tests for goodness-of-fit},
	Volume = {25},
	Year = {1954}}

@article{sima2006what,
	Author = {C. Sima and E. R. Dougherty},
	Date-Added = {2007-06-19 12:14:29 +0200},
	Date-Modified = {2007-06-19 12:15:29 +0200},
	Journal = {Bioinformatics},
	Number = {19},
	Pages = {2430-2436},
	Title = {What should be expected from feature selection in small-sample settings},
	Volume = {22},
	Year = {2006}}

@article{freeman1999quantitative,
	Author = {W. M. Freeman and S. J. Walker and K. E. Vrana},
	Date-Added = {2007-06-18 21:08:35 +0200},
	Date-Modified = {2007-06-27 08:03:36 +0200},
	Journal = {Biotechniques},
	Number = {1},
	Pages = {124-125},
	Title = {Quantitative {RT-PCR}: pitfalls and potential},
	Volume = {26},
	Year = {1999}}

@article{breiman1998arcing,
	Author = {L. Breiman},
	Date-Added = {2007-06-18 15:25:04 +0200},
	Date-Modified = {2007-06-18 15:26:18 +0200},
	Journal = {Annals of Statistics},
	Pages = {801-824},
	Title = {Arcing classifiers},
	Volume = {26},
	Year = {1998}}

@book{taylor2004kernel,
	Author = {J.-S. Taylor and N. Cristianini},
	Date-Added = {2007-06-17 18:35:29 +0200},
	Date-Modified = {2007-06-17 18:36:53 +0200},
	Publisher = {Cambridge University Pres},
	Title = {Kernel Methods for Pattern Analysis},
	Year = {2004}}

@article{parsons2004subspace,
	Author = {L. Parsons and E. Haque and H. Liu},
	Date-Added = {2007-06-17 17:35:15 +0200},
	Date-Modified = {2007-06-17 17:38:51 +0200},
	Journal = {Sigkdd Explorations},
	Number = {1},
	Pages = {91-105},
	Title = {Subspace Clustering for High Dimensional Data: A Review},
	Volume = {6},
	Year = {2004}}

@book{parmigiani2003analysis,
	Author = {G. Parmigiani and E. S. Garett and R. A. Irizarry and S. L. Zeger},
	Date-Added = {2007-06-16 18:34:47 +0200},
	Date-Modified = {2007-06-16 18:36:14 +0200},
	Publisher = {Springer},
	Title = {The Analysis of Gene Expression Data},
	Year = {2003}}

@article{barret2005ncbi,
	Author = {T. Barrett and T. O. Suzek and D. B. Troup and S. E. Wilhite and W.-C. Ngau and P. and D. Rudnev and A. E. Lash and W. Fujibuchi and R. Edgar},
	Date-Added = {2007-06-16 14:25:55 +0200},
	Date-Modified = {2007-06-27 08:02:09 +0200},
	Journal = {Nucleic Acids Research},
	Pages = {D562},
	Title = {{NCBI GEO}: mining millions of expression profiles - database and tool},
	Volume = {33},
	Year = {2005}}

@inproceedings{leisch2003sweave,
	Author = {F. Leisch},
	Booktitle = {Third International Workshop on Distributed Statistical Computing},
	Date-Added = {2007-06-16 13:59:14 +0200},
	Date-Modified = {2007-06-16 14:01:46 +0200},
	Title = {Sweave and Beyond: Computations in Text Documents},
	Year = {2003}}

@article{gentleman2005reproducible,
	Author = {R. Gentleman},
	Date-Added = {2007-06-16 10:47:31 +0200},
	Date-Modified = {2007-06-16 10:49:00 +0200},
	Journal = {Statistical Applications in Genetics and Molecular Biology},
	Number = {1},
	Title = {Reproducible Research: A Bioinformatics Case Study},
	Volume = {4},
	Year = {2005}}

@periodical{gentleman2004statistical,
	Author = {R. Gentleman and D. T. Lang},
	Date-Added = {2007-06-16 10:40:54 +0200},
	Date-Modified = {2007-06-16 10:43:17 +0200},
	Journal = {Bioconductor Project Working Papers},
	Title = {Statistical Analyses and Reproducible Research},
	Url = {http://www.bepress.com/bioconductor/paper2},
	Year = {2004},
	Bdsk-Url-1 = {http://www.bepress.com/bioconductor/paper2}}

@article{whitlock2005combining,
	Author = {M. C. Whitlock},
	Date-Added = {2007-06-15 10:11:31 +0200},
	Date-Modified = {2007-06-15 10:13:32 +0200},
	Journal = {J. Evol. Biol.},
	Pages = {1368-1373},
	Title = {Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach},
	Volume = {18},
	Year = {2005}}

@book{mclachlan2000finite,
	Author = {G. McLachlan and D. Peel},
	Date-Added = {2007-06-11 14:06:17 +0200},
	Date-Modified = {2007-06-11 14:14:17 +0200},
	Publisher = {J. Wiley and Sons},
	Series = {Probability and statistics. Applied probability and statistics.},
	Title = {Finite Mixture Models},
	Year = {2000}}

@article{scholkopf2002nonlinear,
	Author = {B. Scholkopf and A. J. Smola and K. R. Muller},
	Date-Added = {2007-06-10 22:36:40 +0200},
	Date-Modified = {2007-06-10 22:39:11 +0200},
	Journal = {Neural Computation},
	Pages = {1299-1319},
	Title = {Nonlinear component analysis as a kernel eigenvalue problem},
	Volume = {10},
	Year = {1998}}

@article{tenenbaum2000global,
	Author = {J. B. Tenenbaum and V. de Silva and J. C. Langford},
	Date-Added = {2007-06-10 22:17:51 +0200},
	Date-Modified = {2007-06-10 22:20:07 +0200},
	Journal = {Science},
	Pages = {2319-2323},
	Title = {A global geometric framework for nonlinear dimensionality reduction},
	Volume = {290},
	Year = {2000}}

@article{grambsch1994proportional,
	Author = {P. Grambsch and T. Therneau},
	Date-Added = {2007-06-10 18:04:10 +0200},
	Date-Modified = {2007-06-10 18:05:47 +0200},
	Journal = {Biometrika},
	Pages = {515-526},
	Title = {Proportional hazards tests and diagnostics based on weighted residuals},
	Volume = {81},
	Year = {1994}}

@inproceedings{yan2004predicting,
	Author = {L. Yan and D. Verbel and O. Saidi},
	Booktitle = {ACM SIGKDD},
	Date-Added = {2007-06-05 14:30:15 +0200},
	Date-Modified = {2007-06-05 14:31:18 +0200},
	Title = {Predicting Prostate Cancer Recurrence via Maximizing the Concordance Index},
	Year = {2004}}

@book{gentleman2005bioinformatics,
	Author = {R. Gentleman and W. Huber and V. J. Carey and R. A. Irizarry and S. Dudoit},
	Date-Added = {2007-05-28 16:10:05 +0200},
	Date-Modified = {2007-05-28 16:13:03 +0200},
	Editor = {R. Gentleman and W. Huber and V. J. Carey and R. A. Irizarry and S. Dudoit},
	Publisher = {Springer},
	Title = {Bioinformatics and Computational Biology Solutions Using R and Bioconductor},
	Year = {2005}}

@inproceedings{zizka2006machine,
	Author = {J. Zizka and T. Hudik},
	Booktitle = {Knowledge Extraction and Modelling Conference},
	Date-Added = {2007-05-24 08:58:22 +0200},
	Date-Modified = {2007-09-21 17:11:32 +0200},
	Month = {September},
	Title = {Machine Learning - Based Knowledge Extraction from Complex Clinical Oncological Data},
	Year = {2006}}

@article{naderi2007geneexpression,
	Author = {A. Naderi and A. E. Teschendorff and N. L. Barbosa-Morais and S. E. Pinder and A. R. Green and D. G. Powe andJ . F. Robertson and S. Aparicio and I. O. Ellis and J. D. Brenton and C. Caldas},
	Date-Added = {2007-05-21 09:43:33 +0200},
	Date-Modified = {2007-05-21 09:46:13 +0200},
	Journal = {Oncogene},
	Pages = {1507-1516},
	Title = {A gene-expression signature to predict survival in breast cancer across independent data sets},
	Volume = {26},
	Year = {2007}}

@article{harr2006comparison,
	Author = {B. Harr and C. Schlotterer},
	Date-Added = {2007-05-14 15:05:56 +0200},
	Date-Modified = {2007-05-14 15:08:00 +0200},
	Journal = {Nucleic Acids Research},
	Number = {2},
	Pages = {8},
	Title = {Comparison of algorithms for the analysis of Affymetrix microarray data as evaluated by co-expression of genes in known operons},
	Volume = {34},
	Year = {2006}}

@article{park2007averaged,
	Author = {M. Park and T. Hastie and R. Tibshirani},
	Date-Added = {2007-05-12 22:56:22 +0200},
	Date-Modified = {2007-05-12 22:57:50 +0200},
	Journal = {Biostatistics},
	Number = {2},
	Pages = {212-227},
	Title = {Averaged Gene Expression for Regression},
	Volume = {8},
	Year = {2007}}

@article{wu2004preprocessing,
	Author = {Z. Wu and R. A. Irizarry},
	Date-Added = {2007-05-11 16:28:07 +0200},
	Date-Modified = {2007-05-11 16:28:59 +0200},
	Journal = {Nature Biotechnology},
	Pages = {656-658},
	Title = {Preprocessing of oligonucleotide array data},
	Volume = {22},
	Year = {2004}}

@techreport{wu2004modelbased,
	Author = {Z. Wu and R. A. Irizarry and R. Gentleman and F. M. Murillo and F. Spencer},
	Date-Added = {2007-05-11 16:00:50 +0200},
	Date-Modified = {2007-05-11 16:03:28 +0200},
	Institution = {Johns Hopkins University Dept. of Biostatistics Working Paper Series},
	Title = {A Model Based Background Adjustment for Oligonucleotide Expression Arrays},
	Year = {2004}}

@article{li2001modelbased,
	Author = {C. Li and W. H. Wong},
	Date-Added = {2007-05-11 15:55:18 +0200},
	Date-Modified = {2007-05-11 15:57:10 +0200},
	Journal = {Genome Biology},
	Number = {8},
	Pages = {1-11},
	Title = {Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application},
	Volume = {2},
	Year = {2001}}

@article{huber2002variance,
	Author = {W. Huber and A. von Heydebreck and H. Sultman and A. Poustka and M. Vingron},
	Date-Added = {2007-05-11 14:06:37 +0200},
	Date-Modified = {2007-05-11 14:08:46 +0200},
	Journal = {Bioinformatics},
	Number = {1},
	Pages = {S96-S104},
	Title = {Variance stabilization applied to microarray data calibration and to the quantification of differential expression},
	Volume = {18},
	Year = {2002}}

@article{kruskal1952ranks,
	Author = {W. H. Kruskal and W. A. Wallis.},
	Date-Added = {2007-04-30 18:28:00 +0200},
	Date-Modified = {2007-04-30 18:29:19 +0200},
	Journal = {Journal of the American Statistical Association},
	Number = {260},
	Pages = {583--621},
	Title = {Use of ranks in one-criterion variance analysis},
	Volume = {47},
	Year = {1952}}

@article{wilcoxon1945individual,
	Author = {F. Wilcoxon},
	Date-Added = {2007-04-30 18:26:19 +0200},
	Date-Modified = {2007-04-30 18:27:14 +0200},
	Journal = {Biometrics Bulletin},
	Pages = {80-83},
	Title = {Individual comparisons by ranking methods},
	Volume = {1},
	Year = {1945}}

@article{friedman1937ranks,
	Author = {M. Friedman},
	Date-Added = {2007-04-30 18:02:26 +0200},
	Date-Modified = {2007-06-14 15:30:34 +0200},
	Journal = {Journal of the American Statistical Association},
	Number = {200},
	Pages = {675-701},
	Title = {The use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance},
	Volume = {32},
	Year = {1937},
	Bdsk-Url-1 = {http://www.jstor.org/pss/2279372}}

@article{cochrane1954combination,
	Author = {W. G. Cochrane},
	Date-Added = {2007-04-30 17:46:57 +0200},
	Date-Modified = {2007-04-30 17:48:18 +0200},
	Journal = {Biometrics},
	Pages = {101-129},
	Title = {The combination of estimates from different experiments},
	Volume = {10},
	Year = {1954}}

@article{cochrane1937problems,
	Author = {W. G. Cochrane},
	Date-Added = {2007-04-30 17:39:20 +0200},
	Date-Modified = {2007-04-30 18:19:57 +0200},
	Journal = {Journal of the Royal Statistical Society},
	Pages = {102-118},
	Title = {Problems arising in the analysis of a series of similar experiments},
	Volume = {4},
	Year = {1937}}

@article{friedman1996bias,
	Author = {J. H. Friedman},
	Date-Added = {2007-03-22 18:17:10 +0100},
	Date-Modified = {2007-03-22 18:26:45 +0100},
	Journal = {Data Mining and knowledge Discovery},
	Pages = {564-569},
	Title = {On bias, variance, 0/1 loss and the curse of dimensionality},
	Year = {1996}}

@inproceedings{meyer2007biological,
	Author = {P. E. Meyer and K. Kontos and G. Bontempi},
	Booktitle = {1st International Conference on Bioinformatics Research and Development},
	Date-Added = {2007-03-22 09:18:06 +0100},
	Date-Modified = {2007-03-22 09:20:18 +0100},
	Title = {Biological Network Inference Using Redundancy Analysis},
	Year = {2007}}

@inproceedings{kontos2006scalefree,
	Author = {K. Kontos and G. Bontempi},
	Booktitle = {Proceedings of AISB'06: Adaptation in Artificial and Biological Systems},
	Date-Added = {2007-03-22 09:14:41 +0100},
	Date-Modified = {2007-03-22 10:29:28 +0100},
	Pages = {133-144},
	Title = {Scale-free paradigm in yeast genetic regulatory network inferred from microarray data},
	Volume = {3},
	Year = {2006}}

@article{butte2000discovering,
	Author = {A. J. Butte and P. Tamayo and D. slonim and T. R. Golubb and I. S. Koshane},
	Date-Added = {2007-03-22 09:07:59 +0100},
	Date-Modified = {2007-03-22 09:10:44 +0100},
	Journal = {PNAS},
	Number = {22},
	Pages = {12182-12186},
	Title = {Discovering functional relationships between RNA expression and chemotherapeutic susceptibilty using relevance networks},
	Volume = {97},
	Year = {2000}}

@article{delafuente2004discovery,
	Author = {A. de la fuente and N. Bing and I. Hoeschele and P. Mendes},
	Date-Added = {2007-03-22 09:05:15 +0100},
	Date-Modified = {2007-03-22 09:07:22 +0100},
	Journal = {Bioinformatics},
	Number = {18},
	Pages = {3565-3574},
	Title = {Discovery of meaningful associations in genomic data using partial correlation coefficients},
	Volume = {20},
	Year = {2004}}

@article{efron1997improvements,
	Author = {B. Efron and R. Tibshirani},
	Date-Added = {2007-03-22 07:39:57 +0100},
	Date-Modified = {2007-03-22 07:42:01 +0100},
	Journal = {Journal of American Statistical Asscoiation},
	Number = {348-360},
	Title = {Improvements on cross-validation: the .632+ bootstrap method},
	Volume = {92},
	Year = {1997}}

@article{baker2006identifying,
	Author = {S. G. Baker and B. S. Kramer},
	Date-Added = {2007-03-21 18:55:26 +0100},
	Date-Modified = {2007-03-21 18:56:50 +0100},
	Journal = {BMC Bioinformatics},
	Number = {407},
	Title = {Identifying genes that contributes most to good classification in microarrays},
	Volume = {7},
	Year = {2006}}

@article{ioannidis2005microarrays,
	Author = {J. P. Ioannidis},
	Date-Added = {2007-03-21 18:49:56 +0100},
	Date-Modified = {2009-02-09 12:17:38 +0100},
	Journal = {Lancet},
	Pages = {454--455},
	Title = {Microarrays and molecular research: noise discovery?},
	Volume = {365},
	Year = {2005}}

@article{varma2006bias,
	Author = {S. Varma and R. Simon},
	Date-Added = {2007-03-21 17:36:03 +0100},
	Date-Modified = {2007-06-30 10:56:41 +0200},
	Journal = {BMC Bioinformatics},
	Number = {91},
	Pages = {1471-2105},
	Title = {Bias in error estimation when using cross-validation for model selection},
	Volume = {7},
	Year = {2006}}

@inproceedings{freund1996experiments,
	Address = {San Francisco},
	Author = {Y. Freund and R. E. Schapire},
	Booktitle = {Machine Learning: Proceedings of the Thirteen International Conference},
	Date-Added = {2007-03-21 15:36:02 +0100},
	Date-Modified = {2007-03-21 15:39:57 +0100},
	Editor = {L. Saitta},
	Pages = {148-156},
	Publisher = {Morgan Kaufmann},
	Title = {Experiments with a new boosting algorithm},
	Year = {1996}}

@article{breiman1996bagging,
	Author = {L. Breiman},
	Date-Added = {2007-03-21 15:32:19 +0100},
	Date-Modified = {2007-03-21 15:33:33 +0100},
	Journal = {Machine Learning},
	Number = {123-140},
	Title = {Bagging Predictors},
	Volume = {24},
	Year = {1996}}

@inproceedings{akaike1973information,
	Author = {H. Akaike},
	Booktitle = {Second international Symposium on Information Theory},
	Date-Added = {2007-03-21 09:47:42 +0100},
	Date-Modified = {2007-03-21 09:50:29 +0100},
	Pages = {267-281},
	Title = {Information theory and an extension of the maximum likelihood principle},
	Year = {1973}}

@book{agresti1990categorical,
	Author = {A. Agresti},
	Date-Added = {2007-03-21 09:45:43 +0100},
	Date-Modified = {2007-03-21 09:46:29 +0100},
	Publisher = {Wiley},
	Title = {Categorical data analysis},
	Year = {1990}}

@article{schwarz1978estimating,
	Author = {G. Schwarz},
	Date-Added = {2007-03-21 09:42:34 +0100},
	Date-Modified = {2007-04-30 18:17:13 +0200},
	Journal = {Annals of Statistics},
	Pages = {461-464},
	Title = {Estimating the dimension of a model},
	Volume = {6},
	Year = {1978}}

@article{zhang2002new,
	Author = {L. Zhang and L. Wang and A. Ravindranathan and M. F. Miles},
	Date-Added = {2007-03-21 08:48:40 +0100},
	Date-Modified = {2007-03-21 08:49:54 +0100},
	Journal = {Journal of Molecular Biology},
	Number = {2},
	Pages = {225-235},
	Title = {A New Algorithm for Analysis of Oligonucleotide Arrays: Application to Expression Profiling in Mouse Brain Regions},
	Volume = {317},
	Year = {2002}}

@book{bezdek1981pattern,
	Author = {J. C. Bezdek},
	Date-Added = {2007-03-20 09:47:59 +0100},
	Date-Modified = {2007-03-20 09:48:45 +0100},
	Publisher = {Plenum},
	Title = {Pattern Recognition with Fuzzy Objective Function Algoritms},
	Year = {1981}}

@article{dunn1973fuzzy,
	Author = {J. C. Dunn},
	Date-Added = {2007-03-20 09:45:18 +0100},
	Date-Modified = {2007-03-20 09:46:29 +0100},
	Journal = {Journal of Cybernetics},
	Pages = {32-57},
	Title = {A Fuzzy Relative of the ISODATA Process and Its Use in Detecting Compact Well-Separated Clusters},
	Volume = {3},
	Year = {1973}}

@article{Zhou87Khargonekar,
	Author = {K. Zhou and P. Khargonekar},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-AC},
	Number = {7},
	Pages = {621--623},
	Title = {Stability Robustness for Linear State-Space Models with Structures Uncertainty},
	Volume = {32},
	Year = {1987}}

@incollection{Zhang94Hutchinson,
	Author = {X.~Zhang and J.~Hutchinson},
	Booktitle = {Time Series Prediction: forecasting the future and understanding the past},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A.~S.~Weigend and N.~A.~Gershenfeld},
	Pages = {219--241},
	Publisher = {Addison Wesley},
	Title = {Simple architectures on fast machines: practical issues in nonlinear time series prediction},
	Year = {1994}}

@article{Zadeh65,
	Author = {L. A. Zadeh},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Information and Control},
	Pages = {338--353},
	Title = {Fuzzy Sets},
	Volume = {8},
	Year = {1965}}

@article{yu2003genomic,
	Author = {H. Yu and N. M. Luscombe and J. Gian and M. Gerstein},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Trend in Genetics},
	Number = {8},
	Pages = {422-427},
	Title = {Genomic analysis of gene expression relationships in transcriptional regulatory networks},
	Volume = {19},
	Year = {2003}}

@article{Yen98WangGillespie,
	Author = {J. Yen and L. Wang and C. W. Gillespie},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE_FS},
	Number = {4},
	Pages = {530--537},
	Title = {Improving the interpretability of {TSK} fuzzy models by combining global learning and global learning},
	Volume = {6},
	Year = {1998}}

@article{Yakowitz87,
	Author = {S.~Yakowitz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JTSA},
	Number = {2},
	Pages = {235--247},
	Title = {Nearest-neighbour methods for time series analysis},
	Volume = {8},
	Year = {1987}}

@article{Yager93Filev,
	Author = {R. R. Yager and D. P. Filev},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-SMC},
	Title = {Unified structure and parameter identification of fuzzy models},
	Volume = {23},
	Year = {1993}}

@inproceedings{Xu95JordanHinton,
	Author = {L. Xu and M. I. Jordan and G. E. Hinton},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {G. Tesauro and D. Touretzky and T. Leen},
	Pages = {633--640},
	Publisher = {The MIT Press},
	Title = {An Alternative Model for Mxtures of Experts},
	Volume = {7},
	Year = {1995}}

@article{wu-1999,
	Author = {Wu D and Bennett K and Cristianini N and Shawe-Taylor J},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {ICML99},
	Title = {Large Margin Decision Trees for Induction and Transduction},
	Year = {1999}}

@article{wright2003gene,
	Author = {G. Wright and B. Tan and A. Rosenwald and E. H. Hurt and A. Wiestner and L. M. Staudt},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {PNAS},
	Number = {17},
	Pages = {9991--9996},
	Title = {A Gene Expression-Based Method to Diagnose Clinically Distinct Subgroups of Diffuse Large B-Cell Lymphoma},
	Volume = {100},
	Year = {2003}}

@article{Woodrofe70,
	Author = {M. Woodrofe},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Ann. Math. Statist.},
	Pages = {1665--1671},
	Title = {On choosing a delta-sequence},
	Volume = {41},
	Year = {1970}}

@proceedings{wong2004support,
	Author = {K. Y. Wong and L. Tham and P. Tan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Australian Computer Society, Inc.},
	Series = {ACM International Conference},
	Title = {Support Vector Machine Approach for Cancer Detection Using Amplified Fragment Length Polymorphism ({AFLP}) Screening Method},
	Year = {2004}}

@article{Wolpert96,
	Author = {D. H. Wolpert},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {NC},
	Pages = {1341--1390},
	Title = {The Lack of {A} Priori Distinctions Between Learning Algorithms},
	Volume = {8},
	Year = {1996}}

@article{Wolpert92,
	Author = {D. Wolpert},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Networks},
	Pages = {241--259},
	Title = {Stacked Generalization},
	Volume = {5},
	Year = {1992}}

@article{wilson2005simpleaffy,
	Author = {C. L. Wilson and C. J. Miller},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {The Paterson Institute Bioinformatics Group},
	Journal = {Bioinformatics Applications Note},
	Number = {18},
	Pages = {3683-3685},
	Title = {Simpleaffy: a BioConductor package for Affymetrix Quality Simpleaffy: a BioConductor package for Affymetrix Quality Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis},
	Volume = {21},
	Year = {2005}}

@article{Williams89Zipser,
	Author = {R. Williams and D. Zipser},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Pages = {270--280},
	Title = {A learning algorithm for continually running fully recurrent neural networks},
	Volume = {1},
	Year = {1989}}

@article{west2001predicting,
	Author = {M. West and C. Blanchette and H. Dressman and E. Huang and S. Ishida and R. Spang and H. Zuzan and J. A. Olson and J. R. Marks and J. R. Nevins},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-03-05 10:06:40 +0100},
	Journal = {PNAS},
	Number = {20},
	Pages = {11462--11467},
	Title = {Predicting the Clinical Status of Human Breast Cancer by Using Gene Expression Profiles},
	Volume = {98},
	Year = {2001}}

@phdthesis{Werbos74,
	Address = {Cambridge, MA},
	Author = {P. Werbos},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Harvard University},
	Title = {Beyond Regression: New Tools for Prediction and Analysis in the Behavioral Sciences},
	Year = {1974}}

@book{weiss1991computer,
	Address = {San Mateo, California},
	Author = {S. M. Weiss and C. A. Kulikowski},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-01 11:20:03 +0200},
	Publisher = {Morgan Kaufmann},
	Title = {Computer Systems that learn},
	Year = {1991}}

@incollection{Weigend96,
	Author = {A.~S.~Weigend},
	Booktitle = {Mathematical Perspectives on Neural Networks},
	Chapter = {12},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M.~C.~Mozer P.~Smolensky and D.~E.~Rumelhart},
	Pages = {395--449},
	Publisher = {Lawrence Erlbaum Associates},
	Title = {Time Series Analysis and Prediction},
	Year = {1996}}

@book{Weigend94Gershenfeld,
	Address = {Harlow, UK},
	Author = {A. S. Weigend and N. A. Gershenfeld},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Addison Wesley},
	Title = {Time Series Prediction: forecasting the future and understanding the past},
	Year = {1994}}

@incollection{Weigend92HubermanRumelhart,
	Author = {A. S. Weigend and B. A. Huberman and D. E. Rumelhart},
	Booktitle = {Nonlinear modeling and forecasting},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. Casdagli and S. Eubank},
	Pages = {395--432},
	Publisher = {Addison-Wesley},
	Title = {Predicting Sunspots and Exchange Rates with Connectionist Networks},
	Year = {1992}}

@article{Watson69,
	Author = {G. Watson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Sankhya, Series},
	Number = {26},
	Pages = {359--372},
	Title = {Smooth regression analysis},
	Volume = {A},
	Year = {1969}}

@inproceedings{Waterhouse96Robinson,
	Author = {S. R. Waterhouse and A. J. Robinson},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {D. S. Touretzky and M. C. Mozer and M. E. Hasselmo},
	Pages = {584--590},
	Publisher = {The MIT Press},
	Title = {Constructive Algorithms for Hierarchical Mixtures of Experts},
	Volume = {8},
	Year = {1996}}

@incollection{Wan94,
	Address = {Harlow, UK},
	Author = {E.~A.~Wan},
	Booktitle = {Time Series Prediction: forecasting the future and understanding the past},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A.~S.~Weigend and N.~A.~Gershenfeld},
	Pages = {195--217},
	Publisher = {Addison Wesley},
	Title = {Time series prediction using a connectionist network with internal delay lines},
	Year = {1994}}

@article{Wahba75Wold,
	Author = {G. Wahba and S. Wold},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Communications in Statistics},
	Number = {1},
	Title = {A completely automatic french curve: Fitting spline functions by cross-validation},
	Volume = {4},
	Year = {1975}}

@article{Vogl88MangisRiglerZinkAlkon,
	Author = {T. P. Vogl and J. K. Mangis and A. K. Rigler and W. T. Zink and D. L. Alkon},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Biological Cybernetics},
	Pages = {257--263},
	Title = {Accelerating the convergence of the back-propagation method},
	Volume = {59},
	Year = {1988}}

@article{Villacci04Bontempi,
	Author = {D. Villacci and G. Bontempi and A. Vaccaro and M. Birattari},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Transactions on Industrial Electronics},
	Note = {To appear},
	Title = {The role of learning methods in the dynamic assessment of power components loading capability.},
	Year = {2004}}

@inproceedings{Vijakumar97Schaal,
	Address = {Monterey, CA},
	Author = {S. Vijakumar and S. Schaal},
	Booktitle = {IEEE International Symposium on Computational Intelligence in Robotics and Automation},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {220--225},
	Title = {Local dimensionality reduction for locally weighted learning},
	Year = {1997}}

@article{Vieu91,
	Author = {P. Vieu},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JRSS_B},
	Number = {2},
	Pages = {453--464},
	Title = {Nonparametric Regression: Optimal local bandwidth choice},
	Volume = {53},
	Year = {1991}}

@book{Vemuri94Rogers,
	Author = {V. Rao Vemuri and R. D. Rogers},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {IEEE Computer Society Press},
	Title = {Artificial Neural Networks. Forecasting Time Series},
	Year = {1994}}

@article{veer2002gene,
	Author = {L. J. {van't Veer} and H. Dai and M. J. {van de Vijver} and Y. D. He and A. A. Hart and M. Mao and H. L. Peterse and K. {van der Kooy} and M. J. Marton and A. T. Witteveen and G. J. Schreiber and R. M. Kerkhiven and C. Roberts and P. S. Linsley and R. Bernards and S. H. Friend},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-11-29 11:32:00 +0100},
	Journal = {Nature},
	Pages = {530-536},
	Title = {Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer},
	Volume = {415},
	Year = {2002}}

@book{vapnik1998statistical,
	Author = {V. N. Vapnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-02-28 11:18:41 +0100},
	Publisher = {Springer},
	Title = {Statistical Learning Theory},
	Year = {1998}}

@book{Vapnik95,
	Address = {New York, NY},
	Author = {V. N. Vapnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer},
	Title = {The Nature of Statistical Learning Theory},
	Year = {1995}}

@inproceedings{Vapnik92,
	Address = {Denver, CO},
	Author = {V. N. Vapnik},
	Booktitle = {Advances in Neural Information Processing Systems},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Optpublisher = {Morgan Kaufmann},
	Title = {Principles of risk minimization for learning theory},
	Volume = {4},
	Year = {1992}}

@article{Vapnik91Chervonenkis,
	Author = {V. N. Vapnik and A. J. Chervonenkis},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Pattern Recognition and Image Analysis},
	Number = {3},
	Pages = {284--305},
	Title = {The necessary and sufficient conditions for consistency of the method of empirical risk},
	Volume = {1},
	Year = {1991}}

@book{Vapnik74Chervonenkis,
	Address = {Moscow},
	Author = {V. N. Vapnik and A. J. Chervonenkis},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {in Russian},
	Publisher = {Nauka},
	Title = {Theory of Pattern Recognition},
	Year = {1974}}

@article{vandevijver2002gene,
	Author = {M. J. {van de Vijver} and Y. D. He and L. {van't Veer} and H. Dai and A. M. Hart and D. W. Voskuil and G. J. Schreiber and J. L. Peterse and C. Roberts and M. J. Marton and M. Parrish and D. Atsma and A. Witteveen and A. Glas and L. Delahaye and T. {van der Velde} and H. Bartelink and S. Rodenhuis and E. T. Rutgers and S. H. Friend and R. Bernards},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-03-17 11:28:31 +0100},
	Journal = {New England Journal of Medicine},
	Number = {25},
	Pages = {1999--2009},
	Title = {A Gene Expression Signature as a Predictor of Survival in Breast Cancer},
	Volume = {347},
	Year = {2002}}

@article{use-onto-express,
	Author = {P. Khatri and S. Draghici and GC Ostermeier and SA. Krawetz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Genomics},
	Pages = {266--270},
	Title = {Profiling Gene Expression Using Onto-Express},
	Volume = {79},
	Year = {2003}}

@techreport{unkn-prior-2004,
	Author = {Saerens M and Souchon N and Renders JM and Decaestecker C},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Free University of Brussels},
	Title = {Dealing with unknown Priors in Supervised Classification},
	Year = {2004}}

@article{unbalanced-pop-2002,
	Author = {Saerens M and Latinne P and Decaestecker C},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Comp.},
	Pages = {21--41},
	Title = {Adjusting the Outputs of a Classifier to New a Priori Probabilities: {A} Simple Procedure},
	Volume = {14},
	Year = {2002}}

@book{tukey1977exploratory,
	Author = {J. W. Tukey},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {Wesley},
	Publisher = {Addison},
	Title = {Exploratory Data Analysis},
	Year = {1977}}

@inproceedings{Tresp95Taniguchi,
	Address = {Cambridge MA},
	Author = {V. Tresp and M. Taniguchi},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {MIT Press},
	Title = {Combining Estimators Using Non-Constant Weighting Functions},
	Year = {1995}}

@book{Tong83,
	Address = {Berlin},
	Author = {H. Tong},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer Verlag},
	Title = {Threshold models in Nonlinear Time Series Analysis},
	Year = {1983}}

@article{Tong80Lim,
	Author = {H. Tong and K. S. Lim},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JRSS_B},
	Pages = {245--292},
	Title = {Thresold Autoregression, Limit Cycles and Cyclical Data},
	Volume = {42},
	Year = {1980}}

@article{Tolle92Parks,
	Author = {H. Tolle and P. C. Parks and E. Ersuand and M . Hormel and J. Militzer},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IJC},
	Number = {2},
	Pages = {291--317},
	Title = {Learning control with interpolating memories - general ideas, design-lay-out, theoretical approaches and practical applications},
	Volume = {56},
	Year = {1992}}

@book{Titterington85SmithMakov,
	Address = {New York},
	Author = {D. M. Titterington and A. F. M. Smith and U. E. Makov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {John Wiley},
	Title = {Statistical Analysis of Finite Mixture Distributions},
	Year = {1985}}

@article{Thorburn18,
	Author = {W. M. Thorburn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Mind},
	Number = {27},
	Pages = {345--353},
	Title = {The myth of Occam's razor},
	Year = {1918}}

@article{Tanaka95,
	Author = {K. Tanaka},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Transactions on Fuzzy Systems},
	Month = {nov},
	Number = {4},
	Pages = {438--447},
	Title = {Stability and Stabilizability of Fuzzy-Neural-Linear Control Systems},
	Volume = {3},
	Year = {1995}}

@article{Tanaka92Sugeno,
	Author = {K. Tanaka and M. Sugeno},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Fuzzy Sets and Systems},
	Pages = {135--156},
	Title = {Stability analysis and design of fuzzy control systems},
	Volume = {45},
	Year = {1992}}

@inbook{Takens81,
	Address = {Berlin},
	Author = {F.~Takens},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer},
	Title = {Dynamical Systems and Turbulence (Detecting strange attractors in fluid turbulence)},
	Year = {1981}}

@article{Takagi85Sugeno,
	Author = {T. Takagy and M. Sugeno},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Transactions on System, Man and Cybernetics},
	Number = {1},
	Pages = {116--132},
	Title = {Fuzzy identification of systems and its applications to modeling and control},
	Volume = {15},
	Year = {1985}}

@manual{svmdoc-2004,
	Author = {D. Meyer},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Organization = {Techische Universitat Wien, Austria},
	Title = {Support Vector Machines: The interface to libsvm in Package e1071},
	Year = {2004}}

@proceedings{svm-shawe-cristianini-1999,
	Author = {Shawe-Taylor J and Cristianini N},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Organization = {COLT99},
	Title = {Further Results on the Margin Distribution},
	Year = {1999}}

@inbook{Suykens98Vandewalle,
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. A. K. Suykens and J. Vandewalle},
	Pages = {241--251},
	Publisher = {Kluwer Academic Publishers},
	Title = {Nonlinear Modeling: Advanced Black-Box Techniques (The {K}. {U}. Leuven Time Series Prediction Competition)},
	Year = {1998}}

@article{Sugeno93Yasukawa,
	Author = {M. Sugeno and T. Yasukawa},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-FS},
	Number = {1},
	Title = {A Fuzzy-Logic-Based Approach to Qualitative Modeling},
	Volume = {1},
	Year = {1993}}

@article{Sugeno88Kang,
	Author = {M. Sugeno and G. T. Kang},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {FSS},
	Pages = {15--33},
	Title = {Structure identification of fuzzy model},
	Volume = {28},
	Year = {1988}}

@article{Stone82,
	Author = {C. J. Stone},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AS},
	Number = {4},
	Pages = {1040--1053},
	Title = {Optimal global rates of convergence for nonparametric regression},
	Volume = {10},
	Year = {1982}}

@article{Stone77b,
	Author = {M. Stone},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JRSS_B},
	Pages = {44--47},
	Title = {An asymptotic equivalence of choice of models by cross-validation and Akaike's criterion},
	Volume = {39},
	Year = {1977}}

@article{Stone77,
	Author = {C. Stone},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AS},
	Pages = {595--645},
	Title = {Consistent nonparametric regression},
	Volume = {5},
	Year = {1977}}

@article{stone1974crossvalidation,
	Author = {M Stone},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-25 13:26:12 +0100},
	Journal = {Journal of the Royal Statistical Society B},
	Number = {1},
	Pages = {111--147},
	Title = {Cross-validatory choice and assessment of statistical predictions},
	Volume = {36},
	Year = {1974}}

@phdthesis{Stenman99,
	Author = {A. Stenman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {No. 571},
	School = {Department of Electrical Engineering, Link{\"{o}}ping University},
	Title = {Model on Demand: Algorithms, Analysis and Applications},
	Year = {1999}}

@inproceedings{Stenman96GustafssonLjung,
	Address = {Kobe, Japan},
	Author = {A. Stenman and F. Gustafsson and L. Ljung},
	Booktitle = {35th IEEE Conference on Decision and Control},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {1115--1120},
	Title = {Just in time models for dynamical systems},
	Year = {1996}}

@book{Stengel86,
	Address = {New York, NY},
	Author = {R. F. Stengel},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {John Wiley and Sons},
	Title = {Stochastic optimal control: theory and application},
	Year = {1986}}

@article{stat-sage,
	Author = {MZ. Man and Z. Wang and Y. Wang},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Bioinformatics},
	Pages = {953--959},
	Title = {{POWERSAGE}: Comparing Statistical Tests for Sage Experiments},
	Volume = {16},
	Year = {2000}}

@article{Stanfill87Waltz,
	Author = {C. Stanfill and D. Waltz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Communications of the ACM},
	Number = {12},
	Pages = {1213--1228},
	Title = {Toward memory-based reasoning},
	Volume = {29},
	Year = {1987}}

@book{speed2003statistical,
	Author = {T Speed and S Lele and J Richtsmeier and G Babu and E Feigelson and J Crowley and S Green and DL Fairclough and L Pronzato and H Wynn and A Zhigljavsky and K Basford and J Tukey and M Waterman and W Gilks ans S Richardson and D Spiegelhalter and A Balter and W Piegrsch},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {T Speed},
	Publisher = {Chapman and Hall/crc},
	Title = {Statistical Analysis of Gene Expression Microarray Data},
	Year = {2003}}

@book{sotiriou2005molecular,
	Author = {C. Sotiriou and C. Desmedt and V. Durbecq and L. Dal Lago and M. Lacroix and F. Cardoso and M. Piccart},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. S. Ross and G. N. Hortobagyi},
	Note = {Chapter 6: Genomic and Molecular Classification of Breast Cancer},
	Publisher = {Jones and Bartlett Publishers},
	Title = {Molecular Oncology of Breast Cancer},
	Year = {2005}}

@article{sotiriou2003molecular,
	Author = {Pusztai L and Sotiriou C and Buchholz TA and Meric F and Symmans WF and Esteva FJ and Liu ET and Sahin A and Hortobagyi GN},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Cancer Genetics and Cytogenetics},
	Pages = {148--153},
	Title = {Molecular profiles of invasive mucinous and invasive ductal carcinomas of the breast, a molecular case study},
	Volume = {141},
	Year = {2003}}

@article{sotiriou2003breast,
	Author = {C. Sotiriou and S. Y. Neo and L. M. McShane and E. L. Korn and P. M. Long and A. Jazaeri and P. Martiat and S.B. Fox and A. L. Harris and E. T. Liu},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Proc. Natl. Acad. Sci.},
	Number = {18},
	Pages = {10393--10398},
	Title = {Breast Cancer Classification and Prognosis Based on Gene Expression Profiles from a Population-Based Study},
	Volume = {100},
	Year = {2003}}

@article{sotiriou-galaxy-2002,
	Author = {Liu T and Sotiriou C},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Breast Cancer Research},
	Number = {4},
	Pages = {141--144},
	Title = {Defining the galaxy of gene expression in breast cancer},
	Volume = {4},
	Year = {2002}}

@article{sotiriou-fna-2002,
	Author = {Sotiriou C and Powles TJ and Dowsett M and Jazaeri AA and Feldman AL and Assersohn L and Gadisetti C and Libutti SK and Liu T},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Breast Cancer Research},
	Number = {3},
	Title = {{FNA}-derived gene expression profiles correlate with response to systemic chemotherapy in breast cancer},
	Volume = {4},
	Year = {2002}}

@article{sorlie2003repeated,
	Author = {T. Sorlie and R. Tibshirani and J. Parker and T. Hastie and J. S. Marron and A. Nobel and S. Deng and H. Johnsen and R. Pesich and S. Geister and J. Demeter and C. Perou and P. E. Lonning and P. O. Brown and A. L. Borresen-Dale and D. Botstein},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-11-29 15:59:04 +0100},
	Journal = {Proc Natl Acad Sci USA},
	Number = {14},
	Pages = {8418--8423},
	Title = {Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Data Sets},
	Volume = {1},
	Year = {2003}}

@article{sorlie2001gene,
	Author = {T. Sorlie and C. M. Perou and R. Tibshirani and T. Aas and S. Geisher and H. Johnsen and T. Hastie and M. B. Eisen and M. van de Rijn and S. S. Jeffrey and T. Thorsen and H. Quist and J. C. Matese. and P. O. Brown and D. Botstein and P. L. Eystein and A. L. Borresen-Dale},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-05-30 14:09:55 +0200},
	Journal = {Proc. Matl. Acad. Sci. USA},
	Number = {19},
	Pages = {10869-10874},
	Title = {Gene Expression Patterns Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications},
	Volume = {98},
	Year = {2001}}

@book{Soderstrom89Stoica,
	Author = {T. S{\"{o}}derstr{\"{o}}m and P. Stoica},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice Hall International},
	Title = {System Identification},
	Year = {1989}}

@book{Slotine91Li,
	Author = {J. J. Slotine and W. Li},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall International},
	Title = {Applied Nonlinear Control},
	Year = {1991}}

@inproceedings{Sjoberg97Agarwal,
	Author = {J. Sj{\"{o}}berg and M. Agarwal},
	Booktitle = {Proceedings of American Control Conference, Albuquerque, New mexico, 4-6 June},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Title = {Non-linear controller tuning based on linearized time-variant model},
	Year = {1997}}

@article{simon2003pitfalls,
	Author = {R. Simon and M. D. Radmacher and K. Dobbin and L. M. McShane},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {J. Natl Cancer Inst},
	Number = {1},
	Pages = {14--18},
	Title = {Pitfalls in the Use of {DNA} Microarray Data for Diagnostic and Prognostic Classification},
	Volume = {95},
	Year = {2003}}

@book{Silverman86,
	Address = {London},
	Author = {B. W. Silverman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman and Hall},
	Title = {Density Estimation for Statistics and Data Analysis},
	Year = {1986}}

@book{Siegel88Castellan,
	Author = {S. Siegel and N. J. Castellan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Edition = {2nd},
	Publisher = {McGraw-Hill International},
	Title = {Non Parametric Statistics for the Behavioral Sciences},
	Year = {1988}}

@book{Sharkey99,
	Author = {A. J. C. Sharkey},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer Verlag},
	Title = {Combining Artificial Neural Nets : Ensemble and Modular Multi-Net Systems (Perspectives in Neural Computing)},
	Year = {1999}}

@article{Shao93,
	Author = {J. Shao},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Number = {422},
	Pages = {486--494},
	Title = {Linear Model Selection by Cross-Validation},
	Volume = {88},
	Year = {1993}}

@article{Shamma92Athans,
	Author = {J. S. Shamma and M. Athans},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-CSMag},
	Pages = {101--107},
	Title = {Gain scheduling: Potential hazards and possible remedies},
	Year = {1992}}

@phdthesis{Shamma88,
	Address = {Cambridge, MA},
	Author = {J. S. Shamma},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Lab. for Information and Decision Sciences, MIT,},
	Title = {Analysis and Design of Gain Scheduled Control Systems},
	Year = {1988}}

@book{Seber89Wild,
	Address = {New York},
	Author = {G. A. F. Seber and C. J. Wild},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Nonlinear regression},
	Year = {1989}}

@book{Scott92,
	Address = {New York},
	Author = {D. W. Scott},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Multivariate density estimation},
	Year = {1992}}

@book{Schuster88,
	Author = {H. G. Schuster},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Weinheim Physik},
	Title = {Deterministic Chaos: An Introduction},
	Year = {1988}}

@incollection{Schott97Bequette,
	Author = {K. D. Schott and B. W. Bequette},
	Booktitle = {Multiple Model Approaches to Modeling and Control},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {R. Murray-Smith and T. A. Johansen},
	Pages = {269--291},
	Publisher = {Taylor and Francis},
	Title = {Multiple Model Adaptive Control},
	Year = {1997}}

@book{scholkopf-1999,
	Author = {Scholkopf C and Burges JC and Smola AJ},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {MIT Press},
	Publisher = {MIT Press},
	Title = {Advances in Kernel Methods},
	Year = {1999}}

@incollection{Schaal99,
	Author = {S. Schaal},
	Booktitle = {Prerational Intelligence in Strategies, High-Level Processes and Collective Behavior},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {H. Ritter ans O. Holland and B. M{\"{o}}hl},
	Note = {in press},
	Publisher = {Kluwer Academic Press},
	Title = {Nonparametric regression for learning nonlinear transformations.},
	Year = {1999}}

@inproceedings{Schaal98VijayakumarAtkeson,
	Author = {S. Schaal and S. Vijayakumar and C. G. Atkeson},
	Booktitle = {Advances in Neural Information Processing Systems 10},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. I. Jordan and M. J. Kearns and S. A. Solla},
	Publisher = {MIT Press},
	Title = {Local Dimensionality Reduction},
	Year = {1998}}

@article{Schaal98Atkeson,
	Author = {S. Schaal and C. G. Atkeson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {NC},
	Pages = {2047--2084},
	Title = {Constructive Incremental Learning from Only Local Information},
	Volume = {10},
	Year = {1998}}

@article{Schaal94Atkeson,
	Author = {S. Schaal and C. G. Atkeson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Control Systems},
	Number = {1},
	Pages = {57--71},
	Title = {Robot Juggling: Implementation of Memory-Based Learning},
	Volume = {14},
	Year = {1994}}

@incollection{Sauer94,
	Address = {Harlow, UK},
	Author = {T.~Sauer},
	Booktitle = {Time Series Prediction: forecasting the future and understanding the past},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A.~S.~Weigend and N.~A.~Gershenfeld},
	Pages = {175--193},
	Publisher = {Addison Wesley},
	Title = {Time series prediction by using delay coordinate embedding},
	Year = {1994}}

@book{Saporta90,
	Address = {Paris},
	Author = {G. Saporta},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Technip},
	Title = {Probabilit\'{e}s: analyse des donn\'{e}es et statistique},
	Year = {1990}}

@article{Sandri95DuboisKalfsbeek,
	Author = {S. A. Sandri and D. Dubois and H. W. Kalfsbeek},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-FS},
	Number = {3},
	Pages = {313--335},
	Title = {Elicitation, Assessment and Pooling of Expert Judgements Using Possibility Theory},
	Volume = {3},
	Year = {1995}}

@article{Salganicoff97,
	Author = {M. Salganicoff},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Review},
	Number = {1--5},
	Pages = {133--155},
	Title = {Tolerating concept and sampling shift in lazy learning using prediction error context switching},
	Volume = {11},
	Year = {1997}}

@incollection{Saerens96RendersBersini,
	Author = {M. Saerens and J. Renders and H. Bersini},
	Booktitle = {Intelligent Control Systems: theory and applications},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. M. Gupta and N. K. Sinha},
	Pages = {292--326},
	Publisher = {IEEE Press},
	Title = {Neurocontrol based on the backpropagation algorithm},
	Year = {1996}}

@book{russel1995ai,
	Author = {S Russel and P Norvig},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {S Russel and P Norvig},
	Publisher = {Prentice Hall},
	Title = {Artificial Intelligence : {A} Modern Approach},
	Year = {1995}}

@article{Ruppert95SheatherWand,
	Author = {D. Ruppert and S. J. Sheather and M. P. Wand},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Pages = {1257--1270},
	Title = {An effective bandwidth selector for local least squares regression},
	Volume = {90},
	Year = {1995}}

@article{Ruppert94Wand,
	Author = {D. Ruppert and M. P. Wand},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {The Annals of Statistics},
	Number = {3},
	Pages = {1346--1370},
	Title = {Multivariate locally weighted least squares regression},
	Volume = {22},
	Year = {1994}}

@article{Rumelhart86HintonWilliams,
	Author = {D. E. Rumelhart and G. E. Hinton and R. K. Williams},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Nature},
	Number = {9},
	Pages = {533--536},
	Title = {Learning representations by backpropagating errors},
	Volume = {323},
	Year = {1986}}

@article{Rugh91,
	Author = {W. J. Rugh},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-CSMag},
	Number = {1},
	Pages = {79--84},
	Title = {Analytical framework for gain scheduling},
	Volume = {11},
	Year = {1991}}

@article{Rosenblatt56,
	Author = {M. Rosenblatt},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AMS},
	Pages = {832--837},
	Title = {Remarks on some nonparametric estimates of a density function},
	Volume = {27},
	Year = {1956}}

@article{Rogers78Wagner,
	Author = {W. H. Rogers and T. J. Wagner},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AS},
	Number = {3},
	Pages = {506--514},
	Title = {A fine sample distribution-free performance bound for local discrimination rules},
	Volume = {6},
	Year = {1978}}

@article{Rissanen78,
	Author = {J. Rissanen},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {ATM},
	Pages = {465--471},
	Title = {Modeling by Shortest Data Description},
	Volume = {14},
	Year = {1978}}

@book{ripley-venables-modern-stat-2002,
	Author = {W. N. Venables and B. D. Ripley},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {Springer},
	Publisher = {Springer},
	Title = {Modern Applied Statistics with {S}},
	Year = {2002}}

@book{ripley-patern-recog-1996,
	Author = {B. D. Ripley},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {Cambridge University Press},
	Note = {ISBN 0 521 46086 7},
	Publisher = {Cambridge University Press},
	Title = {Pattern Recognition and Neural Networks},
	Year = {1996}}

@article{Rice84,
	Author = {J. Rice},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AS},
	Pages = {1215--1230},
	Title = {Bandwidth choice for nonparametric regression},
	Volume = {12},
	Year = {1984}}

@article{Reed93,
	Author = {R. Reed},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-NN},
	Number = {5},
	Pages = {740--746},
	Title = {Pruning Algorithms: {A} Survey},
	Volume = {4},
	Year = {1993}}

@book{Rao73,
	Address = {New York},
	Author = {C. R. Rao},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Edition = {2nd},
	Publisher = {J. Wiley and Sons},
	Title = {Linear Statistical Inference and its Applications},
	Year = {1973}}

@manual{R2007,
	Address = {Vienna, Austria},
	Author = {{R Development Core Team}},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-11-03 19:08:19 +0100},
	Note = {{ISBN} 3-900051-07-0},
	Organization = {R Foundation for Statistical Computing},
	Title = {R: A language and environment for statistical computing},
	Url = {http://www.R-project.org},
	Year = {2007},
	Bdsk-Url-1 = {http://www.R-project.org}}

@inproceedings{Quinlan93,
	Author = {J. R. Quinlan},
	Booktitle = {Machine Learning. Proceedings of the Tenth International Conference},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {236--243},
	Publisher = {Morgan Kaufmann},
	Title = {Combining instance-based and model-based learning},
	Year = {1993}}

@article{Quinlan90,
	Author = {J. R. Quinlan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-SMC},
	Number = {2},
	Pages = {339--346},
	Title = {Decision trees and decisionmaking},
	Volume = {20},
	Year = {1990}}

@article{Quinlan87,
	Author = {J. R. Quinlan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Man-Machine Studies},
	Pages = {221--234},
	Title = {Simplyfying decision trees},
	Volume = {27},
	Year = {1987}}

@article{Quinlan86,
	Author = {J. R. Quinlan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {ML},
	Pages = {81--106},
	Title = {Induction of decision trees},
	Volume = {1},
	Year = {1986}}

@incollection{quinlan-1997,
	Author = {Quinlan J},
	Booktitle = {Programs for Machine Learning},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Kaufmann M},
	Series = {Machine Learning},
	Title = {{C4}.5},
	Year = {1997}}

@article{prior-2002,
	Author = {Saerens M and Latinne P and Decaestecker C},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Pages = {21--41},
	Title = {Adjusting the Outputs of a Classifier to New a Priori Probabilities: {A} Simple Procedure},
	Volume = {14},
	Year = {2002}}

@book{Priestley88,
	Author = {M. B. Priestley},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Non-linear and Non-stationary time series analysis},
	Year = {1988}}

@article{Priestley72Chao,
	Author = {M. B. Priestley and M. T. Chao},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JRSS_B},
	Pages = {385--392},
	Title = {Non-parametric Function Fitting},
	Volume = {34},
	Year = {1972}}

@book{Press92TeukolskyVetterlingFlannery,
	Author = {W. H. Press and S. A. Teukolsky and W. T. Vetterling and B. P. Flannery},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {Second ed.},
	Publisher = {Cambridge University Press},
	Title = {Numerical Recipes in {C} (The Art of Scientific Computing)},
	Year = {1992}}

@inbook{Powell87,
	Address = {Oxford},
	Author = {M. J. D. Powell},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {143--167},
	Publisher = {Clarendon Press},
	Title = {Algorithms for Approximation: Radial Basis Functions for multivariable interpolation (a review)},
	Year = {1987}}

@article{Poggio90Girosi,
	Author = {R. Poggio and F. Girosi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Science},
	Pages = {978--982},
	Title = {Regularization algorithms for learning that are equivalent to multilayer networks},
	Volume = {247},
	Year = {1990}}

@techreport{Plaut86NowlanHinton,
	Author = {D. Plaut and S. Nowlan and G. E. Hinton},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Department of Computer Science, Carnegie Mellon University, Pittsburgh, PA},
	Number = {CMU-CS-86-126},
	Title = {Experiments on learning by back propagation},
	Year = {1986}}

@article{Platt91,
	Author = {J. Platt},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Number = {2},
	Title = {Resource-allocating network for function interpolation},
	Volume = {3},
	Year = {1991}}

@book{webb2003statistical,
	Author = {A Webb},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-09-05 15:03:13 +0200},
	Edition = {second},
	Isbn = {0-470-84513-9},
	Publisher = {John Wiley and Sons},
	Title = {Statistical Pattern Recognition},
	Year = {2003},
	Bdsk-Url-1 = {http://www.statistical-pattern-recognition.net/}}

@incollection{Passino96Yurkovich,
	Author = {K. M. Passino and S. Yurkovich},
	Booktitle = {The Control Handbook},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {W. S. Levine},
	Pages = {1001--1017},
	Publisher = {IEEE Press},
	Title = {Fuzzy Control},
	Year = {1996}}

@article{Parzen62,
	Author = {E. Parzen},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AMS},
	Pages = {1065--1076},
	Title = {On estimation of a probability density function and mode},
	Volume = {33},
	Year = {1962}}

@article{Park90Marron,
	Author = {B. U. Park and J. S. Marron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Pages = {66--72},
	Title = {Comparison of data-driven bandwidth selectors},
	Volume = {85},
	Year = {1990}}

@book{Papoulis91,
	Author = {A. Papoulis},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {McGraw Hill},
	Title = {Probability, Random Variables, and Stochastic Processes},
	Year = {1991}}

@article{Palm97Rehfuess,
	Author = {T. Palm and U. Rehfuess},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {FSS},
	Pages = {233--246},
	Title = {Fuzzy controllers as gain scheduling approximators},
	Volume = {85},
	Year = {1997}}

@book{Palm97HellendoornDriankov,
	Author = {R. Palm and H. Hellendoorn and D. Driankov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer},
	Title = {Model Based Fuzzy Control},
	Year = {1997}}

@article{Packard80CrutchfeldFarmerShaw,
	Author = {N.~H.~Packard and J.~P.~Crutchfeld and J.~D.~Farmer and R.~S.~Shaw},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Physical Review Letters},
	Number = {9},
	Pages = {712--716},
	Title = {Geometry from a time series},
	Volume = {45},
	Year = {1980}}

@manual{OptimMatlab94,
	Author = {Andrew Grace},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Month = {oct},
	Organization = {The MATHWORKS Inc.},
	Title = {Optimization Toolbox ForUse with {MATLAB}},
	Year = {1994}}

@book{Nicolis77Prigogine,
	Address = {New York},
	Author = {G. Nicolis and I. Prigogine},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Self Organisation in Nonequilibrium Systems},
	Year = {1977}}

@article{lohrisch2000breast,
	Author = {Lohrisch C and Piccart M},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-07-04 10:27:10 +0200},
	Journal = {Ann. Oncol.},
	Title = {Breast cancer: new aspects of adjuvant hormonal therapy},
	Year = {2000}}

@article{Nene97Nayar,
	Author = {S. A. Nene and S. K. Nayar},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Transactions on Pattern Analysis and Machine Intelligence},
	Month = {sep},
	Number = {9},
	Pages = {989--1003},
	Title = {A Simple Algorithm for Nearest Neighbor Search in High Dimensions},
	Volume = {19},
	Year = {1997}}

@article{Nelder72Wedderburn,
	Author = {J. A. Nelder and R. W. M. Wedderburn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JRSS_A},
	Pages = {370--384},
	Title = {Generalized linear models},
	Volume = {153},
	Year = {1972}}

@article{Narendra97Balakrishnan,
	Author = {K. S. Narendra and J. Balakrishnan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Transactions on Automatic Control},
	Number = {2},
	Pages = {171--187},
	Title = {Adaptive Control Using Multiple Models},
	Volume = {42},
	Year = {1997}}

@incollection{Narendra96Mukhopadyhay,
	Author = {K. S. Narendra and S. Mukhopadyhay},
	Booktitle = {Intelligent Control Systems: theory and applications},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. N. Gupta and N. K. Sinha},
	Pages = {151--186},
	Publisher = {IEEE Press},
	Title = {Intelligent Control using Neural Networks},
	Year = {1996}}

@incollection{Narendra96Li,
	Author = {K. S. Narendra and S. M. Li},
	Booktitle = {Mathematical Perspectives on Neural Networks},
	Chapter = {11},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. C. Mozer P. Smolensky and D. E. Rumelhart},
	Pages = {347--394},
	Publisher = {Lawrence Erlbaum Associates},
	Title = {Neural Networks in Control Systems},
	Year = {1996}}

@article{Narendra92Parthasarathy,
	Author = {K. S. Narendra and K. Parthasarathy},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Int. Journal of Approximate Reasoning},
	Pages = {109--131},
	Title = {Neural Networks and dynamical systems},
	Volume = {6},
	Year = {1992}}

@incollection{Narendra92,
	Address = {New York},
	Author = {K. S. Narendra},
	Booktitle = {Handbook of Intelligent Control},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {D. A. White and D. A. Sofge},
	Pages = {141--183},
	Publisher = {Van Nostrand Reinhold},
	Title = {Adaptive Control of Dynamical Systems Using Neural Networks},
	Year = {1992}}

@book{Narendra89Annaswamy,
	Address = {Englewood Cliffs, NJ},
	Author = {K. S. Narendra and A. M. Annaswamy},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice Hall},
	Title = {Stable Adaptive Systems},
	Year = {1989}}

@techreport{naef2001features,
	Author = {F. Naef and D. A. Lim and M. O. Magnasco},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-27 08:07:39 +0200},
	Institution = {Institut fur Hydromechanik und Wasserwirtschaft},
	Title = {rom Features to Expression: High Density Oligonucleotide Array Analysis Revisited},
	Year = {2001}}

@article{Nadaraya64,
	Author = {E. Nadaraya},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Theory of Prob. and Appl.},
	Pages = {141--142},
	Title = {On estimating regression},
	Volume = {9},
	Year = {1964}}

@book{myers1994classical,
	Address = {Boston, {MA}},
	Author = {Raymond H. Myers},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-31 13:25:48 +0100},
	Edition = {second},
	Publisher = {PWS-KENT Publishing Company},
	Title = {Classical and Modern Regression with Applications},
	Year = {1994},
	Bdsk-Url-1 = {http://www.amazon.com/Classical-Regression-Applications-Duxbury-Classic/dp/0534380166}}

@incollection{murraysmith1997local,
	Author = {R. {Murray-Smith} and T. A. Johansen},
	Booktitle = {Multiple Model Approaches to Modeling and Control},
	Chapter = {7},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-11-27 07:57:24 +0100},
	Editor = {R. {Murray-Smith} and T. A. Johansen},
	Pages = {185--210},
	Publisher = {Taylor and Francis},
	Title = {Local Learning in Local Model Networks},
	Year = {1997}}

@book{murraysmith1997multiple,
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-12-16 11:57:29 +0100},
	Editor = {R. Murray-Smith and T. A. Johansen},
	Publisher = {Taylor and Francis},
	Title = {Multiple Model Approaches to Modelling and Control},
	Year = {1997}}

@incollection{MurraySmith95Hunt,
	Author = {R. Murray-Smith and K. Hunt},
	Booktitle = {Neural Network Engineering in dynamic control systems},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {K. J. Hunt and G. R. Irwin and K. Warwick},
	Pages = {61--82},
	Publisher = {Springer},
	Title = {Local Model Architectures for Nonlinear Modelling and Control},
	Year = {1995}}

@phdthesis{murraysmith1994local,
	Address = {Strathclyde, {UK}},
	Author = {R. Murray-Smith},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-12-16 12:13:58 +0100},
	School = {Department of Computer Science, University of Strathclyde},
	Title = {A local model network approach to nonlinear modelling},
	Year = {1994}}

@incollection{Mozer94,
	Address = {Harlow, UK},
	Author = {M. C. Mozer},
	Booktitle = {Time Series Prediction: forecasting the future and understanding the past},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A. S. Weigend and N. A. Gershenfeld},
	Pages = {175--193},
	Publisher = {Addison Wesley},
	Title = {Neural net architectures for temporal sequence processing},
	Year = {1994}}

@article{Morgan63Sonquist,
	Author = {J. N. Morgan and J. A. Sonquist},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Pages = {415--434},
	Title = {Problems in the analysis of survey data, and a proposal},
	Volume = {58},
	Year = {1963}}

@inproceedings{Moore97SchneiderDeng,
	Author = {A. W. Moore and J. Schneider and K. Deng},
	Booktitle = {Proceedings 0f the 1997 International Machine Learning Conference},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {ftp at http://www.cs.cmu.edu/\~awm/papers.html},
	Publisher = {Morgan Kaufmann Publishers},
	Title = {Efficient Locally Weighted Polynomial Regression Predictions},
	Year = {1997}}

@inproceedings{moore94efficient,
	Author = {A. W. Moore and M. S. Lee},
	Booktitle = {International Conference on Machine Learning},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	File = {moore94efficient.ps},
	Pages = {190--198},
	Publisher = {Morgan Kaufmann Publishers, Inc.},
	Title = {Efficient Algorithms for Minimizing Cross Validation Error},
	Year = {1994}}

@incollection{Moore92HillJohnson,
	Address = {Cambridge, MA},
	Author = {A. W. Moore and D. J. Hill and M. P. Johnson},
	Booktitle = {Computational Learning Theory and Natural Learning Systems},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {S. Janson and S. Judd and T. Petsche},
	Publisher = {MIT Press},
	Title = {An empirical investigation of brute force to choose features, smoothers and function approximators},
	Volume = {3},
	Year = {1992}}

@inproceedings{Moore91,
	Address = {San Mateo, CA},
	Author = {A. Moore},
	Booktitle = {Advances in neural information processing systems, NIPS 4},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. E. Moody and S. J. Hanson and R. P. Lippman},
	Publisher = {Morgan Kaufmann},
	Title = {Fast, robust adaptive control by learning only forward models.},
	Year = {1991}}

@inproceedings{Moody92,
	Address = {Palo Alto},
	Author = {J. Moody},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. Moody and Hanson and Lippmann},
	Pages = {847--854},
	Publisher = {Morgan Kaufmann},
	Title = {The Effective Number of Parameters: An Analysis of Generalization and Regularization in Nonlinear Learning Systems},
	Volume = {4},
	Year = {1992}}

@article{moody1989fast,
	Author = {J. Moody and C. J. Darken},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-12-16 11:58:51 +0100},
	Journal = {Neural Computation},
	Number = {2},
	Pages = {281--294},
	Title = {Fast learning in networks of locally-tuned processing units},
	Volume = {1},
	Year = {1989}}

@book{mol-cell-biol,
	Author = {Lodish H and Kaiser CA and Berk A and Krieger M and Matsudaira P and Scott MP},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Edition = {4},
	Editor = {W. H. Freeman and Company},
	Publisher = {Sara Tenney},
	Title = {Molecular Cell Biology},
	Year = {2003}}

@book{mitchell1997machine,
	Author = {T. Mitchell},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {McGraw},
	Publisher = {McGraw},
	Title = {Machine Learning},
	Year = {1997}}

@book{Miller1990SuttonWerbos,
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {W. T. MillerIII and R. S. Sutton and P. J. Werbos},
	Publisher = {The MIT Press},
	Title = {Neural Networks for Control},
	Year = {1990}}

@article{Miller87,
	Author = {W. T. Miller},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-RA},
	Pages = {157--165},
	Title = {Sensor-based control of robotic manipulators using a general learning algorithm},
	Volume = {3},
	Year = {1987}}

@article{aach2001minimum,
	Author = {A. Brazma and P. Hingcamp and J. Quackenbush and G. Sherlock and P. Speliman and C. Stoeckert and J. Aach and W. Ansorge and C. A. Ball and H. C. Causton and T. Gaasterland and P. Glenisson and F. C. Holstege and I. F. Kim and V. Markowitz and J. C. Matese and H. Parkinson and A. Robinson and U. Sarkans and S. Schulze-Kremer and J. Stewart and R. Taylor and J. Vilo and M. Vingron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-27 13:17:23 +0200},
	Journal = {Nature Genetics},
	Number = {4},
	Pages = {365--371},
	Title = {Minimum Information About a Microarray Experiment ({MIAME}) - toward standards for microarray data},
	Volume = {29},
	Year = {2001}}

@unpublished{miame,
	Author = {Microarray Gene Expression Data Society},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.mged.org/miame},
	Title = {Minimum information about a microarray experiment ({MIAME})},
	Year = {1999}}

@misc{Merz98Murphy,
	Author = {C. J. Merz and P. M. Murphy},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.ics.uci.edu/$\sim$mlearn/MLRepository.html},
	Title = {\emph{UCI} Repository of machine learning databases},
	Year = {1998}}

@article{Merz97Pazzani,
	Author = {C. J. Merz and M. J. Pazzani},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Machine Learning},
	Title = {A Principal Components Approach to Combining Regression Estimates},
	Year = {1997}}

@inproceedings{Meir95,
	Address = {Cambridge MA},
	Author = {R. Meir},
	Booktitle = {NIPS 7},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {MIT Press},
	Title = {Bias, Variance and the Combination of Least Squares Estimators},
	Year = {1995}}

@article{McNames99SuykensVandewalle,
	Author = {J. McNames and J. Suykens and J. Vandewalle},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Bifurcation and Chaos},
	Note = {to appear},
	Title = {Winning Contribution of the {K}.{U}. Leuven time-series prediction competition},
	Year = {1999}}

@phdthesis{McNames99,
	Author = {J. McNames},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Stanford University},
	Title = {Innovations in local modeling for time series prediction},
	Year = {1999}}

@inproceedings{McNames98,
	Address = {Belgium},
	Author = {J. McNames},
	Booktitle = {Proceedings of the InternationalWorkshop on Advanced Black-Box Techniques for Nonlinear Modeling},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Organization = {K.U. Leuven},
	Pages = {112--128},
	Title = {A nearest trajectory strategy for time series prediction},
	Year = {1998}}

@article{mcculloch1943logical,
	Author = {W. McCulloch and W. Pitts},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Bulletin of Mathematical Biophysics},
	Pages = {115--133},
	Title = {A Logical Calculus in Nervous Activity},
	Volume = {5},
	Year = {1943}}

@book{McCullagh83Nelder,
	Address = {London},
	Author = {P. McCullagh and J. A. Nelder},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman and Hall},
	Title = {Generalized Linear Models},
	Year = {1983}}

@manual{matlab-2002,
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {version 6},
	Organization = {The MathWorks Inc.},
	Title = {Matlab},
	Year = {2002}}

@book{Masters95,
	Address = {New York, NY},
	Author = {T. Masters},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Practical Neural Network Recipes in {C}++},
	Year = {1995}}

@incollection{massone-sensorimotor,
	Author = {L. Massone},
	Booktitle = {The Handbook of Brain Theory and Neural Networks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {MIT Press},
	Title = {Sensorimotor learning},
	Year = {1994}}

@article{mason1982areas,
	Author = {S. J. Mason and N. E. Graham},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Q. J. R. Meteorol. Soc.},
	Pages = {291-303},
	Title = {Areas Beneath the Relative Operating Characteristics (ROC) and Relative Operating Levels (ROL) curves: Statistical Significance and Interpretation},
	Volume = {30},
	Year = {1982}}

@article{maron1997racing,
	Author = {O. Maron and A. W. Moore},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Review},
	Number = {1-5},
	Pages = {193-225},
	Title = {The Racing Algorithm: Model Selection for Lazy Learners},
	Url = {citeseer.ist.psu.edu/maron97racing.html},
	Volume = {11},
	Year = {1997},
	Bdsk-Url-1 = {citeseer.ist.psu.edu/maron97racing.html}}

@book{Marino95Tomei,
	Address = {UK},
	Author = {R. Marino and P. Tomei},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice Hall},
	Title = {Nonlinear Control Design: Geometric, Adaptive and Robust.},
	Year = {1995}}

@unpublished{map-ulb,
	Author = {Latouche G},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.ulb.ac.be/ di/map/map\_def.html},
	Title = {{M}\'{e}thodes Algorithmiques en Probabilit\'{e}s ({MAP})}}

@article{Mamdani75Assilian,
	Author = {E. H. Mamdani and S. Assilian},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Man-Machine Studies},
	Number = {1},
	Pages = {1--13},
	Title = {An experiment in linguistic synthesis with a fuzzy logic controller},
	Volume = {7},
	Year = {1975}}

@article{Mallows74,
	Author = {C. Mallows},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {TC},
	Pages = {187--188},
	Title = {Discussion of a paper of Beaton and Tukey},
	Volume = {16},
	Year = {1974}}

@article{Mallows73,
	Author = {C. L. Mallows},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {TC},
	Pages = {661},
	Title = {Some comments on ${C}_p$},
	Volume = {15},
	Year = {1973}}

@article{Mak99MortonWood,
	Author = {W. K. Mak and D. P. Morton and R. K. Wood},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Operations Research Letters},
	Pages = {47--56},
	Title = {Monte Carlo bounding techniques for determining solution quality in stochastic programs},
	Volume = {24},
	Year = {1999}}

@article{Mackey77Glass,
	Author = {M. C. Mackey and L. Glass},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Science},
	Number = {287},
	Title = {Oscillations and Chaos in Physiological Control Systems},
	Volume = {197},
	Year = {1977}}

@book{Lyapunov1892,
	Author = {A. M. Lyapunov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {in Russian},
	Publisher = {Kharkov Mathematical Society},
	Title = {The general problem of the stability of motion},
	Volume = {Collected Works II},
	Year = {1892}}

@book{Luenberger84,
	Address = {Reading, MA},
	Author = {D. G. Luenberger},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Addison Wesley},
	Title = {Linear and Nonlinear Programming},
	Year = {1984}}

@book{Luenberger79,
	Author = {D. Luenberger},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Introduction to dynamic systems : theory, models, and applications},
	Year = {1979}}

@inproceedings{Lowe91Webb,
	Author = {D. Lowe and A. R. Webb},
	Booktitle = {IEE Proceedings-F},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {17--24},
	Title = {Time Series Prediction by Adaptive Networks: {A} Dynamical System Perspective},
	Volume = {128},
	Year = {1991}}

@article{Lorenz69,
	Author = {E.~N.~Lorenz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of the Atmospheric Sciences},
	Pages = {636--646},
	Title = {Atmospheric predictability as revealed by naturally occurring analogues},
	Volume = {26},
	Year = {1969}}

@techreport{Loader87,
	Author = {C. R. Loader},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Bell-Labs},
	Title = {Old Faithful Erupts: Bandwidth Selection Reviewed},
	Year = {1987}}

@article{ll-model-2000,
	Author = {Bontempi G and Birattari M and Bersini H},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Communications},
	Number = {1},
	Pages = {41--48},
	Title = {A Model Selection Approach for Local Learning},
	Volume = {13},
	Year = {2000}}

@article{ll-1999,
	Author = {Bontempi G and Birattari M and Bersini H},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Control},
	Number = {7/8},
	Pages = {643--658},
	Title = {Lazy Learning for Modeling and Control Design},
	Volume = {72},
	Year = {1999}}

@book{Ljung87,
	Address = {Englewood Cliffs, NJ},
	Author = {L. Ljung},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall},
	Title = {System identification: Theory for the User},
	Year = {1987}}

@article{Ljung78,
	Author = {L. Ljung},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-AC},
	Number = {5},
	Pages = {770--783},
	Title = {Convergence Analysis of Parametric Identification Methods},
	Volume = {23},
	Year = {1978}}

@phdthesis{Lindskog96,
	Author = {P. Lindskog},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Linkoping University},
	Title = {Methods, Algorithms and Tools for System Identification Based on Prior Knowledge},
	Year = {1996}}

@book{Lichtenberg83Lieberman,
	Address = {New York},
	Author = {A.~J.~Lichtenberg and M.~A.~Lieberman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer-Verlag},
	Title = {Regular and Stochastic Motion},
	Year = {1983}}

@unpublished{libsvm,
	Author = {C. Chang and H. Lin},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.csie.ntu.edu.tw/cijlin/libsvm},
	Title = {A Library for Support Vector Machines}}

@article{Leontaritis85Billings,
	Author = {I. J. Leontaritis and S. A. Billings},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Control},
	Number = {2},
	Pages = {303--344},
	Title = {Input-output parametric models for non-linear systems},
	Volume = {41},
	Year = {1985}}

@book{Larson82,
	Address = {New York, {NY}, {USA}},
	Author = {H.~Larson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {John Wiley \& Sons},
	Title = {Introduction to Probability Theory and Statistical Inference},
	Year = {1982}}

@techreport{Lapedes87Farber,
	Address = {Los Alamos, NM},
	Author = {A. Lapedes and R. Farber},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Los Alamos National Laboratory},
	Number = {LA-UR-87-2662},
	Title = {Nonlinear Signal Processing Using Neural Networks},
	Year = {1987}}

@article{lacroix2004relevance,
	Author = {M. Lacroix and G. Leclercq},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Breast Cancer Res and Treat},
	Pages = {530--536},
	Title = {Relevance of Breast Cancer Cell Lines as Models for Breast Tumors: an Update},
	Volume = {415},
	Year = {2004}}

@article{Kuperstein88,
	Author = {M. Kuperstein},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Science},
	Pages = {1308--1311},
	Title = {Neural model of adaptive hand-eye coordination for single postures},
	Volume = {239},
	Year = {1988}}

@book{Kolodner93,
	Author = {J. Kolodner},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Morgan Kaufmann},
	Title = {Case-Based Reasoning},
	Year = {1993}}

@book{Kolmogorov33,
	Address = {Berlin},
	Author = {A. N. Kolmogorov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Title = {Foundations of Probability},
	Year = {1933}}

@phdthesis{Koivisto95,
	Address = {Tampere, Finland},
	Author = {H. Koivisto},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Tampere University of Technology},
	Title = {A Practical Approach to Model Based Neural Network Control},
	Year = {1995}}

@inproceedings{kohavi1995study,
	Author = {R. Kohavi},
	Booktitle = {Proceedings of IJCAI-95},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {available at http://robotics.stanford.edu/users/ronnyk/ronnyk-bib.html},
	Title = {A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection},
	Year = {1995}}

@article{kohavi1997wrappers,
	Author = {R. Kohavi and G. H. John},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-18 08:23:38 +0200},
	Journal = {Artificial Intelligence},
	Number = {1-2},
	Pages = {273-324},
	Title = {Wrappers for Feature Subset Selection},
	Volume = {97},
	Year = {1997}}

@article{Kleywegt01ShapiroHomem,
	Author = {A. J. Kleywegt and A. Shapiro and T. Homem-de-Mello},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {SIAM Journal of Optimization},
	Pages = {479--502},
	Title = {The sample average approximation method for stochastic discrete optimization},
	Volume = {12},
	Year = {2001}}

@inbook{Kleywegt01Shapiro,
	Address = {New York, NY},
	Author = {A. J. Kleywegt and A. Shapiro},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {2625--2649},
	Publisher = {John Wiley and Sons},
	Title = {Handbook of Industrial Engineering (Stochastic Optimization)},
	Year = {2001}}

@article{Kirkpatrick83GelattVecchi,
	Author = {S. Kirkpatrick and C. D. Gelatt and M. P. Vecchi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Science},
	Number = {4598},
	Pages = {671--680},
	Title = {Optimization by simulated annealing},
	Volume = {220},
	Year = {1983}}

@article{Kearns99Ron,
	Author = {M. Kearns and D. Ron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {NC},
	Number = {6},
	Pages = {1427--1454},
	Title = {Algorithmic Stability and Sanity-Check Bounds for Leave-One-Out Cross-Validation},
	Volume = {11},
	Year = {1999}}

@inproceedings{Kearns97Ron,
	Author = {M. Kearns and D. Ron},
	Booktitle = {Tenth Annual Conference on Computational Learning Theory},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Title = {Algorithmic Stability and Sanity-Check Bounds for Leave-One-Out Cross-Validation},
	Year = {1997}}

@inproceedings{Kearns96,
	Author = {M. Kearns},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {183--189},
	Title = {A bound on the error of cross validation, with consequences for the training-test split},
	Voulme = {8},
	Year = {1996}}

@article{Katkovnik79,
	Author = {V. Y. Katkovnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Soviet Automatic Control},
	Pages = {25--34},
	Title = {Linear and nonlinear methods of nonparametric regression analysis},
	Volume = {5},
	Year = {1979}}

@article{jordan1994hierarchical,
	Author = {M. J. Jordan and R. A. Jacobs},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-31 11:51:24 +0100},
	Journal = {NC},
	Pages = {181--214},
	Title = {Hierarchical Mixtures of Experts and the {EM} Algorithm},
	Volume = {6},
	Year = {1994}}

@techreport{Jordan93Xu,
	Address = {Cambridge},
	Author = {M. I. Jordan and L. Xu},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Computational Cognitive Science, MIT},
	Number = {9301},
	Title = {Convergence Properties of the {EM} Approach to Learning in Mixture-of-Experts Architectures},
	Year = {1993}}

@article{Jordan92Rumelhart,
	Author = {M. I. Jordan and D. E. Rumelhart},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Cognitive Science},
	Pages = {307--354},
	Title = {Forward Models: Supervised Learning with a Distal Teacher},
	Volume = {16},
	Year = {1992}}

@inproceedings{jordan1992hierarchies,
	Address = {San Mateo, CA},
	Author = {M. I. Jordan and R. A. Jacobs},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-31 11:50:31 +0100},
	Editor = {J. Moody and S. Hanson and R. Lippmann},
	Pages = {985--993},
	Publisher = {Morgan Kaufmann},
	Title = {Hierarchies of adaptive experts},
	Volume = {4},
	Year = {1992}}

@article{Jones95MarronSheather,
	Author = {M. C. Jones and J. S. Marron and S. J. Sheather},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Title = {A brief survey of bandwidth selection for density estimation},
	Volume = {90},
	Year = {1995}}

@inproceedings{John96Langley,
	Author = {G. H. John and P. Langley},
	Booktitle = {Proceedings of the Second International Conference on Knowledge Discovery in Databases and Data Mining},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {AAAI/MIT Press},
	Title = {Static versus dynamic sampling for data mining},
	Year = {1996}}

@phdthesis{Johansson99,
	Author = {M. Johansson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Department of Automatic Control, Lund Institute of Technology},
	Title = {Piecewise Linear Control Systems},
	Year = {1999}}

@incollection{Johansen95Foss,
	Author = {T. A. Johansen and B. A. Foss},
	Booktitle = {Neural Network Engineering in dynamic control systems},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {K. J. Hunt and G. R. Irwin and K. Warwick},
	Pages = {105--126},
	Publisher = {Springer},
	Title = {Semi-Empirical Modeling of Nonlinear Dynamic Systems through Identification of Operating Regimes and Local Models},
	Year = {1995}}

@article{Johansen1993constructing,
	Author = {T. A. Johansen and B. A. Foss},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-10-08 12:12:00 +0200},
	Journal = {International Journal of Control},
	Pages = {1125--1153},
	Title = {Constructing {NARMAX} models using {ARMAX} models},
	Volume = {58},
	Year = {1993}}

@book{Jang97SunMizutani,
	Author = {J. S. R. Jang and C. T. Sun and E. Mizutani},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice Hall},
	Series = {Matlab Curriculum Series},
	Title = {Neuro-Fuzzy and Soft Computing},
	Year = {1997}}

@article{Jang93,
	Author = {J.-S. R. Jang},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-FS},
	Number = {3},
	Pages = {665--685},
	Title = {{ANFIS}: Adaptive-Network-based Fuzzy Inference Systems},
	Volume = {23},
	Year = {1993}}

@article{Jain87DubesChen,
	Author = {A. K. Jain and R. C. Dubes and C. Chen},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-PAMI},
	Pages = {628--633},
	Title = {Bootstrap Techniques for Error Estimation},
	Volume = {5},
	Year = {1987}}

@book{Jacobson70Mayne,
	Address = {New York},
	Author = {D. Jacobson and D. Mayne},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Elsevier Sci. Publ.},
	Title = {Differential Dynamic Programming},
	Year = {1970}}

@article{Jacobs95,
	Author = {R. A. Jacobs},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {NC},
	Number = {5},
	Pages = {867--888},
	Title = {Methods for Combining Experts' Probability Assessments},
	Volume = {7},
	Year = {1995}}

@article{Jacobs1991adaptive,
	Author = {R. A. Jacobs and M. I. Jordan and S. J. Nowlan and G. E. Hinton},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-31 11:49:20 +0100},
	Journal = {NC},
	Pages = {79--87},
	Title = {Adaptive mixtures of local experts},
	Volume = {3},
	Year = {1991}}

@article{Jacobs91JordanBarto,
	Author = {R. A. Jacobs and M. I. Jordan and A. G. Barto},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Cognitive Science},
	Title = {Task decomposition through competition in a modular connectionist architecture: The what and where vision tasks},
	Year = {1991}}

@book{Isidori89,
	Address = {Berlin, Germany},
	Author = {A. Isidori},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer-Verlag},
	Title = {Nonlinear control systems},
	Year = {1989}}

@article{irizarry2003summaries,
	Author = {R. A. Irizarry and B. M. Boldstad and F. Collin and L. M. Cope and B. Hobbs and T. R. Speed},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Nucleic Acids Research},
	Number = {4},
	Title = {Summaries of Affymetrix GeneChip Probe Level Data},
	Volume = {31},
	Year = {2003}}

@article{irizarry2003normalization,
	Author = {R. A. Irizarry and B. Hobbs and F. Collin and Y. D. Beazer-Barclay and R. J. Antonellis and U. Scherf and T. P. Speed},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Biostatistics},
	Number = {2},
	Pages = {249--264},
	Title = {Normalization, and Summaries of High Density Oligonucleotide Array Probe Level Data},
	Volume = {4},
	Year = {2003}}

@book{Ioannou96Sun,
	Author = {P. A. Ioannou and J. Sun},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall},
	Title = {Robust adaptive control},
	Year = {1996}}

@techreport{imbalanced-strat-2000,
	Author = {Japokowicz N},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {University of DalTech/Dalhousie},
	Title = {Learning from Imbalanced Data Sets: {A} Comparison of Various Strategies},
	Year = {2000}}

@article{Ikeguchi95Aihara,
	Author = {T.~Ikeguchi and K.~Aihara},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEICE Transactions on Fundamentals of Electronics, Communications and Computer Sciences},
	Number = {10},
	Title = {Prediction of Chaotic Time Series with Noise},
	Volume = {78},
	Year = {1995}}

@incollection{Hubner94WeissAbrahamTang,
	Address = {Harlow, UK},
	Author = {U. Hubner and C. O. Weiss and N. B. Abraham and D. Tang},
	Booktitle = {Time Series Prediction: forecasting the future and understanding the past},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A.~S.~Weigend and N.~A.~Gershenfeld},
	Publisher = {Addison Wesley},
	Title = {Lorenz-like chaos in {NH3}-{FIR} lasers},
	Year = {1994}}

@book{Huber81,
	Address = {New York},
	Author = {P. J. Huber},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Robust Statistics},
	Year = {1981}}

@book{Hsu96,
	Address = {Boca Raton, {Fl}, {USA}},
	Author = {J.~Hsu},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman \& Hall/CRC},
	Title = {Multiple Comparisons},
	Year = {1996}}

@techreport{Holden96,
	Author = {S. B. Holden},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Dept. of CS, Univ. College, London},
	Number = {RN/96/94},
	Title = {Cross-validation and the {PAC} learning model},
	Year = {1996}}

@article{Hoeffding63,
	Author = {W. Hoeffding},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Pages = {13--30},
	Title = {Probability inequalities for sums of bounded random variables},
	Volume = {58},
	Year = {1963}}

@book{Hjorth94,
	Author = {J. S. U. Hjorth},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman and Hall},
	Title = {Computer Intensive Statistical Methods},
	Year = {1994}}

@inproceedings{Higuchi91KitanoFuruyaHandaTakahashiKokubu,
	Address = {Cambridge, MA},
	Author = {T. Higuchi and H. Kitano and T. Furuya and K. Handa and N. Takahashi and A. Kokubu},
	Booktitle = {Ninth National Conference on Artificial Intelligence},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {296--303},
	Publisher = {AAAI Press/The MIT Press},
	Title = {{IXM2}: {A} parallel associative processor for knowledge processing},
	Year = {1991}}

@book{hastie2001elements,
	Author = {T. Hastie and R. Tibshirani and J. Friedman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-09-05 12:12:28 +0200},
	Editor = {P. Bickel and P. Diggle and S. Fienberg and U. Gather and I. Otkin and S. Zeger},
	Isbn = {978-0-387-95284-0},
	Publisher = {Springer},
	Series = {Statistics},
	Title = {The elements of statistical learning},
	Year = {2001},
	Bdsk-Url-1 = {http://www.springer.com/statistics/statistical+theory+and+methods/book/978-0-387-95284-0}}

@article{Hastie96Tibshirani,
	Author = {T. Hastie and R. Tibshirani},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-PAMI},
	Number = {6},
	Pages = {607--615},
	Title = {Discriminant Adaptive Nearest Neighbor Classification},
	Volume = {18},
	Year = {1996}}

@article{Hastie93Loader,
	Author = {T. Hastie and C. Loader},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {SS},
	Pages = {120--143},
	Title = {Local regression: automatic kernel carpentry},
	Volume = {8},
	Year = {1993}}

@book{hastie1990generalized,
	Address = {London, UK},
	Author = {T. Hastie and R. Tibshirani},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-30 14:26:05 +0200},
	Publisher = {Chapman and Hall},
	Title = {Generalized Additive Models},
	Year = {1990}}

@techreport{hartmann2003low,
	Author = {O Hartmann and B Samans and H Schafer},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Insitiute of Medical Biometry and Epidemiology. Faculty of Medicine and Hospital, Philippe-University},
	Title = {Low Level Analysis for Affymetrix GeneChips: Normalization and Quality Control},
	Year = {2003}}

@article{Hardle95Marron,
	Author = {W. Hardle and J. S. Marron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Comp. Statist. Data Anal.},
	Pages = {1--17},
	Title = {Fast and simple scatterplot smoothing},
	Volume = {20},
	Year = {1995}}

@book{Hand81,
	Address = {New York},
	Author = {D. J. Hand},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {John Wiley},
	Title = {Discrimination and classification},
	Year = {1981}}

@book{Hajek69,
	Address = {San Francisco},
	Author = {J. H\'{a}jek},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Holden Day},
	Title = {A course in nonparametric statistics},
	Year = {1969}}

@article{guyon2000gene,
	Author = {I. Guyon and J. Weston and S. Barnhill and V. Vapnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-02-28 11:13:46 +0100},
	Journal = {Machine Learning},
	Number = {1-3},
	Pages = {389--422},
	Title = {Gene Selection for Cancer Classification using Support Vector Machines},
	Volume = {46},
	Year = {2002}}

@article{guyon2003introduction,
	Author = {I. Guyon and A. Elisseeff},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-05-16 11:13:36 +0200},
	Journal = {Journal of Machine Learning Research},
	Pages = {1157--1182},
	Title = {An Introduction to Variable and Feature Selection},
	Volume = {3},
	Year = {2003}}

@inproceedings{Gustafson79Kessel,
	Address = {San Diego, CA,USA},
	Author = {D. E. Gustafson and W. C. Kessel},
	Booktitle = {Proc. IEEE CDC},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {761--776},
	Title = {Fuzzy clustering with a fuzzy covariance matrix},
	Year = {1979}}

@article{gruvberger-2001,
	Author = {Gruvberger S. and Ringner M. Chen Y. and Panavally S. and Saal L. H. and Borg A. and Ferno M. and Peterson C. and and Meltzer P. S.},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Cancer Res},
	Number = {16},
	Pages = {5979--5984},
	Title = {Estrogen Receptor Status in Breast Cancer Is Associated with Remarkably Distainct Gene Expression Patterns},
	Volume = {61},
	Year = {2001}}

@article{group1998polychemotherapy,
	Author = {{EBCT Collaborative Group}},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Lancet},
	Note = {Early Breast Cancer Trialists' Collaborative Group},
	Pages = {930--942},
	Title = {Polychemotherapy for Early Breast Cancer: an Overview of the Randomized Trials},
	Volume = {352},
	Year = {1998}}

@book{Graybill76,
	Address = {Boston, Massachusetts},
	Author = {F. A. Graybill},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Duxbury},
	Title = {Theory and Applications of the Linear Model},
	Year = {1976}}

@inproceedings{gratch93learning,
	Author = {Jonathan Gratch and Steve Chien and Gerald DeJong},
	Booktitle = {International Conference on Machine Learning},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {135--142},
	Title = {Learning Search Control Knowledge for Deep Space Network Scheduling},
	Year = {1993}}

@book{Goodwin84Sin,
	Author = {G. C. Goodwin and K. S. Sin},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall},
	Title = {Adaptive Filtering Prediction and Control},
	Year = {1984}}

@article{gominer,
	Author = {Zeeberg BR and Feng W and Wang G and Wang MD and Fojo AT and Sunshine M and Narasimhan S and Kane DW and Reinhold WC and Lababidi S and Bussey KJ and Riss J and Barrett JC and Weinstein JN},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Genome Biology},
	Number = {4},
	Pages = {R28},
	Title = {GoMiner: {A} Ressource for Biological Interpretation of Genomic and Proteomic Data},
	Volume = {4},
	Year = {2003}}

@article{goldhirsh2003meeting,
	Author = {A. Goldhirsh and W. C. Wood and R. D. Gelber and A. S. Coates and B. Thurlimann and H. J. Senn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-11-22 15:43:07 +0100},
	Journal = {Journal of Clinical Oncology},
	Number = {17},
	Pages = {3357--3365},
	Title = {Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer.},
	Volume = {21},
	Year = {2003}}

@article{goldhirsh1998meeting,
	Author = {A. Goldhirsh and J. H. Glick and R. D. Gelber and H. Senn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of National Cancer Institute},
	Number = {1601-1608},
	Title = {Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer},
	Volume = {90},
	Year = {1998}}

@book{Goldberg89,
	Address = {Reading, MA},
	Author = {D. E. Goldberg},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Addison-Wesley},
	Title = {Genetic Algorithms in Search, Optimization and Machine Learning},
	Year = {1989}}

@article{global-profiling,
	Author = {P. Khatri and S. Draghici and RP. Martins and GC Ostermeier and SA. Krawetz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {enomics},
	Pages = {98--104},
	Title = {Global Functional Profiling of Gene Expression},
	Volume = {81},
	Year = {2003}}

@book{Gill81MurrayWright,
	Address = {London},
	Author = {P. E. Gill and W. Murray and M. H. Wright},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Practical optimization},
	Year = {1981}}

@book{Ghezzi91JazayeriMandrioli,
	Author = {C. Ghezzi and M. Jazayeri and D. Mandrioli},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall},
	Title = {Fundamentals of software engineering},
	Year = {1991}}

@inproceedings{Ghahramani94Jordan,
	Address = {San Mateo, CA},
	Author = {Z. Ghahramani and M. I. Jordan},
	Booktitle = {NIPS},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. D. Cowan and G. T. Tesauro and J. Alspector},
	Pages = {120--127},
	Publisher = {Morgan Kaufmann},
	Title = {Supervised learning from incomplete data via an {EM} approach},
	Volume = {6},
	Year = {1994}}

@article{Geman92BienenstockDoursat,
	Author = {S. Geman and E. Bienenstock and R. Doursat},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Number = {1},
	Pages = {1--58},
	Title = {Neural networks and the bias/variance dilemma},
	Volume = {4},
	Year = {1992}}

@techreport{gautier2004description,
	Author = {L Gautier and R Irizarry and L Cope and B Boldstad},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Bioconductor},
	Title = {Description of affy},
	Year = {2004}}

@book{Gauss1809,
	Address = {New York},
	Author = {K. F. Gauss},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Dover},
	Title = {Teoria Motus Corporum Coelestium in Sectionibus Conicus Solem Ambientieum},
	Year = {1809}}

@article{fuzzy-ll-2001,
	Author = {Bontempi G and Birattari M and Bersini H},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Fuzzy Sets and Systems},
	Number = {1},
	Pages = {59--72},
	Title = {The Local Paradigm for Modeling and Control: from Neuro-Fuzzy to Lazy Learning},
	Volume = {121},
	Year = {2001}}

@article{furey200support,
	Author = {T. S. Furey and N. Cristianini and N. Duffy and D. W. Bednarski and M. Schummer and D. Haussler},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Bioinformatics},
	Number = {10},
	Pages = {906--914},
	Title = {Support Vector Machine Classification of Cancer Tissue Samples Using Microarray Expression Data},
	Volume = {16},
	Year = {2000}}

@techreport{Friedman94,
	Annote = {http://playfair.stanford.edu/reports/friedman},
	Author = {J. H. Friedman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Stanford University},
	Title = {Flexible metric nearest neighbor classification},
	Year = {1994}}

@article{Friedman91,
	Author = {J. H. Friedamn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {The Annals of Statistics},
	Number = {1},
	Pages = {1--141},
	Title = {Multivariate adaptive regression splines},
	Volume = {19},
	Year = {1991}}

@book{Fomby84HillJohnson,
	Author = {T. B. Fomby and R. C. Hill and S. R. Johnson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer-Verlag},
	Title = {Advanced econometric methods},
	Year = {1984}}

@techreport{Fix51Hodges,
	Author = {E. Fix and J. L. Hodges},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {USAF School of Aviation Medicine},
	Number = {Project 21-49-004, Report Number 4},
	Title = {Discriminatory Analysis: Nonparametric Discrimination:consistency Properties},
	Year = {1951}}

@book{Feldbaum65,
	Address = {New York, NY},
	Author = {A. A. Fel'dbaum},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Optimal control systems},
	Year = {1965}}

@book{Fedorov72,
	Author = {V. Fedorov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Theory of Optimal Experiments},
	Year = {1972}}

@article{Fayyad96,
	Author = {U. Fayyad and G. Piatetsky-Shapiro and P. Smyth},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Communications of the ACM},
	Month = {nov},
	Number = {11},
	Pages = {27--34},
	Title = {The {KDD} Process for Extracting Useful Knowledge from Volumes of Data},
	Volume = {39},
	Year = {1996}}

@techreport{Farmer88Sidorowich,
	Author = {J.~D.~Farmer and J.~J.~Sidorowich},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Los Alamos National Laboratory},
	Title = {Exploiting chaos to predict the future and reduce noise},
	Year = {1988}}

@article{Farmer87Sidorowich,
	Author = {J. D. Farmer and J. J. Sidorowich},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Physical Review Letters},
	Number = {59},
	Pages = {845--848},
	Title = {Predicting chaotic time series.},
	Volume = {8},
	Year = {1987}}

@book{Fan96Gijbels,
	Author = {J. Fan and I. Gijbels},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman and Hall},
	Title = {Local Polynomial Modelling and Its Applications},
	Year = {1996}}

@article{Fan95Gijbels,
	Author = {J. Fan and I. Gijbels},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {J. Comp. Graph. Statist.},
	Pages = {213--227},
	Title = {Adaptive order polynomial fitting: bandwidth robustification and bias reduction},
	Volume = {4},
	Year = {1995}}

@article{Fan92Gijbels,
	Author = {J. Fan and I. Gijbels},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AS},
	Number = {4},
	Pages = {2008--2036},
	Title = {Variable bandwidth and local linear regression smoothers},
	Volume = {20},
	Year = {1992}}

@article{Fan92,
	Author = {J. Fan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Number = {420},
	Pages = {998--1004},
	Title = {Design-adaptive nonparametric regression},
	Volume = {87},
	Year = {1992}}

@book{FaddeevFaddeeva,
	Annote = {available at VUB WtW 517G FADD 63},
	Author = {D. K. Faddeev and V. N. Faddeeva},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {W. H. Freeman and Company},
	Title = {Computational Methods of Linear Algebra}}

@unpublished{exactranktests-library,
	Author = {Hothorn T},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {R library},
	Title = {Exact Distributions for Rank and Permutation Tests},
	Year = {2004}}

@article{tan2003evaluation,
	Author = {Tan PK and Downey TJ and Spitznagel EL Jr and Xu P and Fu D and Dimitrov DS and Lempicki RA and Raaka BM and Cam MC},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-02-12 14:40:38 +0100},
	Journal = {Nucleic Acids Res},
	Number = {19},
	Pages = {5676--5684},
	Title = {Evaluation of Gene Expression Measurements from Commercial Microarray Platforms},
	Volume = {31},
	Year = {2003}}

@article{estim-vapnik-1979,
	Author = {V Vapnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Nauka},
	Note = {English translation Springer Verlag 1982},
	Title = {Estimation of Dependences Based on Empirical Data},
	Year = {1979}}

@article{pisani1999estimateserratum,
	Author = {Pisani P and Parkin DM and Bray F and Ferlay J},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-08-28 13:50:59 +0200},
	Journal = {International Journal of Cancer},
	Pages = {870--873},
	Title = {Erratum: Estimates of the worldwide mortality from 25 cancers in 1990},
	Volume = {83},
	Year = {1999}}

@article{Epanechnikov69,
	Author = {V. A. Epanechnikov},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Theory of Probability and Its Applications},
	Number = {14},
	Pages = {153--158},
	Title = {Non parametric estimation of a multivariate probability density.},
	Year = {1969}}

@article{eisen1998cluster,
	Author = {M. Eisen and P. Spellman and P. Brown and D. Botstein},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {PNAS},
	Pages = {14863--14868},
	Title = {Cluster Analysis and Display of Genome-Wide Expression Patterns},
	Volume = {95},
	Year = {1998}}

@article{eifel2001national,
	Author = {P. Eifel and J. A. Axelson and J. Costa and J. Crowley and W. J. Curran and A. Deshler and S. Fulton and C. B. Hendricks and M. Kemeny and A. B. Kornblith and T. A. Louis and M. Markman and R. Mayer and D. Roter},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-11-23 11:01:33 +0100},
	Journal = {Journal of National Cancer Institute},
	Number = {13},
	Pages = {979--989},
	Title = {National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer},
	Volume = {93},
	Year = {2001}}

@book{Efron93Tibshirani,
	Address = {New York},
	Author = {B. Efron and R. J. Tibshirani},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Chapman and Hall},
	Title = {An Introduction to the Bootstrap},
	Year = {1993}}

@book{efron1982jacknife,
	Author = {B. Efron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-01-30 09:13:33 +0100},
	Note = {Monograph 38},
	Publisher = {SIAM},
	Title = {The Jacknife, the Bootstrap and Other Resampling Plans},
	Year = {1982}}

@article{Efron79,
	Author = {B. Efron},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Annals of Statistics},
	Pages = {1--26},
	Title = {Bootstrap Methods: Another Look at the Jacknife},
	Year = {1979}}

@article{Efron73Morris,
	Author = {B. Efron and C. Morris},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {J. Royal Statistical Society Ser.B},
	Pages = {379--421},
	Title = {Combining possibly related estimation problems},
	Volume = {35},
	Year = {1973}}

@techreport{effect-class-distr-2001,
	Author = {Weiss GM and Provost F},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {University of Rutgers},
	Title = {The Effect of Class Distribution on Classifier Learning: An Empirical Study},
	Year = {2001}}

@book{duda2001pattern,
	Author = {R. O. Duda and P. R. Hart and D. G. Stork},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-06-18 17:13:15 +0200},
	Publisher = {John Wiley and Sons},
	Title = {Pattern classification},
	Year = {2001}}

@book{Duda76Hart,
	Author = {R. O. Duda and P. E. Hart},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Pattern Classification and Scene Analysis},
	Year = {1976}}

@article{Dressler92Farmer,
	Author = {U. Dressler and J. D. Farmer},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {PHYD},
	Pages = {365--377},
	Title = {Generalized Lyapunov exponents corresponding to higher derivatives},
	Volume = {59},
	Year = {1992}}

@book{Draper81Smith,
	Address = {New York},
	Author = {N. R. Draper and H. Smith},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {John Wiley and Sons},
	Title = {Applied Regression Analysis},
	Year = {1981}}

@article{draghici2003ontotools,
	Author = {S. Draghici and P. Khatri and P. Bhavsar and A. Shah and SA. Krawetz and MA. Tainsky},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Nucleic Acids Research},
	Number = {13},
	Pages = {3775--3781},
	Title = {Onto-Tools, the Toolkit of the Modern Biologist: Pnto-Express, Onto-Compare, Onto-Design and Onto-Translate},
	Volume = {31},
	Year = {2003}}

@techreport{diif-gene-expression,
	Author = {Anja von Heydebreck},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Max-Planck-Institute for Molecular Genetics},
	Title = {Differential Gene Expression},
	Year = {2004}}

@article{kuo2002analysis,
	Author = {W. P. Kuo and T. K. Jenssen and A. J. Butte and L. Ohno-Machado and I. S. Kohane},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-22 09:05:08 +0100},
	Journal = {Bioinformatics},
	Number = {3},
	Pages = {405--412},
	Title = {Analysis of Matched m{RNA} Measurements from Two Different Microarray Technologies},
	Volume = {18},
	Year = {2002}}

@techreport{diag-computers,
	Author = {Rainer Spang},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Max-Planck-Institute for Molecular Genetics},
	Title = {Diagnosis Using Computers},
	Year = {2004}}

@article{Devroye88,
	Author = {L. Devroye},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-PAMI},
	Pages = {530--543},
	Title = {Automatic pattern recognition: {A} study of the probability of error},
	Volume = {10},
	Year = {1988}}

@article{Devroye79Wagner,
	Author = {L. Devroye and T. J. Wagner},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-IT},
	Number = {2},
	Pages = {202--207},
	Title = {Distribution-free inequalities for the deleted and holdout error estimates},
	Volume = {25},
	Year = {1979}}

@article{dempster1977maximum,
	Author = {A. P. Dempster and N. M. Laird and D. B. Rubin},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 10:12:50 +0100},
	Journal = {Journal of the Royal Statistical Society, B},
	Number = {1},
	Pages = {1-38},
	Title = {Maximum likelihood from incomplete data via the {EM} algorithm},
	Volume = {39},
	Year = {1977}}

@book{DeBoor78,
	Address = {New York},
	Author = {C. De Boor},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer},
	Title = {A Practical guide to splines},
	Year = {1978}}

@book{Dean99,
	Address = {New York, {NY}, {USA}},
	Author = {A.~Dean and D.~Voss},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer Verlag},
	Title = {Design and Analysis of Experiments},
	Year = {1999}}

@article{dataset-size-2003,
	Author = {Mukherjee S and Tamayo P and Rogers S and Rifkin R and Engle A and Campbell C and Golub TR and Mesirov JP},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Computational Biology},
	Pages = {119--142},
	Title = {Estimating Dataset Size Requirements for Classifying {DNA} Microarray Data},
	Year = {2003}}

@book{Dasarathy91,
	Author = {B. V. Dasarathy},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {IEEE Computer Society Press},
	Title = {Nearest neighbor ({NN}) norms : {NN} pattern classification techniques},
	Year = {1991}}

@incollection{Cybenko96,
	Author = {G. Cybenko},
	Booktitle = {Identification, Adaptation, Learning. The Science of Learning Models from data},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {S. Bittanti and G. Picci},
	Pages = {423--434},
	Publisher = {Springer},
	Series = {NATO ASI Series},
	Title = {Just-in-Time Learning and Estimation},
	Year = {1996}}

@book{cristianini2001introduction,
	Author = {N Cristianini and J Shawe-Taylor},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {Cambridge Cambridge University Press},
	Note = {ISBN 0-521-78019-5},
	Publisher = {Cambridge University Press, Cambridge},
	Title = {An Introduction to Support Vector Machines and Other Kernel-Based Learning Methods},
	Year = {2000}}

@article{Craven79Wahba,
	Author = {P. Craven and G. Wahba},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Numer. Math.},
	Pages = {377--403},
	Title = {Smoothing noisy data with spline functions: Estimating the correct degree of smoothing by the method of generalized cross-validation},
	Volume = {31},
	Year = {1979}}

@article{Cover67Hart,
	Author = {T. Cover and P. Hart},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Proc. IEEE Trans. Inform. Theory},
	Pages = {21--27},
	Title = {Nearest neighbor pattern classification},
	Year = {1967}}

@book{Conover1999,
	Address = {New York, {NY}, {USA}},
	Author = {W. J. Conover},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Edition = {Third},
	Publisher = {John Wiley \& Sons},
	Title = {Practical Nonparametric Statistics},
	Year = {1999}}

@book{Cohen95,
	Address = {Cambridge, MA},
	Author = {P. R. Cohen},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {The MIT Press},
	Title = {Empirical Methods for Artificial Intelligence},
	Year = {1995}}

@article{Cleveland95Loader,
	Author = {W. S. Cleveland and C. Loader},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Computational Statistics},
	Title = {Smoothing by Local Regression: Principles and Methods},
	Volume = {11},
	Year = {1995}}

@article{Cleveland88DevlinGrosse,
	Author = {W. S. Cleveland and S. J. Devlin and E. Grosse},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Econometrics},
	Pages = {87--114},
	Title = {Regression by local fitting: methods, properties and computational algorithms},
	Volume = {37},
	Year = {1988}}

@article{Cleveland88Devlin,
	Author = {W. S. Cleveland and S. J. Devlin},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {JASA},
	Pages = {596--610},
	Title = {Locally weighted regression: an approach to regression analysis by local fitting},
	Volume = {83},
	Year = {1988}}

@article{Cleveland79,
	Author = {W. S. Cleveland},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of the American Statistical Association},
	Pages = {829--836},
	Title = {Robust locally weighted regression and smoothing scatterplots.},
	Volume = {74},
	Year = {1979}}

@book{Clarke94,
	Author = {D. W. Clarke},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Oxford University Press},
	Title = {Advances in Model-Based Predictive Control},
	Year = {1994}}

@article{Clarke87MohtadiTuffs,
	Author = {D. W. Clarke and C. Mohtadi and P. S. Tuffs},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AU},
	Number = {2},
	Title = {Generalised predictive control},
	Volume = {23},
	Year = {1987}}

@article{Clarke75Gawthrop,
	Author = {D. W. Clarke and P. J. Gawthrop},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Proceedings IEEE},
	Number = {9},
	Pages = {929--934},
	Title = {Self tuning controller},
	Volume = {122},
	Year = {1975}}

@article{ChingHungLee04,
	Author = {Ching-Hung Lee},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {International Journal of Computational Cognition},
	Number = {3},
	Pages = {63--100},
	Title = {A Survey of {PID} Controller Design Based on Gain and Phase Margins},
	Volume = {2},
	Year = {2004}}

@article{chien99efficient,
	Author = {Steve Chien and Andre Stechert and Darren Mutz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of Artificial Intelligence Research},
	Pages = {375--397},
	Title = {Efficient Heuristic Hypothesis Ranking},
	Volume = {10},
	Year = {1999}}

@article{Chien95efficient,
	Author = {Steve Chien and Jonathan Gratch and Michael Burl},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	File = {Chien95efficient.ps},
	Journal = {Pattern Analysis and Machine Intelligence},
	Number = {7},
	Pages = {652--665},
	Title = {On the Efficient Allocation of Resources for Hypothesis Evaluation: {A} Statistical Approach},
	Volume = {17},
	Year = {1995}}

@book{Cherkassy98Mulier,
	Address = {New York},
	Author = {V. Cherkassky and F. Mulier},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Learning from Data: Concepts, Theory, and Methods},
	Year = {1998}}

@article{Chen90Billings,
	Author = {S. Chen and S. A. Billings},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IJC},
	Number = {6},
	Pages = {1327--1350},
	Title = {Practical identification of {NARMAX} models using Radial Basis Functions},
	Volume = {53},
	Year = {1990}}

@article{chang2003gene,
	Author = {J. C. Chang and E. C. Wooten and A. Tsimelzon and S. G. Hilsenbeck and M. C. Gutierrez and R. Elledge and S. Mohsin and C. K. Osborne and G. C. Chamness and D. C. Allred and P. O. Connell},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Lancet},
	Pages = {362-369},
	Title = {Gene Expression Profiling Predicts Therapeutic Response to Docetaxel in Breast Cancer Patients},
	Volume = {362},
	Year = {2003}}

@article{Casdagli91EubankFarmerGibson,
	Author = {M.~Casdagli and S.~Eubank and J.~D.~Farmer and J.~Gibson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {PHYD},
	Pages = {52--98},
	Title = {State space reconstruction in the presence of noise},
	Volume = {51},
	Year = {1991}}

@article{Carpenter88Grossberg,
	Author = {G. A. Carpenter and S. Grossberg},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Computer},
	Number = {3},
	Pages = {77--88},
	Title = {The art of adaptive pattern recognition by a self-organising neural network},
	Volume = {21},
	Year = {1988}}

@article{cancer-lifetime-1993,
	Author = {Feuer EJ and Wun LM and Boring CC and Flanders WD and Timmel MJ and Tong T},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of National Cancer Institute},
	Pages = {892--897},
	Title = {The lifetime risk of developing breast cancer},
	Volume = {85},
	Year = {1993}}

@book{C45-1993,
	Author = {JR Quinlan},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Morgan Kaufmann Publishers Inc.},
	Title = {{C4}.5: Programs for Machine Learning},
	Year = {1993}}

@article{burges-1998,
	Author = {Burges CJ},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Data Mining and Knowledge Discovery},
	Number = {2},
	Pages = {121--167},
	Title = {A tutorial on Support Vector Machines for Pattern Recognition},
	Volume = {2},
	Year = {1998}}

@book{BrownHarris94,
	Address = {Hemel Hempstead},
	Author = {M. Brown and C. J. Harris},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice Hall},
	Title = {Neurofuzzy adaptive modelling and control},
	Year = {1994}}

@unpublished{brown1999support,
	Author = {M. Brown and W. N. Grundy and D. Lin and N. Cristianini and C. Sugnet and M. Ares and D. Haussler},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {University of California, Santa Cruz and University of Bristol},
	Title = {Support Vector Machine Classification of Microarray Gene Expression Data},
	Year = {1999}}

@article{Broomhead88Lowe,
	Author = {D. Broomhead and D. Lowe},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Complex Systems},
	Pages = {321--355},
	Title = {Multivariable functional interpolation and adaptive networks},
	Volume = {2},
	Year = {1988}}

@article{Broomhead87King,
	Author = {D.~S.~Broomhead and G.~P.~King},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {PHYD},
	Title = {Extracting qualitative dynamics from experimental data},
	Volume = {20},
	Year = {1987}}

@article{brooks-robust-lay-ctrl,
	Author = {R. Brooks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE Journal of Robotics and Automation},
	Title = {A Robust Layered Control System for a Mobile Robot},
	Year = {1986}}

@article{brooks-new-appr,
	Author = {R. Brooks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Science},
	Title = {New Approaches to Robotics},
	Volume = {253},
	Year = {1991}}

@article{brooks-emerg-behav,
	Author = {R. Brooks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Title = {A Robot that Walks : Emergent Behavior from a Carefully Evolved Network},
	Year = {1989}}

@article{brooks-behav-lang,
	Author = {R. Brooks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {MIT AI Lab MEMO 1127},
	Title = {The behavior Language : User's Guide},
	Year = {1990}}

@book{Brockett70,
	Address = {New York},
	Author = {R. Brockett},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Wiley},
	Title = {Finite Dimensional Linear Systems},
	Year = {1970}}

@article{Breiman96,
	Author = {L. Breiman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Machine Learning},
	Number = {1},
	Pages = {49--64},
	Title = {Stacked regressions},
	Volume = {24},
	Year = {1996}}

@unpublished{brb,
	Author = {R. Simon and A. Peng},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://linus.nci.nih.gov/BRB-ArrayTools.html},
	Title = {{BRB} ArrayTools},
	Year = {2003}}

@article{Bottou92Vapnik,
	Author = {L. Bottou and V. N. Vapnik},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Neural Computation},
	Number = {6},
	Pages = {888--900},
	Title = {Local learning algorithms.},
	Volume = {4},
	Year = {1992}}

@inproceedings{Bontempi99BirattariBersini-ICML99,
	Address = {San Francisco, CA},
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Booktitle = {Machine Learning: Proceedings of the Sixteenth International Conference},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {I. Bratko and S. Dzeroski},
	Pages = {32--38},
	Publisher = {Morgan Kaufmann Publishers},
	Title = {Local learning for iterated time-series prediction},
	Year = {1999}}

@inproceedings{Bontempi99BirattariBersini_Eufit,
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Booktitle = {Proceeding of the 7th European Congress on Inteligent Techniques and Soft Computing EUFIT '99},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Title = {Lazy Learners at work: the Lazy Learning Toolbox},
	Year = {1999}}

@article{Bontempi99BirattariBersini_2,
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {AICOM},
	Number = {1},
	Title = {A model selection approach for local learning},
	Volume = {121},
	Year = {2000}}

@article{Bontempi99BirattariBersini,
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IJC},
	Number = {7/8},
	Pages = {643--658},
	Title = {Lazy learning for modeling and control design},
	Volume = {72},
	Year = {1999}}

@inproceedings{Bontempi99Birattari_2,
	Author = {G. Bontempi and M. Birattari},
	Booktitle = {Proceedings of the Eleventh Netherlands/Belgium Conference on Artificial Intelligence (BNAIC 99)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {(Best Paper Award)},
	Pages = {115--122},
	Title = {A bound on the cross-validation estimate for algorithm assessment},
	Year = {1999}}

@techreport{Bontempi99Birattari,
	Address = {Bruxelles, Belgium},
	Author = {G. Bontempi and M. Birattari},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {IRIDIA-ULB},
	Number = {99-9},
	Title = {Toolbox for Neuro-Fuzzy Identification and Data Analysis, For use with Matlab},
	Year = {1999}}

@article{Bontempi99BersiniBirattari,
	Author = {G. Bontempi and H. Bersini and M. Birattari},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {FSS},
	Number = {1},
	Pages = {59--72},
	Title = {The local paradigm for modeling and control: From neuro-fuzzy to lazy learning},
	Volume = {121},
	Year = {2001}}

@phdthesis{bontempi1999local,
	Author = {G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-21 13:18:37 +0100},
	School = {IRIDIA- Universit\'{e} Libre de Bruxelles},
	Title = {Local Learning Techniques for Modeling, Prediction and Control},
	Year = {1999}}

@inproceedings{Bontempi98BirattariBersini-ESANN,
	Address = {Brussels},
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Booktitle = {European Symposium on Artificial Neural Networks (ESANN-98)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. Verleysen},
	Pages = {73--78},
	Publisher = {D-Facto},
	Title = {Lazy learning for control design},
	Year = {1998}}

@inproceedings{Bontempi98BirattariBersini-ECML98,
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Booktitle = {Machine Learning: ECML-98 (10th European Conference on Machine Learning)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {292--303},
	Publisher = {Springer},
	Title = {Recursive lazy learning for modeling and control},
	Year = {1998}}

@inproceedings{Bontempi98BirattariBersini_NOLCOS,
	Author = {G. Bontempi and M. Birattari and H. Bersini},
	Booktitle = {Nonlinear Control Systems Design Symposium 1998},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {H. J. C. Huiberts and H. Nijmeijer},
	Organization = {University of Twente, Enschede, The Netherlands},
	Pages = {360--365},
	Publisher = {IFAC},
	Title = {Local learning for nonlinear control},
	Volume = {2},
	Year = {1998}}

@inproceedings{Bontempi98BirattariBersini_Leuven,
	Author = {G.~Bontempi and M.~Birattari and H.~Bersini},
	Booktitle = {Proceedings of the International Workshop on Advanced Black-Box Techniques for Nonlinear Modeling},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J.~A.~K.~Suykens and J.~Vandewalle},
	Organization = {Katholieke Universiteit Leuven, Belgium},
	Pages = {62--68},
	Title = {Lazy learning for iterated time series prediction},
	Year = {1998}}

@inproceedings{Bontempi97Birattari,
	Author = {G. Bontempi and M. Birattari},
	Booktitle = {Abstracts of Workshop on Multiple Model Approaches to Modeling and Control},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {72--80},
	Title = {Lazy learning indirect control for discrete time nonlinear systems},
	Year = {1997}}

@inproceedings{Bontempi97Bersini,
	Author = {G. Bontempi and H. Bersini},
	Booktitle = {Neural Networks in Engineering systems (Proceedings of the 1997 International Conference on Engineering Applications of Neural Networks (EANN '97), Stockolm, Sweden)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A. B. Bulsari and S. Kallio},
	Pages = {325--328},
	Title = {Identification of a sensor model with hybrid neuro-fuzzy methods},
	Year = {1997}}

@inproceedings{Bontempi96,
	Address = {Ghent, Belgium},
	Author = {A. Bonarini and G. Bontempi},
	Booktitle = {Modeling and Simulation ESM 96 (Proceedings European Simulation Multiconference 1996)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A. Javor and A. Lehmann and I. Molnar},
	Pages = {615--619},
	Publisher = {SCS International},
	Title = {Qua.Si. {III}: {A} software tool for simulation of fuzzy dynamical systems},
	Year = {1996}}

@techreport{Bontempi95,
	Author = {G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {IRIDIA - ULB},
	Note = {(submitted to IEEE Transaction on Fuzzy Sets)},
	Number = {95-16},
	Title = {Modeling with uncertainty in continuous dynamical systems: the probability and possibility approach},
	Year = {1995}}

@article{Bontempi04Kruijtzer,
	Author = {G. Bontempi and W. Kruijtzer},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Soft Computing},
	Note = {To appear},
	Title = {The use of intelligent data analysis techniques for system-level design: a software estimation example.},
	Year = {2004}}

@inproceedings{Bontempi00Birattari,
	Author = {G. Bontempi and M. Birattari},
	Booktitle = {European Symposium on Artificial Neural Networks (ESANN-2000)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {To appear.},
	Title = {A multi-step-ahead prediction method based on local dynamic properties},
	Year = {2000}}

@inproceedings{Bontempi00BertolissiBirattari,
	Author = {G. Bontempi and E. Bertolissi and M. Birattari},
	Booktitle = {Proceedings of CIFEr00 (Conference on Computational Intelligence for Financial Engineering)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {To appear},
	Title = {Predicting stock markets in boundary conditions with local models.},
	Year = {2000}}

@techreport{BonBir2004:Di525,
	Address = {BRUSSELS},
	Author = {Gianluca Bontempi and Mauro Birattari},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {DIULB},
	Number = {525},
	Title = {Sample average approximation for model selection},
	Year = {2004}}

@inproceedings{Bonarini94Bontempi_2,
	Address = {Ghent, Belgium},
	Author = {A. Bonarini and G. Bontempi},
	Booktitle = {Modeling and Simulation ESM 94 (Proceedings European Simulation Multiconference 1994)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {A. Guasch and R. M. Huber},
	Pages = {420--424},
	Publisher = {SCS International},
	Title = {Qua.Si.: {A} qualitative simulation approach for fuzzy models},
	Year = {1994}}

@inproceedings{Bonarini94Bontempi_1,
	Address = {Singapore},
	Author = {A. Bonarini and G. Bontempi},
	Booktitle = {Cybernetics and Systems Research '94 (Proc. of the 12th European Meeting of Cybernetics and Systems Research)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {R. Trappl},
	Pages = {359--366},
	Publisher = {World Scientific Publishing},
	Title = {Qualitative simulation of approximate models: an approach based on fuzzy sets},
	Year = {1994}}

@article{Bonarini94Bontempi,
	Author = {A. Bonarini and G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {ACM Transactions on Modeling and Computer Simulation},
	Number = {4},
	Pages = {258--313},
	Title = {A qualitative simulation approach for fuzzy dynamical models},
	Volume = {4},
	Year = {1994}}

@techreport{bolstad2004affy,
	Author = {Bolstad B},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {Bioconductor},
	Title = {Affy: Built-in Processing Methods},
	Year = {2004}}

@article{bolstad2003comparison,
	Author = {B. M. Bolstad and R. A. Irizarry and M. Astrand and T. P. Speed},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Bioinformatics},
	Number = {2},
	Pages = {185--193},
	Title = {A Comparison of Normalization Methods for High Density Oligonucleotide Array Data Based on Variance and Bias},
	Volume = {19},
	Year = {2003}}

@misc{Blake98KeoghMerz,
	Author = {C. Blake and E. Keogh and C. J. Merz},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {University of California, Irvine, Dept. of Information and Computer Sciences},
	Title = {{UCI} Repository of machine learning databases},
	Url = {http://www.ics.uci.edu/$\sim$mlearn/MLRepository.html},
	Year = {1998},
	Bdsk-Url-1 = {http://www.ics.uci.edu/$%5Csim$mlearn/MLRepository.html}}

@book{Bishop94,
	Address = {Oxford, UK},
	Author = {C. M. Bishop},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Oxford University Press},
	Title = {Neural Networks for Statistical Pattern Recognition},
	Year = {1994}}

@inproceedings{birattari2002racing,
	Author = {M. Birattari and T. Stutzle and L. Paquete and K. Varrentrapp},
	Booktitle = {GECCO 2002},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {W. B. Langdon},
	Pages = {11-18},
	Publisher = {Morgan Kaufmann},
	Title = {A Racing Algorithm for Configuring Metaheuristics},
	Year = {2002}}

@inproceedings{Birattari99BontempiBersini,
	Address = {Cambridge},
	Author = {M. Birattari and G. Bontempi and H. Bersini},
	Booktitle = {NIPS 11},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. S. Kearns and S. A. Solla and D. A. Cohn},
	Pages = {375--381},
	Publisher = {MIT Press},
	Title = {Lazy learning meets the recursive least-squares algorithm},
	Year = {1999}}

@techreport{Birattari99Bontempi_speedy,
	Address = {Brussels, Belgium},
	Author = {M. Birattari and G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {IRIDIA-ULB},
	Number = {TR/IRIDIA/99-6},
	Title = {Lazy Learning Vs. Speedy Gonzales : {A} fast algorithm for recursive identification and recursive validation of local constant models},
	Year = {1999}}

@techreport{Birattari99Bontempi,
	Address = {Brussels, Belgium},
	Author = {M. Birattari and G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {IRIDIA-ULB},
	Number = {TR/IRIDIA/99-7},
	Title = {The Lazy Learning Toolbox, For use with Matlab},
	Year = {1999}}

@mastersthesis{Birattari97,
	Author = {M. Birattari},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {(in Italian)},
	School = {Politecnico di Milano, Italy},
	Title = {Modelli Locali per l'Apprendimento: dall'approccio neuro-fuzzy al lazy learning},
	Year = {1997}}

@techreport{Birattari03Bontempi,
	Author = {M. Birattari and G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Institution = {IRIDIA-ULB, Universit\'{e} Libre de Bruxelles},
	Number = {TR/IRIDIA/2003-38},
	Title = {The \textsf{lazy} package for~\textsf{R}. {L}azy learning for local regression},
	Year = {2003}}

@unpublished{biovallee,
	Author = {IBMM ULB and UMH},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.biovallee.be},
	Title = {BioVallee},
	Year = {2003}}

@unpublished{biomerieux,
	Author = {C M\'{e}rieux},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Note = {http://www.biomerieux.com},
	Title = {bio{M}\'{e}rieux},
	Year = {1974}}

@article{Billings87Voon,
	Author = {S. A. Billings and W. S. G. Voon},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IJC},
	Pages = {215--235},
	Title = {Piecewise linear identification of nonlinear systems},
	Volume = {46},
	Year = {1987}}

@book{Bierman77,
	Address = {New York, NY},
	Author = {G. J. Bierman},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Academic Press},
	Title = {Factorization Methods for Discrete Sequential Estimation},
	Year = {1977}}

@article{Bezdek85Anderson,
	Author = {J. C. Bezdek and I. M. Anderson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-SMC},
	Number = {5},
	Pages = {637--641},
	Title = {An Application of the c-Varieties Clustering Algorithms to Polygonal Curve Fitting},
	Volume = {15},
	Year = {1985}}

@article{Bezdek81CorayGundersonWatson,
	Author = {J. C. Bezdek and C. Coray and R. Gunderson and J. Watson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {SIAM Journal of Applied Mathematics},
	Number = {2},
	Pages = {339--372},
	Title = {Detection and characterization of cluster substructure},
	Volume = {40},
	Year = {1981}}

@article{Bezdek1975optimal,
	Author = {J. C. Bezdek and J. C. Dunn},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 09:47:38 +0100},
	Journal = {IEEE Transactions on Computers},
	Pages = {835--838},
	Title = {Optimal fuzzy partition: a heuristic for estimating the parameters in a mixture of normal distributions},
	Volume = {24},
	Year = {1975}}

@phdthesis{Bezdek73,
	Address = {Ithaca},
	Author = {J. C. Bezdek},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {Applied Math. Center, Cornell University},
	Title = {Fuzzy Mathematics in Pattern Classification},
	Year = {1973}}

@book{Bertsekas95,
	Address = {Belmont, Massachusetts},
	Author = {D. P. Bertsekas},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Athena Scientific},
	Title = {Dynamic Programming and Optimal Control},
	Year = {1995}}

@article{Bertolissi01BirattariBontempiDuchateauBersini,
	Author = {E. Bertolissi and M. Birattari and G. Bontempi and A. Duchateau and H. Bersini},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {FSS},
	Number = {1},
	Pages = {3--14},
	Title = {Data-Driven Techniques for Direct Adaptive Control: the Lazy and the Fuzzy Approach.},
	Volume = {128},
	Year = {2002}}

@inproceedings{Bertolissi00BirattariBontempiDuchateauBersini,
	Author = {E. Bertolissi and M. Birattari and G. Bontempi and A. Duchateau and H. Bersini},
	Booktitle = {Proceedings of International Conference on Artificial and Computational Intelligence For Decision, Control and Automation In Engineering and Industrial Applications},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-03-14 14:11:37 +0100},
	Note = {To appear.},
	Title = {Two multiple-model approaches for adaptive control.},
	Year = {2000}}

@inproceedings{Bersini98BontempiBirattari,
	Author = {H. Bersini and G. Bontempi and M. Birattari},
	Booktitle = {Fuzzy Neuro Systems 98 - Computational Intelligence},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {W. Brauer},
	Note = {Proceedings of the 5th International Workshop on Fuzzy-Neuro Systems},
	Pages = {10--25},
	Title = {Is readability compatible with accuracy: from neuro-fuzzy to lazy learning},
	Year = {1998}}

@article{Bersini97Gorrini,
	Author = {H. Bersini and V. Gorrini},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-NN},
	Number = {2},
	Pages = {437--441},
	Title = {A Simplification of the Back-Propagation-Through-Time Algorithm for Optimal Neurocontrol},
	Volume = {8},
	Year = {1997}}

@inproceedings{Bersini97Bontempi-IFSA,
	Address = {Prague},
	Author = {H. Bersini and G. Bontempi},
	Booktitle = {IFSA '97 (7th International Fuzzy Systems Association World Congress, Prague)},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {354--359},
	Publisher = {Academia},
	Title = {Fuzzy models viewed as multi-expert networks},
	Year = {1997}}

@article{Bersini97Bontempi,
	Author = {H. Bersini and G. Bontempi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Fuzzy Sets and Sytems},
	Number = {2},
	Pages = {161--170},
	Title = {Now comes the time to defuzzify the neuro-fuzzy models},
	Volume = {90},
	Year = {1997}}

@inproceedings{Bersini97BirattariBontempi,
	Author = {H. Bersini and M. Birattari and G. Bontempi},
	Booktitle = {Proceedings of the 1998 IEEE International Joint Conference on Neural Networks},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {2102--2106},
	Title = {Adaptive memory-based regression methods},
	Year = {1998}}

@article{benjamini1995controlling,
	Author = {Y. Benjamini and Y. Hochberg},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of the Royal Statistical Society Series B},
	Pages = {289-300},
	Title = {Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing},
	Volume = {57},
	Year = {1995}}

@article{Benedetti77,
	Author = {J. K. Benedetti},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of the Royal Statistical Society, Series B},
	Number = {39},
	Pages = {248--253},
	Title = {On the non parametric estimation of regression functions.},
	Year = {1977}}

@article{Bello92,
	Author = {M. G. Bello},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-NN},
	Number = {6},
	Pages = {864--875},
	Title = {Enhanced training algorithms, and integrated training/architecture selection for multilayer perceptron networks},
	Volume = {3},
	Year = {1992}}

@article{Baxt92,
	Author = {W. G. Baxt},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {NC},
	Pages = {772--780},
	Title = {Improving the accuracy of an artificial neural network using multiple differently trained networks},
	Volume = {4},
	Year = {1992}}

@article{Baumann86Rugh,
	Author = {W. T. Baumann and W. J. Rugh},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IEEE-AC},
	Number = {1},
	Pages = {40--46},
	Title = {Feedback control of nonlinear systems by extended linearization},
	Volume = {31},
	Year = {1986}}

@inproceedings{Barron84,
	Address = {New York},
	Author = {A. R. Barron},
	Booktitle = {Self-Organizing Methods in Modeling},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {S. J. Farlow},
	Pages = {87--103},
	Publisher = {Marcel Dekker},
	Title = {Predicted squared error: a criterion for automatic model selection},
	Volume = {54},
	Year = {1984}}

@incollection{Babuska97Verbruggen,
	Author = {R. Babuska and H. B. Verbruggen},
	Booktitle = {Multiple Model Approaches to Modeling and Control},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {R. Murray-Smith and T. A. Johansen},
	Pages = {75--100},
	Publisher = {Taylor and Francis},
	Title = {Fuzzy Set Methods for Local Modelling and Identification},
	Year = {1997}}

@phdthesis{babuska1996fuzzy,
	Author = {R. Babuska},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2009-09-11 14:20:54 +0200},
	School = {Technische Universiteit Delft},
	Title = {Fuzzy Modeling and Identification},
	Year = {1996}}

@article{Atkeson97MooreSchaalCONTROL,
	Author = {C. G. Atkeson and A. W. Moore and S. Schaal},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Review},
	Number = {1--5},
	Pages = {75--113},
	Title = {Locally weighted learning for control},
	Volume = {11},
	Year = {1997}}

@article{Atkeson97MooreSchaal,
	Author = {C. G. Atkeson and A. W. Moore and S. Schaal},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Review},
	Number = {1--5},
	Pages = {11--73},
	Title = {Locally weighted learning.},
	Volume = {11},
	Year = {1997}}

@inproceedings{Atkeson94,
	Author = {C. G. Atkeson},
	Booktitle = {Advances in Neural Information Processing Systems 6},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {J. D. Cowan and G. Tesauro and J. Alspector},
	Pages = {663--670},
	Publisher = {Morgan Kaufmann},
	Title = {Using local optimizers to speed up global optimization in dynamic programming},
	Year = {1994}}

@incollection{Atkeson92,
	Author = {C. G. Atkeson},
	Booktitle = {Nonlinear Modeling and Forecasting},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {M. Casdagli and S. Eubank},
	Pages = {503--521},
	Publisher = {Addison Wesley},
	Title = {Memory-based approaches to approximating continuous functions},
	Year = {1992}}

@inproceedings{Atkeson89,
	Address = {San Mateo, CA},
	Author = {C. G. Atkeson},
	Booktitle = {Advances in neural information processing systems, 1},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Editor = {D. Touretzky},
	Pages = {79--86},
	Publisher = {Morgan Kaufmann},
	Title = {Using local models to control movement},
	Year = {1989}}

@book{Astrom90Wittenmark,
	Author = {K. J. {\AA}str{\"{o}}m and B. Wittenmark},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Prentice-Hall International Editions},
	Title = {Computer-controlled Systems: Theory and Design},
	Year = {1990}}

@article{Astrom83,
	Author = {K. J. {\AA}str{\"{o}}m},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Automatica},
	Number = {5},
	Pages = {471--486},
	Title = {Theory and Applications of Adaptive Control - {A} Survey},
	Volume = {19},
	Year = {1983}}

@article{Astrom67,
	Author = {K. J. {\AA}str{\"{o}}m},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {IBM J. Res. Dev.},
	Pages = {389--404},
	Title = {Computer Control of a Paper Machine. An application of linear stochastic control theory},
	Volume = {11},
	Year = {1967}}

@article{ashburner2000gene,
	Author = {M. Ashburner and C. A. Ball and J. A. Blake and D. Botstein and H. Butler and J. M. Cherry and A. P. Davis and K. Dolinski and S. S. Dwoght and J. T. Eppig and M. A. Harris and D. P. Hill and L. Issel-Tarver and A. Kasarskis and S. Lewis and J. C. Matese and J. E. Richardson and M. Ringwald and G. M. Rubin and G. Sherlock},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-09-24 14:47:14 +0200},
	Journal = {Nature Genetics},
	Pages = {25--29},
	Title = {Gene ontology: tool for the unfication of biology. The Gene Ontology Consortium},
	Volume = {25},
	Year = {2000}}

@book{Arnold84,
	Author = {V. I. Arnol'd},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer-Verlag},
	Title = {Ordinary differential equations},
	Year = {1984}}

@article{Anderson84Deistler,
	Author = {B. D. O. Anderson and M. Deistler},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Journal of Time Series Analysis},
	Pages = {1--13},
	Title = {Identifiability in dynamic errors-in-variables models},
	Volume = {5},
	Year = {1984}}

@book{Anderson71,
	Author = {T. W. Anderson},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {J. Wiley and sons},
	Title = {The statistical analysis of time series},
	Year = {1971}}

@article{allen1974relationship,
	Author = {D. M. Allen},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Technometrics},
	Pages = {125-127},
	Title = {The Relationship Between Variable and Data Augmentation and a Method of Prediction},
	Volume = {16},
	Year = {1974}}

@article{akaike74new,
	Author = {H. Akaike},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-21 09:50:51 +0100},
	Journal = {IEEE-AC},
	Number = {6},
	Pages = {716--723},
	Title = {A New Look at the Statistical Model Identification},
	Volume = {19},
	Year = {1974}}

@article{Akaike70,
	Author = {H. Akaike},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Ann. Inst. Stat. Math.},
	Pages = {203--217},
	Title = {Statistical Predictor Identification},
	Volume = {22},
	Year = {1970}}

@article{Akaike69,
	Author = {H. Akaike},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Annals of the Institute of Statistical Mechanics},
	Pages = {243--247},
	Title = {Fitting autoregressive models for prediction},
	Volume = {21},
	Year = {1969}}

@article{Aha97,
	Author = {D. W. Aha},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Journal = {Artificial Intelligence Review},
	Number = {1--5},
	Pages = {1--6},
	Title = {Editorial},
	Volume = {11},
	Year = {1997}}

@phdthesis{Aha90,
	Author = {D. W. Aha},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	School = {University of California, Irvine, Department of Information and Computer Science},
	Title = {A Study of Instance-Based Algorithms for Supervised Learning Tasks: Mathematical, Empirical and Psychological Observations},
	Year = {1990}}

@inproceedings{Aha89,
	Address = {San Mateo, CA},
	Author = {D. W. Aha},
	Booktitle = {Sixth International Machine Learning Workshop},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Pages = {387--391},
	Publisher = {Morgan Kaufmann},
	Title = {Incremental, instance-based learning of independent and graded concept descriptions.},
	Year = {1989}}

@manual{affymetrix2002manual,
	Author = {Affymetrix},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Title = {GeneChip Expression Analysis},
	Year = {2002}}

@article{hortobagyi2000adjuvant,
	Author = {G Hortobagyi},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2008-07-04 10:26:42 +0200},
	Journal = {Annual Revision of Medicine},
	Title = {Adjuvant therapy for breast cancer},
	Year = {2000}}

@book{Abarbanel96,
	Author = {H. Abarbanel},
	Date-Added = {2007-03-20 08:04:10 +0100},
	Date-Modified = {2007-03-20 08:04:10 +0100},
	Publisher = {Springer},
	Title = {Analysis of observed chaotic data},
	Year = {1996}}

@book{kaufman1990finding,
	Author = {L. Kaufman and P. J. Rousseeuw},
	Date-Added = {2007-03-19 15:18:53 +0100},
	Date-Modified = {2007-03-19 15:20:06 +0100},
	Publisher = {Wiley},
	Title = {Finding groups in Data},
	Year = {1990}}

@article{vanderlaan2003hybrid,
	Author = {M. van der Laan and K. Pollard},
	Date-Added = {2007-03-19 15:15:11 +0100},
	Date-Modified = {2007-03-19 15:17:25 +0100},
	Journal = {Journal of Statistical Planning and Inference},
	Pages = {275-303},
	Title = {Hybrid clustering of gene expression data with visualization and the bootstrap},
	Volume = {117},
	Year = {2003}}

@article{liu2007prognostic,
	Author = {R. Liu and X. Wang and G. Y. Chen and P. Dalerba and A. Gurney and T. Hoey and G. Sherlock and J. Lewicki and K. Shedden and M. F. Clarke},
	Date-Added = {2007-01-23 10:28:32 +0100},
	Date-Modified = {2007-01-23 10:39:32 +0100},
	Journal = {The New England Journal of Medicine},
	Number = {3},
	Pages = {217-226},
	Title = {The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells},
	Volume = {356},
	Year = {2007}}

@article{kennedy2006sscore,
	Author = {R. E. Kennedy and R. T. Kerns and X. Kong and K. J. Archer and M. F. Miles},
	Date-Added = {2006-11-30 16:55:49 +0100},
	Date-Modified = {2006-11-30 16:57:49 +0100},
	Journal = {Bioinformatics Applications Note},
	Number = {10},
	Pages = {1272-1274},
	Title = {SScore: an R package for detecting differential gene expression without gene expression summaries},
	Volume = {22},
	Year = {2006}}

@article{mueller1994hazard,
	Author = {H. G. Mueller and J. L. Wang},
	Date-Added = {2006-11-21 18:25:12 +0100},
	Date-Modified = {2006-11-21 18:26:26 +0100},
	Journal = {Biometrics},
	Pages = {61-76},
	Title = {Hazard Rates Estimation Under Random Censoring with Varying Kernels and Bandwidths},
	Volume = {50},
	Year = {1994}}

@article{chang2004gene,
	Author = {H. Y. Chang and J. B. Sneddon and A. A. Alizadeh and R. Sood and R. B. West and K. Montgomery and J. Chi and M. van de Rijn and D. Botstein and P. O. Brown},
	Date-Added = {2006-11-14 16:58:30 +0100},
	Date-Modified = {2006-11-14 17:01:24 +0100},
	Journal = {PLOS Biology},
	Number = {2},
	Pages = {206-214},
	Title = {Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds},
	Volume = {2},
	Year = {2004}}

@article{pawitan2005gene,
	Author = {Y. Pawitan and J. Bjohle and L. Amler and A. Borg and S. Egyhazi and P. Hall and X. Han and L. Holmberg and F. Huang and S. Klaar and E. T. Liu and L. Miller and H. Nordgren and A. Ploner and K? Sandelin and P. M. Shaw and J. Smeds and L. Skoog and S. Wedren and J. Bergh},
	Date-Added = {2006-11-11 09:45:43 +0100},
	Date-Modified = {2006-11-11 09:50:39 +0100},
	Journal = {Breast Cancer Research},
	Number = {6},
	Pages = {953-964},
	Title = {Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts},
	Volume = {7},
	Year = {2005}}

@article{kittler1998combining,
	Author = {J. Kittler and M. Hatef and R. Duin and J. Matas},
	Date-Added = {2006-09-19 14:43:24 +0200},
	Date-Modified = {2006-09-19 14:45:33 +0200},
	Journal = {IEEE Transactions on Pattern Analysis and Machine Intelligence},
	Number = {3},
	Pages = {226-238},
	Title = {On Combining Classifiers},
	Volume = {20},
	Year = {1998}}

@inproceedings{moore1994efficient,
	Author = {A. W. Moore and M. S. Lee},
	Booktitle = {International Conference on Machine Learning},
	Date-Added = {2006-09-13 11:21:37 +0200},
	Date-Modified = {2006-09-13 11:34:21 +0200},
	Number = {190-198},
	Title = {Efficient Algorithms for Minimizing Cross Validation Error},
	Year = {1994}}

@inproceedings{maron1994hoeffding,
	Author = {O. Maron and A. W. Moore},
	Booktitle = {Advances in Neural Information Processing Systems 6},
	Date-Added = {2006-09-13 11:20:04 +0200},
	Date-Modified = {2006-09-13 11:35:57 +0200},
	Number = {59-66},
	Title = {Accelerating Model Selection Search for Classification and Function Approximation},
	Year = {1994}}

@article{ji2006refseq,
	Author = {Y. Ji and K. Coombes and J. Zhang and S. Wen and J. Mitchell and L. Pusztai and W. F. Symmans and J. Wang},
	Date-Added = {2006-08-21 09:57:11 +0200},
	Date-Modified = {2006-08-21 10:00:24 +0200},
	Journal = {Applied Bioinformatics},
	Number = {2},
	Pages = {89-98},
	Title = {Refseq Refinements of Unigene-Based Gene Matching Improve the Correlation of Expression Measurements Between Two Microarray Platforms},
	Volume = {5},
	Year = {2006}}

@article{miller1999rapid,
	Author = {C. Miller and J. Gurd and A. Brass},
	Date-Added = {2006-08-18 12:05:28 +0200},
	Date-Modified = {2006-08-18 12:07:14 +0200},
	Journal = {Bioinformatics},
	Number = {111-121},
	Title = {A RAPID algorithm for sequence database comparisons: application to the identification of vector contamination in the EMBL databases},
	Volume = {15},
	Year = {1999}}

@article{oh2006estrogenregulated,
	Author = {D. S. Oh and M. A. Troester and J. Usary and Z. Hu and X. He and C. Fan and J. Wu and L. A. Carey and C. M. Perou},
	Date-Added = {2006-06-26 14:01:34 +0200},
	Date-Modified = {2006-06-26 14:14:54 +0200},
	Journal = {Journal of Clinical Oncology},
	Number = {11},
	Title = {Estrogen-Regulated Genes Predict Survival in Hormone Receptor--Positive Breast Cancers},
	Volume = {24},
	Year = {2006}}

@article{miller2005expression,
	Author = {L. D. Miller and J. Smeds and J. George and V. B. Vega and L. Vergara and A. Pioner and Y. Pawitan and P. Hall and S. Klaar and E. T. Liu and J. Bergh},
	Date-Added = {2006-06-26 13:55:13 +0200},
	Date-Modified = {2006-06-26 13:58:17 +0200},
	Journal = {PNAS},
	Number = {38},
	Pages = {13550-13555},
	Title = {An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival},
	Volume = {102},
	Year = {2005}}

@article{foekens2006multicenter,
	Author = {J. A. Foekens and D. Atkins and Y. Zhang and F. C. Sweep and N. Harbeck and A. Paradiso and T. Cufer and A. M. Sieuwerts and D. Talantov and P. N. Span and V. C. Tjan-Heijnen and A. F. Zito and K. Specht and H. Hioefler and R. Golouh and F. Schittulli and M. Schmitt and L. V. Beex and J. G. Klijn and Y. Wang},
	Date-Added = {2006-06-26 13:45:57 +0200},
	Date-Modified = {2006-06-26 13:51:09 +0200},
	Journal = {Journal of Clinical Oncology},
	Number = {11},
	Title = {Multicenter Validation of a Gene Expression--Based Prognostic Signature in Lymph Node--Negative Primary Breast Cancer},
	Volume = {24},
	Year = {2006}}

@article{kerns2003application,
	Author = {R. T. Kerns and L. Zhang and M. F. Miles},
	Date-Added = {2006-06-23 09:44:36 +0200},
	Date-Modified = {2006-06-23 09:45:02 +0200},
	Journal = {Methods},
	Number = 3,
	Pages = {274--281},
	Title = {Application of the S-score algorithm for analysis of oligonucleotide microarrays},
	Volume = 31,
	Year = 2003}

@article{stoppiglia2003ranking,
	Author = {H. Stoppiglia and G. Dreyfus and R. Dubois and Y. Oussar},
	Date-Added = {2006-06-22 18:08:47 +0200},
	Date-Modified = {2006-06-22 18:09:32 +0200},
	Journal = {Journal of Machine Learning Research},
	Pages = {1389-1414},
	Title = {Ranking a Random Feature for Variable and Feature Selection},
	Volume = {3},
	Year = {2003}}

@book{miller2002subset,
	Author = {A. Miller},
	Date-Added = {2006-06-22 18:06:51 +0200},
	Date-Modified = {2006-06-22 18:08:35 +0200},
	Edition = {second},
	Publisher = {Chapman \& Hall/CRC},
	Series = {Monographs on Statistics and Applied Probability},
	Title = {Subset Selection in Regression},
	Volume = {95},
	Year = {2002}}

@article{korn2004controlling,
	Author = {E. L. Korn and J. Troendie and L. M. McShane and R. Simon},
	Date-Added = {2006-05-18 08:44:05 +0200},
	Date-Modified = {2006-05-18 08:46:40 +0200},
	Journal = {Journal of Statist Plann Inference},
	Pages = {379-398},
	Title = {Controlling the Number of False Discoveries: Application to High Dimensional Genomic Data},
	Volume = {124},
	Year = {2004}}

@book{westfall1993resamplingbased,
	Author = {P. H. Westfall and S. S. Young},
	Date-Added = {2006-05-18 08:42:07 +0200},
	Date-Modified = {2006-05-18 08:43:54 +0200},
	Publisher = {New-York wiley},
	Title = {Resampling-based multiple testing: examples and methods for p-value adjustment},
	Year = {1993}}

@article{hedges1987statistical,
	Author = {L. Hedges and I. Olkin},
	Date-Added = {2006-05-18 08:39:31 +0200},
	Date-Modified = {2008-07-31 12:31:55 +0200},
	Journal = {Journal of the American Statistical Association},
	Number = {397},
	Pages = {350-351},
	Title = {Statistical Methods for Meta-Analysis},
	Url = {http://www.jstor.org/pss/2289186},
	Volume = {82},
	Year = {1987},
	Bdsk-Url-1 = {http://www.jstor.org/pss/2289186}}

@article{hastie2001supervised,
	Author = {T. Hastie and R. Tibshirani and D. Bolstein and P. Brown},
	Date-Added = {2006-04-25 15:43:11 +0200},
	Date-Modified = {2006-04-25 15:45:22 +0200},
	Journal = {Genome Biology},
	Number = {1},
	Pages = {1-12},
	Title = {Supervised Harvesting of Expression Trees},
	Volume = {2},
	Year = {2001}}

@article{saldanha2004java,
	Author = {A. J. Saldanha},
	Date-Added = {2006-04-05 11:31:10 +0200},
	Date-Modified = {2006-04-05 11:34:08 +0200},
	Journal = {Bioinformatics Applications Note},
	Number = {17},
	Pages = {3246-3248},
	Title = {Java Treeview - extensible visualization of microarray data},
	Urldate = {http://jtreeview.sourceforge.net/},
	Volume = {20},
	Year = {2004}}

@book{hollander1973nonparametric,
	Author = {M. Hollander and D. A. Wolfe},
	Date-Added = {2006-04-04 16:50:01 +0200},
	Date-Modified = {2006-04-04 16:51:55 +0200},
	Publisher = {New York: John Wiley and Sons},
	Title = {Nonparametric statistical inference},
	Year = {1973}}

@article{eindor2005outcome,
	Author = {L. Ein-Dor and I. Kela and and G. Getz and E. Domany},
	Date-Added = {2006-03-02 08:54:08 +0100},
	Date-Modified = {2006-03-02 09:15:27 +0100},
	Journal = {Bioinformatics},
	Pages = {171-178},
	Title = {Outcome Signature Genes in Breast Cancer: Is There a Unique Set?},
	Volume = {21},
	Year = {2005}}

@article{shen2004prognostic,
	Author = {R. Shen and D. Ghosh and A. M. Chinnaiyan},
	Date-Added = {2006-02-27 22:09:28 +0100},
	Date-Modified = {2006-02-27 22:11:31 +0100},
	Journal = {BMC Genomics},
	Number = {94},
	Title = {Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data},
	Volume = {5},
	Year = {2004}}

@article{rhodes2004largescale,
	Author = {D. R. Rhodes and J. Yu and K. Shanker and N. Desphande and R. Varambally and D. Ghosh and T. Barrette and A. Pandey and A. M. Chinnaiyan},
	Date-Added = {2006-02-27 22:03:59 +0100},
	Date-Modified = {2006-02-27 22:07:22 +0100},
	Journal = {PNAS},
	Number = {25},
	Pages = {9309-9314},
	Title = {Latge-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression},
	Volume = {101},
	Year = {2004}}

@article{scheel2005influence,
	Author = {I. Scheel and M. Aldrin and I. K. Glad and R. Serum and H. Lyng and A. Frigessi},
	Date-Added = {2006-02-23 11:02:56 +0100},
	Date-Modified = {2006-02-23 11:07:34 +0100},
	Journal = {Bioinformatics},
	Number = {23},
	Pages = {4272-4279},
	Title = {The Influence of Missing Value Imputation on detection of Differentially Expressed Genes From Microarray data},
	Volume = {21},
	Year = {2005}}

@article{oba2003bayesian,
	Author = {S. Oba and M. Sato and I. Takemasa and M. Monden and K. Matsubara and S. Ishii},
	Date-Added = {2006-02-23 10:56:42 +0100},
	Date-Modified = {2006-02-23 10:59:13 +0100},
	Journal = {Bioinformatics},
	Number = {16},
	Title = {A Bayesian Missing Value Estimation Method for Gene Expression Profile Data},
	Volume = {19},
	Year = {2004}}

@article{kim2005missing,
	Author = {H. Kim and G. H. Golub and H. Park},
	Date-Added = {2006-02-23 10:54:14 +0100},
	Date-Modified = {2006-02-23 10:56:21 +0100},
	Journal = {Bioinformatics},
	Number = {2},
	Pages = {187-198},
	Title = {Missing Value estimation for DNA Microarray Gene Expression Data: local Least Squares Imputation},
	Volume = {21},
	Year = {2005}}

@book{breiman1984classification,
	Author = {L. Breiman and J. H. Friedman and R. A. Olshen and C. J. Stone},
	Date-Added = {2006-02-10 09:57:34 +0100},
	Date-Modified = {2006-02-10 10:00:08 +0100},
	Publisher = {Chapman and Hall, New-York},
	Title = {Classification and Regression Trees},
	Year = {1984}}

@article{benhur2002stability,
	Author = {A. Ben-Hur and A. Elisseeff and I. Guyon},
	Date-Added = {2006-02-02 15:50:45 +0100},
	Date-Modified = {2006-02-02 16:56:19 +0100},
	Journal = {Proc. Symp. Biocomput.},
	Pages = {6-17},
	Title = {A stability based method for discovering structure in clustered data A stability based method for discovering structure in clustered data},
	Volume = {7},
	Year = {2002}}

@article{valentini2006clusterv,
	Author = {G. Valentini},
	Date-Added = {2006-02-02 15:12:11 +0100},
	Date-Modified = {2006-02-02 17:01:32 +0100},
	Journal = {Bioinformatics Applications Note},
	Number = {3},
	Pages = {369-370},
	Title = {Clusterv: a tool for assessing the reliability of clusters},
	Volume = {22},
	Year = {2006}}

@book{kruskal1978multidimensional,
	Author = {J. B. Kruskal and M. Wish},
	Date-Added = {2006-02-01 15:30:56 +0100},
	Date-Modified = {2006-02-01 15:32:16 +0100},
	Publisher = {Beverly Hills, California},
	Title = {Multidimensional Scaling},
	Year = {1978}}

@inproceedings{macqueen1967some,
	Author = {J. B. MacQueen},
	Booktitle = {Proceedings of 5-th Berkeley Symposium on Mathematical Statistics and Probability},
	Date-Added = {2006-02-01 14:05:41 +0100},
	Date-Modified = {2006-02-01 14:08:06 +0100},
	Pages = {281-297},
	Title = {Some Methods for classification and Analysis of Multivariate Observations},
	Volume = {1},
	Year = {1967}}

@book{kohonen1997selforganizating,
	Author = {T. Kohonen},
	Date-Added = {2006-01-30 14:47:48 +0100},
	Date-Modified = {2006-01-30 14:49:17 +0100},
	Publisher = {Springer-Verlag},
	Title = {Self-Organizating Maps},
	Year = {1997}}

@book{critchlow1985metric,
	Author = {D. E. Critchlow},
	Date-Added = {2006-01-24 09:33:23 +0100},
	Date-Modified = {2006-01-24 09:34:40 +0100},
	Publisher = {Springer-Verlag},
	Title = {Metric Methods for Analyzing Partially Ranked Data},
	Year = {1985}}

@conference{reid2005predicting,
	Author = {J. F. Reid},
	Booktitle = {International BCB-Workshop on Machine Learning in Bioinformatics},
	Date-Added = {2005-12-08 10:16:21 +0100},
	Date-Modified = {2005-12-08 10:17:46 +0100},
	Title = {Predicting clinical outcome of breast cancer patients treated with Tamoxifen using gene expression data},
	Year = {2005}}

@article{wang2005geneexpression,
	Author = {Y. Wang and J. G. Klijn and Y. Zhang and A. M. Sieuwerts and M. P. Look and F. Yang and D. Talantov and M. Timmermans and M. E. Meijer-van Gelder and J. Yu and T. Jatkoe and E. M. Berns and D. Atkins and J. A. Foekens},
	Date-Added = {2005-12-08 10:02:38 +0100},
	Date-Modified = {2009-12-07 11:25:17 -0500},
	Journal = {Lancet},
	Number = {9460},
	Pages = {671-679},
	Title = {Gene-Expression Profiles to Predict Distant Metastasis of Lymph-Node-Negative Primary Breast Cancer},
	Volume = {365},
	Year = {2005}}

@book{marden1995analyzing,
	Author = {J. I. Marden},
	Date-Added = {2005-12-06 14:05:35 +0100},
	Date-Modified = {2005-12-06 14:52:29 +0100},
	Publisher = {Chapman and Hall},
	Read = {No},
	Title = {Monographs on Statistics and Applied Probability 64: Analyzing and Modeling Rank Data},
	Year = {1995}}

@article{tibshirani1997lasso,
	Author = {R. Tibshirani},
	Journal = {Statistics in Medicine},
	Pages = {385-395},
	Title = {The LASSO Method for Variable Selection in the Cox Model},
	Volume = {16},
	Year = {1997}}

@book{allison1995survival,
	Author = {P. D. Allison},
	Date-Modified = {2007-09-26 14:01:13 +0200},
	Editor = {{SAS Institute Inc.}},
	Publisher = {SAS Institute Inc.},
	Title = {Survival Analysis Using SAS: A Practical Guide},
	Year = {1995},
	Bdsk-Url-1 = {http://support.sas.com/publishing/bbu/companion_site/55233.html}}

@book{baldi2001bioinformatics,
	Author = {P. Baldi and S. Brunak},
	Editor = {Bradford},
	Publisher = {MIT press},
	Title = {Bioinformatics: The Machine Learning Approach},
	Year = {2001}}

@article{beer2002gene,
	Author = {D. G. Beer and L. R. Kardia and C-C. Huang and T. J. Giordano and A. M. Levin and D. E. Misek and L. Lin and G. Chen and T. G. Gharib and D. G. Thomas and M. L. Lizyness and R. Kuick and S. Hayasaka and J. M. G. Taylor and M. D. Lannettoni and M. B. Orringer and S. Hanash},
	Journal = {Nature Medicine},
	Title = {Gene-Expression Profiles Predict Survival of Patients with Lung Adenocarcinoma},
	Year = {2002}}

@article{cox1972regression,
	Author = {Cox, David R.},
	Date-Modified = {2008-09-26 15:50:23 +0200},
	Journal = {Journal of the Royal Statistical Society Series B},
	Pages = {187-220},
	Title = {Regression Models and Life Tables},
	Volume = {34},
	Year = {1972}}

@article{hanahan2000hallmarks,
	Author = {D. Hanahan and R. A. Weinberg},
	Journal = {Cell},
	Pages = {57-70},
	Title = {The Hallmarks of Cancer},
	Volume = {100},
	Year = {2000},
	Bdsk-Url-1 = {http://www.cell.com/fulltext/S0092-8674(00)81683-9}}

@book{sakamoto1986akaike,
	Author = {Y. Sakamoto and M. Ishiguro and G. Kitagawa},
	Publisher = {D. Reidel Publishing Company},
	Title = {Akaike Information Criterion Statistics},
	Year = {1986}}

@article{desmet2002adaptive,
	Author = {F. {De Smet} and J. Mathys and K. Marchal and G. TRhijs and B. {De Moor} and Y. Moreau},
	Journal = {Bioinformatics},
	Number = {5},
	Pages = {735-746},
	Title = {Adaptive Quality-Based Clustering of Gene Expression Profiles},
	Volume = {18},
	Year = {2002}}

@article{dorey1987effective,
	Author = {F. J. Dorey and E. L. Korn},
	Journal = {Statistics in Medicine},
	Pages = {679-687},
	Title = {Effective sample sizes for confidence intervals for survival probabilities},
	Volume = {6},
	Year = {1987}}

@article{fisher1935logic,
	Author = {R. A. Fisher},
	Journal = {Journal of the Royal Statistical Society},
	Pages = {39-54},
	Title = {The logic of inductive inference},
	Volume = {98},
	Year = {1935}}

@book{vittinghoff2005regression,
	Author = {E. Vittinghof and D. V. Glidden and S. C. Shiboski and C. E. McCulloch},
	Editor = {Springer},
	Publisher = {Springer},
	Title = {Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models},
	Year = {2005}}

@article{akritas1986bootstrapping,
	Author = {M. G. Akritas},
	Journal = {Journal of the American Statistical Association},
	Pages = {1032-1038},
	Title = {Bootstrapping the Kaplan-Meier Estimator},
	Volume = {81},
	Year = {1986}}

@article{blair2004semisupervised,
	Author = {E. Bair and R. Tibshirani},
	Date-Modified = {2008-04-10 16:44:23 +0200},
	Journal = {PLOS Biology},
	Number = {4},
	Pages = {511-522},
	Title = {Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data},
	Volume = {2},
	Year = {2004}}

@article{holder2001statistical,
	Author = {D. Holder and R. F. Rauberras and V. B. Pikounis and V. Svetnik and K. Shoper},
	Journal = {Proceedings of the ASA Annual Meeting Atlanta, GA},
	Title = {Statistical analysis of High Density Oligonucleotide Arrays: a SAFER Approach},
	Year = {2001}}

@article{akritas1994nearest,
	Author = {M. G. Akritas},
	Journal = {Annals of Statistics},
	Pages = {1299-1327},
	Title = {Nearest Neighbor Estimation of a Bivariate Distribution Under Random Censoring},
	Volume = {22},
	Year = {1994}}

@article{huang2002penalized,
	Author = {J. Huang and D. Harrington},
	Journal = {Biometrics},
	Title = {Penalized Partial Likelihood Regression for Right-Censored Data with Bootstrap Selection of the Penalty Parameter},
	Year = {2002}}

@article{fleming1984nonparametric,
	Author = {T. H. Fleming and D. P. Harrington},
	Journal = {Comm in Statistics},
	Pages = {2469-2486},
	Title = {Nonparametric estimation of the survival distribution in censored data},
	Volume = {13},
	Year = {1984}}

@article{dudoit2002comparison,
	Author = {S. Dudoit and J. Fridlyand and T. P. Speed},
	Journal = {Journal of the American Statistical Association},
	Number = {457},
	Pages = {77-87},
	Title = {Comparison of discrimination methods for the classification of tumors using gene expression data},
	Volume = {97},
	Year = {2002}}

@article{gautier2004affy,
	Author = {L. Gautier and L. M. Cope and B. M. Bolstad and R. A. Irizarry},
	Journal = {Bioinformatics},
	Number = {3},
	Pages = {307-315},
	Title = {Affy - Analysis of Affymetrix GeneChip data at the probe level},
	Volume = {20},
	Year = {2004}}

@article{hans2004confirmation,
	Author = {C. P. Hans and D. D. Weisenburger and T. C. Greiner and R. D. Gascoyne and J. Delabie and G. Ott and H. K. Muller-Hermelink and E. Campo and R. M. Braziel and E. S. Jaffe and Z. Pan and P. Farinha and L. M. Smith and B. Falini and A. H. Banham and A. Rosenwald and L. M. Staudt and J. M. Connors and J. O. Armitage and W. C. Chan},
	Journal = {Blood},
	Number = {1},
	Pages = {275-282},
	Title = {Confirmation of the Molecular Classification of Diffuse Large B-Cell by Immunochemistry Using a Tissue Microarray},
	Volume = {103},
	Year = {2004}}

@article{greenwood1926errors,
	Author = {M. Greenwood},
	Journal = {Reports on Public Health and Statistical Subjects},
	Pages = {1-26},
	Title = {The Errors of Sampling of the Survivorship Tables},
	Volume = {33},
	Year = {1926}}

@article{greenwood1922discussion,
	Author = {M. Greenwood},
	Journal = {Journal of the Royal Statistical Society},
	Pages = {1-26},
	Title = {Discussion on the value of life-tables in statistical research},
	Volume = {33},
	Year = {1922}}

@book{collett2003modelling,
	Author = {D. Collett},
	Edition = {second edition},
	Editor = {Chopman and Hall},
	Publisher = {Chapman and Hall},
	Title = {Modelling Survival Data in Medical Research},
	Year = {2003}}

@article{garfield1990most,
	Author = {E. Garfield},
	Journal = {Current Contents},
	Month = {February},
	Title = {100 Most Cited Papers of All Time},
	Year = {1990}}

@book{droesbeke1988elements,
	Author = {J. J. Droesbeke},
	Editor = {Ellipses},
	Publisher = {Ellipses},
	Title = {Elements de Statistique},
	Year = {1988}}

@article{meier1975estimation,
	Author = {P. Meier},
	Journal = {Perspectives in Probability and Statistics},
	Pages = {67-87},
	Title = {Estimation of a Distribution Function from Incomplete Observations},
	Year = {1975}}

@article{efron1977efficiency,
	Author = {B. Efron},
	Journal = {Journal of the American Statistical Association},
	Pages = {312-319},
	Title = {The Efficiency of Cox's Likelihood Function for Censored Data},
	Volume = {76},
	Year = {1977}}

@article{kaplan1958nonparametric,
	Author = {E. L. Kaplan and P. Meier},
	Journal = {Journal of American Statistical Asscoiation},
	Pages = {457-451},
	Title = {Nonparametric Estimation from Incomplete Observations},
	Volume = {53},
	Year = {1958}}

@article{heagerty2000timedependent,
	Author = {P. J. Heagerty and T. Lumley and M. S. Pepe},
	Journal = {Biometrics},
	Pages = {337-344},
	Title = {Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker},
	Volume = {56},
	Year = {2000}}

@article{coombes2004randomized,
	Author = {R. C. Coombes and E. Hall},
	Date-Modified = {2007-11-29 10:33:43 +0100},
	Journal = {New England Journal of Medicine},
	Number = {11},
	Pages = {1081-1092},
	Title = {A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cance},
	Volume = {350},
	Year = {2004}}

@article{huang2002subset,
	Author = {J. Z. Huang and W. G. Sanger and T. C. Greiner and L. M. Staudt and D. D. Weizenburger and D. L. Pickering and J. C. Lynch and J. O. Armitage and R. A. Warnke and A. A. Alizadeh and I. S. Lossos and R. Levy and W. C. Chan},
	Journal = {Blood},
	Number = {7},
	Pages = {2285-2290},
	Title = {The t(14;18) Defines a Unique Subset of Diffuse Large B-Cell Lymphoma with a Germinal Center B-Cell Gene Expression Profile},
	Volume = {99},
	Year = {2002}}

@article{goss2003randomized,
	Author = {P. E. Goss and N. Ingle},
	Journal = {New England Journal of Medicine},
	Number = {19},
	Pages = {1793-1802},
	Title = {A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer},
	Volume = {349},
	Year = {2003}}

@article{iqbal2004bcl2,
	Author = {J. Iqbal and W. G. Sanger and D. E. Horsman and A. Rosenwald and D. L. Pickering and B. Dave and S. Dave and L. Xiao and K. Cao and Q. Zhu and S. Sherman and C. P. Hans and D. D. Weisenburger and T. C. Greiner and R. D. Gascoyne and G. Off and H. K. Muller-Hermelink and J. Delabie and R. M. Braziel and E. S. Jaffe and E. Campo and J. C. Lynch and J. M. Connors and J. M. Vose and J. O. Armitage and T. M. Grogan and L. M. Staudt and W. C. Chan},
	Journal = {AJP},
	Number = {1},
	Pages = {159-166},
	Title = {BCL2 Traslocation Defines a Unique Tumor Subset within Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma},
	Volume = {165},
	Year = {2004}}

@article{howell2005results,
	Author = {A. Howell and J. Cuzick},
	Journal = {Lancet},
	Number = {9453},
	Pages = {60-62},
	Title = {Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer},
	Volume = {365},
	Year = {2005}}

@article{jansen2005molecular,
	Author = {M. Jansen and J. A. Foekens and I. L. van Staveren and M. M. Dirkzwager-Kiel and K. Ritstier and M. P. Look and M. E. Meijer-van Gelder and A. M. Sieuwerts and H. Portengen and L. C. Dorssers and J. Jlijn and M. Berns},
	Journal = {Journal of Clinical Oncology},
	Number = {4},
	Pages = {732-740},
	Title = {Molecular Clasification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling},
	Volume = {23},
	Year = {2005}}

@article{li2004comparative,
	Author = {T. Li and C. Zhang M. Ogihara},
	Journal = {Bioinformatics},
	Number = {15},
	Pages = {2429-2437},
	Title = {A Comparative Study of Feature Selection and Multiclass Classification Methods for Tissue Classification based on Gene Expression.},
	Volume = {20},
	Year = {2004}}

@article{gui2004penalized,
	Author = {J. Gui and H. Li},
	Journal = {Center for Bioinformatics and Molecular Biostatistic, paper L1Cox},
	Note = {http://repositories.cdlib.org/cbmb/L1Cox},
	Title = {Penalized Cox Regression Analysis in the High-Dimensional and Low-sample Size Settings, with Applications to Microarray Gene Expression Data},
	Year = {2004}}

@article{li2004partial,
	Author = {H. Li and J. Gui},
	Date-Modified = {2007-11-22 18:39:38 +0100},
	Journal = {Bioinformatics},
	Number = {Suppl. 1},
	Pages = {i208-i215},
	Title = {Partial Cox Regression Analysis for High-Dimensional Microarray Gene Expression Data},
	Volume = {200},
	Year = {2004}}

@article{ma2004twogene,
	Author = {X. J. Ma and Z. Wang and P. D. Ryan and S. J. Isakoff and A. Barmettler and A. Fuller and B. Muir and G. Mohapatra and R. Salunga and J. T. Tuggle and Y. Tran and D. Tran and A. Tassin and P. Amon and W. Wang and W. Wang and E. Enright and K. Stecker and E Estepa-Sabal and B. Smith and J. Younger and U. Balis and J. Michaelson and A. Bhan and K. Habion and T. M. Baer and J. Brugge and D. A. Haber and M. G. Erlander and D. S. Sgroi},
	Journal = {Cancer Cell},
	Pages = {607-616},
	Title = {A Two-Gene Expression Ratio Predicts Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen},
	Volume = {5},
	Year = {2004}}

@book{mccullagh1989generalized,
	Author = {P. McCullagh and J. A. Nelder},
	Editor = {Chapman and Hall},
	Publisher = {Chapman and Hall},
	Title = {Generalized Linear Models},
	Year = {1989}}

@article{paik2004multigene,
	Author = {S. Paik and S. Shak and G. Tang and C. Kim and J. Bakker and M. Cronin and F. L. Baehner and M. G. Walker and D. Watson and T. Park and W. Hiller and E. R. Fisher and D. L. Wickerham and J. Bryant and N. Wolmark},
	Date-Modified = {2009-03-28 13:41:06 +0100},
	Journal = {New England Journal of Medicine},
	Number = {27},
	Pages = {2817-2826},
	Title = {A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer},
	Volume = {351},
	Year = {2004}}

@article{ramaswamy2003molecular,
	Author = {S. Ramaswamy and K. N. Ross and E. S. Lander and T. R. Golub},
	Journal = {Nature Genetics},
	Pages = {49-53},
	Title = {A Molecular Signature of Metastasis in Primary Solid Tumors},
	Volume = {33},
	Year = {2003}}

@article{rosenwald2002molecular,
	Author = {A. Rosenwald and G. Wright and W. C. Chan and J. M. Connors and E. Campo and R. I. Fisher and R. D. Gascoyne and H. K. Muller-Hermelink and E. B. Smeland and L. M. Staudt},
	Journal = {N Engl J Med},
	Number = {25},
	Pages = {1937-1947},
	Title = {The Use of Molecular Profiling to Predict Survivalk After Chemotherapy for Diffuse Large B-Cell Lymphoma},
	Volume = {346},
	Year = {2002}}

@book{rossi1980money,
	Author = {P. H. Rossi and R. A. Berk and K. J. Lenihan},
	Editor = {New Yord Academic Press Inc.},
	Publisher = {New Yord Academic Press Inc.},
	Title = {Money, Work and Crime: Some Experimental Results},
	Year = {1980}}

@unpublished{rpvm2004interface,
	Author = {N. M. Li and A.J. Rossini},
	Note = {rpvm package},
	Title = {R interface to PVM (Parallel Virtual Machine)},
	Year = {2004}}

@article{shipp2002diffuse,
	Author = {M. A. Shipp and K. N. Ross and P. Tamayo},
	Journal = {Nature Medicine},
	Pages = {68-74},
	Title = {Diffuse Large B-Cell Lymphoma Outcome Prediction by Gene-Expression Profiling},
	Volume = {8},
	Year = {2002}}

@book{therneau2000modeling,
	Author = {Therneau, T. M. and Grambsch, P. M.},
	Booktitle = {Modeling Survival Data: Extending the Cox Model},
	Date-Modified = {2008-08-08 09:09:06 +0200},
	Doi = {10.1002/sim.956},
	Editor = {Gail, M. and Krickeberg, K. and Samet, J.M. and Tsiatis, A. and Wong, W.},
	Isbn = {978-0-387-98784-2},
	Publisher = {Springer-Verlag New-York},
	Series = {Statistics for Biology and Health},
	Title = {Modeling Survival Data: Extending the Cox Model},
	Url = {http://www.springer.com/statistics/stats+life+sci/book/978-0-387-98784-2},
	Year = {2000},
	Bdsk-Url-1 = {http://www.springer.com/statistics/stats+life+sci/book/978-0-387-98784-2}}

@article{tusher2001significance,
	Author = {V. G. Tusher and R. Tibshirani and G. Chu},
	Journal = {PNAS},
	Pages = {5116-5121},
	Title = {Significance analysis of microarrays applied to the ionizing radiation response},
	Volume = {98},
	Year = {2001}}

@article{michiels2005prediction,
	Author = {S. Michiels and S. Koscielny and C. Hill},
	Date-Modified = {2007-06-27 08:06:20 +0200},
	Journal = {Lancet},
	Pages = {488-492},
	Title = {Prediction of Cancer Outcome with Microarrays: a Multiple Random Validation Strategy},
	Volume = {365},
	Year = {2005}}

@book{cox1984analysis,
	Author = {Cox and D. Oakes},
	Editor = {Chapman and Hall (London)},
	Publisher = {Chapman and Hall (London)},
	Title = {Analysis of Survival Data},
	Year = {1984}}

@article{gray1992flexible,
	Author = {Gray},
	Journal = {JASA},
	Pages = {942-951},
	Title = {Flexible methods of analysing survival data using splines, with applications to breast cancer prognosis},
	Volume = {87},
	Year = {1992}}

@book{gross1975survival,
	Author = {A. J. Gross and V. A. Clark},
	Editor = {Wiley},
	Publisher = {Wiley},
	Title = {Survival Distributions: Reliability Applications in the Biomedical Sciences},
	Year = {1975}}

@article{hsieh1995cautionary,
	Author = {F. Y. Hsieh},
	Journal = {The American Statistician},
	Pages = {226-228},
	Title = {A Cautionary Note on the Analysis of Extreme Data with Cox Regression},
	Volume = {49},
	Year = {1995}}

@article{farewell1980approximation,
	Author = {V. T. Farewell and R. L. Prentice},
	Journal = {Biometrika},
	Pages = {273-278},
	Title = {The Approximation of Partial Likelihood with Emphasis on Case-Control Studies},
	Volume = {67},
	Year = {1980}}

@article{lockhart1996expression,
	Author = {D. J. Lockhart and H. Dong and M. C. Byrne and M. T. Follette and M. V. Gallow and M. S. Chee and M. Mittmann and C. Wang and M? Kbayashi and H. Horton and E. L. Brown},
	Journal = {Nature Biotech.},
	Pages = {1675-1680},
	Title = {Expression MOnitoring by Hybridization to High-Density Oligonucletoide Arrays},
	Volume = {14},
	Year = {1996}}

@article{blum1997selection,
	Author = {A. Blum and P. Langley},
	Journal = {Artificial Intelligence},
	Number = {1-2},
	Pages = {245-271},
	Title = {Selection of Relevant Features and Examples in Machine Learning},
	Volume = {97},
	Year = {1997}}

@article{fodor1991lightdirected,
	Author = {S. P. Fdor and J. L. Read and M. C. Pirrung and L. Stryer and A. T. Lu and D. Solas},
	Journal = {Science},
	Number = {767-773},
	Title = {Light-Directed, Spatially Addressable Parallel Chemical Synthesis},
	Volume = {251},
	Year = {1991}}

@article{amaldi1998approximation,
	Author = {E. Amaldi and V. Kann},
	Journal = {Theoretical Computer Science},
	Pages = {237-260},
	Title = {On the Approximation of Minimizing Non Zero Variables or Unstaisfied Relations in Linear Systems},
	Volume = {209},
	Year = {1998}}

@article{hartemink2001maximum,
	Author = {A. J. Hartemink and D. K. Gifford and T. S. Jaakola and R. A. Young},
	Journal = {SPIE BiOS},
	Title = {Maximum Likelihood Estimation of Optimal Scaling Factors for Expression Array Normalization},
	Year = {2001}}

@book{hartigan1975clustering,
	Author = {J. A. Hartigan},
	Date-Modified = {2007-03-22 07:31:54 +0100},
	Publisher = {Wiley},
	Title = {Clustering Algorithms},
	Year = {1975}}

@article{gautier2005alternative,
	Author = {AL. Gautier and M. Moller and L. Frijs-Hansen and S. Knudsen},
	Journal = {BMC Bioinformatics},
	Number = {111},
	Title = {Alternative Mapping of Probes to Genes for Affymetrix Chips},
	Volume = {5},
	Year = {2005}}

@article{ploner2005correlation,
	Author = {A. Ploner and L. D. Miller and P. Hall and J. Bergh and Y. Pawitan},
	Date-Modified = {2007-09-21 17:09:42 +0200},
	Journal = {BMC Bioinformatics},
	Number = {80},
	Pages = {1-20},
	Title = {Correlation Test to Assess Low-Level Processing of High-Density Oligonucletide Microarray Data},
	Volume = {6},
	Year = {2005}}

@article{shedden2005comparison,
	Author = {K. Sheden and W. Chen and R. Kuick and D. Ghosh and J. Macdonald and K. R. Cho and T. J. Giordano and S. B. Gruber and E. R. Fearon and J. M. Taylor and S. Hanash},
	Journal = {BMC Bioinformatics},
	Number = {26},
	Title = {Comparison of Seven Methods for Producing Affymetrix Expression Score Based on False Discovery Rate in Disease Profiling Data},
	Volume = {6},
	Year = {2005}}

@article{praz2003cleanex,
	Author = {V. Praz and V. Jagannathan and P. Bucher},
	Journal = {Nucleic Acids Research},
	Pages = {542-547},
	Title = {CleanEx: a database of heterogeneous gene expression data based on a consistent gene nomenclature},
	Volume = {32},
	Year = {2003}}

@article{troyanskaya2001missing,
	Author = {O. Troyanskaya and M. Cantor and G. Sherlock and P. Brown and T. Hastie and R. Tibshirani and D. Bolstein and R. B. Altman},
	Journal = {Bioinformatics},
	Number = {6},
	Pages = {520-525},
	Title = {Missing Value Estimation Methods for DNA Microarrays},
	Volume = {17},
	Year = {2001}}

	@article{toussaint2010low,
		Abstract = {<sec>
	<title>Purpose</title>
	<p>Optimal management of breast ductal carcinoma <italic>in situ</italic> (DCIS) is controversial, and many patients are still overtreated. The local death of myoepithelial cells (MECs) is believed to be a pre-requisite to tumor invasion. We thus hypothesized that loss of CD10 expression, a MEC surface peptidase, would signify basement membrane disruption and confer increased risk of relapse in DCIS. The aim of our study was to retrospectively evaluate the prognostic value of CD10 in DCIS.</p>
	</sec><sec>
	<title>Experimental Design</title>
	<p>CD10 expression was evaluated by quantitative RT-PCR and immunohistochemistry using paraffin-embedded samples of normal breast tissue (n=11); of morphologically normal ducts associated with DCIS (n=10); and of DCIS without an invasive component (n=154).</p>
	</sec><sec>
	<title>Results</title>
	<p>CD10 immunostaining was only observed in MECs in normal tissue and in DCIS. Normal tissue showed high mRNA expression levels of CD10, whereas DCIS showed a variable range. After a median follow-up of 6 years, DCIS with CD10 expression below the levels observed in normal tissue (71%) demonstrated a higher risk of local relapse (HR=1.88; [95CI:1.30--2.70], p=0.001) in univariate analysis. No relapse was observed in patients expressing high CD10 mRNA levels (29%) similar to the ones observed in normal tissue. In multivariate analysis including known prognostic factors, low CD10 mRNA expression remained significant (HR=2.25; [95%CI:1.24--4.09], p=0.008), as did the recently revised Van Nuys Prognostic Index (VNPI) score (HR=2.03; [95%CI:1.23--3.35], p=0.006).</p>
	</sec><sec>
	<title>Conclusion</title>
	<p>The decrease of CD10 expression in MECs is associated with a higher risk of relapse in DCIS; this knowledge has the potential to improve DCIS management.</p>
	</sec>},
		Author = {Toussaint, J{\'e}r{\^o}me AND Durbecq, Virginie AND Altintas, Sevilay AND Doriath, Val{\'e}rie AND Rouas, Ghizlane AND Paesmans, Marianne AND Bedard, Philippe AND Haibe-Kains, Benjamin AND Tjalma, Wiebren A. AND Larsimont, Denis AND Piccart, Martine AND Sotiriou, Christos},
		Date-Added = {2010-09-02 09:21:50 -0400},
		Date-Modified = {2010-09-02 09:22:02 -0400},
		Doi = {10.1371/journal.pone.0012100},
		Journal = {PLoS ONE},
		Month = {08},
		Number = {8},
		Pages = {e12100},
		Publisher = {Public Library of Science},
		Title = {Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)},
		Url = {http://dx.doi.org/10.1371%2Fjournal.pone.0012100},
		Volume = {5},
		Year = {2010},
		Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0012100}}

	@article{lecalve2010long,
		Author = {Benjamin {Le Calv\'{e}} and Michal Rynkowski and Marie LeMercier and C{\'e}line Bruy{\`e}re and Caroline Lonez and Thierry Gras and Benjamin Haibe-Kains and Gianluca Bontempi and Christine Decaestecker and Jean-Marie Ruysschaert and Robert Kiss and Florence Lefranc},
		Date-Added = {2010-09-02 09:05:54 -0400},
		Date-Modified = {2010-09-02 09:06:57 -0400},
		Journal = {Neoplasia},
		Number = {9},
		Pages = {727-739},
		Title = {Long term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression},
		Volume = {12},
		Year = {2010},
		Bdsk-Url-1 = {http://www.neoplasia.com/abstract.php?msid=3537}}

	@article{haibekains2010threegene,
		Author = {Benjamin {Haibe-Kains} and Christine Desmedt and Aedin Culhane and Sherene Loi and Gianluca Bontempi and John Quackenbush and Christos Sotiriou},
		Date-Added = {2010-07-15 12:31:08 -0400},
		Date-Modified = {2010-07-15 12:33:30 -0400},
		Journal = {submitted},
		Title = {A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes},
		Year = {2010}}

	@article{dedeurwaerder2010epigenetic,
		Author = {Sarah Dedeurwaerder and Christine Desmedt and Emilie Calonne and Sandeep K. Singhal and Benjamin Haibe-Kains and Matthieu Defrance and Stefan Michiels and Michael Volkmar and Rachel Deplus and Judith Luciani and Fran{\c c}oise Lallemand and Denis Larsimont and J{\'e}r{\^o}me Toussaint and Sandy Haussy and Fran{\c c}oise Roth{\'e} and Ghizlane Rouas and Otto Metzger and Samira Majjaj and Kamal Saini and Pascale Putmans and G{\'e}rald Hames and Nicolas van Baren and Michel Georges and Pierre G. Coulie and Christos Sotiriou and Fran{\c c}ois Fuks},
		Date-Added = {2010-07-12 07:56:46 -0400},
		Date-Modified = {2010-07-12 08:00:09 -0400},
		Journal = {Nature},
		Title = {Epigenetic portraits of human breast cancers},
		Volume = {submitted},
		Year = {2010}}

	@article{loi2010pik3ca,
		Abstract = { mutations are reported to be present in approximately 25% of breast cancer (BC), particularly the estrogen receptor--positive (ER+) and HER2-overexpressing (HER2+) subtypes, making them one of the most common genetic aberrations in BC. In experimental models, these mutations have been shown to activate  and induce oncogenic transformation, and hence these lesions have been hypothesized to render tumors highly sensitive to therapeutic PI3K/mTOR inhibition. By analyzing gene expression and protein data from nearly 1,800 human BCs, we report that a  mutation--associated gene signature (-GS) derived from exon 20 (kinase domain) mutations was able to predict  mutation status in two independent datasets, strongly suggesting a characteristic set of gene expression--induced changes. However, in ER+/HER2 BC despite pathway activation,  mutations were associated with a phenotype of relatively low mTORC1 signaling and a good prognosis with tamoxifen monotherapy. The relationship between clinical outcome and the -GS was also assessed. Although the -GS was not associated with prognosis in ER and HER2+ BC, it could identify better clinical outcomes in ER+/HER2 disease. In ER+ BC cell lines,  mutations were also associated with sensitivity to tamoxifen. These findings could have important implications for the treatment of -mutant BCs and the development of PI3K/mTOR inhibitors.
	},
		Author = {Loi, Sherene and Haibe-Kains, Benjamin and Majjaj, Samira and Lallemand, Francoise and Durbecq, Virginie and Larsimont, Denis and Gonzalez-Angulo, Ana M. and Pusztai, Lajos and Symmans, W. Fraser and Bardelli, Alberto and Ellis, Paul and Tutt, Andrew N. J. and Gillett, Cheryl E. and Hennessy, Bryan T. and Mills, Gordon B. and Phillips, Wayne A. and Piccart, Martine J. and Speed, Terence P. and McArthur, Grant A. and Sotiriou, Christos},
		Date-Added = {2010-06-21 09:55:58 -0400},
		Date-Modified = {2010-06-21 09:56:24 -0400},
		Doi = {10.1073/pnas.0907011107},
		Eprint = {http://www.pnas.org/content/107/22/10208.full.pdf+html},
		Journal = {Proceedings of the National Academy of Sciences},
		Number = {22},
		Pages = {10208-10213},
		Title = {{PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor--positive breast cancer}},
		Url = {http://www.pnas.org/content/107/22/10208.abstract},
		Volume = {107},
		Year = {2010},
		Bdsk-Url-1 = {http://www.pnas.org/content/107/22/10208.abstract},
		Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0907011107}}

	@article{juul2010assessment,
		Author = {Nicolai Juul and Zoltan Szallasi and Aron C Eklund and Qiyuan Li and Rebecca A Burrell and Marco Gerlinger and Vicente Valero and Eleni Andreopoulou and Francisco J Esteva and W Fraser Symmans and Christine Desmedt and Benjamin Haibe-Kains and Christos Sotiriou and Lajos Pusztai and Charles Swanton},
		Date-Added = {2010-03-02 19:19:34 -0500},
		Date-Modified = {2010-03-02 19:19:34 -0500},
		Doi = {DOI: 10.1016/S1470-2045(10)70018-8},
		Issn = {1470-2045},
		Journal = {The Lancet Oncology},
		Pages = {-},
		Title = {Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials},
		Url = {http://www.sciencedirect.com/science/article/B6W85-4YGM2VS-1/2/1663485ad346d9f7b88b8f2cc8f0c5d6},
		Volume = {In Press, Corrected Proof},
		Year = {2010},
		Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/B6W85-4YGM2VS-1/2/1663485ad346d9f7b88b8f2cc8f0c5d6},
		Bdsk-Url-2 = {http://dx.doi.org/10.1016/S1470-2045(10)70018-8}}

	@article{haibekains2010fuzzy,
		Abstract = {Early gene expression studies classified breast tumors into at least three clinically relevant subtypes. Although most current gene signatures are prognostic for estrogen receptor (ER) positive/ human epidermal growth factor receptor 2 (HER2) negative breast cancers, few are informative for ER negative/HER2 negative and HER2 positive subtypes. Here we present Gene Expression Prognostic Index Using Subtypes (GENIUS), a fuzzy approach for prognostication that takes into account the molecular heterogeneity of breast cancer. In systematic evaluations, GENIUS significantly outperformed current gene signatures and clinical indices in the global population of patients. },
		Author = {Haibe-Kains, Benjamin and Desmedt, Christine and Rothe, Francoise and Piccart, Martine and Sotiriou, Christos and Bontempi, Gianluca},
		Date-Added = {2010-02-16 07:50:50 -0500},
		Date-Modified = {2010-02-16 07:51:17 -0500},
		Doi = {10.1186/gb-2010-11-2-r18},
		Issn = {1465-6906},
		Journal = {Genome Biology},
		Number = {2},
		Pages = {R18},
		Title = {A fuzzy gene expression-based computational approach improves breast cancer prognostication},
		Url = {http://genomebiology.com/2010/11/2/R18},
		Volume = {11},
		Year = {2010},
		Bdsk-Url-1 = {http://genomebiology.com/2010/11/2/R18},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/gb-2010-11-2-r18}}

	@article{li2010amplification,
		Annote = {10.1038/nm.2090},
		Author = {Li, Yang and Zou, Lihua and Li, Qiyuan and Haibe-Kains, Benjamin and Tian, Ruiyang and Li, Yan and Desmedt, Christine and Sotiriou, Christos and Szallasi, Zoltan and Iglehart, J Dirk and Richardson, Andrea L and Wang, Zhigang Charles},
		Date = {2010/01/24/online},
		Date-Added = {2010-01-25 08:31:03 -0500},
		Date-Modified = {2010-02-17 14:33:56 -0500},
		Day = {24},
		Isbn = {1546-170X},
		Journal = {Nat Med},
		L3 = {http://www.nature.com/nm/journal/vaop/ncurrent/suppinfo/nm.2090_S1.html},
		M3 = {10.1038/nm.2090},
		Month = {February},
		Number = {2},
		Pages = {214-218},
		Publisher = {Nature Publishing Group},
		Title = {Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer},
		Ty = {JOUR},
		Url = {http://dx.doi.org/10.1038/nm.2090},
		Volume = {16},
		Year = {2010},
		Bdsk-Url-1 = {http://dx.doi.org/10.1038/nm.2090}}

	@conference{ignatiadis2009metaanalysis,
		Author = {Ignatiadis, M and Bedard, PL and Haibe-Kains, B and Singhal, SK and Loi, S and Criscitiello, C and Desmedt, C and Bontempi, G and Piccart, MJ and Sotiriou, C},
		Booktitle = {San Antonio Breast Cancer Symposium},
		Date-Added = {2010-01-13 09:01:34 -0500},
		Date-Modified = {2010-01-13 09:20:39 -0500},
		Month = {December},
		Title = {A Meta-Analysis of Gene Expression Profiling Studies Identifies Clinically Relevant Oncogenic Pathways in Basal-Like Breast Cancer},
		Year = {2009},
		Bdsk-Url-1 = {http://www.sabcs.org}}

	@conference{bedard2009limited,
		Author = {Bedard, PL and Ignatiadis, M and Haibe-Kains, B and Loi, S and Criscitiello, C and Desmedt, C and Bontempi, G and Piccart, MJ and Sotiriou, C},
		Booktitle = {San Antonio Breast Cancer Symposium},
		Date-Added = {2010-01-13 08:50:01 -0500},
		Date-Modified = {2010-01-13 09:20:49 -0500},
		Month = {December},
		Title = {Limited Clinical Utility of Prognostic Gene Expression Profiles in Grade 3 Node-Negative Early Stage Breast Cancer},
		Year = {2009},
		Bdsk-Url-1 = {http://sabcs.org/}}

	@conference{singhal2009early,
		Author = {Singhal, SK and Bedard, PL and Ignatiadis, M and Haibe-Kains, B and Desmedt, C and Loi, S and Evans, DB and Dixon, JM and Miller, WR and Sotiriou, C},
		Booktitle = {San Antonio Breast Cancer Symposium},
		Date-Added = {2010-01-13 08:44:55 -0500},
		Date-Modified = {2010-01-13 08:47:20 -0500},
		Month = {December},
		Title = {Early Assessment of Proliferation by the Genomic Grade Index (GGI) Predicts Response to Neo-Adjuvant Letrozole},
		Year = {2009},
		Bdsk-File-1 = {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}}

	@conference{meyer2009metaanalysis,
		Author = {Meyer, PE and Haibe-Kains, B and Bontempi, G},
		Booktitle = {5th RCOMB Statellite on Systems Biology},
		Date-Added = {2010-01-13 08:25:25 -0500},
		Date-Modified = {2010-01-13 08:27:58 -0500},
		Month = {December},
		Title = {Meta-Analysis in Transcriptional Network Inference},
		Url = {http://compbio.mit.edu/recombsat/AcceptedPresentations.html},
		Year = {2009},
		Bdsk-File-1 = {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}}

	@article{lamoral2010longterm,
		Author = {Lamoral-Theys, Delphine and Le Mercier, Marie and {le Calve}, Benjamin and Rynkowski, Michal A and Bruyere, Celine and Deacestecker, Christine and Haibe-Kains, Benjamin and Bontempi, Gianluca and Dubois, Jacques and Lefranc, Florence and Kiss, Robert},
		Date-Added = {2010-01-05 11:24:03 -0500},
		Date-Modified = {2010-01-05 11:28:15 -0500},
		Journal = {Neoplasia},
		Number = {1},
		Pages = {69--79},
		Title = {Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells},
		Url = {http://www.neoplasia.com/abstract.php?msid=2941},
		Volume = {12},
		Year = {2010},
		Bdsk-Url-1 = {http://www.neoplasia.com/abstract.php?msid=2941}}

	@article{loi2009gene,
		Abstract = {BACKGROUND:Within estrogen receptor-positive breast cancer (ER+ BC), the expression levels of proliferation-related genes can define two clinically distinct molecular subtypes. When treated with adjuvant tamoxifen, those ER+ BCs that are lowly proliferative have a good prognosis (luminal-A subtype), however the clinical outcome of those that are highly proliferative is poor (luminal-B subtype).METHODS:To investigate the biological basis for these observations, gene set enrichment analysis (GSEA) was performed using microarray data from 246 ER+ BC samples from women treated with adjuvant tamoxifen monotherapy. To create an in vitro model of growth factor (GF) signaling activation, MCF-7 cells were treated with heregulin (HRG), an HER3 ligand.RESULTS:We found that a gene set linked to GF signaling was significantly enriched in the luminal-B tumors, despite only 10% of samples over-expressing HER2 by immunohistochemistry. To determine the biological significance of this observation, MCF-7 cells were treated with HRG. These cells displayed phosphorylation of HER2/3 and downstream ERK and S6. Treatment with HRG overcame tamoxifen-induced cell cycle arrest with higher S-phase fraction and increased anchorage independent colony formation. Gene expression profiles of MCF-7 cells treated with HRG confirmed enrichment of the GF signaling gene set and a similar proliferative signature observed in human ER+ BCs resistant to tamoxifen.CONCLUSION:These data demonstrate that activation of GF signaling pathways, independent of HER2 over-expression, could be contributing to the poor prognosis of the luminal-B ER+ BC subtype.},
		Author = {Loi, Sherene and Sotiriou, Christos and Haibe-Kains, Benjamin and Lallemand, Francoise and Conus, Nelly and Piccart, Martine and Speed, Terence and McArthur, Grant},
		Date-Added = {2010-01-04 18:36:09 -0500},
		Date-Modified = {2010-01-04 18:36:18 -0500},
		Doi = {10.1186/1755-8794-2-37},
		Issn = {1755-8794},
		Journal = {BMC Medical Genomics},
		Number = {1},
		Pages = {37},
		Pubmedid = {19552798},
		Title = {Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer},
		Url = {http://www.biomedcentral.com/1755-8794/2/37},
		Volume = {2},
		Year = {2009},
		Bdsk-Url-1 = {http://www.biomedcentral.com/1755-8794/2/37},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/1755-8794-2-37}}

	@article{desmedt2009multifactor,
		Author = {C. Desmedt},
		Date-Added = {2009-11-18 17:31:37 +0100},
		Date-Modified = {2009-11-18 17:32:30 +0100},
		Title = {Multi-factor approach to predicting sensitivity to anthracyclines: the results of the TOP trial},
		Year = {2009}}

	@article{ravoet2009molecular,
		Abstract = {The clonal CD3-CD4+ T cell population characterizing lymphocytic variant hypereosinophilic syndrome (L-HES) persists for years, with a subgroup of patients ultimately progressing to T lymphoma. The molecular changes associated with the persistence of the pre-malignant clone and the emergence of malignant subclones are unknown, precluding the development of targeted therapy for this HES variant. In this study, we used whole genome arrays, flow cytometry and qRT-PCR to examine gene expression in the CD3-CD4+ T cells and found that 850 genes were differentially regulated during chronic disease compared with CD3+CD4+ T cells from healthy donors. Changes in the expression of 349 genes were altered in association with the clinical progression from chronic L-HES to T lymphoma in one patient, with 87/349 genes representing further changes in genes whose expression was altered in all chronic disease patients (87/850). Array analysis after CD2/CD28-mediated activation revealed that the major gene expression changes observed in the CD3-CD4+ T cells do not reflect activation induced alterations but rather pathways involved in T cell homeostasis, including TGF{beta} signaling, apoptosis and T cell maturation, signaling and migration. microRNA expression in the CD3-CD4+ T cells from patients with chronic disease was examined using qRT-PCR and identified 23 microRNAs that changed significantly, among which miR-125a further decreased in association with one patient's evolution to T lymphoma.
	},
		Author = {Ravoet, Marie and Sibille, Catherine and Gu, Chunyan and Libin, Myriam and Haibe-Kains, Benjamin and Sotiriou, Christos and Goldman, Michel and Roufosse, Florence and Willard-Gallo, Karen},
		Date-Added = {2009-09-14 08:47:16 +0200},
		Date-Modified = {2009-09-14 08:47:32 +0200},
		Doi = {10.1182/blood-2008-08-175091},
		Eprint = {http://bloodjournal.hematologylibrary.org/cgi/reprint/bloodjournal;blood-2008-08-175091v1.pdf},
		Journal = {Blood},
		Pages = {blood-2008-08-175091},
		Title = {{Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways}},
		Url = {http://bloodjournal.hematologylibrary.org/cgi/content/abstract/bloodjournal;blood-2008-08-175091v1},
		Year = {2009},
		Bdsk-Url-1 = {http://bloodjournal.hematologylibrary.org/cgi/content/abstract/bloodjournal;blood-2008-08-175091v1},
		Bdsk-Url-2 = {http://dx.doi.org/10.1182/blood-2008-08-175091}}

	@article{toussaint2009improvement,
		Abstract = {BACKGROUND:Proliferation and tumor differentiation captured by the genomic grade index (GGI) are important prognostic indicators in breast cancer (BC) especially for the estrogen receptor positive (ER+) disease. The aims of this study were to convert this microarray index to a qRT-PCR assay (PCR-GGI), which could be realized on formalin fixed paraffin embedded samples (FFPE), and to assess its prognostic performance and predictive value of clinical benefit in early and advanced ER+ BC patients treated with tamoxifen. METHODS:The accuracy and concordance of the PCR-GGI with the GGI was assessed using BC patients for which frozen and FFPE tissues as well as microarray data were available (n=19). The evaluation of the prognostic value of the PCR-GGI was assessed on FFPE material using a consecutive series of 212 systemically treated early BC patients. The predictive performance for tamoxifen benefit was assessed using two ER+ BC populations treated either with adjuvant tamoxifen only (n=77+139) or first-line tamoxifen for advanced disease (n=270). RESULTS:The PCR-GGI is based on the expression of 8 genes (4 representative of the GGI genes and 4 reference genes). A significant correlation was observed between the microarray-derived GGI and the qRT-PCR assay using frozen (rho=0.95, p<10E-06) and FFPE material (rho=0.89, p<10E-06). The prognostic performance of the PCR-GGI was confirmed on FFPE samples (HRunivar.=1.89; [95CI:1.01-3.54], p=0.05). The PCR-GGI further identified two subgroups of patients with statistically different time to distant metastasis free survival (DMFS) across the two cohorts of ER+ BC patients treated with adjuvant tamoxifen. Additionally, the PCR-GGI was associated with response to tamoxifen in the advanced setting (HRunivar.=1.98; [95CI:1.51-2.59], p=6.9E-07). CONCLUSIONS:PCR-GGI recapitulates in an accurate and reproducible manner the performances of the GGI using frozen and FFPE samples.
	},
		Author = {Toussaint, Jerome and Sieuwerts, Anieta and Haibe-Kains, Benjamin and Desmedt, Christine and Rouas, Ghizlane and Harris, Adrian and Larsimont, Denis and Piccart, Martine and Foekens, John and Durbecq, Virginie and Sotiriou, Christos},
		Date-Added = {2009-09-14 08:25:38 +0200},
		Date-Modified = {2009-09-14 08:26:01 +0200},
		Doi = {10.1186/1471-2164-10-424},
		Issn = {1471-2164},
		Journal = {BMC Genomics},
		Number = {1},
		Pages = {424},
		Pubmedid = {19744330},
		Title = {Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues},
		Url = {http://www.biomedcentral.com/1471-2164/10/424},
		Volume = {10},
		Year = {2009},
		Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/10/424},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-10-424}}

	@article{stamatopoulos2009gene,
		Abstract = {BackgroundZeta-associated protein 70 (ZAP70) is a widely recognized prognostic factor in chronic lymphocytic leukemia, but mechanisms by which its higher expression leads to a poor outcome must still be fully explained.  Design and MethodsIn an attempt to unveil unfavorable cellular properties linked to high ZAP70 expression, we used gene expression profiling to identify genes associated with disparities in B cells from chronic lymphocytic leukemia patients expressing high versus low ZAP70 mRNA, measured by quantitative real-time PCR. Two groups of 7 patients were compared, selected on the basis of either high or low ZAP70 mRNA expression.  ResultsTwenty-seven genes were differentially expressed with an FDR<10%, and several genes were significant predictors of treatment-free survival (TFS) and/or overall survival; PDE8A and FCRL family genes (down-regulated in ZAP70+ patients) could predict TFS and overall survival; ITGA4 mRNA (up-regulated in ZAP70+ patients) could significantly predict overall survival. Importantly, gene set enrichment analysis revealed overrepresentation of adhesion/migration genes. We therefore investigated in vitro adhesion/migration capacity of chronic lymphocytic leukemia cells into a stromal microenvironment or in response to conditioned medium. We showed that ZAP70+ cells had better adhesion/migration capacities and only ZAP70+ patient cells responded to microenvironment contact by CXCR4 downregulation.  ConclusionsWe concluded that several prognostic factors are the reflection of microenvironment interactions and that the increased adhesion/migratory capacity of ZAP70+ cells in their microenvironment can explain their better survival and thus the aggressiveness of the disease.
	},
		Author = {Stamatopoulos, Basile and Haibe-Kains, Benjamin and Equeter, Carole and Meuleman, Nathalie and Soree, Anne and De Bruyn, Cecile and Hanosset, Delphine and Bron, Dominique and Martiat, Philippe and Lagneaux, Laurence},
		Date-Added = {2009-08-18 08:40:25 +0200},
		Date-Modified = {2009-08-18 08:40:38 +0200},
		Doi = {10.3324/haematol.2008.002626},
		Eprint = {http://www.haematologica.org/cgi/reprint/94/6/790.pdf},
		Journal = {Haematologica},
		Number = {6},
		Pages = {790-799},
		Title = {{Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA}},
		Url = {http://www.haematologica.org/cgi/content/abstract/94/6/790},
		Volume = {94},
		Year = {2009},
		Bdsk-Url-1 = {http://www.haematologica.org/cgi/content/abstract/94/6/790},
		Bdsk-Url-2 = {http://dx.doi.org/10.3324/haematol.2008.002626}}

	@article{loi2009correlation,
		Abstract = {533  Background: The phosphathidylinositol-3-kinase (PI3K) signaling pathway is frequently deregulated in tumor biology and is an attractive target for cancer therapy. Our aim was to characterize the molecular and clinical outcome effects of PIK3CA mutations in breast cancer (BC). Methods: We analyzed 173 BC samples for PIK3CA mutations. Corresponding gene expression profiles were used to understand its effects on the PI3K pathway. We validated a PIK3CA-GS in 2 independent BC cohorts (n = 183) with known PIK3CA mutation status and evaluated its correlation with clinical outcome in 1748 BC samples stratified by treatment and subtype. Results: 26% of BCs had a PIK3CA mutation. Tumors with PIK3CA mutation demonstrated a distinct gene expression signature (p = 0.03 after 1000 perm). In 2 datasets it could discriminate PIK3CA mutation carriers from wild-type (ROC 0.68, 0.71, p = 0.001for both). However, the PIK3CA-GS was correlated with deactivation of the PI3K pathway probably through a negative feedback loop. This observation was supported by: 1) the PIK3CA-GS was significantly correlated with gene expression changes induced by PI3K inhibitors (Connectivity Map, Gene set enrichment analyses) and 2) the PIK3CA-GS was anti-correlated with a GS of PTEN loss (R = -0.3; Saal et al, 2007). Higher levels of the PIK3CA signature were observed in HER-2+ and estrogen receptor positive (ER+), luminal BC subtypes. Whilst there was no association with mutation status alone and prognosis, increasing expression of the PIK3CA-GS (suggesting deactivation) was significantly associated with better clinical outcome in both untreated (p = 0.04) and particularly ER+, luminal-B, tamoxifen only-treated (p = 0.004) BC. Multivariate analysis (HR: 0.4; 95%CI: 0.3-0.7; p = 0.002) confirmed that the PI3KCA-GS provided independent prognostic information. Conclusions: Paradoxically, the PIK3CA-GS correlates with inhibition of the PI3K pathway in ER+ BC and identifies a subgroup of luminal B BCs with a favorable outcome. The PIK3CA-GS may be a better indicator of PI3K pathway dysfunction than mutation status, potentially indicating patients who may benefit from combined endocrine therapy and PI3K inhibition.  No significant financial relationships to disclose.
	},
		Author = {Loi, S. and Haibe-Kains, B. and Lallemand, F. and Pusztai, L. and Bardelli, A. and Gillett, C. and Ellis, P. and Piccart-Gebhart, M. J. and Phillips, W. A. and McArthur, G. A. and Sotiriou, C.},
		Date-Added = {2009-08-18 08:13:12 +0200},
		Date-Modified = {2009-08-18 08:13:25 +0200},
		Journal = {J Clin Oncol (Meeting Abstracts)},
		Number = {15S},
		Pages = {533-},
		Title = {{Correlation of PIK3CA mutation-associated gene expression signature (PIK3CA-GS) with deactivation of the PI3K pathway and with prognosis within the luminal-B ER+ breast cancers}},
		Url = {http://meeting.ascopubs.org/cgi/content/abstract/27/15S/533},
		Volume = {27},
		Year = {2009},
		Bdsk-Url-1 = {http://meeting.ascopubs.org/cgi/content/abstract/27/15S/533}}

	@article{stamatopoulos2009microrna29c,
		Abstract = {Aberrant expression of microRNAs has been recently associated with chronic lymphocytic leukemia (CLL) outcome. Although disease evolution can be predicted by several prognostic factors, a better outcome individualization in a given patient is still of utmost interest. Here, we showed that miR-29c and miR-223 expression levels decreased significantly with progression from Binet stage A to C were significantly lower in poor prognostic subgroups (defined by several prognostic factors) and could significantly predict treatment-free survival (TFS) and overall survival (OS). Furthermore, we developed a quantitative real-time polymerase chain reaction (qPCR) score combining miR-29c, miR-223, ZAP70, and LPL (from 0 to 4 poor prognostic markers) to stratify treatment and death risk in a cohort of 110 patients with a median follow-up of 72 months (range, 2-312). Patients with a score of 0/4, 1/4, 2/4, 3/4, and 4/4 had a median TFS of greater than 312, of 129, 80, 36, and 19 months, respectively (hazard ratio, HR0/4 < 1/4 < 2/4 < 3/4 < 4/4 = 17.00, P < .001). Patients with a score of 0-1/4, 2-3/4, and 4/4 had a median OS of greater than 312, of 183 and 106 months, respectively (HR0/4 < 1/4 < 2/4 < 3/4 < 4/4 = 13.69, P = .001). This score will help to identify, among the good and poor prognosis subgroups, patients who will need early therapy and thus will require a closer follow-up.
	},
		Author = {Stamatopoulos, Basile and Meuleman, Nathalie and Haibe-Kains, Benjamin and Saussoy, Pascale and Van Den Neste, Eric and Michaux, Lucienne and Heimann, Pierre and Martiat, Philippe and Bron, Dominique and Lagneaux, Laurence},
		Date-Added = {2009-08-07 08:24:53 +0200},
		Date-Modified = {2009-08-07 08:25:16 +0200},
		Doi = {10.1182/blood-2008-11-189407},
		Eprint = {http://bloodjournal.hematologylibrary.org/cgi/reprint/bloodjournal;113/21/5237.pdf},
		Journal = {Blood},
		Number = {21},
		Pages = {5237-5245},
		Title = {{microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification}},
		Url = {http://bloodjournal.hematologylibrary.org/cgi/content/abstract/bloodjournal;113/21/5237},
		Volume = {113},
		Year = {2009},
		Bdsk-Url-1 = {http://bloodjournal.hematologylibrary.org/cgi/content/abstract/bloodjournal;113/21/5237},
		Bdsk-Url-2 = {http://dx.doi.org/10.1182/blood-2008-11-189407}}

	@article{desmedt2009gene,
		Abstract = {BACKGROUND:We have previously shown that the Gene expression Grade Index (GGI) was able to identify two subtypes of estrogen receptor (ER)-positive tumors that were associated with statistically distinct clinical outcomes in both untreated and tamoxifen-treated patients. Here, we aim to investigate the ability of the GGI to predict relapses in postmenopausal women who were treated with tamoxifen (T) or letrozole (L) within the BIG 1-98 trial. METHODS:We generated gene expression profiles (Affymetrix) and computed the GGI for a matched, case-control sample of patients enrolled in the BIG 1-98 trial from the two hospitals where frozen samples were available. All relapses (cases) were identified from patients randomized to receive monotherapy or from the switching treatment arms for whom relapse occurred before the switch.  Each case was randomly matched with four controls based upon nodal status and treatment (T or L).  The prognostic value of GGI was assessed as a continuous predictor and divided at the median.  Predictive accuracy of GGI was estimated using time-dependent area under the curve (AUC) of the ROC curves. RESULTS:Frozen samples were analyzable for 48 patients (10 cases and 38 controls).  Seven of the 10 cases had been assigned to receive L. Cases and controls were comparable with respect to menopausal and nodal status, local and chemotherapy, and HER2 positivity. Cases were slightly older than controls and had a larger proportion of large, poorly differentiated ER+/PgR- tumors.  The GGI was significantly and linearly related to risk of relapse: each 10-unit increase in GGI resulted in an increase of approximately 11% in the hazard rate (p=0.02).  Within the subgroups of patients with node-positive disease or who were treated with L, the hazard of relapse was significantly greater for patients with GGI at or above the median. AUC reached a maximum of 78% at 27 months.CONCLUSIONS:This analysis supports the GGI as a good predictor of relapse for ER-positive patients, even among patients who receive L.  Validation of these results, in a larger series from BIG 1-98, is planned using the simplified GGI represented by a smaller set of genes and tested by qRT-PCR on paraffin-embedded tissues. },
		Author = {Desmedt, Christine and Giobbie-Hurder, Anita and Neven, Patrick and Paridaens, Robert and Christiaens, Marie-Rose and Smeets, Ann and Lallemand, Francoise and Haibe-Kains, Benjamin and Viale, Giuseppe and Gelber, Richard and Piccart, Martine and Sotiriou, Christos},
		Date-Added = {2009-07-02 10:47:10 +0200},
		Date-Modified = {2009-07-02 10:47:10 +0200},
		Doi = {10.1186/1755-8794-2-40},
		Issn = {1755-8794},
		Journal = {BMC Medical Genomics},
		Number = {1},
		Pages = {40},
		Title = {The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial},
		Url = {http://www.biomedcentral.com/1755-8794/2/40},
		Volume = {2},
		Year = {2009},
		Bdsk-Url-1 = {http://www.biomedcentral.com/1755-8794/2/40},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/1755-8794-2-40}}

	@article{liedtke2009genomic,
		Abstract = {PurposeThe genomic grade index (GGI) is a 97-gene measure of histological tumor grade. High GGI is associated with decreased relapse-free survival in patients receiving either endocrine or no systemic adjuvant therapy. Herein we examined whether GGI predicts pathologic response to neoadjuvant chemotherapy in patients with HER-2-normal breast cancer.  MethodsGene expression data (gene chips) was generated from fine-needle aspiration biopsies (n = 229) prospectively collected before neoadjuvant paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy. Pathologic response was quantified using the residual cancer burden (RCB) method. The association between the GGI and pathologic response was assessed in univariate and multivariate analyses. The performance of a response predictor combining clinical variables and GGI was evaluated under cross-validation.  ResultsEighty-five percent of grade 1 tumors had low GGI, 89% of grade 3 tumors had high GGI, and 63% of grade 2 tumors had low GGI. Among both estrogen receptor (ER)-positive and -negative cancers, high GGI score was associated with pathologic complete response (RCB-0) or minimal residual disease (RCB-1). A multivariate model combining GGI and clinical parameters had an overall accuracy of 71%, compared with 58% for the GGI alone, for prediction of pathologic response. However, high GGI score was also associated with significantly worse distant relapse-free survival in patients with ER-positive cancer (P = .005), and was not associated with survival in patients with ER-negative cancer.  ConclusionHigh GGI is associated with increased sensitivity to neoadjuvant paclitaxel plus fluorouracil, adriamycin, and cyclophosphamide chemotherapy in both ER-negative and ER-positive patients, but it remains a predictor of worse survival in ER-positive patients.
	},
		Author = {Liedtke, Cornelia and Hatzis, Christos and Symmans, William Fraser and Desmedt, Christine and Haibe-Kains, Benjamin and Valero, Vicente and Kuerer, Henry and Hortobagyi, Gabriel N. and Piccart-Gebhart, Martine and Sotiriou, Christos and Pusztai, Lajos},
		Date-Added = {2009-07-01 17:16:35 +0200},
		Date-Modified = {2009-07-01 17:16:54 +0200},
		Doi = {10.1200/JCO.2008.18.5934},
		Eprint = {http://jco.ascopubs.org/cgi/reprint/27/19/3185.pdf},
		Journal = {J Clin Oncol},
		Number = {19},
		Pages = {3185-3191},
		Title = {{Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer}},
		Url = {http://jco.ascopubs.org/cgi/content/abstract/27/19/3185},
		Volume = {27},
		Year = {2009},
		Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/27/19/3185},
		Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2008.18.5934}}

	@article{desmedt2010multifactor,
		Author = {C. Desmedt and E. Azambuja and D. Larsimont and F. Lallemand and B.Haibe-Kains and J. Selleslags and S. Delaloge3 and C. Duhem and JP Kains5 and B. Carly and M. Maerevoet and A. Vindevoghel and F. Cardoso and G. Rouas and V. Durbecq and R. Salgado and JM Nogaret and I. Veys and JC Schobbens and D. Notterman and A. Di Leo and V. D'Hondt and M. Piccart-Gebhart and C. Sotiriou},
		Date-Added = {2009-06-15 10:52:34 +0200},
		Date-Modified = {2010-01-28 15:30:09 -0500},
		Journal = {Manuscript submitted},
		Title = {Multi-factor approach to predicting sensitivity to anthracyclines: the results of the TOP trial},
		Year = {2010}}

	@article{lemercier2009galectin1,
		Abstract = {We have previously reported that galectin 1 (Gal-1) plays important biological roles in astroglial as well as in oligodendroglial cancer cells. As an oligodendroglioma model, we make use of the Hs683 cell line that has been previously extensively characterized at cell biology, molecular biology, and genetic levels. Galectin 1 has been shown to be involved in Hs683 oligodendroglioma chemoresistance, neoangiogenesis, and migration. Down-regulating Gal-1 expression in Hs683 cells through targeted small interfering RNA provokes a marked decrease in the expression of the brain-expressed X-linked gene: BEX2. Accordingly, the potential role of BEX2 in Hs683 oligodendroglioma cell biology has been investigated. The data presented here reveal that decreasing BEX2 expression in Hs683 cells increases the survival of Hs683 orthotopic xenograft-bearing mice. Furthermore, this decrease in BEX2 expression impairs vasculogenic mimicry channel formation in vitro and angiogenesis in vivo, and modulates glioma cell adhesion and invasive features through the modification of several genes previously reported to play a role in cancer cell migration, including MAP2, plexin C1, SWAP70, and integrin beta(6). We thus conclude that BEX2 is implicated in oligodendroglioma biology.},
		Address = {Laboratory of Toxicology, Institute of Pharmacy, Universite Libre de Bruxelles (ULB), Brussels, Belgium.},
		Author = {Le Mercier, Marie and Fortin, Shannon and Mathieu, Veronique and Roland, Isabelle and Spiegl-Kreinecker, Sabine and Haibe-Kains, Benjamin and Bontempi, Gianluca and Decaestecker, Christine and Berger, Walter and Lefranc, Florence and Kiss, Robert},
		Crdt = {2009/05/05 09:00},
		Da = {20090504},
		Date = {2009 May},
		Date-Added = {2009-05-19 10:04:11 +0200},
		Date-Modified = {2009-05-19 10:04:26 +0200},
		Edat = {2009/05/05 09:00},
		Issn = {1476-5586 (Electronic)},
		Jid = {100886622},
		Journal = {Neoplasia},
		Jt = {Neoplasia (New York, N.Y.)},
		Language = {eng},
		Mhda = {2009/05/05 09:00},
		Month = {May},
		Number = {5},
		Oid = {NLM: PMC2671859},
		Own = {NLM},
		Pages = {485--496},
		Phst = {2008/12/03 {$[$}received{$]$}; 2009/03/02 {$[$}revised{$]$}; 2009/03/02 {$[$}accepted{$]$}},
		Pl = {Canada},
		Pmc = {PMC2671859},
		Pmid = {19412433},
		Pst = {ppublish},
		Pt = {Journal Article; Research Support, Non-U.S. Gov't},
		Sb = {IM},
		Source = {Neoplasia. 2009 May;11(5):485-96.},
		Status = {In-Process},
		Title = {Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression.},
		Volume = {11},
		Year = {2009}}

	@phdthesis{haibekains2009identification,
		Author = {Benjamin {Haibe-Kains}},
		Date-Added = {2009-04-02 11:34:20 +0200},
		Date-Modified = {2009-08-13 15:13:17 +0200},
		Month = {April},
		School = {Universit\'{e} Libre de Bruxelles},
		Title = {Identification and Assessment of Gene Signatures in Human Breast Cancer},
		Url = {http://theses.ulb.ac.be/ETD-db/collection/available/ULBetd-02182009-083101/},
		Year = {2009},
		Bdsk-Url-1 = {http://www.ulb.ac.be/di/map/bhaibeka/phdthesis/haibekains2009phdthesis.pdf},
		Bdsk-Url-2 = {http://theses.ulb.ac.be/ETD-db/collection/available/ULBetd-02182009-083101/}}

	@article{lefranc2009temozolomide,
		Author = {F. Lefranc and S. Spiegl-Kreinecker and B. Haibe-Kains and G. Bontempi and C. Decaestecker and W. Berger and R. Kiss},
		Date-Added = {2009-01-13 18:07:58 +0100},
		Date-Modified = {2009-01-13 18:07:58 +0100},
		Doi = {DOI: 10.1016/j.surneu.2008.10.015},
		Issn = {0090-3019},
		Journal = {Surgical Neurology},
		Keywords = {Mechanism of action},
		Number = {1},
		Pages = {134 - 134},
		Title = {Temozolomide displays antimigratory effects in human glioblastoma cells mediated through neuregulin-1 down-regulation},
		Url = {http://www.sciencedirect.com/science/article/B6TCB-4V476Y7-9/2/dd6fa6ad847cc0c353806b903b014035},
		Volume = {71},
		Year = {2009},
		Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/B6TCB-4V476Y7-9/2/dd6fa6ad847cc0c353806b903b014035},
		Bdsk-Url-2 = {http://dx.doi.org/10.1016/j.surneu.2008.10.015}}

	@article{haibekains2008comparative,
		Abstract = {Motivation: Survival prediction of breast cancer (BC) patients independently of treatment, also known as prognostication, is a complex task since clinically similar breast tumors, in addition to be molecularly heterogeneous, may exhibit different clinical outcomes. In recent years, the analysis of gene expression profiles by means of sophisticated data mining tools emerged as a promising technology to bring additional insights into BC biology and to improve the quality of prognostication. The aim of this work is to assess quantitatively the accuracy of prediction obtained with state-of-the-art data analysis techniques for BC microarray data through an independent and thorough framework.  Results: Due to the large number of variables, the reduced amount of samples and the high degree of noise, complex prediction methods are highly exposed to performance degradation despite the use of cross-validation techniques. Our analysis shows that the most complex methods are not significantly better than the simplest one, a univariate model relying on a single proliferation gene. This result suggests that proliferation might be the most relevant biological process for BC prognostication and that the loss of interpretability deriving from the use of overcomplex methods may be not sufficiently counterbalanced by an improvement of the quality of prediction.  Availability: The comparison study is implemented in an R package called survcomp and is available from http://www.ulb.ac.be/di/map/bhaibeka/software/survcomp/.  Contact: bhaibeka@ulb.ac.be  Supplementary information: Supplementary data are available at Bioinformatics online.
	},
		Author = {Haibe-Kains, B. and Desmedt, C. and Sotiriou, C. and Bontempi, G.},
		Date-Added = {2008-09-26 14:00:03 +0200},
		Date-Modified = {2008-09-26 14:00:03 +0200},
		Doi = {10.1093/bioinformatics/btn374},
		Eprint = {http://bioinformatics.oxfordjournals.org/cgi/reprint/24/19/2200.pdf},
		Journal = {Bioinformatics},
		Number = {19},
		Pages = {2200-2208},
		Title = {{A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?}},
		Url = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/24/19/2200},
		Volume = {24},
		Year = {2008},
		Bdsk-Url-1 = {http://bioinformatics.oxfordjournals.org/cgi/content/abstract/24/19/2200},
		Bdsk-Url-2 = {http://dx.doi.org/10.1093/bioinformatics/btn374}}

	@article{journe2008farnesoidb,
		Author = {F. Journe and V. Durbecq and B. Haibe-Kains and C. Chaboteaux and G. Rouas and G. Laurent and D. Larsimont and M. J. Piccart and J.J. Body and C. Sotiriou},
		Date-Added = {2008-09-15 19:22:38 +0200},
		Date-Modified = {2008-09-15 19:24:52 +0200},
		Journal = {European Journal of Cancer Supplements},
		Month = {April},
		Number = {7},
		Pages = {112},
		Title = {Farnesoid X receptor (FXR) status complements the evaluation of estrogen receptor alpha (ER) in breast cancer (BC) patients and predicts benefit from tamoxifen},
		Volume = {6},
		Year = {2008},
		Bdsk-Url-1 = {http://91.142.242.133/ciw-08ebcc/index.cfm?fuseaction=CIS2002&hoofdnav=Abstracts&content=abs.details&what=AUTHOR&searchtext=haibe-kains&topicselected=*&selection=ABSTRACT&qryStartRowDetail=1}}

	@article{toussaint2008molecular,
		Author = {J. Toussaint and A. Sieuwerts and V. Durbecq and B. Haibe-Kains and E. Berns and A. L. Harris and D. Larsimont and M. Piccart and J. Foekens and C. Sotiriou},
		Date-Added = {2008-09-15 19:09:43 +0200},
		Date-Modified = {2008-09-15 19:17:14 +0200},
		Journal = {European Journal of Cancer Supplements},
		Month = {April},
		Number = {7},
		Pages = {140},
		Title = {Molecular qRT-PCR grade index: a new tool for breast cancer (BC) patient grading improvement},
		Volume = {6},
		Year = {2008},
		Bdsk-Url-1 = {http://91.142.242.133/ciw-08ebcc/index.cfm?fuseaction=CIS2002&hoofdnav=Abstracts&content=abs.details&what=AUTHOR&searchtext=haibe-kains&topicselected=*&selection=ABSTRACT&qryStartRowDetail=2}}

	@article{haibekains2008comparison,
		Abstract = {BACKGROUND:During the last years, several groups have identified prognostic gene expression signatures with apparently similar performances. However, signatures were never compared on an independent population of untreated breast cancer patients, where risk assessment was computed using the original algorithms and microarray platforms.RESULTS:We compared three gene expression signatures, the 70-gene, the 76-gene and the Gene expression Grade Index (GGI) signatures, in terms of predicting distant metastasis free survival (DMFS) for the individual patient. To this end, we used the previously published TRANSBIG independent validation series of node-negative untreated primary breast cancer patients. We observed agreement in prediction for 135 of 198 patients (68%) when considering the three signatures. When comparing the signatures two by two, the agreement in prediction was 71% for the 70- and 76-gene signatures, 76% for the 76-gene signature and the GGI, and 88% for the 70-gene signature and the GGI. The three signatures had similar capabilities of predicting DMFS and added significant prognostic information to that provided by the classical parameters.CONCLUSION:Despite the difference in development of these signatures and the limited overlap in gene identity, they showed similar prognostic performance, adding to the growing evidence that these prognostic signatures are of clinical relevance.},
		Author = {Haibe-Kains, Benjamin and Desmedt, Christine and Piette, Fanny and Buyse, Marc and Cardoso, Fatima and van't Veer, Laura and Piccart, Martine and Bontempi, Gianluca and Sotiriou, Christos},
		Date-Added = {2008-09-10 06:45:48 +0200},
		Date-Modified = {2008-09-10 06:45:48 +0200},
		Doi = {10.1186/1471-2164-9-394},
		Issn = {1471-2164},
		Journal = {BMC Genomics},
		Number = {1},
		Pages = {394},
		Pubmedid = {18717985},
		Title = {Comparison of prognostic gene expression signatures for breast cancer},
		Url = {http://www.biomedcentral.com/1471-2164/9/394},
		Volume = {9},
		Year = {2008},
		Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/9/394},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-9-394}}

	@article{wirapati2008metaanalysis,
		Abstract = {INTRODUCTION:Breast cancer subtyping and prognosis have been studied extensively by gene expression profiling, resulting in disparate signatures with little overlap in their constituent genes. Although a previous study demonstrated a prognostic concordance among gene expression signatures, it was limited to only one dataset and did not fully elucidate how the different genes were related to one another nor did it examine the contribution of well-known biological processes of breast cancer tumorigenesis to their prognostic performance.METHOD:To address the above issues and to further validate these initial findings, we performed the largest meta-analysis of publicly available breast cancer gene expression and clinical data, which are comprised of 2,833 breast tumors. Gene coexpression modules of three key biological processes in breast cancer (namely, proliferation, estrogen receptor [ER], and HER2 signaling) were used to dissect the role of constituent genes of nine prognostic signatures.RESULTS:Using a meta-analytical approach, we consolidated the signatures associated with ER signaling, ERBB2 amplification, and proliferation. Previously published expression-based nomenclature of breast cancer 'intrinsic' subtypes can be mapped to the three modules, namely, the ER-/HER2- (basal-like), the HER2+ (HER2-like), and the low- and high-proliferation ER+/HER2- subtypes (luminal A and B). We showed that all nine prognostic signatures exhibited a similar prognostic performance in the entire dataset. Their prognostic abilities are due mostly to the detection of proliferation activity. Although ER- status (basal-like) and ERBB2+ expression status correspond to bad outcome, they seem to act through elevated expression of proliferation genes and thus contain only indirect information about prognosis. Clinical variables measuring the extent of tumor progression, such as tumor size and nodal status, still add independent prognostic information to proliferation genes.CONCLUSION:This meta-analysis unifies various results of previous gene expression studies in breast cancer. It reveals connections between traditional prognostic factors, expression-based subtyping, and prognostic signatures, highlighting the important role of proliferation in breast cancer prognosis.},
		Author = {Wirapati, Pratyaksha and Sotiriou, Christos and Kunkel, Susanne and Farmer, Pierre and Pradervand, Sylvain and Haibe-Kains, Benjamin and Desmedt, Christine and Ignatiadis, Michail and Sengstag, Thierry and Schutz, Frederic and Goldstein, Darlene and Piccart, Martine and Delorenzi, Mauro},
		Date-Added = {2008-09-05 14:30:59 +0200},
		Date-Modified = {2008-09-05 14:31:22 +0200},
		Doi = {10.1186/bcr2124},
		Issn = {1465-5411},
		Journal = {Breast Cancer Research},
		Number = {4},
		Pages = {R65},
		Pubmedid = {18662380},
		Title = {Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures},
		Url = {http://breast-cancer-research.com/content/10/4/R65},
		Volume = {10},
		Year = {2008},
		Bdsk-Url-1 = {http://breast-cancer-research.com/content/10/4/R65},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/bcr2124}}

	@article{loi2005prediction,
		Abstract = {509  Background: The majority of early-stage BC express estrogen receptors (ER) and receive tamoxifen in the adjuvant setting. Yet up to 40% of these patients will relapse on tamoxifen and develop incurable metastatic disease. Recent evidence from three large randomised controlled trials exploring the role of AI in the adjuvant setting shows a benefit from the novel strategy, however the optimal sequence and duration of AI/tamoxifen treatment is unknown. Therefore, it is vital that we learn to identify those women at higher risk of tamoxifen resistance. Our aim was to identify genes that could predict for this subset of women. Methods: We determined the gene expression profiles from 105 tamoxifen-only treated ER positive early stage BC (training set) using Affymetrix U133 A and B chips. Within this group, 30 (29%) patients developed distant recurrence at a median time to relapse of 3.8 years (yrs) and 75 (71%) remained disease free at a median of 5.7 yrs of follow-up. The independent validation set consisted of 64 ER+ tamoxifen only treated BC patients (17 recurrences) from a different institution (Karolinska, Sweden). Results: Cox proportional hazards regression analysis identified 50 genes that were significantly associated with distant relapse on tamoxifen. The probability of selecting these genes by chance was estimated to be p=0.001 after 1000 random permutations. These genes were powerful predictors of clinical outcome in the independent validation set, dividing the cohort into 2 statistically different prognostic groups (p=0.02) in the poor prognostic group (tamoxifen resistant) the median time to distant relapse was 2.4yrs compared with 7yrs in the good prognostic one (tamoxifen sensitive). We are currently validating this signature in another independent dataset (Guys hospital, UK). Conclusions: These results suggest that a group of genes can identify BC patients at risk of early distant relapse on tamoxifen. These patients could be the ideal candidates for upfront AIs, while the others would be considered for sequential tamoxifen/AI. This hypothesis will be tested in an upcoming prospective clinical trial "MINDACT".
	},
		Author = {Loi, S. and Piccart, M. and Haibe-Kains, B. and Desmedt, C. and Harris, A. L. and Bergh, J. and Tutt, A. and Miller, L. D. and Liu, E. T. and Sotiriou, C.},
		Date-Added = {2008-09-01 17:20:56 +0200},
		Date-Modified = {2008-09-01 17:20:56 +0200},
		Journal = {J Clin Oncol (Meeting Abstracts)},
		Number = {16_suppl},
		Pages = {509-},
		Title = {{Prediction of early distant relapses on tamoxifen in early-stage breast cancer (BC): A potential tool for adjuvant aromatase inhibitor (AI) tailoring}},
		Url = {http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/509},
		Volume = {23},
		Year = {2005},
		Bdsk-Url-1 = {http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/509}}

	@article{sotiriou2006gene,
		Abstract = {Background: Histologic grade in breast cancer provides clinically important prognostic information. However, 30%-60% of tumors are classified as histologic grade 2. This grade is associated with an intermediate risk of recurrence and is thus not informative for clinical decision making. We examined whether histologic grade was associated with gene expression profiles of breast cancers and whether such profiles could be used to improve histologic grading. Methods: We analyzed microarray data from 189 invasive breast carcinomas and from three published gene expression datasets from breast carcinomas. We identified differentially expressed genes in a training set of 64 estrogen receptor (ER)-positive tumor samples by comparing expression profiles between histologic grade 3 tumors and histologic grade 1 tumors and used the expression of these genes to define the gene expression grade index. Data from 597 independent tumors were used to evaluate the association between relapse-free survival and the gene expression grade index in a Kaplan-Meier analysis. All statistical tests were two-sided. Results: We identified 97 genes in our training set that were associated with histologic grade; most of these genes were involved in cell cycle regulation and proliferation. In validation datasets, the gene expression grade index was strongly associated with histologic grade 1 and 3 status; however, among histologic grade 2 tumors, the index spanned the values for histologic grade 1-3 tumors. Among patients with histologic grade 2 tumors, a high gene expression grade index was associated with a higher risk of recurrence than a low gene expression grade index (hazard ratio = 3.61, 95% confidence interval = 2.25 to 5.78; P<.001, log-rank test). Conclusions: Gene expression grade index appeared to reclassify patients with histologic grade 2 tumors into two groups with high versus low risks of recurrence. This approach may improve the accuracy of tumor grading and thus its prognostic value.
	},
		Author = {Sotiriou, Christos and Wirapati, Pratyaksha and Loi, Sherene and Harris, Adrian and Fox, Steve and Smeds, Johanna and Nordgren, Hans and Farmer, Pierre and Praz, Viviane and Haibe-Kains, Benjamin and Desmedt, Christine and Larsimont, Denis and Cardoso, Fatima and Peterse, Hans and Nuyten, Dimitry and Buyse, Marc and Van de Vijver, Marc J. and Bergh, Jonas and Piccart, Martine and Delorenzi, Mauro},
		Date-Added = {2008-08-25 10:58:08 +0200},
		Date-Modified = {2008-08-25 10:58:22 +0200},
		Doi = {10.1093/jnci/djj052},
		Eprint = {http://jnci.oxfordjournals.org/cgi/reprint/jnci;98/4/262.pdf},
		Journal = {J. Natl. Cancer Inst.},
		Number = {4},
		Pages = {262-272},
		Title = {{Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis}},
		Url = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;98/4/262},
		Volume = {98},
		Year = {2006},
		Bdsk-Url-1 = {http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;98/4/262},
		Bdsk-Url-2 = {http://dx.doi.org/10.1093/jnci/djj052}}

	@article{loi2007definitionreply,
		Author = {Loi, Sherene and Haibe-Kains, Benjamin and Desmedt, Christine and Sotiriou, Christos},
		Date-Added = {2008-08-25 10:55:55 +0200},
		Date-Modified = {2008-08-25 10:55:55 +0200},
		Doi = {10.1200/JCO.2007.12.8694},
		Eprint = {http://jco.ascopubs.org/cgi/reprint/25/27/4317.pdf},
		Journal = {J Clin Oncol},
		Number = {27},
		Pages = {4317-4318},
		Title = {{In Reply}},
		Url = {http://jco.ascopubs.org},
		Volume = {25},
		Year = {2007},
		Bdsk-Url-1 = {http://jco.ascopubs.org},
		Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2007.12.8694}}

	@article{loi2007definition,
		Abstract = {PurposeA number of microarray studies have reported distinct molecular profiles of breast cancers (BC), such as basal-like, ErbB2-like, and two to three luminal-like subtypes. These were associated with different clinical outcomes. However, although the basal and the ErbB2 subtypes are repeatedly recognized, identification of estrogen receptor (ER) -positive subtypes has been inconsistent. Therefore, refinement of their molecular definition is needed.  Materials and MethodsWe have previously reported a gene expression grade index (GGI), which defines histologic grade based on gene expression profiles. Using this algorithm, we assigned ER-positive BC to either high-or low-genomic grade subgroups and compared these with previously reported ER-positive molecular classifications. As further validation, we classified 666 ER-positive samples into subtypes and assessed their clinical outcome.  ResultsTwo ER-positive molecular subgroups (high and low genomic grade) could be defined using the GGI. Despite tracking a single biologic pathway, these were highly comparable to the previously described luminal A and B classification and significantly correlated to the risk groups produced using the 21-gene recurrence score. The two subtypes were associated with statistically distinct clinical outcome in both systemically untreated and tamoxifen-treated populations.  ConclusionThe use of genomic grade can identify two clinically distinct ER-positive molecular subtypes in a simple and highly reproducible manner across multiple data sets. This study emphasizes the important role of proliferation-related genes in predicting prognosis in ER-positive BC.
	},
		Author = {Loi, Sherene and Haibe-Kains, Benjamin and Desmedt, Christine and Lallemand, Francoise and Tutt, Andrew M. and Gillet, Cheryl and Ellis, Paul and Harris, Adrian and Bergh, Jonas and Foekens, John A. and Klijn, Jan G.M. and Larsimont, Denis and Buyse, Marc and Bontempi, Gianluca and Delorenzi, Mauro and Piccart, Martine J. and Sotiriou, Christos},
		Date-Added = {2008-08-25 10:53:32 +0200},
		Date-Modified = {2008-08-25 10:54:01 +0200},
		Doi = {10.1200/JCO.2006.07.1522},
		Eprint = {http://jco.ascopubs.org/cgi/reprint/25/10/1239.pdf},
		Journal = {J Clin Oncol},
		Number = {10},
		Pages = {1239-1246},
		Title = {{Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor-Positive Breast Carcinomas Through Genomic Grade}},
		Url = {http://jco.ascopubs.org/cgi/content/abstract/25/10/1239},
		Volume = {25},
		Year = {2007},
		Bdsk-Url-1 = {http://jco.ascopubs.org/cgi/content/abstract/25/10/1239},
		Bdsk-Url-2 = {http://dx.doi.org/10.1200/JCO.2006.07.1522}}

	@article{desmedt2007strong,
		Abstract = {Purpose: Recently, a 76-gene prognostic signature able to predict distant metastases in lymph node-negative (N-) breast cancer patients was reported. The aims of this study conducted by TRANSBIG were to independently validate these results and to compare the outcome with clinical risk assessment.  Experimental Design: Gene expression profiling of frozen samples from 198 N- systemically untreated patients was done at the Bordet Institute, blinded to clinical data and independent of Veridex. Genomic risk was defined by Veridex, blinded to clinical data. Survival analyses, done by an independent statistician, were done with the genomic risk and adjusted for the clinical risk, defined by Adjuvant! Online.  Results: The actual 5- and 10-year time to distant metastasis were 98% (88-100%) and 94% (83-98%), respectively, for the good profile group and 76% (68-82%) and 73% (65-79%), respectively, for the poor profile group. The actual 5- and 10-year overall survival were 98% (88-100%) and 87% (73-94%), respectively, for the good profile group and 84% (77-89%) and 72% (63-78%), respectively, for the poor profile group. We observed a strong time dependence of this signature, leading to an adjusted hazard ratio of 13.58 (1.85-99.63) and 8.20 (1.10-60.90) at 5 years and 5.11 (1.57-16.67) and 2.55 (1.07-6.10) at 10 years for time to distant metastasis and overall survival, respectively.  Conclusion: This independent validation confirmed the performance of the 76-gene signature and adds to the growing evidence that gene expression signatures are of clinical relevance, especially for identifying patients at high risk of early distant metastases.
	},
		Author = {Desmedt, Christine and Piette, Fanny and Loi, Sherene and Wang, Yixin and Lallemand, Francoise and Haibe-Kains, Benjamin and Viale, Giuseppe and Delorenzi, Mauro and Zhang, Yi and d'Assignies, Mahasti Saghatchian and Bergh, Jonas and Lidereau, Rosette and Ellis, Paul and Harris, Adrian L. and Klijn, Jan G.M. and Foekens, John A. and Cardoso, Fatima and Piccart, Martine J. and Buyse, Marc and Sotiriou, Christos},
		Date-Added = {2008-08-25 10:52:48 +0200},
		Date-Modified = {2008-11-16 09:56:48 +0100},
		Doi = {10.1158/1078-0432.CCR-06-2765},
		Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/13/11/3207.pdf},
		Journal = {Clin Cancer Res},
		Number = {11},
		Pages = {3207-3214},
		Title = {{Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series}},
		Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/11/3207},
		Volume = {13},
		Year = {2007},
		Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/13/11/3207},
		Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-06-2765}}

	@article{journe2008farnesoid,
		Author = {Fabrice Journe and Virginie Durbecq and Carole Chaboteaux and Ghislane Rouas and Benjamin Haibe-Kains and Hichame IdBoufker and Guy Laurent and Christos Sotiriou and Denis Larsimont and Jean-Jacques Body},
		Date-Added = {2008-08-25 09:58:23 +0200},
		Date-Modified = {2008-08-25 09:58:23 +0200},
		Id = {S0305-7372(08)00073-X},
		Isbn = {0305-7372},
		Journal = {Cancer treatment reviews},
		Journal1 = {Cancer treatment reviews},
		Journal2 = {Cancer Treat Rev},
		Pages = {50},
		Publisher = {Saunders},
		Title = {OC3. Farnesoid X receptor (FXR): A new marker for the prediction of bone metastases in breast cancer},
		Ty = {ABST},
		Url = {http://linkinghub.elsevier.com/retrieve/pii/S030573720800073X},
		Volume = {34},
		Year = {2008},
		Bdsk-Url-1 = {http://linkinghub.elsevier.com/retrieve/pii/S030573720800073X}}

	@conference{bontempi2005feature,
		Author = {G. Bontempi and B. Haibe-Kains},
		Booktitle = {The interface between Data Mining and Operations Research ORBEL One-day Symposium},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Feature selection methods for mining bioinformatics data},
		Year = {2005}}

	@inproceedings{desmedt2005four,
		Author = {C. Desmedt and S. M. Loi and B. Haibe-Kains and A. Soree and F. Lallemand and V. Durbecq and D. Larsimont and A. Tutt and P. Ellis and C. Gillett and K. Ryder and A. Harris and F. Cardoso and P. H. Martiat and M. Piccart and C. Sotiriou},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Pages = {S129},
		Title = {Four genes by {RT-PCR} predicts distant relapse for women given adjuvant tamoxifen},
		Volume = {94},
		Year = {2005}}

	@inproceedings{desmedt2006gene,
		Author = {C. Desmedt and E. Azambuja and A. Di Leo and D. Larsimont and V. Durbecq and D. Antoine and F. Lallemand and B. Haibe-Kains and F. Cardoso and J. M. Nogaret and D. Fontaine and F. Liebens and C. Dunhem and J. P. Kains and M. Maerevoet and V. Richard and A. Vindevoghel and S. Delaloge and M. Buyse and V. D"Hondt and M. J. Piccart and C. Sotiriou},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Pages = {S131},
		Title = {Gene expression profiling can predict pathological complete response (pCR) to anthracycline-monotherapy in estrogen-receptor (ER) negative breast cancer (BC) patients},
		Volume = {100},
		Year = {2006}}

	@inproceedings{desmedt2007gene,
		Author = {C. Desmedt and F. Andre and E. Azambuja and B. Haibe-Kains and D. Larsimont and V. {D'Hondt} and A. {Di Leo} and M. Piccart and L. Pusztai and C. Sotiriou},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {18S},
		Pages = {10564},
		Title = {Gene expression profiling can predict pathological complete response (pCR) to anthracycline-based therapy in estrogen- receptor (ER) negative breast cancer (BC) patients},
		Volume = {25},
		Year = {2007}}

	@inproceedings{desmedt2007transbig,
		Author = {C. Desmedt and F. Piette and F. Cardoso and Y. Wang and S. Loi and F. Lallemand and J. Klijn and B. Haibe-Kains and G. Viale and M. Delorenzi and Y. Zhang and M. {Saghatchian d'Assignies} and J. Bergh and R. Lidereau and P. Ellis and A. Harris and J. Foekens and M. Buyse and M. Piccart and C. Sotiriou},
		Booktitle = {European Breast Cancer Conference},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {TRANSBIG multi-centre independent validation of the Rotterdam 76-gene prognostic signature for patients with node-negative breast cancer},
		Year = {2007}}

	@article{desmedt2008biological,
		Abstract = {Purpose: Recently, several prognostic gene expression signatures have been identified; however, their performance has never been evaluated according to the previously described molecular subtypes based on the estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2), and their biological meaning has remained unclear. Here we aimed to perform a comprehensive meta-analysis integrating both clinicopathologic and gene expression data, focusing on the main molecular subtypes.  Experimental Design: We developed gene expression modules related to key biological processes in breast cancer such as tumor invasion, immune response, angiogenesis, apoptosis, proliferation, and ER and HER2 signaling, and then analyzed these modules together with clinical variables and several prognostic signatures on publicly available microarray studies (>2,100 patients).  Results: Multivariate analysis showed that in the ER+/HER2- subgroup, only the proliferation module and the histologic grade were significantly associated with clinical outcome. In the ER-/HER2- subgroup, only the immune response module was associated with prognosis, whereas in the HER2+ tumors, the tumor invasion and immune response modules displayed significant association with survival. Proliferation was identified as the most important component of several prognostic signatures, and their performance was limited to the ER+/HER2- subgroup.  Conclusions: Although proliferation is the strongest parameter predicting clinical outcome in the ER+/HER2- subtype and the common denominator of most prognostic gene signatures, immune response and tumor invasion seem to be the main molecular processes associated with prognosis in the ER-/HER2- and HER2+ subgroups, respectively. These findings may help to define new clinicogenomic models and to identify new therapeutic strategies in the specific molecular subgroups.
	},
		Author = {Desmedt, Christine and Haibe-Kains, Benjamin and Wirapati, Pratyaksha and Buyse, Marc and Larsimont, Denis and Bontempi, Gianluca and Delorenzi, Mauro and Piccart, Martine and Sotiriou, Christos},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Doi = {10.1158/1078-0432.CCR-07-4756},
		Eprint = {http://clincancerres.aacrjournals.org/cgi/reprint/14/16/5158.pdf},
		Journal = {Clin Cancer Res},
		Number = {16},
		Pages = {5158-5165},
		Title = {{Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes}},
		Url = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/16/5158},
		Volume = {14},
		Year = {2008},
		Bdsk-Url-1 = {http://clincancerres.aacrjournals.org/cgi/content/abstract/14/16/5158},
		Bdsk-Url-2 = {http://dx.doi.org/10.1158/1078-0432.CCR-07-4756}}

	@inproceedings{durbecq2007transforming,
		Author = {V. Durbecq and J. Toussaint and B. Haibe-Kains and C. Desmedt and G. Rouas and D. Larsimont and M. Buyse and G. Bontempi and M. J. Piccart and C. Sotiriou},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {18S},
		Pages = {21058},
		Title = {Transforming genomic grade index ({GGI}) into a user-friendly qRT-PCR tool which will assist clinicians and patients in optimizing treatment of early breast cancer},
		Volume = {25},
		Year = {2007}}

	@inproceedings{equeter2007cd4,
		Author = {C. Equeter and F. El Ouriaghli and B. Haibe-Kains and B. Stamatopoulos and F. Andr{\'e} and F. Lallemand and V. Filippov and D. Larsimont and C. Sotiriou and K. Willard-Gallo},
		Booktitle = {Fourth International Conference on Tumor Microenvironment (AACR)},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {CD4+ T cells infiltrating breast tumors exhibit altered expression of T cell immune response genes in comparison with their counterparts from the lymph node and blood},
		Year = {2007}}

	@mastersthesis{haibekains2003learning,
		Author = {B. Haibe-Kains},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-26 17:38:36 +0200},
		School = {Universit\'{e} Libre de Bruxelles},
		Title = {Learning a Control Task for a {LEGO} Mindstorms Mobile Robot},
		Year = {2003}}

	@mastersthesis{haibekains2004breast,
		Author = {B. Haibe-Kains},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		School = {Universit\'{e} Libre de Bruxelles},
		Title = {Breast Cancer Diagnosis Using Microarray},
		Year = {2004}}

	@mastersthesis{haibekains2005machine,
		Author = {B. Haibe-Kains},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		School = {Universit\'{e} Libre de Bruxelles},
		Title = {Use of Machine Learning in Bioinformatics to Identify Prognosis and Predictive Molecular Signatures in Human Breast Cancer},
		Year = {2005}}

	@conference{haibekains2006class,
		Author = {B. Haibe-Kains and C. Sotiriou and G. Bontempi},
		Booktitle = {OECI course program about Microarray Data Generation and Analysis},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Class Discovery and Class Prediction from Human Cancer Microarray Datasets},
		Year = {2006}}

	@conference{haibekains2007model,
		Author = {B. Haibe-Kains and C. Desmedt and C. Sotiriou and G. Bontempi},
		Booktitle = {Emerging Design and Analysis Issues in Genomic Studies in Population Sciences},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Model selection in meta-analytical framework for prototype-based clustering},
		Year = {2007}}

	@inbook{haibekains2008computational,
		Author = {B. Haibe-Kains and C. Desmedt and S. Loi and M. Delorenzi and C. Sotiriou and G. Bontempi},
		Booktitle = {Applications of Computational Intelligence in Biology},
		Chapter = {10},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Doi = {10.1007/978-3-540-78534-7},
		Editor = {T. G. Smolinski and M. M. Milanova and A. E. Hassanien},
		Isbn = {978-3-540-78533-0},
		Pages = {237-268},
		Publisher = {Springer-Verlag Berlin/Heidelberg},
		Series = {Studies in Computational Intelligence},
		Title = {Computational Intelligence in Clinical Oncology : Lessons Learned from an Analysis of a Clinical Study},
		Url = {http://www.springer.com/engineering/book/978-3-540-78533-0},
		Volume = {122},
		Year = {2008},
		Bdsk-File-1 = {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},
		Bdsk-Url-1 = {http://www.springer.com/engineering/book/978-3-540-78533-0}}

	@article{haibekains2008subtype,
		Author = {B. Haibe-Kains and C. Desmedt and C. Sotiriou and G. Bontempi},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {work in progress},
		Title = {Identification of Molecular Subtypes Improves Breast Cancer Prognostication},
		Year = {2008}}

	@conference{lacroix2003potential,
		Author = {M. Lacroix and B. Haibe-Kains and J. F. Laes and B. Hennuy and F. Cardoso and F. Lallemand and I. Gonze and G. Leclercq and M. Piccart and C. Sotiriou},
		Booktitle = {San Antonio Breast Cancer Symposium},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Potential importance of PKC-alpha activity in defining breast tumor luminal/basal phenotype.Potential importance of PKC-alpha activity in defining breast tumor luminal/basal phenotype},
		Year = {2003}}

	@article{lacroix2004gene,
		Author = {M. Lacroix and B. Haibe-Kains and J. F. Laes and B. Hennuy and F. Lallemand and I. Gonze and F. Cardoso and M. Piccart and G. Leclercq and C. Sotiriou},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Oncology Report},
		Number = {4},
		Pages = {701-707},
		Rating = {0},
		Title = {Gene Regulation by Phorbol 12-myristate 13-acetate ({PMA}) in two Highly Different Breast Cancer Cell Lines},
		Volume = {12},
		Year = {2004}}

	@inproceedings{lefranc2007orp150,
		Author = {F. Lefranc and M. {Le Mercier} and V. Mathieu and B. Haibe-Kains and G. Bontempi and T. Mijatovic and C. Decaestecker and R. Kiss},
		Booktitle = {Belgium society for cell and developmental biology autumn meeting},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {ORP150, a major target of Galectin-1 pro-angiogenic effects in human Hs683 glioblastoma xenografts},
		Year = {2007}}

	@inproceedings{lemercier2006decreasing,
		Author = {M. Le Mercier and I. Camby and V. Mathieu and P. Dumont and N. {De Neve} and I. Roland and B. Haibe-Kains and G. Bontempi and T. Mijatovic and Y. Kondo and C. Decaestecker and R. Kiss and F. Lefranc},
		Booktitle = {Belgium society for cell and developmental biology autumn meeting},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Decreasing Galectin-1 Expression in Human Hs683 Glioblastoma Cells Impairs their Response to Endoplasmic Reticulum Stress},
		Year = {2006}}

	@inproceedings{lemercier2007galectin1,
		Author = {M. {Le Mercier} and F. Lefranc and T. Mijatovic and O. Debeir and B. Haibe-Kains and G. Bontempi and C. Decaestecker and R. Kiss and V. Mathieu},
		Booktitle = {Belgium society for cell and developmental biology autumn meeting},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Galectin-1 regulates P53 and is implicated in glioma cell resistance to cytotoxic drugs},
		Year = {2007}}

	@article{lemercier2008evidence,
		Author = {M. {Le Mercier} and F. Lefranc and T. Mijatovic nd O. Debeir and B. Haibe-Kains and G. Bontempi and C. Decaestecker and R. Kiss and V. Mathieu},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Toxicology and Applied Pharmacology},
		Number = {2},
		Pages = {172-183},
		Title = {vidence of galectin-1 involvement in glioma chemoresistance},
		Volume = {229},
		Year = {2008}}

	@article{lemercier2008knocking,
		Author = {M. {Le Mercier} and V. Mathieu and B. Haibe-Kains and G. Bontempi and T. Mijatovic and C. Decaestecker and R. Kiss and F. Lefranc},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Journal of Neuropathology and Experimental Neurology},
		Number = {5},
		Pages = {356-469},
		Title = {Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses},
		Volume = {67},
		Year = {2008}}

	@inproceedings{loi2005predicting,
		Author = {S. Loi and C. Desmedt and B. Haibe-Kains and F. Lallemand and C. Gillett and A. Tutt and K. Ryder and P. Ellis and A. Harris and J. Smeds and J. Bergh and F. Cardoso and M. J. Piccart and C. Sotiriou},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Pages = {S129},
		Title = {Predicting relapse in estrogen receptor (ER) positive breast cancer (luminal) subgroups treated with adjuvant tamoxifen},
		Volume = {94},
		Year = {2005}}

	@article{loi2007expression,
		Author = {S. Loi and B. Haibe-Kains and C. Desmedt and C. Sotiriou},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Journal of Clinical Oncology},
		Month = {September},
		Number = {27},
		Pages = {4317-4318},
		Title = {Reply: Expression Profiling in Breast Carcinoma: New Insights on Old Prognostic Factors?},
		Volume = {25},
		Year = {2007}}

	@conference{loi2007identification,
		Author = {S. Loi and B. Haibe-Kains and W. A. Phillips and F. Lallemand and I. G. Campbell and M. J. Piccart and C. Sotiriou and G. A. McArthur},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Identification of potential therapeutic targets in estrogen receptor-positive breast cancer by gene expression profiling},
		Year = {2007}}

	@inproceedings{loi2007investigating,
		Author = {S. Loi and C. Sotiriou and B. Haibe-Kains and F. Lallemand and N. Conus and M. J. Piccart and T. Speed and G. A. McArthur},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {18S},
		Pages = {10603},
		Title = {Investigating tamoxifen resistance in the luminal B estrogen receptor positive breast cancer subtype: Tailoring treatment in hormone responsive breast cancer},
		Volume = {25},
		Year = {2007}}

	@article{loi2008predicting,
		Abstract = {BACKGROUND:Estrogen receptor positive (ER+) breast cancers (BC) are heterogeneous with regard to their clinical behavior and response to therapies. The ER is currently the best predictor of response to the anti-estrogen agent tamoxifen, yet up to 30-40% of ER+BC will relapse despite tamoxifen treatment. New prognostic biomarkers and further biological understanding of tamoxifen resistance are required. We used gene expression profiling to develop an outcome-based predictor using a training set of 255 ER+ BC samples from women treated with adjuvant tamoxifen monotherapy. We used clusters of highly correlated genes to develop our predictor to facilitate both signature stability and biological interpretation. Independent validation was performed using 362 tamoxifen-treated ER+ BC samples obtained from multiple institutions and treated with tamoxifen only in the adjuvant and metastatic settings.RESULTS:We developed a gene classifier consisting of 181 genes belonging to 13 biological clusters. In the independent set of adjuvantly-treated samples, it was able to define two distinct prognostic groups (HR 2.01 95%CI: 1.29-3.13; p = 0.002). Six of the 13 gene clusters represented pathways involved in cell cycle and proliferation. In 112 metastatic breast cancer patients treated with tamoxifen, one of the classifier components suggesting a cellular inflammatory mechanism was significantly predictive of response.CONCLUSION:We have developed a gene classifier that can predict clinical outcome in tamoxifen-treated ER+ BC patients. Whilst our study emphasizes the important role of proliferation genes in prognosis, our approach proposes other genes and pathways that may elucidate further mechanisms that influence clinical outcome and prediction of response to tamoxifen.},
		Author = {Loi, Sherene and Haibe-Kains, Benjamin and Desmedt, Christine and Wirapati, Pratyaksha and Lallemand, Francoise and Tutt, Andrew and Gillet, Cheryl and Ellis, Paul and Ryder, Kenneth and Reid, James and Daidone, Maria and Pierotti, Marco and Berns, Els and Jansen, Maurice and Foekens, John and Delorenzi, Mauro and Bontempi, Gianluca and Piccart, Martine and Sotiriou, Christos},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Doi = {10.1186/1471-2164-9-239},
		Issn = {1471-2164},
		Journal = {BMC Genomics},
		Number = {1},
		Pages = {239},
		Pubmedid = {18498629},
		Title = {Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen},
		Url = {http://www.biomedcentral.com/1471-2164/9/239},
		Volume = {9},
		Year = {2008},
		Bdsk-Url-1 = {http://www.biomedcentral.com/1471-2164/9/239},
		Bdsk-Url-2 = {http://dx.doi.org/10.1186/1471-2164-9-239}}

	@article{megalizzi20074ibp,
		Author = {V. Megalizzi and V. Mathieu and T. Mijatovic and P. Gailly and O. Debeir and N. De Neve and M. Van Damme and G. Bontempi and B. Haibe-Kains and C. Decaestecker and Y. Kondo and R. Kiss and F. Lefranc},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Neoplasia},
		Number = {5},
		Pages = {358-369},
		Title = {4-IBP, a sigma(1) Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of Proapoptotic and Proautophagic Drugs},
		Volume = {9},
		Year = {207}}

	@inproceedings{mijatovic2007nucleolus,
		Author = {T. Mijatovic and N. {De N{\`e}ve} and P. Gailly and V. Mathieu and B. Haibe-Kains and G. Bontempi and C. Decaestecker and V. Facchini and R. Kiss},
		Booktitle = {Belgium society for cell and developmental biology autumn meeting},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {The nucleolus, a potential target of cardenolide-mediated anti-tumor activity},
		Year = {2007}}

	@article{mijatovic2008nucleolus,
		Abstract = {The use of cardenolides like ouabain, digitoxin, or oleandrin has been reported previously many times as a means of potentially combating human refractory prostate cancer by inducing apoptosis through an increase in intracellular calcium concentrations. The aims of the current study were to investigate if part of the antitumor effects mediated by cardenolides concerned disorganization of nucleolar structure and whether this was further associated with a marked decrease in c-Myc expression. Accordingly, the antitumor activity of a novel hemisynthetic cardenolide [1R,3aS,3bR,5aS,6aR,7aS,9R,12aR,13aR,15aR]-3a,11a-dihydroxy-13a-(hydroxymethyl)-9,15a-dimethyl-1-(5-oxo-2,5-dihydrofuran-3-yl)icosahydro-1H,4'H-spiro[cyclopenta [7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxine-11,2'-[1,3]thiazolidin]-4'-one (UNBS1450)] was compared with that of classic cardenolides and reference anticancer agents in prostate cancer cell lines in vitro and in vivo following s.c. and orthotopic prostate cancer cell grafting into mice. The present study indicates that UNBS1450 markedly decreases the in vitro viability/proliferation of human prostate cancer cell lines but not of normal cells. The induced effects are not linked to an increase in intracellular calcium concentrations and subsequent induction of apoptosis. Rather, they appear to relate to the compound's capacity to disorganize nucleolar structure and function (through an impairment of cyclin-dependent kinase and c-Myc expression and related signaling pathways; paralleled by the disorganization of cancer cell-specific perinucleolar bodies as revealed by disruption of Sam68). This nonapoptotic cancer cell death mediated by severe nucleolar targeting and down-regulation of c-Myc expression is a completely new cardenolide-induced mechanism of antitumor action. [Mol Cancer Ther 2008;7(5):1285-96]
	},
		Author = {Mijatovic, Tatjana and De Neve, Nancy and Gailly, Philippe and Mathieu, Veronique and Haibe-Kains, Benjamin and Bontempi, Gianluca and Lapeira, Javier and Decaestecker, Christine and Facchini, Vincenzo and Kiss, Robert},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Doi = {10.1158/1535-7163.MCT-07-2241},
		Eprint = {http://mct.aacrjournals.org/cgi/reprint/7/5/1285.pdf},
		Journal = {Mol Cancer Ther},
		Number = {5},
		Pages = {1285-1296},
		Title = {{Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity}},
		Url = {http://mct.aacrjournals.org/cgi/content/abstract/7/5/1285},
		Volume = {7},
		Year = {2008},
		Bdsk-Url-1 = {http://mct.aacrjournals.org/cgi/content/abstract/7/5/1285},
		Bdsk-Url-2 = {http://dx.doi.org/10.1158/1535-7163.MCT-07-2241}}

	@article{mijatovic2008unbs5162,
		Author = {Tatjana Mijatovic and Tina Mahieu and Nancy De Neve and Janique Dewelle and Gentiane Simon and Mischael JM Dehoux and Ellen {van der Aar} and Benjamin {Haibe-Kains} and Gianluca Bontempi and Christine Deacestecker and Eric {Van Quaquebeke} and Francis Darro and Robert Kiss},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Journal = {Neoplasia},
		Number = {6},
		Pages = {573-586},
		Title = {UNBS5162, a Novel Naphthalimide That Decreases CXCL Chemokine Expression in Experimental Prostate Cancers},
		Volume = {10},
		Year = {2008}}

	@inproceedings{sotiriou2005better,
		Author = {C. Sotiriou and P. Wirapati and S. Loi and C. Desmedt and V. Durbecq and A. Harris and J. Bergh and J. Smeds and B. Haibe-Kains and D. Larsimont and F. Cardoso and M. Buyse and M. Delorenzi and M. Piccart},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Pages = {S19},
		Title = {Better characterization of estrogen receptor ({ER}) positive luminal subtypes using genomic grade},
		Volume = {94},
		Year = {2005}}

	@inproceedings{sotiriou2005breast,
		Author = {C. Sotiriou and P. Wirapati and S. M. Loi and C. Desmedt and V. Durbecq and A. Harris and J. Bergh and J. Smeds and B. Haibe-Kains and D. Larsimont and F. Cardoso and M. Buyse and M. Delorenzi and M. Piccart},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Pages = {S30},
		Title = {Breast tumours with intermediate histological grade can be reclassified into prognostically distinct groups by gene expression profiling},
		Volume = {94},
		Year = {2005}}

	@inproceedings{sotiriou2005geneb,
		Author = {C. Sotiriou and P. Wirapati and S. Loi and A. Harris and J. Bergh and J. Smeds and P. Farmer and V. Praz and B. Haibe-Kains and F. Lallemand and M. Buyse and M. Piccart and M. Delorenzi},
		Booktitle = {International Symposium on the Molecular Biology of Breast Cancer},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Gene Expression Profiling in Breast Cancer Challenges the Existence of Intermediate Histological Grade},
		Year = {2005}}

	@inproceedings{sotiriou2006comprehensive,
		Author = {C. Sotiriou and P. Wirapati and S. Loi and B. Haibe-Kains and C. Desmedt and A. Tutt and P. Ellis and M. Buyse and M. Delorenzi and M. Piccart},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {18S},
		Pages = {507},
		Read = {Yes},
		Title = {Comprehensive analysis integrating both clinicopathological and gene expression data in more than 1500 samples: Proliferation captured by gene expression grade index appears to be the strongest prognostic factor in breast cancer (BC)},
		Volume = {24},
		Year = {2006}}

	@inproceedings{sotiriou2006comprehensiveb,
		Author = {C. Sotiriou and B. Haibe-Kains and C. Desmedt and P. Wirapati and V. Durbecq and A. Harris and D. Larsimont and G. Bontempi and M. Buyse and M. Delorenzi and M. Piccart},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {M. E. Lippman},
		Number = {1},
		Pages = {S86},
		Publisher = {Springer Netherlands},
		Series = {Medicine},
		Title = {Comprehensive molecular analysis of several prognostic signatures using molecular indices related to hallmarks of breast cancer: proliferation index appears to be the most significant component of all signatures},
		Url = {http://www.springerlink.com/content/y81136417955451w/?p=9bf96e061a3146afb26209d61b459878&pi=11},
		Volume = {100},
		Year = {2006},
		Bdsk-Url-1 = {http://www.springerlink.com/content/y81136417955451w/?p=9bf96e061a3146afb26209d61b459878&pi=11}}

	@inproceedings{sotiriou2006is,
		Author = {C. Sotiriou and P. Wirapati and S. Loi and B. Haibe-Kains and F. Piette and M. Buyse and G. Bontempi and M. Delorenzi and M. Piccart},
		Booktitle = {European Journal of Cancer Supplements},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Number = {2},
		Pages = {177},
		Title = {Is genomic grading killing histological grading ?},
		Volume = {4},
		Year = {2006}}

	@inproceedings{sotiriou2007biological,
		Author = {C. Sotiriou and C. Desmedt and B. Haibe-Kains and A. Harris and D. Larsimont and ,M. Buyse and P. Wirapati and M. Delorenzi and G. Bontempi and M. J. Piccart},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {18S},
		Pages = {10581},
		Title = {Biological mechanisms that trigger breast cancer (BC) tumor progression are molecular subtype dependent},
		Volume = {25},
		Year = {2007}}

	@inproceedings{sotiriou2007integrative,
		Author = {C. Sotiriou and P. Wirapati and S. Kunkel and P. Farmer and S. Pradervand and Haibe-Kains B and C. Desmedt and T. Sengstag and F. Sch{\"u}tz and D. R. Goldstein and M. Delorenzi and M. Piccart},
		Booktitle = {Breast Cancer Research and Treatment},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Number = {supplement 1},
		Pages = {S56-S7},
		Title = {Meta-analysis of gene-expression profiles in breast cancer: towards a unified understanding of breast cancer sub-typing and prognosis signatures},
		Volume = {106},
		Year = {2007}}

	@inproceedings{sotiriou2007interactions,
		Author = {C. Sotiriou and F. El Ouriaghli and S. Majjaj and B. Haibe-Kains and C. Desmedt and F. Lallemand and D. Larsimont and M. Piccart},
		Booktitle = {San Antonio Breast Cancer Symposium},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Number = {poster 3092},
		Title = {Interactions between breast cancer cells and their stromal component: an analysis of alterations in gene expression},
		Year = {2007}}

	@inproceedings{sotiriou2008correlation,
		Author = {C. Sotiriou and C.Equeter and F. El Ouriaghli and B. Haibe-Kains and V. Durbecq and D. Larsimont and M. Igniatiadis and C. Desmedt and K. Willard-Gallo and M. J. Piccart},
		Booktitle = {ASCO Annual Meeting Proceedings},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Editor = {Journal of Clinical Oncology},
		Number = {11022},
		Title = {Correlation of gene expression analysis of tumor-infiltrating CD4+ cells with immune function and survival according to different breast cancer (BC) molecular subtypes},
		Volume = {20},
		Year = {2008}}

	@conference{stamatopolous2007zap70,
		Author = {B. Stamatopoulos and N. Heuleman and B. Haibe-Kains and H. Duvillier and M. Massy and P. Martiat and D. Bron and L. Lagneaux},
		Booktitle = {12th Congress of the European Hematology Association},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Number = {0111},
		Title = {Zap-70 mRNA expression quantified in B cell by real time PCR is a powerful prognostic factor in Chronic Lymphocytic Leukemia},
		Year = {2007}}

	@conference{stamatopoulos2007gene,
		Author = {B. Samatopoulos and C. Equeter and B. Haibe-Kains and A. Soree and C. Sotiriou and D. Bron and P. Martiat and L. Lagneaux},
		Booktitle = {12th Congress of the European Hematology Association},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Number = {0513},
		Title = {Gene expression comparison between B cells expressing high and low level of Zap-70 mRNA reveals distinct profiles, potential therapeutic targets and new prognostic factors for Chronic Lymphocytic Leukemia},
		Year = {2007}}

	@inproceedings{stamatopoulos2008cll,
		Author = {B. Stamatopoulos and B. Haibe-Kains and N. Meuleman and D. Bron and P. Martiat and L. Lagneaux},
		Booktitle = {13th Congress of the European Hematology Association (EHA)},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {CLL patient comparison according to Zap70 mRNA level: new prognostic factors, differences in microRNA expression and distinct interaction capacities with the microenvironment},
		Year = {2008}}

	@inproceedings{stamatopoulos2008gene,
		Author = {B. Stamatopoulos and B. Haibe-Kains and N. Meuleman and D. Bron and P. Martiat and L. Lagneaux},
		Booktitle = {6th Scientific Symposium of European Research Initiative on CLL (ERIC)},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Title = {Gene expression profiles based on ZAP70 mRNA level},
		Year = {2008}}

	@article{stamatopulos2007quantification,
		Abstract = {Background: Chronic lymphocytic leukemia (CLL) is heterogeneous with respect to prognosis and clinical outcome. The mutational status of the immunoglobulin variable heavy chain region (IGHV) has been used to classify patients into 2 groups in terms of overall survival (OS) and clinical characteristics, but the labor-intensive nature and the cost of this time-consuming analysis has prompted investigations of surrogate markers.  Methods: We developed a standardized quantitative real-time reverse transcription-PCR (qPCR) method to measure zeta-chain (TCR)-associated protein kinase (ZAP70) mRNA in purified CD19+ cells. We evaluated this and other methods (flow cytometry analyses of ZAP70 and CD38 proteins and qPCR analysis of lipoprotein lipase mRNA) in a cohort of 108 patients (median follow-up, 82 months) to evaluate any associations with IGHV mutational status, OS, and treatment-free survival (TFS).  Results: The association between qPCR-measured ZAP70 and IGHV mutational status was statistically significant [{chi}2 (1) = 50.95; P <0.0001], and the value of Cramer's V statistic (0.72) indicated a very strong relation. This method also demonstrated sensitivity, specificity, and positive and negative predictive values of 87.8%, 85.7%, 87.5%, and 86%, respectively. ZAP70 expression was significantly associated with OS (P = 0.0021) and TFS (P <0.0001). ZAP70+ patients had significantly shorter median TFS (24 months) than ZAP70- patients (157 months) (P <0.0001). Moreover, qPCR-measured ZAP70 expression has greater prognostic power than IGHV mutational status and the other prognostic markers tested.  Conclusions: ZAP70 mRNA quantification via qPCR is a strong surrogate marker of IGHV mutational status and a powerful prognostic factor.
	},
		Author = {Stamatopoulos, Basile and Meuleman, Nathalie and Haibe-Kains, Benjamin and Duvillier, Hughes and Massy, Martine and Martiat, Philippe and Bron, Dominique and Lagneaux, Laurence},
		Date-Added = {2008-08-25 09:32:54 +0200},
		Date-Modified = {2008-08-25 09:32:54 +0200},
		Doi = {10.1373/clinchem.2007.089326},
		Eprint = {http://www.clinchem.org/cgi/reprint/53/10/1757.pdf},
		Journal = {Clin Chem},
		Number = {10},
		Pages = {1757-1766},
		Title = {{Quantification of ZAP70 mRNA in B Cells by Real-Time PCR Is a Powerful Prognostic Factor in Chronic Lymphocytic Leukemia}},
		Url = {http://www.clinchem.org/cgi/content/abstract/53/10/1757},
		Volume = {53},
		Year = {2007},
		Bdsk-Url-1 = {http://www.clinchem.org/cgi/content/abstract/53/10/1757},
		Bdsk-Url-2 = {http://dx.doi.org/10.1373/clinchem.2007.089326}}

